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ABSTRACT 
 
 
 
Articular cartilage and fibrocartilage have limited abilities to self-repair following disease- or 
injury-induced degradation. With such cartilages providing the critical roles of protecting the 
osseous features of the knee joint and ensuring smooth, stable joint articulation, it is therefore 
critical that treatment modalities are created to promote the repair and/or regeneration of these 
tissues. A promising novel treatment modality comes from the potential of tissue engineered 
cartilage. While much progress has been recently made toward achieving engineered articular 
cartilage and fibrocartilage with compressive properties on par with native tissue values, their 
tensile properties still remain far behind. It is, therefore, critical that novel treatments be 
established to generate robust neotissue to address the approximately 46.4 million individuals 
affected by arthritis in the United States alone. 
Motivated by the potential of tissue engineering, this thesis had three global objectives: 1) 
to investigate novel molecular pathways toward regenerating articular cartilage in in vitro and in 
vivo experimental models of cartilage defects and osteoarthritis, 2) to develop and optimize 
treatment modalities toward engineering neocartilage of clinical applicability, and 3) to promote 
neotissue maturation and foster integration between self-assembled neocartilage and native 
tissue. Toward achieving these goals, this thesis sought to tailor the use of exogenous agents to 
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promote native articular cartilage and fibrocartilage organization in engineered tissues. To begin, 
a treatment regimen consisting of copper and hydroxylysine was utilized to enhance the collagen 
crosslink content of self-assembled neocartilage constructs. A hypoxia treatment regimen was 
also investigated with the similar goal of enhancing the crosslink content and, therefore, the 
functional properties of engineered cartilage. Given the promising correlation between increased 
collagen crosslink content and neotissue tensile properties, a more direct approach to increase 
these crosslinks was established via application of the exogenous agent lysyl oxidase (LOX) to 
further enhance neotissue functional properties.  
Other studies in this thesis focused on developing approaches for enhancing the collagen 
content and organization of the engineered tissues that, when combined with the novel collagen 
crosslinking approaches, would potentially result in mature engineered tissues capable of 
repairing cartilage defects in experimental (animal) models. Specifically, two agents known to 
modulate intracellular Ca2+ signaling (digoxin and adenosine triphosphate) were investigated as 
an alternative means to improve matrix content and biomechanical properties of neocartilage 
through promoting both collagen enhancement and collagen crosslinking. In addition, similar 
studies were focused on optimizing a treatment regimen consisting of the biophysical agent 
chondroitinase-ABC (C-ABC) and the biochemical agent transforming growth factor-β1 (TGF-
β1) to enhance the functional properties of self-assembled neofibrocartilage constructs. 
Biomechanical stimulation in the form of passive axial compressive loading was also examined 
to aid in further driving in vitro development of self-assembled neofibrocartilage in an organized, 
shape-specific manner. An additional study investigated the possibility of alternative primary cell 
sources from the ankle joint as a superior cell source for generating tissue-specific self-
assembled neocartilage for ankle joint cartilage defects. 
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Finally, this thesis investigated the potential of the exogenously applied LOX molecular 
mechanism to promote integration between neocartilage and native tissue. An initial study 
investigated the ability of LOX to promote integration between neocartilage and native articular 
cartilage. Promising results lead to combining LOX with C-ABC and TGF-β1 with the goal of 
inducing simultaneous neofibrocartilage maturation and integration. Specifically, this novel 
combination of stimuli was first applied to an in vitro model of integration, and then on an 
experimental animal model of integration to investigate the ability of the in vivo environment to 
further promote such integration.  
 Overall, the series of studies presented in this thesis represent various novel and 
potentially clinically significant molecular strategies to enhance the functional properties of a 
spectrum of collagen-rich tissues. Specifically, copper, endogenous LOX enhancement though 
hypoxia, and exogenous LOX application were all found to improve the mechanical properties of 
engineered cartilage, demonstrating the ability of enhancing collagen crosslinks to promote the 
development of mechanically robust, biomimetic neotissues. Further, agents such as digoxin, 
adenosine triphosphate, C-ABC, TGF-β1, and static weight application were all found to exhibit 
significant abilities toward promoting collagen enhancement and collagen crosslinking in 
neotissues. Finally, exogenous LOX applied alone and in combination with C-ABC and TGF-β1 
was found to foster in vitro and in vivo tissue maturation and integration, illustrating the promise 
of this novel combination of agents to promote in vivo tissue regeneration. Taken together, these 
studies provide an overview of several exciting and promising technologies to 1) increase the 
functional properties of both native and engineered tissues, and 2) to enhance their in vivo 
integration potential, highlighting the tremendous potential of such agents toward developing 
clinically robust neotissues to repair and/or replace those damaged by injury or disease. 
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INTRODUCTION – CONCEPTS IN ARTICULAR CARTILAGE 
REGENERATION: FROM CURRENT REPAIR TECHNIQUES TO FUTURE 
TISSUE-ENGINEERING APPROACHES	  	  
ABSTRACT 
Chondral and osteochondral lesions due to injury or other pathologic conditions often result in 
the development of osteoarthritis, eventually leading to progressive joint destruction. While 
current progress suggests that biologic agents can delay the advancement of such deterioration, 
they are incapable of promoting tissue restoration. The limited ability of articular cartilage to 
self-repair and regenerate renders joint arthroplasty unavoidable, creating the need for 
alternative means to treat pathologic joints. This review describes current, widely used clinical 
repair techniques for resurfacing articular cartilage defects; short- and long-term outcomes of 
these techniques are also discussed. Further, the potential of developing a biologic pipeline of 
regenerative products to achieve functional articular cartilage healing, including cell-based and 
cell-free materials, autologous and allogeneic cell-based approaches, and multipotent and 
pluripotent stem cell-based techniques, and how such techniques will undoubtedly revolutionize 
joint care over the next decade, is examined. Finally, the prominent role of tissue engineering in 
the translation of biologic technologies into clinical products with the concomitant regulatory 
processes will be explored. 
 
 
 
 
 
 
 
Chapter submitted as: Makris, E.A., Gomoll, A.H., Malizos, K.N., Hu, J.C., & Athanasiou, 
K.A. Concepts in Articular Cartilage Regeneration: From Current Repair Techniques to 
Future Tissue-engineering Approaches. In AJSM. 2014.  
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INTRODUCTION 
The management of articular cartilage defects continues to be one of the most challenging 
clinical problems for orthopedic surgeons. Articular cartilage is a highly organized tissue 
exhibiting substantial durability, yet a poor intrinsic capacity for healing; damage from trauma 
or degeneration inevitably results in morbidity and functional impairment. Given time, both 
treated and untreated lesions often lead to debilitating joint pain, dysfunction, and degenerative 
arthritis. The individual and societal burden of joint diseases such as osteoarthritis has prompted 
the development of regenerative medicine and tissue engineering solutions aimed toward 
restoring cartilage and bone. Current cartilage repair strategies include bone marrow stimulation 
techniques, as well as cell-based, cell-plus-scaffold-based, or whole-tissue transplantation 
techniques. In this review, we discuss the basic science, indications, advantages, shortcomings, 
and outcomes of cartilage regenerative interventions with the goal of providing an evidence-
based assessment for the treatment of articular cartilage pathologic conditions. Moreover, we 
discuss current and prospective tissue engineering approaches for joint repair, with an emphasis 
on the different cell types that could be used, the clinical aspects of cell administration, in vitro 
and in situ recruitment of mesenchymal stem cells (MSCs), and cell-free or factor-based 
therapies. Finally, the scientific and regulatory challenges in translating these approaches to the 
clinic are discussed. 
PRESENT REPAIR TECHNIQUES 
A. Microfracture  
Over the past few decades, the field of orthopedics has seen the development of many 
surgical approaches for treating chondral and osteochondral lesions. Leading this effort was the 
microfracture technique, developed in the late 1980s and early 1990s to treat knee cartilage 
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defects. Microfracture was further adapted for use in the ankle, shoulder, elbow, and hip. The 
premise of this procedure is to surgically induce lesions that penetrate the subchondral bone, 
allowing mesenchymal stem cells (MSCs) to migrate from the marrow to the defect site (Fig. 1). 
The environment of the cartilage defect, however, places the MSCs under numerous 
biochemical and biomechanical stimuli, causing the cells to dedifferentiate and form a 
mechanically inferior fibrocartilage-like repair tissue (1). Without the mechanical robustness of 
a hyaline tissue, the repair tissue is vulnerable to the high mechanical demands of the joint 
environment, leaving the joint susceptible to bone edema, pain, and progressive degeneration. 
Failure of this procedure is therefore eminent, with deterioration occurring approximately 23 
months post-surgery (1). As a result, microfracture is no longer considered a cartilage 
regenerative procedure and is now only used as a means to delay cartilage degeneration.  
Specific indications have been proposed for performing this technique in cartilage 
lesions (Fig. 2). When used only for treating full thickness femoral condylar defects 2 – 3 cm2 
in diameter in patients under 40 years old and with a normal body mass index, microfracture has 
been shown to effectively delay cartilage deterioration (2). However, when used to treat femoral 
condylar defects of larger sizes, patellofemoral defects of any size, patients of advanced age, or 
those presenting with abnormally high body mass indices, microfracture has proven ineffective. 
A detailed description of microfracture and its clinical outcomes are considered outside the 
scope of this regenerative-strategy focused review. A brief understanding of this technique is 
important to consider, however, as the shortcomings of microfracture ultimately spurred the 
development of procedures that aim to fully regenerate cartilage defects with hyaline-like repair 
tissue.  
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B. Autologous Chondrocyte Implantation 
The impetus to generate techniques that promote hyaline-like repair tissue in cartilage defects 
lead to the development of autologous chondrocyte implantation (ACI). This procedure, which 
is conducted via two surgeries, has become one of the most widely used techniques for articular 
cartilage regeneration. To conduct ACI, a 200-300 mg full-thickness cartilage biopsy from a 
non-weight-bearing region of the knee joint is first performed. The chondrocytes are then 
extracted from the biopsy, purified, and expanded for approximately 4 weeks to achieve 
between 15-20 million cells. Once this critical number is achieved, they are implanted directly 
into the defect site. This procedure is traditionally finalized by securing the cells under a 
periosteal flap (Fig. 3A-D). There are two major benefits of ACI: 1) Use of the patients’ own 
cells avoids the potential immune complications that might arise from implanting allogeneic 
cells or foreign materials. 2) ACI has been found to promote better clinical outcomes and 
efficacy compared to microfracture (3). Together, these benefits result in a longer lasting repair 
tissue and, thus, improved outcomes.  
Controlled prospective clinical trials have confirmed the improved clinical outcomes of 
ACI. One of the earliest reports on ACI followed 23 patients, ages 14 – 48, an average of 48 
months post-surgery. For osteochondral defects ranging from 1.6 to 6.5 cm2, biopsy results 
revealed approximately half the patients to have hyaline-like cartilage filling the defect (4). In a 
more recent prospective study in young patients (mean age 38.3 years) having a mean defect 
size of 4.9 cm2, a 5-year follow up evaluation revealed 50 – 75% improvement in WOMAC 
subscales; 92% of patients were found to function well and were therefore able to delay the 
need for joint replacement (5). Similarly, a prospective study was carried out in 126 patients 
who received ACI after a previously failed cartilage repair procedure (6). When patients were 
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assessed an average of 4 years post-ACI-surgery based on knee pain, quality of life, and overall 
health, approximately 76% were found to have overall positive clinical results. The study did 
not find any differences in outcomes when a patient had previously undergone a different 
method of articular cartilage repair treatment. This study, therefore, concluded that ACI was an 
effective means to repair cartilage defects and to improve the quality of life of patients whose 
first procedure had failed. Finally, long-term evaluation of patients treated with ACI (up to 20 
years follow-up) have demonstrated that the technique is an effective and durable solution for 
the treatment of large surface lesions of the knee joint (7). 
Whether ACI is superior to other standard treatments in prospective controlled clinical 
trials, however, still remains controversial. Superiority in terms of structural outcome was 
shown with ACI over autologous osteochondral transplantation (mosaicplasty) in a study of 100 
patients averaging 31 years in age and having defects of approximately 4.7 cm2 (8). Good-to-
excellent clinical results were found in 88% of ACI patients and 69% of mosaicplasty patients 
approximately 19 months following the respective procedure. One year later, arthroscopic 
evaluation revealed good-to-excellent repair to remain in 82% of ACI patients, while only 34% 
of those receiving mosaicplasty maintained this status. This suggests that ACI provides a better 
long-term clinical solution for treating articular cartilage defects in comparison to mosaicplasty. 
In a separate study, 46 patients having lesions greater than 2 cm2 received either ACI or 
microfracture surgery. While patients receiving microfracture had a mean Cincinnati score of 
1.3 follow surgery, patients receiving ACI had a significantly greater score of 3.1 (9). It should 
be noted, though, that the microfracture outcomes reported in this study were considerably 
inferior to those described in other reports (10). In a more recent study, 118 patients were 
assessed at 12 and 18 months following either ACI or microfracture (11). Clinical outcomes 
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were similar in both groups, although ACI was associated with increased structural repair. At 5 
years, clinical outcomes were again comparable. However, at this time point, ACI was found to 
be statistically more effective in a subgroup of patients who had undergone the procedures close 
to presentation of symptoms (12). Finally, a systematic review of the literature found cartilage 
repair in the knee with microfracture, ACI, or osteochondral autograft to provide only short-
term success (13).  
 In spite of the clinical efficacy and benefits achieved with ACI, there are two major 
drawbacks to this procedure: 1) the necessity to undergo two operations, and 2) the long 
recovery time required to ensure proper maturation of the repair tissue. An additional 
disadvantage of ACI is the tediousness of this procedure. The surgery itself is highly invasive, 
requiring an open procedure to access the joint space, which leaves the patient susceptible to 
potential arthrofibrosis and joint stiffness. Further, harvesting of the periosteal patch 
necessitates an additional incision, leading to the possibility of donor site morbidity, infections 
and additional post-operative pain. In terms of the implantation itself, the most frequently 
reported adverse effect is hypertrophy of the periosteal flap. In a report of 52 adverse events 
following ACI in 101 patients, 26 were found to have hypertrophy of the periosteum, while 7 
had complete graft failure (14). To bypass the potential for hypertrophy, the use of porcine 
collagen I/III matrix as a substitute for periosteal grafts has been presented as an alternative. 
Finally, in terms of articular cartilage phenotype during expansion, a few reports have described 
dedifferentiation of the primary cells into fibrochondrocytes (15). Overall, these inherent 
drawbacks are likely responsible for the inconsistent and irreproducible outcomes of ACI seen 
in the literature (16). 
To standardize clinical outcomes of ACI, patient-specific and defect-specific factors 
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have been established to generate a treatment algorithm that limits the likelihood of adverse 
effects from this procedure (Fig. 2). For instance, ACI should only be considered in patients 
presenting with either trochlear or patellar lesions and only once rehabilitation has failed. 
Further, in determining the likelihood of success using ACI, surgeons must consider defect size 
and location, patient body mass index, expectations, and whether the patient has had any 
previous treatments for this particular defect. ACI has been found to work best for treating 
medium to large, full-thickness, focal, single or multiple articular cartilage defects. It is also 
important that the rim of the lesion is intact to best support the sutures used to secure the 
periosteal or scaffold flap. Furthermore, patients selected for ACI must be capable of following 
time consuming, tedious rehabilitation regimens and be free of a recent history of inflammatory 
arthritis or infection. Overall, while adverse events associated with ACI can be unfavorable and 
require the patient to undergo additional repair surgery, the frequency of such outcomes is quite 
low compared to other cartilage repair techniques. Therefore, when used within the appropriate 
indications, ACI remains as one of the most promising repair strategies for patients suffering 
from cartilage defects. 
 
C. Scaffold-based approaches in clinical practice 
In addition to the challenges examined above, the lack of a supportive scaffolding 
material to guide matrix synthesis and organization may, in part, account for the observed 
outcome variability across patient populations, as seen in the literature. Successful cartilage 
regeneration is dependent upon both autologous chondrocyte proliferation rate and 
differentiation capacity; use of a tissue-engineered, three-dimensional (3D) matrix as a cell 
carrier has been shown to maintain and support these crucial cellular characteristics (17). 
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Efforts, therefore, have focused on development of scaffold-based mechanisms for delivering 
autologous chondrocytes to the defect site, introducing the second generation of ACI. The major 
advantages of scaffold-based approaches include: 1) increased control over filling the defect 
site, 2) decreased donor site morbidity 3) a less technical surgical procedure, and 4) decreased 
recovery time post-surgery due to increased graft stability. Additionally, because the 
chondrocytes are cultured in a 3D environment, they are less prone to dedifferentiation and 
therefore better retain the ability to produce a more hyaline-like repair cartilage (18). Further, in 
vitro culture prior to implantation may help to maintain quality control of scaffold-based repair 
strategies.  
 There are several important aspects to be considered when designing a suitable scaffold 
for repairing cartilage defects. The ideal articular cartilage scaffold will excel in three criteria: 
bioactivity, mechanics, and logistics. First, the scaffolding or matrix material must be both 
biocompatible and biodegradable so that it degrades safely in accordance with healing time. It is 
also important that the material promotes even distribution of the cells to encourage uniform 
deposition of neomatrix fill. Important bioactive aspects include that the scaffold maintains cell 
phenotype, induces ECM synthesis, lacks immunogenicity, and promotes tissue integration. 
Since heterogeneous loading of articular cartilage occurs in vivo on a daily basis, the implanted 
material must impart the appropriate mechanical properties, tissue anisotropy, geometry, and 
lubrication characteristics to function properly immediately upon implantation (19). Finally, the 
logistics of a successful scaffolding or supportive matrix material must not be unwieldy: supply, 
processability, and surgical implantation practicality must all be considered. 
 
C.1. Matrix-assisted Chondrocyte Implantation 
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The most common technique currently in clinical practice for scaffold-plus-cell based therapy is 
known as matrix-associated chondrocyte implantation (MACI). Similar to ACI, MACI 
comprises two surgical procedures: The first surgery is conducted to retrieve the autologous 
tissue from which the patient’s chondrocytes are isolated. Once isolated, the cells are expanded 
in vitro to achieve the desired number and then seeded on an absorbable porcine-derived 
collagen type I/II 3D matrix for 3 days prior to implantation. These matrices are specifically 
engineered to have a looser fiber arrangement on one side to promote chondrocyte infiltration 
and attachment, and a denser, smoother side to facilitate low-friction lubrication. Upon 
receiving the cell-seeded scaffold, a mini-arthrotomy is performed to expose and debride the 
lesion, after which the matrix is implanted and secured using fibrin glue such that the cell-laden 
side faces the subchondral bone and the low-friction surface faces into the joint cavity (Fig. 3A-
B,E-F).  
 The benefits of MACI are best represented through clinical findings. In a prospective 
study, 21 patients having symptomatic, traumatic articular cartilage defects of the knee (>2cm2) 
and presented without knee instability or malalignment, were treated with MACI implants fixed 
in place with fibrin glue (20). Five years post-surgery, most patients treated with the implants 
demonstrated significant clinical and radiological outcomes and good quality of repair tissue. 
Thus, the study concluded MACI to be a safe and effective treatment for symptomatic, 
traumatic chondral knee defects. In a separate preliminary clinical report, 35 patients presenting 
with defects averaging 4 cm2 and treated with MACI were followed for at least 6 months post-
surgery (21). Using both subjective parameters and objective outcomes, MACI was concluded 
to produce a hyaline-like repair cartilage that relieved pain and restored knee function. To assess 
chondrocyte phenotype after being implanted on collagen type I/III scaffolds, histological 
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analysis was performed over the course of 6 months in 56 patients receiving MACI (22). 
Results found chondrocytes to maintain a spherical-like morphology, reminiscent of native 
tissue cell morphology. Further, the cells were found to express several chondrogenic markers, 
including aggrecan and collagen type II. Overall, following 6 months of implantation, 75% of 
the implants resulted in the development of a hyaline-like cartilage within the defect site.  
While clinical results of MACI are extremely promising, it is important to note that the 
majority of the reports are on case studies. One of the few prospective randomized clinical trials 
conducted thus far to assess MACI evaluated 91 patients presenting with symptomatic chondral 
defects (23). Patients were treated with either ACI or MACI and evaluated 1-year post-surgery. 
No significant differences were found between the main clinical scores in MACI-treated 
patients and ACI-treated patients at the 1-year time point. Further, arthroscopic evaluation at 1 
year found hyaline-like repair cartilage to be equally prevalent in approximately 40% of patients 
following either surgery. In a separate randomized controlled trial 21 patients presenting with 
full thickness cartilage defects averaging 4.1 cm2 received either ACI or MACI. Although both 
Lysholm and Gillquist scores and MRI results initially favored ACI, no differences in any of the 
outcomes between the two techniques were observed by the 12- and 24-month time points. 
Further, while a few patients from each procedural group suffered from adverse effects, 
including transplant delamination, osteochondral dissection, and transplant hypertrophy, the 
majority of patients remained adverse-free (24). Overall, both studies found MACI and ACI to 
have similar, mainly positive outcomes.  
Recently, a method used to fill deep cartilage defects, called the “sandwich” MACI 
technique, has been developed. This technique is performed by first securing one cell-seeded 
membrane into the base of the defect with fibrin glue such that the side seeded with cells faces 
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up. A second cell-seeded membrane is then secured into place via fibrin glue to the surrounding 
articular cartilage, this time with the cell-seeded side facing down into the defect. This method 
was used in 5 patients having defects greater than 8 mm in depth, with improvements in both 
the Cincinnati knee and Stanmore functional rating 6 months following surgery (25). One year 
post-surgery, 4 of the patients received arthroscopy, showing a well-formed repair tissue. The 
ability of the “sandwich” technique to fill deep cartilage defects further encourages future 
studies to investigate the true potential of MACI.  
 
C.2. Hyaluronan-Based Scaffolds 
Another means recently being explored to introduce chondrocytes within 3D, biodegradable 
environments is via hyaluronan-based scaffolds. These scaffolds contain fibers 20 mm thick in 
diameter, having interstices of varying sizes. Similar to porcine collagen derived matrices, 
hyaluronan-based scaffolds provide an environment intended to maintain the chondrocytic 
phenotype and genotype during in vitro culture, as well as to provide structural support for the 
cells following implantation. An added advantage of this material is that its degradation rate can 
be precisely tailored to match the rate of the cell-induced matrix to aid in integration with the 
defect site (26).  
 Delivering autologous chondrocytes on hyaluronan-based scaffolds has displayed much 
promise as a method for treating cartilage defects, with accounts of a hyaline-like cartilage 
developing approximately 1 year post-implantation. For instance, in a case series, hyaluronan-
based MACI was used to treat 32 patellofemoral chondral lesions averaging 4.7 cm2 in size 
(27). Cell-seeded scaffolds were implanted either arthroscopically or via mini-arthrotomy 
following debridement of the defect site. ICRS-IKDC scoring was found to improve 
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dramatically in all patients at both a 1- and 2-year time point, while MRI at the later time point 
showed complete filling of the defects with signals very similar to that of native articular 
cartilage in 71% of patients. Patients were also reported to have positive clinical outcomes at the 
2-year assessment, with arthroscopy revealing a hyaline-like histology in 6 of the patients. In a 
cohort study, 41 professional or semi-professional male soccer players were treated surgically 
and evaluated prospectively at 2 years and again at a minimum of 4 years post-surgery (28). Of 
these patients, 21 were treated arthroscopically using a hyaluronan-based MACI technique, 
while the remaining 20 received microfracture surgery. In both groups, patients were found to 
have significantly improved clinical scores by the final follow-up time point, with nearly 80% 
of patients receiving microfracture and 86% receiving hyaluronan-based MACI to return to 
competition. Players who had microfracture required at least 8 months of recover prior to 
returning to the field, while those receiving MACI required 12.5 months. 
Recently, a multicenter study evaluated patients receiving autologous chondrocyte 
seeded hyaluronan-based scaffolds an average of 38 months following implantation (29). Of the 
141 patients, results found 96% to have normal or near-normal physician evaluations, while 
92% had enhanced IKDC scores. In a separate study, patients receiving either hyaluronan-based 
MACI or microfracture repair techniques were compared 5 years post-respective surgery. 
Results found those having the hyaluronan-based scaffold implantations to have overall higher 
IKDC objective and subjective scores than those undergoing microfracture, although both 
groups did have significantly higher IKDC scores compared to their pre-surgical conditions. 
Such promising results likewise merits future research on the potential of hyaluronan-based 
MACI techniques. Overall, in spite of the demonstrated potential of MACI, such techniques are 
only thus far approved in Europe; FDA approval is currently pending in the USA. 
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 While the clinical outcomes of MACI have been shown to be similar to ACI, there are 
several important technical considerations that use of a matrix helps to solve. For instance, due 
to the ease of implantation when using a scaffold cell carrier as opposed to that of traditional 
ACI, MACI has been found to be less technically demanding and to reduce surgery time by 
approximately 19.2 minutes (30). Further, MACI, which can be performed using minimally 
invasive procedures, avoids the need for a periosteal harvest, thus avoiding the possibility of 
donor site morbidity and graft hypertrophy. While use of a 3D scaffold does suggest a more 
supportive environment that promotes cellular adhesion, proliferation, and development of a 
more hyaline-like cartilage, quantitative assessments have yet to prove such assumptions. 
Likewise, whether MACI decreases the likelihood of graft delamination or dislocation has yet to 
be fully explored.  
 
FUTURE REGENERATIVE APPROACHES  
A. Ex Vivo Engineered Tissue Using Autologous Chondrocytes  
Aside from the technical advantages of MACI, studies thus far have revealed clinical outcomes 
of this method to be very similar to those of ACI. A plausible explanation is that following 
chondrocyte expansion, the collagen matrices are implanted into the patient within 3 days of 
cell seeding, leaving the neotissue implant in an immature, and therefore, vulnerable form. To 
improve the efficacy of such tissue engineered procedures, novel approaches are under 
development in which autologous chondrocytes are introduced to a 3D matrix and cultured in 
vitro for longer periods, typically around 4 – 6 weeks. During this time, chondrocytes induced 
by external stimuli produce their own ECM components within the 3D environment, resulting in 
an implant with biochemical and, subsequently, functional integrity closer to that of native 
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articular cartilage prior to implantation. Surgical techniques similar to those established for 
MACI are used to both obtain the autologous tissue and perform the implantation. Overall, the 
enhanced mechanical robustness following ex vivo 3D culture renders implants better suited to 
the joint environment, and may improve overall patient outcomes.  
 While in vitro culture of 3D matrices seeded with autologous chondrocytes may result in 
more robust chondral implants, time alone is not enough to promote sufficient maturation of the 
implants. Thus, researchers have sought out exogenous stimuli representing those chondrocytes 
typically face in vivo to promote mechanically robust implants. Coming from a complex, highly 
loaded environment, chondrocytes are extremely responsive to mechanical stimulation; in the 
body, these cells can experience loads approximately six times body weight (31). Exogenous 
mechanical stimulation has been introduced to cell-laden matrices in the form of either 
hydrostatic pressure (32) or dynamic compression supplemented with the growth-factors, such 
as TGF–β3 (33, 34). Such stimulation aids in maintaining the native chondrocyte phenotype 
and, thus, promotes the development of implants donning structure-function relationships closer 
to those of native articular cartilage. Overall, implants formed using such stimulation have been 
shown to develop more hyaline-like properties compared to those formed in the absence of such 
stimulation (32-34).  
 There are only a few clinical reports currently available on the outcomes of using 
autologous chondrocyte-laden, tissue engineered scaffolds subjected to in vitro culture. One 
such study reports the results of an FDA phase I clinical trial on 8 patients receiving tissue-
engineered collagen type I scaffolds seeded with autologous chondrocytes (35). These cell-
seeded scaffolds were subjected to hydrostatic pressure for several weeks via a bioreactor prior 
to implantation. Results found patients to have decreased pain scores in as little as 12 months 
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post-surgery. At the 1-year time point, 7 of 8 patients were found to have almost fully or 
completely filled defects, and remained as such in 6 patients 2 years following surgery. Further, 
this study found no adverse responses to the treatment, and that the defects filled with a mature 
and organized repair tissue. Based on these promising results, a phase II clinical trial was 
conducted comparing the use of autologous chondrocyte-seeded tissue-engineered collagen type 
I scaffolds to microfracture (36). Overall, this phase II trial found the cell-seeded scaffold to 
have similar outcomes to microfracture, with greater clinical efficacy 2 years post-implantation.  
 
B. Alternative cell sources 
Thus far, current cell-based clinical practices for treating articular cartilage defects and 
degeneration only utilize autologous chondrocytes. In spite of efforts to try and more closely 
recapitulate the in vivo environment through 3D culture systems, bioreactors, and exogenous 
mechanical and biochemical stimulation, a repair tissue achieving native hyaline cartilage 
properties prior to implantation remains elusive. Thus, in an effort to avoid the many drawbacks 
associated with autologous chondrocytes, methods are currently being developed around the use 
of stem cells, many of which are currently in queue for FDA approval to proceed with clinical 
studies.  
 
B.1. Bone marrow MSCs 
Of the various types of stem cells found in the body, bone marrow-derived mesenchymal stem 
cells (bMSCs) offer many advantages. First, they are comparatively easy to both isolate and 
expand, allowing the potential to obtain bMSCs from allogeneic donors and store them in 
readily available cell banks. Further, extensive work has found bMSCs capable of 
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differentiating into both cartilage and bone, meriting their use for regeneration of both 
osteochondral and chondral defects (37, 38). Another beneficial trait of bMSCs is their ability to 
selectively migrate toward diseased tissues and organs, where they have been found to secrete 
immunosuppressive mediators for T cells (39). Thus, in the case of articular cartilage repair, use 
of bMSCs may provide a more targeted repair system that releases factors of interest directly 
into chondral lesions (40). Through promoting a more regenerative environment, bMSCs may 
also encourage the patient’s own stem cells to enter the defect and aid in the regeneration of the 
damaged tissue. 
 Preliminary studies utilizing bMSCs have been conducted in humans. In one such study, 
the knee joints of 4 osteoarthritis-afflicted patients were injected with bMSCs; 1 year after 
injection, the patients were found to have decreased pain and improved joint mobility without 
any noticeable side effects (41). In a larger scale study, 72 patients presenting with cartilaginous 
lesions were treated with either ACI or injected with bMSCs. The stem cells, which were found 
to treat the chondral defects as effectively as ACI, were associated with comparatively lower 
costs while avoiding the risk of donor site morbidity (42). The reported favorable outcomes of 
cartilage healing and regeneration with direct injection of bMSCs into affected knee joints, 
however, lacks the benefit of tissue engineering-based approaches. Thus, MACI-based 
strategies have been developed to employ stem cells. Thus far, three case studies have been 
conducted using bMSC-seeded collagen scaffolds (43-45). A separate study found bMSCs 
derived from patients with advanced osteoarthritis to respond well to ex vivo culture, and in the 
presence of transforming growth factor-β1, to maintain a chondrocytic phenotype. Further, re-
implantation of these cells using MACI techniques resulted in the regeneration of a hyaline-like 
cartilage (46, 47). The positive outcomes of these studies have shed light onto the tremendous 
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potential of bMSCs for cartilage repair. While it remains to be seen how bMSC-based 
techniques compare to more established procedures via controlled studies, further investigation 
of the use of bMSCs isolated from healthy allogeneic donors is necessary to enhance the 
cartilage forming potential of these cells, as well as to better understand the clinical feasibility 
of this cell source.  
 
B.2. Other MSC sources 
Thus far, most work concerning the use of MSCs has been carried out on those of the bone 
marrow lineage, as the characteristics of these cells are best known among MSCs. Furthermore, 
aspiration methods for obtaining bMSCs, although painful, are well known, making it easy to 
retrieve these cells from either allogeneic or autologous sources. However, there are several 
other sources from which stem cells can be derived, including adipose tissue, muscle, 
synovium, periosteum, and umbilical cord (48). Of these other sources, stem cells derived from 
adipose tissue are readily accessible and have been shown to have similar proliferative profiles 
and differentiation capacities to those of bMSCs (49, 50). An advantage of adipose derived stem 
cells over bMSCs is their ability to be isolated in comparatively large quantities (51). Both in 
vitro and in vivo work has shown stem cells derived from synovial tissue, on the other hand, to 
have a marked chondrogenic potential over other sources (52, 53). Further work with MSCs 
derived from sources other than bone marrow will answer the many questions concerning the 
clinical applicability of these cells.   
 
B.3. Pluripotent stem cells 
An additional means for obtaining clinically relevant cells comes from the promise of induced 
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pluripotent stem cells (iPSCs). These recently discovered cells have been shown to be capable 
of differentiating into both cartilage and bone, and have been speculated to be the precursor 
cells to those comprising adult joint tissues (54). Chondrogenically differentiated iPSCs derived 
from adult mouse fibroblasts were used in an in vitro cartilage defect model with promising 
results, indicating the potential of iPSC-derived cells to contribute to cartilage regeneration (55). 
In a separate study, iPSCs derived from synovial fibroblasts of patients presenting with 
advanced osteoarthritis have been used to generate MSCs, chondrocytes, and osteoblasts (56). 
In spite of the promising results observed thus far with this autologous cell source, several 
questions remain to be answered, including: 1) the use of viral vectors in forming iPSCs, 2) the 
best practices to differentiate these cells ex vivo, 3) the potential of teratoma formation in vivo, 
and 4) the status of iPSCs with regulatory agencies. Although much remains to be understood, 
the enormous potential of iPSCs for treating cartilage degeneration merits future studies to find 
answers to these underlying uncertainties.  
 
C. Novel cell-free biomaterials 
While autologous chondrocytes and MSC-based cell techniques offer much promise for 
articular cartilage repair, methods for extracting, expanding, and differentiating cells are both 
timely and costly. Further, because MACI- and hyaluronan scaffold-based techniques contain 
cells, they may be considered both a medical device and biologic from the FDA’s perspective, 
resulting in long and costly regulatory approval processes. Products that do not contain cells, 
therefore, intend to offer advantages to those that contain cells. Recent research has thus begun 
to consider cell-free material-based products for cartilage regeneration and repair.  
One example of a cell-free method is autologous matrix-induced chondrogenesis 
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(AMIC), a technique that can be performed in a single surgery. To perform AMIC, a mini-
arthrotomy is first used to expose and clean the defect site. Next, microfracture is employed to 
release both blood and bone marrow containing MSCs, followed by suturing or gluing of a 
collagen I/III matrix into the defect site (57). The implanted collagen matrix may stabilize the 
resulting blood clot, helping to promote early mechanical stability and aid in cartilage 
regeneration. Studies have found AMIC to be both safe and effective in treating full-thickness 
cartilage defects (58), with comparable outcomes to ACI, MACI, and microfracture in terms of 
pain relief, restoration of joint functionality, and cartilage regeneration (59). For instance, one 
study used AMIC to treat localized full-thickness cartilage defects averaging 4.2 cm2 in 
diameter in 27 patients. Patients were followed for up to 5 years post-surgery, with significant 
improvements in Tegner, Lysholm, ICRS, and Cincinnati scores as early as 12 months post-
surgery. Further, MRI results revealed moderate to complete filling of all chondral defects (60). 
Interestingly, unlike microfracture, ACI, or MACI, results with AMIC did not find a correlation 
between clinical outcomes and a patient's age, body mass index, or number of previous 
operations. The simplicity and cost-effectiveness of this procedure, therefore, merits more work 
in terms of identifying the quality of neocartilage formation, the repeatability of the technique, 
and potential pitfalls, in order to fully understand its potential impact.  
 
C.1. Active in situ approaches 
A novel approach to enhance AMIC is to deliver factors known to selectively recruit and 
stimulate MSCs from the subchondral bone marrow within cell-free materials. The goal of this 
technique is to further enhance cartilage formation in the defect site. Such factors can be 
tailored to also activate chondrocytes in the surrounding, healthy tissue to aid in the remodeling 
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of the repair tissue filling the defect site. Through such a combination, these materials 
specifically target the area most in need of cartilage repair and regeneration.  
 As a strategy for active in situ AMIC, one study investigated the effects of implanting 
polyglycolic acid polymer-based materials combined with autologous serum or platelet-rich 
plasma (PRP) and hyaluronic acid following initial microfracture of the defect (61). This 
particular approach is novel in its use of autologous serum or PRP, as these agents have been 
found to recruit bMSCs from the underlying subchondral bone, while hyaluronic acid may help 
the bMSCs differentiate toward a chondrogenic phenotype. A prospective study using this 
approach found 52 patients receiving the treatment to have improved KOOS scores 1 year 
following surgery. Histological evaluation of the repair cartilage from the same patient 
population identified the defects to fill with a hyaline-like repair tissue (62).   
 While active in situ regeneration in combination with AMIC offers much promise as a 
clinical treatment for cartilage degeneration, knowledge of factors that both recruit and 
stimulate MSCs must be enhanced before such methods will be clinically applicable. For 
example, factors known to effect MSC recruitment, which include bone morphogenetic 
proteins, whole blood serum, chemokines, and PRP, do so in dose-dependent and tissue-specific 
manners (63). Thus, different active agents may need to be used depending on a patient’s 
condition as well as the location of the defect. Growth factors, such as those belonging to the 
TGF-β and fibroblast growth factor families, have also been shown to aid in the development of 
robust cartilage repair tissue (64). Methods are therefore being developed that combine both 
growth factors and active agents to further enhance cartilage regeneration. To do so effectively, 
such systems are being tailored to release the agents, which are typically secured to the surface 
of matrices or included within nanoparticles, in a controlled manner.  
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D. Scaffoldless Approaches 
While several tissue-engineering approaches for cartilage repair forgo the use of either cells or 
exogenous stimulation, another option more recently being explored is to omit the use of 
scaffolds. Without a scaffold to interrupt cell-cell signaling and stress shielding, the resulting 
neotissue may have a more bioactive microenvironment, which may enhance its ability to both 
respond to stimuli and integrate with surrounding tissue upon implantation. Studies have found 
subjecting scaffold-free articular cartilage to various exogenous stimuli, including biochemical, 
biophysical, and biomechanical stimulation, to promote the development of robust neotissue 
with functional properties approaching those of native cartilage (65, 66). Such work has also 
found the scaffold-free neotissue capable of both integration and in vivo maturation (67-71). 
Studies comparing scaffold-free to scaffold-based techniques have found scaffoldless neotissue 
to have greater mechanical properties and higher ECM content (72, 73). Thus, scaffold-free 
neotissue presents as a promising new avenue for generating highly bioactive implants to 
enhance cartilage repair.  
 There are currently two scaffold-free technologies for articular cartilage regeneration 
undergoing clinical trials. The first technology is based on generating spheroids of autologous 
chondrocytes for implantation. In an animal study, the chondrospheres were able to adhere and 
integrate with full-thickness cartilage defects and produce a cartilaginous ECM (74). This 
process is currently in a phase I clinical trial. The second scaffold-free technology utilizes 
juvenile allogeneic chondrocytes; pre-clinical studies found the cells to have a significantly 
stronger and more stable chondrogenic activity in vitro, and to avoid any immunologic 
responses in vivo (75). The resulting graft, which is implanted in a single step procedure, has 
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been found to form hyaline-like tissue upon implantation (76). This technology is currently in 
phase III clinical trials.  
 
CONCLUSIONS 
This review focused on the basic science, indications, advantages, disadvantages, and outcomes 
of current and future cartilage regenerative strategies. An emphasis was placed on tissue 
engineering approaches as such techniques are forming the basis for the next generation of 
novel cartilage regeneration technologies. Specifically, tissue-engineering aims to develop 
biomimetic tissues that recapitulate the biological, structural, and functional features of native 
tissue, increasing the ability of implants to withstand and adapt to the highly loaded 
environment of the knee. Such strategies are targeted to not only stop the progression of 
cartilage degeneration, but to restore a patient’s joint back to its original state. These novel 
biomimetic solutions will help to diminish the currently overwhelming proportion of individuals 
facing cartilage pathologies, and equally importantly, the tremendous healthcare costs.  
 In spite of the many efforts outlined above, the generation of truly biomimetic chondral 
and osteochondral replacements still remains elusive; however, technology development is 
occurring rapidly from many different directions (Fig. 4). For instance, tissue engineering 
approaches using a variety of cell sources, including autologous, allogeneic, xenogeneic, and 
stem cell approaches, have yielded repair tissues having hyaline-like characteristics, annulling 
patient pain, and delaying the process of degenerative pathologies such as osteoarthritis. While 
a gold standard cell source has yet to be identified, stem cells do stand out among the rest in 
terms of their availability and minimization or complete lack of donor site morbidity. Further, 
the combination of tissue engineering technologies with both biochemical and biomechanical 
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exogenous stimulation has resulted in repair tissues displaying even greater hyaline-like 
properties. Other promise has been seen in the absence of cells all together, via tissue 
engineered, cell-free scaffolds, as well as via cell-based, scaffold-free approaches.  
 Overall, a technology has yet to be developed that satisfies all of the fundamental 
requirements of a successful chondral defect; namely, one which embodies the appropriate 
structure-function relationships, ECM organization, bioactivity, and surgical logistics. To 
address these success criteria, work must be conducted to improve not only the mechanical 
properties of the tissue, but to shape and organize their development in a way that better mimics 
native morphogenesis. Further, an emphasis must be placed on the degradation characteristics of 
scaffold-based approaches to ensure degradation rates match tissue regeneration. In cell-based 
applications, a thorough understanding of how to maintain the chondrocytic phenotypic of 
autologous and allogeneic chondrocytes, and how to foster complete chondrogenic 
differentiation of stem cells, must be established. Once technologies are able to capture all of 
the necessary success criteria, stringent manufacturing methods that ensure reproducibility of 
the resulting implants and functional clinical outcomes in humans will need to be developed. 
Further, standardization of the approval process should be attempted and streamlined across 
countries, as current practices in Europe allow faster translation of promising technologies than 
does the FDA, hindering progress in the US.  
 Crucial to all of these endeavors is to develop better chondral defect animal models for 
in vivo testing prior to implanting technologies into patients in well-designed prospective, 
randomized, and controlled clinical trials. Further, it is important that such clinical studies 
compare novel technologies to current “gold standard” clinical approaches. The resulting repair 
tissue must also be subjected to rigorous biochemical and biomechanical evaluation to 
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specifically determine how close the regenerative tissue is to native tissue. Further, what 
quantifies a robust, hyaline-like repair tissue, and what threshold of such quantifiable 
characteristics is necessary for successful clinical outcomes, must be clearly determined. Use of 
non-invasive, quantitative measures both pre- and post-surgery is also important for determining 
long-term clinical outcomes of such trials. Such information will be especially critical to 
determining which technologies result in the best outcomes: those that result in repair tissue that 
truly captures the structure-function relationships of native, healthy cartilage. Equally 
important, measures should be taken to determine the appropriate indications, contradictions, 
patient selection criteria, and surgical practices for each technology developed. The idea of 
minimizing health care costs must be also importantly considered. All in all, the idea of 
biomimetic cartilage regenerative therapies are the focus of novel techniques, and while much 
work remains, we are closer than ever to making such a concept a clinical reality. 	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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.1 – OVERVIEW OF THE MICROFRACTURE TECHNIQUE. A) Full-thickness focal 
chondral lesion. B) Debridment of the lesion to ensure healthy, stable margins for integration of 
the fill tissue. C) Removal of the calcified zone of articular cartilage to promote clot adhesion. 
D) Channels created using a 45° awl, spaced 3-4 mm apart, and made deep enough to penetrate 
the subchondral marrow.  
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FIGURE 1.2 – ALGORITHM FOR TREATING FOCAL CHONDRAL LESIONS. Once it has been 
established that rehabilitation is not a viable option for a patient, the surgeon should assess both 
the size and location of the defect, determine whether the patient desires a more active (high 
demand) or sedintary (low demand) lifestyle, and find out if the patient has sought previous 
treatment. Answers to such questions will aid as a guide toward performing the  appropriate 
surgical procedure for a given patient. The asterix indicates the best treatment option for a given 
situation. 
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FIGURE 1.3 – OVERVIEW OF ACI AND MACI TECHNIQUES. A) Full-thickness focal chondral 
lesion. B) Debridment of the lesion to ensure healthy, stable margins for integration of the fill 
tissue. C) Drided lesion is covered with a periostal flap or collagen type I/III membrane, and 
filled with expanded autologous chondrocytes for ACI. D) Arthroscopic photograph of ACI-
induced neocartilage. 
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FIGURE 1.4 – SCHEMATIC REPRESENTATION OF THE TISSUE ENGINEERING PARADIGM. Figure 
is tailored to the specific tissue engineering approaches discussed in this review. The paradigm 
shows that cells, signals, and scaffolds are the major elements of tissue engineering approaches, 
which may be used either alone or in combination. 
 
 
 
 
  
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  29 
CHAPTER 1 – THE KNEE MENISCUS: STRUCTURE-FUNCTION, 
PATHOPHYSIOLOGY, CURRENT REPAIR TECHNIQUES, AND 
PROSPECTS FOR REGENERATION 
 
ABSTRACT  
Extensive scientific investigations in recent decades have established the anatomical, 
biomechanical, and functional importance that the meniscus holds within the knee joint. As a 
vital part of the joint, it acts to prevent the deterioration and degeneration of articular cartilage, 
and the onset and development of osteoarthritis. For this reason, research into meniscus repair 
has been the recipient of particular interest from the orthopedic and bioengineering 
communities. Current repair techniques are only effective in treating lesions located in the 
peripheral vascularized region of the meniscus. Healing lesions found in the inner avascular 
region, which functions under a highly demanding mechanical environment, is considered to be 
a significant challenge. An adequate treatment approach has yet to be established, though many 
attempts have been undertaken. The current primary method for treatment is partial 
meniscectomy, which commonly results in the progressive development of osteoarthritis. This 
drawback has shifted research interest towards the fields of biomaterials and bioengineering, 
where it is hoped that meniscal deterioration can be tackled with the help of tissue engineering. 
So far, different approaches and strategies have contributed to the in vitro generation of 
meniscus constructs, which are capable of restoring meniscal lesions to some extent, both 
functionally as well as anatomically. The selection of the appropriate cell source (autologous, 
allogeneic, or xenogeneic  
Chapter submitted as: Makris, E.A., Hadidi, H., & Athanasiou, K.A. The knee meniscus: 
Structure–function, pathophysiology, current repair techniques, and prospects for regeneration. 
In Biomaterials. 32(30): 7411-7431, 2011 
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cells, or stem cells) is undoubtedly regarded as key to successful meniscal tissue engineering. 
Furthermore, a large variation of scaffolds for tissue engineering have been proposed and 
produced in experimental and clinical studies, although a few problems with these (e.g., 
byproducts of degradation, stress shielding) have shifted research interest towards new 
strategies (e.g., scaffoldless approaches, self-assembly). A large number of different chemical 
(e.g., TGF-β1, C-ABC) and mechanical stimuli (e.g., direct compression, hydrostatic pressure) 
have also been investigated, both in terms of encouraging functional tissue formation, as well as 
in differentiating stem cells. Even though the problems accompanying meniscus tissue 
engineering research are considerable, we are undoubtedly in the dawn of a new era, whereby 
recent advances in biology, engineering, and medicine are leading to the successful treatment of 
meniscal lesions. 	  
INTRODUCTION 
Six decades ago, the discovery that removing the meniscus from the knee joint—then 
commonly seen as the sole technique for treating sports-related injuries—resulted in the 
deterioration of articular cartilage and the gradual development of arthritis, radically changed 
the approach for treating meniscus-related problems [1]. In 1982, partial meniscectomy was 
suggested as an alternative to complete meniscectomy [2], while the first published account of a 
meniscus transplant dates back to 1989 [3]. These studies are landmarks in understanding the 
anatomical and functional utility of the knee meniscus, and have since resulted in numerous 
investigations into different treatment approaches. 
   The current prevailing trend in repairing meniscus-related lesions is to maintain the 
tissue intact whenever possible [4-6]. However, the inability of surgeons to restore the tissue—
both anatomically and functionally—in cases of complex or total traumatic lesions continues to 
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present challenges. The simultaneous inability to delay the progressive development of 
osteoarthritis presents a similar motivation to search for new therapeutic avenues. 
   This review will cover current knowledge regarding anatomical and biochemical 
characteristics of the knee meniscus, and discuss the tissue’s biomechanical and functional 
properties. The review will also address the causal pathologies precipitating the need for 
meniscus treatment, and the effectiveness of current tissue repair methods, among different age 
groups. Finally, current therapeutic developments in repairing the meniscus will be discussed, 
focusing especially on the field of tissue engineering. Within this topic, special emphasis will be 
placed on advances in scaffolds and scaffold-free approaches to regenerate meniscal tissue. 
Finally, perspectives for the future of meniscus repair will be given. 	  	  
STRUCTURE AND FUNCTION OF THE KNEE MENISCUS 
2.1 Meniscus Anatomy 
The knee joint contains the meniscus structure, comprised of both a medial and a lateral 
component situated between the corresponding femoral condyle and tibial plateau (Figure 1) 
[7]. Each is a glossy-white, complex tissue comprised of cells, specialized extracellular matrix 
(ECM) molecules, and region-specific innervation and vascularization. Both menisci are critical 
components of a healthy knee joint [7-12]. The main stabilizing ligaments are the medial 
collateral ligament, the transverse ligament, the meniscofemoral ligaments, and attachments at 
the anterior and posterior horns (Figure 2) [8]. The meniscofemoral ligaments, also known as 
the Humphrey and Wrisberg ligaments, connect the posterior horn of the lateral meniscus to a 
location near the insertion site of the posterior cruciate ligament on the medial femoral condyle. 
Though only 46% of people have both of these ligaments, 100% of people have at least one of 
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them [8]. The meniscus surface appears smooth upon both gross inspection and microscopically 
[9]. Human medial and lateral menisci have distinctly different dimensions: lateral menisci are 
approximately 32.4-35.7 mm in length and 26.6-29.3 mm wide, while medial menisci are 40.5-
45.5 mm long and 27 mm wide [10, 11]. Though both menisci are roughly wedge-shaped and 
semi-lunar, lateral menisci display greater variety in size, shape, thickness, and mobility than 
medial menisci [12, 13]. Lateral menisci also cover a larger portion of the tibial plateau (75-
93% laterally) in comparison to medial menisci (51-74% medially) [13]. 
   Vascularization in this tissue is of high relevance. From prenatal development until 
shortly after birth, the meniscus is fully vascularized. Afterwards, however, vascularization 
appears to subside. At 10 years of age, vascularization is present in around 10-30% of the 
meniscus, and at maturity the meniscus contains blood vessels and nerves only in the peripheral 
10-25% of the tissue [13]. Subsequently, two distinct regions of the meniscus can be 
distinguished: the outer, vascular/neural region (red-red zone), and the inner, completely 
avascular/aneural region (white-white zone). These two areas are separated by the red-white 
region, which presents attributes from both the red-red and white-white regions (Figure 3). 
Critically, the healing capacity of each area is directly related to blood circulation, leaving the 
white region susceptible to permanent post-traumatic and degenerative lesions [14]. 
 
2.2 Biochemical Content 
Regarding composition by wet weight, the meniscus is highly hydrated (72% water), with the 
remaining 28% comprised of organic matter, mostly ECM and cells [15]. In general, collagens 
make up the majority (75%) of this organic matter, followed by GAGs (17%), DNA (2%), 
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adhesion glycoproteins (<1%), and elastin (<1%) [15, 16]. The above proportions might vary 
depending on age, injuries, and other pathological conditions [17, 18]. 
   Although collagen is the main fibrillar component of the meniscus, different collagen 
types exist in varying quantities in each region of the tissue. In the red-red zone, collagen type I 
is predominant, at approximately 80% composition by dry weight, with other collagen variants 
(type II, III, IV, VI, and XVIII) present at less than 1%. In the white-white zone, collagen makes 
up 70% of the tissue by dry weight, of which 60% is collagen type II and 40% is collagen type I 
[19]. Aside from collagen, another fibrillar component is elastin: a combination of mature and 
immature elastin fibers has been found in very low concentrations (<0.6%) in the adult 
meniscus. Elastin’s exact biochemical and functional importance in the meniscus has yet to be 
determined [9, 18, 20]. 
    Proteoglycans are heavily glycosylated molecules that constitute a major component 
of the meniscus ECM [21]. These molecules are comprised of a core protein which is decorated 
with glycosaminoglycans (GAGs). The main types of GAGs found in normal human meniscal 
tissue are chondoitin-6-sulfate (60%), dermatan sulfate (20-30%), chondroitin-4-sulfate (10-
20%), and keratin sulfate (15%) [15]. Aggrecan is the major large proteoglycan of the meniscus 
while biglycan and decorin are the main small proteoglycans [22]. Regional variation of these 
molecules has also been observed, with the inner two-thirds containing a relatively higher 
proportion of proteoglycans than the outer one-third [22]. Their main function is to enable the 
meniscus to absorb water, whose confinement supports the tissue under compression [22, 23]. 
Adhesion glycoproteins are also indispensible components of the meniscus matrix, as they serve 
as a link between ECM components and cells. The main adhesion glycoproteins present in the 
human meniscus are fibronectin, thrombospondin, and collagen VI [18, 24]. 
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2.3 Meniscus Cells 
During early development, all meniscus cells present the same cellular morphology—in terms 
of both size and shape—with no regional variations. However, later in development, 
morphologically and phenotypically-distinct cells appear, which also vary in terms of number 
and topographic localization (Figure 3) [25]. Ghadially et al. [9] suggested categorization of 
meniscus cells according to their shape and the presence or absence of territorial matrix. Under 
this classification method, chondrocytes, fibroblasts, or intermediate cells exhibiting 
characteristics of both were identified. Today, the characterization of meniscus cells appears 
somewhat controversial in the literature, with a number of different terms being used (i.e., 
fibrocytes, fibroblasts, meniscus cells, fibrochondrocytes, and chondrocytes) [25]. Regardless of 
the varying terminology used, it is apparent that outer zone cells have an oval, fusiform shape 
and are similar in appearance and behavior to fibroblasts. Thus, they may be described as 
fibroblast-like cells. These cells also display long cell extensions, which facilitate 
communication with other cells and the extracellular matrix. The matrix surrounding these cells 
is mainly comprised of type I collagen, with small percentages of glycoproteins and collagen 
types III and V present [26, 27]. In contrast, cells in the inner portion of the tissue appear more 
round and are embedded in an ECM comprised largely of type II collagen intermingled with a 
smaller but significant amount of type I collagen and a higher concentration of GAGs than in 
the outer region. This relative abundance of collagen type II and aggrecan in the inner region is 
more reminiscent of hyaline articular cartilage. Therefore, cells in this region are classified as 
fibrochondrocytes or chondrocyte-like cells [27, 28]. A third cell population has also been 
recognized in the superficial zone of the meniscus. These cells possess a flattened, fusiform 
morphology and are absent of cell extensions. It has been suggested that these cells are possibly 
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specific progenitor cells with therapeutic and regenerative capabilities [29]. In summary, cell 
phenotype and ECM composition render the outer portion of the meniscus akin to fibrocartilage, 
while the inner portion possesses similar, but not identical, traits to articular cartilage. 
 
2.4 Biomechanical and Functional Properties 
The meniscus withstands many different forces such as shear, tension, and compression. It also 
plays a crucial role in load-bearing, load transmission, shock absorption, as well as lubrication 
and nutrition of articular cartilage [16, 30-33]. These multiple and complex functions require a 
specialized form. Since the tissue is wedge-shaped, it proves highly adept at stabilizing the 
curved femoral condyle during articulation with the flat tibial plateau [17, 34, 35]. During 
everyday activity, axial tibiofemoral forces compress the menisci. The wedge shape of the 
meniscus and its horn attachments serve to convert the vertical compressive forces to horizontal 
hoop stresses (Figure 4). At the same time, shear forces are developed between the collagen 
fibers within the meniscus while the meniscus is deformed radially [17, 32, 36]. 
   The biomechanical properties of the knee meniscus are appropriately tuned to 
withstand the forces exerted on the tissue. Many studies have helped to quantify the properties 
of the tissue both in humans and in animal models (Tables 1 and 2). According to these studies, 
the meniscus resists axial compression with an aggregate modulus of 100-150 kPa [37]. The 
tensile modulus of the tissue varies between the circumferential and radial directions; it is 
approximately 100-300 MPa circumferentially and 10-fold lower than this radially [38]. Finally, 
the shear modulus of the meniscus is approximately 120 kPa [38]. 
   The contact forces on the meniscus within the human knee joint have been mapped. It 
has been calculated that the intact menisci occupy approximately 60% of the contact area 
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between the articular cartilage of the femoral condyles and the tibial plateau, while they transmit 
>50% of the total axial load applied in the joint [6, 39, 40]. However, these percentages are 
highly dependent on degree of knee flexion and tissue health. For every 30° of knee flexion, the 
contact surface between the two knee bones decreases by 4% [41]. When the knee is in 90° of 
flexion the applied axial load in the joint is 85% greater than when it is in 0° of flexion [40]. In 
full knee flexion, the lateral meniscus transmits 100% of the load in the lateral knee 
compartment, whereas the medial meniscus takes on approximately 50% of the medial load 
[36]. 
   Conversely, of notable interest are the changes in contact area and contact force 
following partial or total meniscectomy. Paletta et al. [42] investigated the biomechanical 
effects of total removal of the lateral meniscus in 10 cadaveric knees and reported a 50% 
decrease in total contact area, resulting in a 235-335% increase in peak local contact load. In a 
similar study, Kurosawa et al. [43] noted that following total meniscectomy the tibiofemoral 
contact area decreased by approximately 50%, therefore leading to an overall increase in contact 
forces by 2-3 times. Correspondingly, partial (16-34%) meniscectomy has been shown to lead 
to a >350% increase in contact forces on the articular cartilage [44].  	  
MENISCUS PATHOPHYSIOLOGY 
In the United States, meniscal lesions represent the most common intra-articular knee injury, 
and are the most frequent cause of surgical procedures performed by orthopedic surgeons [45, 
46]. The mean annual incidence of meniscal lesions has been reported to be 66 per 100,000 
inhabitants, 61 of which result in meniscectomy [47, 48]. Men are more prone to such injuries 
than women, with a male to female incidence ratio between 2.5:1 and 4:1, and overall incidence 
peaking at 20-29 years of age for both sexes [47, 49, 50]. Meniscal lesions are most commonly 
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found in the right knee [47] and occur in all age groups, with the main etiological and 
pathophysiological factors varying and being highly dependent upon the patient’s age [46, 51]. 
 
3.1 Meniscus Tears in Young People 
In young patients, sports-related (football, basketball, soccer, baseball, and skiing in particular) 
injuries are the most common cause of meniscal lesions, accounting for more than 1/3 of all 
cases [47, 49]. The underlying mechanism of these injuries usually involves cutting or twisting 
movements, hyperextension, or actions of great force [12]. Meniscal tearing during these sports 
is accompanied by anterior cruciate ligament (ACL) tearing in >80% of cases [52-58]. Most 
patients report an acute onset of sharp pain following a twisting injury with the knee flexed and 
the foot planted on the ground [59, 60]. Meniscal tears resulting from vehicle accidents are also 
associated with increased incidences of meniscus lesions in this particular age group [47]. 
   Classification of meniscal injuries occurs depending on location, thickness, and 
resulting stability [6, 12, 61]. Thus, tears in the peripheral vascularized portion are denoted as 
red-red tears, in the middle third portion as red-white or white-white tears, and in the inner 
avascular portion as white-white tears. According to the depth of the tear, injuries are observed 
as partial or full thickness, of which full thickness injuries can be further categorized as stable 
or unstable. Another means of classifying meniscal injuries is based on tear pattern [6, 62]. This 
way, one can distinguish between different types of meniscal tears—the most important being 
vertical/longitudinal (including bucket handle), flat/oblique, radial/transverse, and 
horizontal/complex (including degenerative) [63]. The above categorization is highly relevant 
when deciding upon the most appropriate and effective therapy. Studies have shown that there 
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is also a significant difference in tear pattern between stable knees and those with concurrent 
ACL lesions [64-66]. 
   Diagnosing meniscal malfunction is greatly dependent upon both the experience and 
insight of a physician. A detailed patient history, a thorough physical exam, and modern 
imaging techniques can help guide the process towards reaching diagnostic consensus. Starting 
from the patient’s history, an accurate description of the injury’s acquisition can set the ground 
for suspected meniscal tearing. Patient complaints concerning pain, swelling, or ‘locking’, and 
diagnostic characteristics during physical examination (joint effusion, joint line tenderness), 
should be taken under serious consideration [12, 67]. The main tests, which will need to be 
conducted each time a patient’s knee presents with any of the above findings, are joint line 
palpation, the flexion McMurray test, the Apley’s grind test, and the Thessaly test [68-70]. 
Imaging modalities that need to be applied when diagnosing such injuries are X-ray and MRI 
[12]. 
 
3.1.1 Peripheral Meniscal Tears 
Numerous techniques have been described and applied regarding surgical meniscus repair in the 
peripheral (vascular) zone. Though such techniques undergo continuous development, surgical 
treatment approaches can be classified under four main categories: inside-out, outside-in, and 
all-inside arthroscopic techniques; and open repair [5, 6, 71]. These techniques have been 
extensively described in the literature, along with their accompanying complications and 
appropriate rehabilitation programs, and will therefore not be largely discussed in the present 
review. 
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   A substantial amount of research has focused on the efficacy and reliability of these 
repair techniques for achieving anatomical and functional restoration of the meniscus. In 
general, there is an ever-increasing amount of literature supporting current meniscus repair 
techniques for treating tears in the vascular zone. Functionally successful outcomes in young 
individuals with stable knees are fairly frequent, with success rates varying from 63% to 91% 
[45, 57, 72-76]. However, more long-term follow-up studies need to be conducted so as to 
robustly confirm such evidence, and exclude the possibility of long-term degenerative 
deteriorations of the articular cartilage and meniscus.  
 
3.1.2 Avascular Zone Meniscal Tears 
Tears in the avascular zone of the meniscus are generally more complex and broad, and are 
often associated with a poor prognosis following repair. Improving the healing process in this 
type of injury is an ongoing challenge for clinicians and researchers. Several different 
therapeutic approaches have been brought forward, with a variety of reported results (Table 3). 
The most notable of these new approaches are: the use of parameniscal synovial tissue, 
trephination of the peripheral meniscus rim with suture of the meniscus tear, creation of 
vascular access channels, and use of mesenchymal stem cells or growth factors [77, 78]. 
   Despite these results, none of the above techniques has been a recipient of general 
acceptance and application. Therefore, the main strategy for treating such tears is partial 
meniscectomy, with its related long-term degenerative implications for articular cartilage [79, 
80]. The lack of acceptance and clinical application of the above methods is mainly due to a 
deficiency in long-term follow-up studies and replication of results, which could confirm these 
findings in a greater number of clinical cases. In future studies, evaluation of articular cartilage 
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in a long-term follow-up is of special importance. In addition to this, investigation of the 
biomechanical properties of healed meniscus in experimental and clinical studies is essential. 
 
3.2 Meniscal Tears in Older People and Children 
In general, meniscal lesions occur frequently in middle-aged and elderly patients. Tears 
encountered in patients belonging to this age group usually result from long-term degeneration. 
Such meniscal lesions lead to joint swelling, joint line pain, and mechanical blocking [81, 82]. 
The reported prevalence of meniscal lesions in patients with clinical and radiographic findings 
of osteoarthritis is 68-90% [83-85]. This high correlation creates a series of diagnostic 
problems, mainly concerning the identification of the main pathology in a symptomatic knee. 
Therefore, on some occasions, symptoms that may be due to a pathological cause (such as 
osteoarthritis) may be attributed by the physician to the presence of a meniscal tear in MRI, 
while on other occasions, symptoms which may result from trauma (such as a meniscal tear) 
may be attributed to osteoarthritis. This has obvious repercussions on the choice of proper 
therapy. For example, treatment of meniscal tears with partial meniscectomy is rather unlikely 
to reduce symptoms caused by osteoarthritis. 
   Regarding the successful application of meniscus repairs in older people, less 
promising findings have been reported as compared to patients in younger age groups [72, 81]. 
The main reason behind such unfavorable results is the degenerative etiology surrounding 
meniscal tears in such patient groups, as well as the declining vascularization of the aging 
meniscus. Barrett et al. [81] reported only a small percentage (6%) of repairable meniscal tears 
in this special aged patient group. In general, the current preferred intervention for the majority 
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of surgeons is meniscectomy, either partial or total, depending on the degree of meniscal 
damage.  
   An increased incidence in meniscal tearing has recently been observed in skeletally-
immature children [86, 87]. The main causative factor behind this increased incidence is the 
growing participation of children in highly-demanding athletic activities. Simultaneously, the 
expansion in health services focused on child pathology, and the extensive use of highly 
specialized imaging techniques such as MRI, have aided in contributing to these diagnoses. 
   Meniscal lesions in children are different than those in adult patients. In children, the 
vast majority of cases (>71%) are isolated meniscal lesions [88-90]. The main mechanism of 
meniscal tearing in children is sports-related twisting of the knee. In a small percentage of these 
cases, a common predisposing factor is a discoid meniscus [91]. Diagnosis is dependent upon 
the presence of a complete medical history for the patient and a clinical examination. If a 
meniscal tear is suspected following clinical examination, the application of an imaging 
technique should be pursued. Nonetheless, the sensitivity and specificity of MRI for diagnosing 
meniscal lesions in children is considerably less than that for adults [92, 93]. 
   Meniscus pathology in children has received fairly limited attention in the literature 
with regards to repair techniques. Most of the studies in this field deal with patient groups 
comprised mostly of adults, with children representing a small portion of cases and with fairly 
short follow-ups [94-98]. In general, most of these studies report that the overall success rate for 
meniscal repair in children appears analogous to that observed in adults, especially for cases of 
isolated tears [96-98].  	  
CELL SOURCES FOR TISSUE ENGINEERING THE KNEE MENISCUS 
4.1 Autologous Cells  
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One of the leading questions in tissue engineering is whether the engineered tissue should be an 
exact replica of the native tissue, or whether it should merely carry out its main functions. 
Several researchers argue that the development of a biomimetic replica of the native meniscus 
necessitates the use of a biodegradable scaffold seeded with native cells that will produce the 
same fibrocartilaginous ECM [99-101]. However, this approach exhibits several limitations. 
Two surgical interventions would be required of a patient: a biopsy to obtain autologous 
meniscal cells, and a second procedure to implant the tissue-engineered meniscus. Moreover, 
tissue scarcity and current techniques yield only a limited number of isolated cells, of which 
only cells from the inner part of the meniscus produce sufficient matrix GAGs [102, 103]. To 
tackle these issues, research has moved to the fairly simple expansion of autologous meniscal 
cells in monolayer culture. However, monolayer expansion of meniscus cells leads to significant 
downregulation of ECM gene expression [104]. Similarly, some approaches have included the 
use of autologous chondrocytes for meniscal tissue engineering, as they have proven to produce 
more GAGs and collagen II compared to meniscal cells after expansion, although they too 
undergo differentiation [99, 105, 106]. 
   Though the development of functional tissue-engineered meniscus constructs has 
advanced, important problems still persist. The limited ability of cell isolation for large-scale 
constructs is a notable example. Furthermore, the dedifferentiation of cells after expansion, as 
well as the possibility of autologous cells already being in either a degenerated state, or in an 
age-related disease state, deem their utility in tissue engineering questionable [107]. For these 
reasons, a wide variety of cell sources may be considered for meniscus tissue engineering. 
 
4.2 Allogeneic and Xenogeneic Cell Sources 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  43 
The realization of the fact that the isolation of a sufficient number of healthy, undifferentiated 
meniscal cells extracted from an injured meniscus ranges from difficult to impossible, and the 
need for alternative cell sources, has led many researchers to use allogeneic cells for meniscus 
tissue engineering [25]. The first trials in this direction have been largely based on the positive 
healing outcomes of allogeneic articular, auricular, and costal chondrocytes in lesions in the 
avascular zone of the meniscus, in a large animal model study [108]. In another study, both 
autologous and allogeneic chondrocytes were seeded in a degradable scaffold and implanted in 
17 pigs to repair previously inflicted bucket-handle meniscal tears [109]. After 12 wks, the 
authors found that both allogeneic and autologous-based scaffolds were capable of promoting 
healing when compared to the control group. The fact that no statistically significant therapeutic 
outcome was found between the two cell-based implants is of importance, as it suggests that the 
use of allogeneic cells is feasible [109]. 
   In terms of the use of xenogeneic cells in tissue engineering, increasing amounts of 
research seem to strongly encourage their use [110-112]. In a study by Ramallal et al. [110], the 
investigators created cartilage defects in the femoral condyle of 30 rabbits and subsequently 
tried to repair the injury by suturing a periosteal flap to the articular cartilage, while also 
infusing cultured pig chondrocytes into the defect void. After 24 wks, the authors reported the 
appearance of articular cartilage neotissue, which integrated with the native tissue, and an 
overall lack of measurable immune response. In another study, researchers used four different 
types of cells: allogeneic chondrocytes, MSCs, fibroblasts, and human umbilical cord blood 
(hUCB) stem cells, and embedded them in PLA scaffolds to repair cartilage defects in a rabbit 
model [111]. Although they found better results when using allogeneic MSCs, they reported no 
immune response when using xenogeneic hUCB stem cells, motivating further investigations in 
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this area. The results from these studies point towards the possibility of using xenogeneic cell 
sources in meniscus tissue engineering, which is further supported by unpublished data from our 
lab based on both in vitro and in vivo studies. 
 
4.3 Human Embryonic Stem Cells 
Lately, an increasing interest in the use of stem cells for regenerating destroyed or degenerative 
tissue (such as articular cartilage, meniscus, intervertebral disc, TMJ disc, and heart muscle) has 
been shown [113-117]. Stem cells can play an important role in rectifying meniscal damage 
through their ability to differentiate and regenerate tissue, and through their ability to produce 
cytokines and growth factors [118]. Human embryonic stem cells (hESCs) have proven to be an 
emerging cell source for fibrocartilage tissue engineering [117]. Some of the main 
characteristics which make this cell source ideal for tissue engineering are pluripotency and 
unlimited proliferative capacity [119, 120]. Attempts towards tissue-engineering the meniscus 
using this cell source are still in early phases. A main step in this direction was made by Hoben 
et al. [121], who investigated hESCs’ differentiation potential into fibrochondrocyte-like cells, 
and characterized the resulting differentiated cells. In this study, hESCs were cultured with 
growth factors (TGF-β3, BMP-2, BMP-4, BMP-6, PDGF-BB, sonic hedgehog protein), and/or 
primary cells (chondrocyte or fibrochondrocytes) for 3 wks. Following this time, their ability to 
produce GAGs and collagen types I, III, and VI was assayed, along with the presence of certain 
surface markers (CD105, CD44, SSEA, PDGFRa). Following comparison of these treatments, 
results showed that the combination of TGF-β3 with BMP-4 yielded embryoid bodies positive 
for collagen type I, II, and VI with 6.7 and 4.8-fold increases in GAG and collagen, 
respectively. Also, co-culture with fibrochondrocytes led to 9.8-fold increases in collagen II 
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production. Results from this study point to the suitability of hESCs for meniscal tissue 
engineering and highlight at least 3 effective strategies to create hESC-derived fibrocartilage 
[121]. 
 
4.4 Adult Stem Cells 
While the usage of hESCs in meniscal tissue engineering remains at a preliminary stage, many 
studies have focused on using mesenchymal stem cells (MSCs) as a potential cell source. MSCs 
are multipotent progenitor cells of stromal origin whose main source is adult bone marrow, 
although they may be isolated from other tissues in both adults and fetuses [122-125]. The large 
scientific interest surrounding these cells is due to two main abilities. First, MSCs have been 
observed to differentiate into many terminally-differentiated cells which synthesize 
mesenchymal tissue (i.e., cartilage, bone, ligaments, muscle, fat, dermal, and other connective 
tissue), and can therefore be used to engineer mesenchymal-derived tissue [126]. Second, MSCs 
secrete a large variety of immunoregulatory molecules, and contribute to the healing process of 
injured tissue by providing paracrine trophic mediators [118].  
   Different strategies for using autologous connective tissue progenitors in MSC-based 
tissue engineering have been described in the literature. An approach that has been investigated 
by many researchers is in situ activation of the migration, proliferation, and differentiation of 
local MSCs. This can be achieved by the transplantation of an acellular scaffold [127] or by the 
local administration of growth factors such as VEGF, which activates these MSC functions 
[128, 129]. 
   Another strategy is the local administration of autologous MSCs to replenish the 
population of local cells which has been diminished due to trauma, degeneration, tissue defects, 
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or compromised vascularity. Currently, many surgeons use this method to transplant bone 
marrow-derived stem cells (BMSCs) for bone healing applications due to its high value and low 
risk and cost [130]. This strategy has been the center of much interest as a therapeutic approach 
for rehabilitating meniscal lesions. Some of the main techniques utilized with this approach 
include the creation of vascular access channels and vascular tunnels by trephination or rasping 
in the vascular region of the meniscus. This allows the influx of blood—and subsequently 
MSCs—into the damaged avascular area [77, 78, 131, 132]. Other techniques use vascularized 
synovial flaps or fibrin clots, based on the same rationale [133-138]. Results of these techniques 
appear to conflict in the existing literature. 
   The transplantation of expanded or modified autologous MSCs is another approach in 
MSC-based tissue engineering. The first attempt of this took place in 2005, when Izuta et al. 
[139] used autologous BMSCs from green fluorescent protein transgenic rats; these were 
isolated, expanded in monolayer culture, and then transplanted into meniscal defects inflicted in 
the avascular zone. After 8 wks follow-up, the investigators found that MSCs could survive and 
proliferate in the meniscal tears while also developing an extensive extracellular matrix, aiding 
the healing process in the avascular meniscus [139]. Similarly, investigators in another study 
reported that autologous BMSCs injected into meniscal wounds of eight canines improved 
healing [140]. In the same light, studies have proven the use of MSCs seeded onto scaffolds for 
meniscus tissue engineering as a rather effective one [141, 142]. Another study showed that 
undifferentiated MSCs, as opposed to precultured cells, display a more potent healing response 
[143]. Here, the investigators studied the therapeutic value of autologous MSCs in meniscal 
tissue lesions in a rabbit model by comparing their action to that of platelet-rich plasma and 
autologous BMSCs. More specifically, they created circular meniscal punch defects (2mm), and 
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either left the resulting gap intact, or covered it with hyaluronan-collagen composite matrices 
using one or none of the above cell categories. Of notable importance is that some of the stem 
cell matrices were precultured in chondrogenic medium for 14 days prior to transplantation. 
Twelve wks after transplant the researchers concluded that the non-precultured autologous 
MSCs led to integrated meniscus-like repair tissue, while the precultured MSCs led only to 
partial integration [143]. 
   Undoubtedly, the expansion of MSCs in vitro has significant advantages and 
disadvantages. The primary advantage of expansion is an increase in cell number. 
Disadvantages include possible cell infection during culture, as well as decreased capacity for 
proliferation prior to implantation [144-146]. Finally, another danger not extensively reported 
on in the literature is the development of tumor-like abnormalities following implantation of 
precultured autologous MSCs with mutations or epigenetic changes [130]. This appears to be a 
relatively unexplored topic, showing the need for more studies. 
   Finally, another strategy utilizing MSCs is ex vivo tissue differentiation/generation, 
with subsequent transplantation of this tissue. Research using this approach is currently being 
conducted in the authors’ lab to generate fibrocartilaginous tissues, including meniscus tissue. 
The main challenges in this field coincide with the main challenges of tissue engineering in 
general: development of functional tissue mirroring the composition of native tissue, which will 
satisfactorily integrate with the host, and which will allow long-term preservation of cell 
viability and meniscus function. 	  
SCAFFOLDS FOR TISSUE ENGINEERING THE KNEE MENISCUS 
Scaffolds for tissue engineering the meniscus may be categorized into four broad classes: 
synthetic polymers, hydrogels, ECM components, or tissue-derived materials. Synthetic 
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polymers are materials that do not exist in the body, at least not in polymer form. Hydrogels are 
hydrophilic colloids capable of holding large amounts of water, and may be derived from 
natural or synthetic sources. ECM component scaffolds are comprised of whole materials 
formed primarily from a component macromolecule of natural matrix, such as collagen or 
hyaluronan. Finally, tissue-derived materials include decellularized ECM and other significant 
components or byproducts of living tissue such as small intestinal submucosa. Importantly 
however, these four categorizations are not mutually exclusive, and rather serve as a broad 
guide to appreciate significant differences in properties among scaffolds. Hybrids and 
composites between these materials also exist. Since cell-seeded polymers consistently 
outperform acellular scaffolds in terms of regenerative capacity [101, 147, 148], this section 
will primarily focus on studies examining the capabilities of scaffolds incorporating cells. 
   The ideal meniscus construct will excel in three criteria: mechanics, bioactivity, and 
logistics (Table 4). Since heterogeneous loading of the meniscus occurs every day in vivo, 
appropriate mechanical properties, tissue anisotropy, geometry [149], and lubrication are 
requirements of the mechanics criterion. Any implanted meniscus construct will also need to 
display sufficient bioactivity. This means maintenance of cell phenotype, induction of ECM 
synthesis, lack of immunogenicity, and capacity for host-tissue integration. Finally, the logistics 
of a successful construct must not be unwieldy: supply, processability, sterilization, and 
eventual surgical implantation must all be practical. 
 
5.1 Synthetic Polymer Scaffolds 
Synthetic polymers, such as polyurethane (PU), polycaprolactone (PCL), polylactic acid (PLA), 
polyglycolic acid (PGA), and polylactic co-glycolic acid (PLGA), hold several advantages, 
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including fabrication under a variety of methods, near-limitless supply, and the potential to 
achieve appropriate pore size, fiber size, mechanical properties, and scaffold geometry. These 
advantages are countered by a central weakness—minimal intrinsic biomimetic and bioactive 
properties. By contrast, the mechanical properties of some more highly bioactive scaffolds, such 
as small intestinal submucosa, are considerably less than that of some synthetic polymers [158-
160]. The lack of inherent biological support among synthetic scaffolds has motivated the 
exploration and use of many synthetic scaffolds as acellular meniscus prostheses, which provide 
some biomechanical functionality, as well as modest tissue regeneration, when implanted [150-
157].  
   Tissue engineering has spurred recent advances in synthetic polymer scaffolds that 
emphasize and build upon the advantages stated above. Methods for generating mechanical 
anisotropy within synthetic cartilage scaffolds are one example. This characteristic is essential, 
since loading of the meniscus in vivo is highly non-uniform [38, 39]. It has been demonstrated 
that fibers in PCL scaffolds may be preferentially aligned by the use of a rotating collection 
platform during electrospinning [161]. When evaluated mechanically, these scaffolds exhibited 
a 33-fold change in tensile moduli if tested in the direction parallel versus perpendicular to fiber 
alignment [161]. Aligned scaffolds can also subsequently promote cell and ECM orientation 
[162-165]. It has been found that aligned PCL scaffolds seeded with meniscus cells and cultured 
over 10 wks display a 7-fold greater increase in tensile modulus in the direction of alignment 
than corresponding non-aligned scaffolds [162]. Importantly, collagen per DNA was not 
statistically different between aligned and non-aligned scaffolds, suggesting differential 
organization of the existing ECM [162], although some studies have also reported that scaffold 
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alignment serves to increase matrix deposition [166, 167]. Regardless of the underlying 
mechanism, scaffold orientation appears to have a beneficial effect. 
   Recent work has also demonstrated that scaffolds may be physically woven to further 
increase their compressive, tensile, and shear properties and to introduce scaffold anisotropy 
[168, 169]. In this strategy, a custom-built weaving loom was used to produce anisotropic PGA 
or PCL scaffolds with mechanical characteristics generally on the same order of magnitude as 
native articular cartilage [168, 169]. These woven scaffolds may be combined with hydrogels to 
make composites capable of supporting seeded articular chondrocytes or adipose-derived stem 
cells [168, 169]. Although these studies focused on engineering articular cartilage, they would 
also be highly relevant for recapitulating the mechanical properties and anisotropy of the knee 
meniscus. 
   Other recent advances focus on making synthetic polymers more biomimetic and 
bioactive. One group of investigators recently reported the fabrication of a peptide scaffold 
sensitive to matrix metalloproteinase-2 (MMP-2) degradation [170]. Although this scaffold has 
not yet been applied to meniscus tissue engineering, it may greatly aid in coupling cell-mediated 
matrix remodeling to scaffold degradation. Since native components of the ECM are nanoscale 
molecules, nanofibrous scaffolds may also help to coax cells to behave as they do in native 
matrix. One study comparing PLLA nanofiber and microfiber scaffolds reported increased 
production of sulfated GAGs, cartilage link protein, collagen II, and aggrecan by bovine 
chondrocytes seeded in the nanofiber scaffolds [171]. Some synthetic polymers may also 
inherently provide a more biomimetic environment than hydrogels for meniscus cells. A 
comparison of meniscus cells cultured in PGA or agarose scaffolds over 7 wks reported 2 to 6-
fold higher cell numbers, 2 to 4-fold higher GAG production, and 3-fold greater collagen 
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production in the PGA scaffolds [172]. The authors concluded that cell proliferation and ECM 
synthesis may be reduced when meniscus cells are forced to assume a round morphology in 
highly hydrophobic agarose, since meniscus cells display a morphology and phenotype that is 
representative of elongated fibroblasts as well as chondrocytes [173, 174]. This conclusion is 
corroborated by other studies of fibroblast functionality in gels, where proliferation diminished 
as cell spreading was restrained [175, 176].  
   Despite the recent advances described above, the main disadvantage of synthetic 
polymer scaffolds still lies in facilitation of the development of a functionally-robust matrix 
prior to scaffold degradation in vivo. Future research in this direction is needed. Integration of 
synthetic polymer tissue constructs with neighboring host tissue also remains an issue to tackle. 
Finally, fine-tuning of synthetic polymers, so as to promote joint lubrication and to prevent 
tissue wear and tear at bone-cartilage interfaces, also represent avenues for further research. 
 
5.2 Hydrogel Scaffolds 
Hydrogels have also been investigated for use as meniscus scaffolds. Hydrogels can be 
synthetic materials such as poly N-isopropyl acrylamide (PNIPAAm), or natural materials such 
as alginate. The physical properties of hydrogels are largely influenced by their water content, 
which is often >90%. Hydrogels are also versatile—they may be crosslinked through various 
methods [177-179], reversibly gelled [180], and patterned with cells [181-184] and growth 
factors [185, 186]. Many hydrogels can also be synthesized from readily available reagents. 
However, hydrogels may hamper meniscus cell phenotype by preventing encapsulated cells 
from assuming their characteristic spread fibroblastic morphology [172, 173, 175]. 
Additionally, the mechanical properties of hydrogel scaffolds are not as easily manipulated as in 
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synthetic polymers. Finally, hydrogels such as polyvinyl alcohol (PVA) [187, 188] and fibrin 
[189, 190] have been investigated as acellular meniscus materials, but these will not be focused 
on in this review. 
   Much research has focused on utilizing the versatile chemistry of hydrogels to create 
more biomimetic structures. The chemical functionalization of hydrogels is one strategy that has 
been pursued to create a more native microenvironment for cells. Hybrid hydrogels (chitosan-
alginate-hyaluronan) have been conjugated with the adhesive arginine-glycine-aspartic acid 
(RGD) polypeptide and cultured with articular chondrocytes over 1 to 2 wks to show higher 
collagen and GAG content over unconjugated controls [191]. Hydrogels have also been 
functionalized to undergo proteolytic degradation by MMPs [192-194]. Both of these 
approaches are highly relevant to meniscus tissue engineering, but further work is needed to 
explore these scaffolds in conjunction with meniscus cells. Hydrogel co-cultures may also be 
created by spatial patterning of different cell types [182-184], using insoluble adhesion 
molecules or sequential photopolymerization. Fibroblasts have been co-cultured with BMSCs in 
this manner [183], although the diverse meniscus cell subpopulations have not. This method is 
one way in which the regional cellular variation of the meniscus may be replicated. 
   Another principal advantage of hydrogels is their ability to reversibly gel in response 
to environmental factors such as temperature, pH, electric field, ultrasound, or salt concentration 
[180]. This has allowed for the development of “smart” biomaterials whose design allows for 
responses according to the environment, which is favorable for tissue engineering because 
injectable scaffolds that solidify in the body can be produced. Building on this concept, Chen et 
al. [195] have produced temperature-sensitive chitosan-hyaluronan-PNIPAAm hybrid gels 
which maintain meniscus cell viability, encourage native matrix synthesis, and reversibly 
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solidify in response to temperature. Though an injectable knee meniscus hydrogel is minimally 
invasive and enticing, a major limiting factor lies in the scaffold’s insufficient mechanical 
properties after solidification. This deficiency may potentially be modulated through increased 
hydrogel crosslinking, but some crosslinking methods have been shown to affect cytotoxicity 
and cellular metabolism [196, 197]. 
   Other tissue engineers have taken advantage of various methods to create cell-seeded 
hydrogel scaffolds that accurately represent the complex geometry of the meniscus. One method 
combines the imaging capabilities of computed tomography or MRI with robotic printing to 
automate creation of a geometrically-accurate model of the meniscus [177, 198]. Alginate 
scaffolds seeded with bovine meniscus cells in high density (50 million/mL) in this manner 
displayed a high geometrical fidelity to the target shape, high cell viability, and some properties 
similar to native tissue (50% of aggregate modulus, 33% of GAG content, but 2% of 
hydroxyproline content), though tensile properties were not examined [198]. However, tissue 
grown in this manner was highly heterogeneous, possibly due to limited transport in the fairly 
large construct. Subsequent work demonstrated the use of a magnetic stir bar “mixing 
bioreactor” to produce constructs with a larger degree of homogeneity, higher equilibrium and 
tensile moduli, and greater ECM deposition, although detrimental effects were observed at 
higher stirring intensities [199]. This work underscores the necessity of, and opportunities and 
challenges associated with, bringing together diverse tools (imaging modalities, processing 
methods, bioreactors) to successfully tissue engineer the knee meniscus. 
   Hydrogels represent a versatile class of tissue engineering scaffolds, but their 
mechanical properties (especially in tension) and bioactivity (especially in promoting meniscus 
cell phenotype and ECM synthesis) need to be improved. Cell-adhesive hydrogels have been 
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created, and these may help with cell spreading and phenotype issues [176]. Other research has 
been directed towards ECM molecule hydrogels, yielding studies on elastin-like polypeptide 
[200, 201] and collagen-mimetic peptide [202, 203] hydrogels. Further research into these 
approaches may combine the bioactivity of ECM molecules with the versatility of hydrogel 
scaffolds. 
 
5.3 ECM Component Scaffolds 
ECM component scaffolds are materials formed primarily from a macromolecule abundant in 
native matrix. Examples include collagen meniscus implants or hyaluronan scaffolds. 
Combinations of these molecules may also be used (i.e., collagen-GAG scaffolds or scaffolds 
containing multiple types of collagen). Collagen scaffolds in particular are amenable to several 
fabrication and processing methods, including nanofiber electrospinning, anisotropic deposition, 
and crosslinking. Because of these methods, ECM scaffolds may possess strength comparable to 
synthetic scaffolds. As far as bioactivity, ECM scaffolds would logically constitute a natural 
environment for seeded cells. Yet, although these scaffolds are made of natural matrix, they 
may not completely recapitulate the cell microenvironment (i.e., the collagen VI pericellular 
matrix, collagen IX crosslinks, etc.). In addition, some other scaffold materials such as silk have 
also been shown to more robustly promote matrix deposition compared to collagen scaffolds 
[204, 205]. Yet, in general, ECM component scaffolds are more intrinsically biomimetic than 
synthetic and hydrogel materials. 
   Since meniscus cells normally rest in a dense network of collagen and GAG 
molecules, scaffolds made from these components would logically provide a natural 
environment for the regeneration of meniscus tissue. Interestingly, not all ECM molecules are 
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equally effective. An early study showed that GAG-collagen II matrices promoted more 
meniscus cell proliferation, more GAG deposition, and less contraction versus GAG-collagen I 
matrices [206]. Other researchers have shown that aggrecan surfaces are more effective in 
encouraging meniscus cell ECM deposition than collagen I surfaces [104]. HYAFF-11 is 
another ECM component scaffold, made by modifying the glucoronic acid groups in 
hyaluronan. A study comparing meniscus cells seeded in HYAFF-11 and collagen scaffolds 
(types I, II, and III) found no differences in GAG and collagen I synthesis [207]. Thus, a variety 
of results have been observed when comparing the efficacy of different ECM component 
scaffolds. More research into these ECM component scaffolds and combinations of these 
scaffolds is needed. 
   Scaffolds, and especially ECM component scaffolds, can exert a strong effect on 
seeded cells through the microenvironment they provide. A recent investigation developed a 
hybrid scaffold consisting of chitosan, hyaluronan, chondroitin-6-sulfate, collagen I, and 
collagen II molecules [208]. Rat meniscus cells passaged in monolayer underwent conventional 
dedifferentiation, but those subsequently cultured in these hybrid scaffolds underwent partial 
redifferentiation over 1 wk. Results from RT-PCR demonstrated the upregulation of collagen I, 
collagen II, and aggrecan, although not to the levels seen prior to passage [208]. Although these 
results are exciting in that they show scaffolds may induce redifferentiation of previously 
dedifferentiated meniscus cells, further studies are needed to characterize the matrix deposited 
in these systems, especially over longer culture periods. 
   From a clinical perspective, ECM scaffolds have received perhaps the most attention 
of all scaffold categories, due to the use of collagen meniscus implants. The collagen meniscus 
implant is a surgical mesh composed of bovine collagen type I, crosslinked with aldehydes, and 
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molded in the shape of the lateral or medial menisci [209]. A multi-center clinical trial of 
collagen meniscus implants showed greater tissue restoration 1 year after operation compared to 
partial meniscectomy; and activity levels also rose in chronic sufferers of meniscal problems 7 
years after implantation [210]. Smaller non-randomized trials report positive patient outcomes 
over longer periods, with losses in pain and higher activity levels documented [211, 212]. 
Despite these results, significant scientific and clinical drawbacks associated with the collagen 
meniscus implant exist. The implant is not an option for patients who have undergone total 
meniscectomy. In addition, once implanted, scaffold degradation and shrinkage as well as shape 
incongruency remain significant issues [213, 214]. The technical difficulty of suturing the 
implant also limits its use [213, 214]. Finally, this acellular scaffold’s primary mode of healing 
is thought to be through host cell migration and subsequent synthesis of meniscus matrix, yet 
results in sheep have indicated more developed healing if collagen meniscus implants are 
seeded with autologous fibrochondrocytes [101]. In this work, seeded constructs were 
significantly larger than unseeded constructs or resection controls after 3 wks of implantation. 
In addition, histology showed greater ECM deposition and lower cellularity in seeded 
constructs, suggesting accelerated matrix remodeling [101]. This lends credit to cell-based 
tissue engineering. Lastly, as of this writing, the FDA approval granted to the collagen meniscus 
implant in 2008 has been rescinded, and the device has been removed from clinical use. 
   In general, ECM component scaffolds display a mix of desirable traits between 
mechanics, bioactivity, and logistics. This category may hold the most promise amongst 
scaffold-based approaches for meniscus tissue engineering. However, the technology and use of 
these materials is still relatively new, and the efficient incorporation and development of 
suitable replacement tissue within ECM scaffolds in vivo and in vitro remains a topic for more 
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investigation. The introduction of appropriate lubrication, and the modulation of ECM 
component scaffold degradation kinetics, also present opportunities for further research in 
functional tissue engineering. 
 
5.4 Tissue-Derived Scaffolds 
Tissue-derived materials comprise the final category of scaffolding currently being investigated 
for engineering the knee meniscus. Tissue-derived materials include processed whole tissue 
such as small intestinal submucosa (SIS), decellularized tissue or ECM (dECM), and silk. The 
hypothesis of using such materials is similar to that of using ECM components: they constitute a 
natural environment for cell seeding, migration, and ECM deposition. Though geometric 
fidelity and bioactivity of these scaffolds can be high, they must be procured from natural 
tissue, and thus supply is problematic. In addition, some decellularization and processing 
protocols compromise the mechanical integrity of these tissues. 
   Several investigations have demonstrated the comparatively high bioactivity of 
processed whole tissue scaffolds. A study of passaged and seeded canine chondrocytes in SIS 
and PLGA scaffolds, implanted in athymic mice, reported that sulfated GAG and 
hydroxyproline content was higher in the SIS scaffolds, although collagen II was present only in 
PLGA scaffolds [158]. SIS has also demonstrated superiority to other tissue-derived meniscus 
scaffolds. In a fairly recent study, three dermis isolates (human, fetal bovine, and crosslinked 
porcine) were compared against two small intestine isolates (porcine and crosslinked porcine) in 
a rat model [215]. Canine meniscal cells, synoviocytes, tendon fibroblasts, and bone marrow 
progenitor cells were seeded in co-culture in all five scaffolds, and porcine small intestine 
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(principally the non-crosslinked scaffolds) displayed the greatest capacity for encouraging 
retention, infiltration, and viability of these cells [215]. 
   Though processed whole tissues such as SIS display significant bioactivity and have 
been seen to induce some tissue regeneration, the resulting tissue mechanics may be 
insufficient, which subsequently compromises knee function. An early work studied unseeded 
porcine SIS implanted in surgically-created canine medial meniscus defects [216]. After 12 
wks, improved lameness scores, less articular cartilage erosion, and some tissue growth and 
retention were observed over controls [216]. Similar results have also been reported in a longer-
term study with SIS specimens assessed after up to 12 months of implantation, although the 
study also reported samples with biomechanics inferior to contralateral meniscectomy [217]. A 
contrasting study reported meniscal regeneration but increased articular cartilage degeneration 
(compared to contralateral controls) in the knee joints of goats implanted with unseeded porcine 
SIS [218]. The fact that tissue growth seems apparent in these studies, but inferior biomechanics 
and/or cartilage degeneration are observed simultaneously, highlights the possibility that this 
regenerated tissue is mechanically insufficient.  
   Other research centers on the considerable difficulty of creating tissue-derived 
scaffolds with appropriate pore sizes. Studies of native menisci have deemed pore sizes of 100-
150 microns as appropriate for meniscus cells [219], yet cell infiltration can be highly variant 
through the depths of both whole processed tissue (SIS, dermis, etc.) [215] and decellularized 
meniscus [220], likely due to the dense matrix present even after processing. However, other 
recent work has achieved progress by increasing decellularized ovine menisci porosity (to a 
value of 80% in the outer meniscus) as well as connected pore volume, although residual DNA 
content was still significant and compressive properties trended lower [221]. 
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   Though decellularized tissue scaffolds are promising, several studies have reported 
decreased mechanical properties (especially compressive properties) due to the treatment 
protocols used for decellularizing tissue. Losses in GAG content are similarly reported. A 
variety of alternate treatment methods have been investigated. One recent study demonstrated 
no reaction to MHC1 and MHC2, and preservation of, or even increases in, compressive 
stiffness after ovine menisci were treated with a self-developed enzymatic solution [222]. 
Further, ovine meniscus cells were successfully cultured within these scaffolds over 4 wks. 
Despite these positive findings, a 3-fold GAG loss and non-uniform cell distributions were 
observed within the re-seeded scaffolds [222]. Decellularization of human meniscus has also 
been performed [223]. This investigation revealed that collagen structure within the meniscus 
was intact, and mechanical properties were comparable to native tissue, after a 2 wk treatment 
with 2% sodium dodecyl sulfate (SDS) [223]. However, the use of SDS is associated with many 
detrimental side effects. Other work has shown that it is possible to remove the vast majority of 
cellular DNA as well as the primary xenogeneic epitope galactose-α-1,3-galactose, though 
significant GAG loss is also observed with this procedure [224]. 
   Despite their advantages, tissue-derived meniscus scaffolds suffer from several 
drawbacks. Uniform cell infiltration and preservation of mechanics and chief ECM components 
such as GAGs are two areas for future research. Additionally, biological and mechanical 
performance after recellularization and in vivo implantation represent areas for further 
exploration. Some work has been done in this regard with devitalized rat menisci re-seeded with 
BMSCs [220, 225]. Constructs displayed cell migration and increases in compressive stiffness 
over 4 wks, but collagen and GAG content was not assayed [220]. More work in this area needs 
to be pursued. By bringing together some of the approaches reviewed above, it may be possible 
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to resolve these problems. However, the bottlenecks of supply, sterilization, and standardization 
of tissue-derived scaffolds still need to be addressed for a large-scale tissue engineering solution 
to be obtained. 
SCAFFOLDLESS SELF-ASSEMBLY OF TISSUE 
The paradigm of tissue engineering has traditionally been defined as the combination of 
replacement cells, cell-signaling stimuli (mechanical or chemical/biochemical), and supporting 
scaffolds (Figure 5). Although the use of these three elements in combination comprises the 
classical approach to engineering replacement tissue, in recent years cell self-assembly has 
begun to gain recognition and support in generation of functional cartilage, fibrocartilage, 
vasculature, and retina [226-231]. In cartilage and fibrocartilage, the self-assembly approach 
supersedes the need for scaffolds by seeding cells in very high density, possibly promoting cell-
cell adhesion, cell-matrix adhesion, and cell-cell signaling; and encouraging cells to rapidly 
develop and integrate into a matrix with quantifiable mechanical properties [226, 232, 233]. 
Characterization of this process in articular chondrocytes shows high expression of N-cadherin 
during cell coalescence, followed by collagen VI pericellular matrix synthesis, and finally 
collagen II and GAG ECM synthesis [233].  
   Obviating the need for a support scaffold conveys key tissue engineering advantages. 
First, the natural synthesis of and adherence to cartilage ECM as it develops bestows the most 
bioactive microenvironment of any approach. Second, the all-biologic construct greatly 
increases likelihood of integration with host tissue. Third, since no material is completely 
biocompatible in every use, the lack of a scaffold diminishes further contributions to an immune 
response. Fourth, removal of any degradation products minimizes potential toxicity and allows 
for greater cell viability. Fifth, stress-shielding effects exerted by scaffolds are mitigated. More 
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robust and homogeneous mechanical stimulation is possible during tissue development, which 
is particularly pertinent for engineering the knee meniscus. Sixth, since self-assembled tissue 
has a continuous ECM, it may be more fully able to remodel itself in response to catabolic 
exogenous agents such as chondroitinase ABC (C-ABC). 
   Indeed, self-assembled constructs have been shown to respond well to treatment with 
exogenous agents [234-236]. A meniscus tissue engineering study using bovine meniscus cells 
and articular chondrocytes found that treatment with TGF-β1 and C-ABC led to a 196% 
increase in collagen per wet weight, a 136% increase in compressive instantaneous modulus, a 
68% increase in compressive relaxation modulus, a 600% increase in circumferential tensile 
modulus, and a 500% increase in radial tensile modulus [232]. Circumferential and radial 
tensile moduli were also significantly different, mirroring prior results indicating anisotropic 
collagen fiber alignment in scaffoldless meniscus constructs [232, 237]. It is thought that 
confinement in circular agarose molds during self-assembly may allow for the development of 
circumferential contractile forces on coalescing neotissue, thus aiding in the development of 
tissue anisotropy [237]. 
   Mechanical stimulation of scaffold-free and self-assembled tissue has also shown 
promising results [229, 232, 238]. Self-assembled articular cartilage has been shown to 
withstand hydrostatic pressures of up to 10 MPa and respond positively by increasing aggregate 
modulus (96%), Young’s modulus (92%), collagen per wet weight (51%) and GAG per wet 
weight (52%) [235]. A somewhat similar study of scaffold-free porcine chondrocyte constructs 
demonstrated beneficial responses to direct compression stimulation at strain amplitudes of 5-
20% [229]. Following this loading, 200-300% increases in construct stiffness and a 250% 
increase in Young’s modulus was measured [229]. Since the knee meniscus is also loaded in 
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cyclic direct compression in vivo [43, 239] these results are promising for tissue engineering of 
the meniscus using scaffold-free self-assembly. 
   It is important to note that while this method is scaffold-free, it is not devoid of the 
utilization of biomaterials. Agarose hydrogel plays an important role in the self-assembly 
process as a hydrophobic negative mold used to prevent cell-substrate adhesion during tissue 
coalescence. Interestingly, it has also been shown that the compliance and surface roughness of 
this mold can alter the biomechanical properties (strength, stiffness) and even biochemical 
content (cellularity, collagen I/II, GAG) of self-assembled constructs [240]. It is possible that 
still other hydrogels and biomaterials may function to significantly modulate the quality of 
tissue formed from scaffold-free self-assembly. 
 
BIOCHEMICAL STIMULI IN MENISCUS TISSUE ENGINEERING 
A large variety of biochemical stimuli have been applied in meniscus tissue engineering 
investigations. Growth factors are the most prominent biochemical stimuli for tissue 
engineering the knee meniscus (Table 5). Overall, for meniscus cell proliferation, b-FGF in 
particular has been seen to elicit a strong response [241-244]. One group studied the ability of 
nine growth factors (EGF, b-FGF, TGF-α, PDGF-AB, a-FGF, TGF-β1, PDGF-AA, IGF-I, and 
NGF) to stimulate proliferation of meniscus cells in monolayer over 4 days [241]. Of these nine, 
b-FGF, PDGF-AB, EGF, and TGF-α encouraged proliferation, with b-FGF inducing the 
greatest effect [241]. These four growth factors also promoted increased collagen synthesis of 
meniscus cells [241]. Another study compared monolayer proliferation of meniscus cells from 
the different tissue regions (inner/middle/outer) [245]. An up to 3-fold increase in DNA 
synthesis was demonstrated when PDGF-AB, HGF, and BMP-2 were applied to these cultured 
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cells, while IGF-1 had no such effect [245]. Interestingly, cells from different regions responded 
differently, with BMP-2 having a slightly stronger effect on cells from the middle zone, and 
HGF exerting a slightly stronger effect on cells from the inner zone [245]. The effects upon 
monolayer meniscus cell migration were also examined. PDGF-AB and HGF stimulated 
migration in cells from all three zones of the meniscus, while EGF, IGF-1, IL-1, and BMP-2 
promoted cell migration only in specific zones of the meniscus (outer and inner, middle and 
inner, outer and middle, and only middle, respectively) [245]. 
   Aside from proliferation and migration, another chief function of growth factors in 
meniscus tissue engineering is to stimulate matrix synthesis. The TGF-β family, regarded as one 
of the most important for cartilage tissue engineering [246-248], has repeatedly demonstrated 
the ability to heighten meniscus cell synthesis of matrix proteins [102, 103, 232]. Since the 
ECM largely confers the mechanical properties which underlie the primary functions of the 
knee meniscus, this is particularly salient. An early study demonstrated increased proteoglycan 
synthesis of meniscus cells in monolayer, explant, and scaffold culture when treated with TGF-
β1 [103]. Increased cell proliferation was also observed, in only the monolayer cultures [103]. 
Additionally, in scaffold and monolayer studies comparing TGF-β1, IGF-1, b-FGF, and PDGF-
AB, only TGF-β1 stimulated significant simultaneous production of both collagens and GAGs 
over controls [244, 249]. TGF-β1 has also been seen to up-regulate the expression and secretion 
of lubricin, or superficial zone protein (SZP) [250]. This protein is thought to provide essential 
function to cartilage by aiding in lubrication. By contrast, the same study found that interleukin-
1β decreased SZP protein content and gene expression [250]. Finally, TGF-β has also 
interestingly been shown to inhibit meniscus cell proliferation [241]. This highlights the 
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proliferation/production interplay in which meniscus cells are preferentially driven to one 
function or the other. 
   One potentially important function of growth factors may be to modulate matrix 
contraction. Both fibroblasts [251] and articular chondrocytes [252] exert local contractile 
forces on their surrounding matrices. Contiguous tissue constructs may actually benefit from 
controlled contraction, because ECM compaction and alignment can lead to anisotropy and 
greater mechanical properties. In fact, inhibition of fibroblast-mediated contraction has been 
shown to disrupt development of tendon mechanical properties [253]. Too much contraction, 
however, can render constructs of incorrect geometry [237]. However, the use of controlled 
contraction as a biophysical means of modulating cartilage development is relatively scarce in 
the literature. Both TGF-β1 and PDGF have been documented as growth factors involved in 
encouraging matrix contraction by meniscus cells, fibroblasts, and articular chondrocytes [232, 
254-256]. FGF-2 and IGF-1 can also induce articular chondrocyte-mediated contraction of 
collagen II/GAG gel scaffolds [257]. The continued exploration of this topic may lead to 
interesting advances in the field. 
   Phenotype maintenance or cell differentiation to fibrochondrocytes is another vital 
application of growth factors in meniscus tissue engineering. Relatively little work has been 
done in this area. However, it has been found that meniscus cell phenotype may be salvaged by 
exposure to FGF-2 during monolayer expansion [258]. Subsequent 3-D pellet culture of FGF-2 
exposed meniscus cells revealed a 200-fold higher expression of collagen II and GAG than 
controls [258]. Fibrochondrogenic differentiation of human embryonic stem cells has also been 
performed [121]. CDMP-1 has also been explored in a PGA scaffold modality to enhance 
fibrochondrogenesis of dermal fibroblasts [259], and has been demonstrated to increase 
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proteoglycan content and collagen II gene expression [260]. Lastly, exposure to TGF-β1 has 
also been suggested to push meniscus fibrochondrocytes towards a more chondrocytic 
phenotype [102]. Since meniscus fibrocartilage is a tissue with varying regions, either similar to 
or distinct from the hyaline articular cartilage produced by chondrocytes, this is a relevant result 
for prospective tissue engineers. These varying results demonstrate considerable potential in, 
and promise for, further investigations of fibrochondrogenic differentiation of cells. 
   Chondroitinase ABC (C-ABC) is another biochemical stimuli that has been employed 
in cartilage tissue engineering. This enzyme cleaves chondroitin and dermatan sulfate from 
proteoglycan chains while leaving collagen fibers unaffected [261, 262]. It has been suggested 
that a dynamic balance between the swelling pressure caused by proteoglycans and the 
restraining strength of the collagen network exists [263]. Subsequently, it has been hypothesized 
that enzymatic depletion of cartilage GAG content (which is afterwards recovered by cellular 
synthesis) may facilitate increased collagen network alignment and density, leading to 
heightened tissue tensile properties [232, 264-266]. Indeed, serum-free C-ABC treatment of 
tissue-engineered articular cartilage (in both self-assembled and agarose scaffold forms) has 
resulted in increased tensile properties versus untreated controls, as well as recovery of GAG 
content and compressive stiffness after 2 to 4 wks of culture post-treatment [264-266]. The 
repeated beneficial results of C-ABC on tissue-engineered articular cartilage motivate its use for 
tissue engineering meniscus fibrocartilage. Along these lines, self-assembled meniscus 
constructs (composed of meniscus cells and articular chondrocytes) treated with C-ABC have 
been seen to display approximate 2 to 3-fold increases in tensile modulus over untreated 
controls and GAG recovery after 3 wks of culture post-treatment [232]. However, more studies 
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using C-ABC for meniscus tissue engineering, especially in conjunction with other stimuli, are 
necessary. 
   Biochemical stimulus selection is not clear-cut, and the study of multiple agents 
(especially growth factors) in conjunction necessitates additional investigations. Culture 
conditions play a non-trivial role in modulating cell responses to biochemical stimulus 
administration, whether the treated tissue is arranged in monolayer, scaffold, explant, or self-
assembled form. The presence of serum in the media of a study is also a critical variable [245, 
267]. Futures studies may focus on unconventional growth factors, such as the serum-derived 
phospholipid agent lysophosphatidic acid (LPA). LPA is naturally present in mammalian sera at 
concentrations ranging from 1-5 µM [268], and has been studied extensively as an anti-
apoptotic factor. Other potent agents may be derived from platelet-rich plasma, which has been 
shown to increase matrix deposition and proliferation of meniscus cells cultured in monolayer 
[269]. Finally, although fibrocartilage is a particularly important soft tissue, research into its 
generation with biochemical stimuli is nascent, and thus future work along these lines may 
produce significant medical advances. Much remains to be studied concerning biochemical 
stimuli used in tissue engineering the knee meniscus. 	  	  
MECHANICAL STIMULATION FOR MENISCUS TISSUE ENGINEERING 
Meniscus cells may respond positively to mechanical stimuli by enhancing the fibrocartilage 
ECM, or negatively by secreting matrix-degrading or inflammatory factors. The mechanical 
properties of the matrix can be enhanced through three general mechanisms: deposition, 
alignment, or compaction. To achieve these results, there are several possible methods of 
stimulating meniscus tissue. These include high and low shear, fluid perfusion, hydrostatic 
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pressure, direct compression, and even ultrasound. However, most current efforts are centered 
on hydrostatic pressure and direct compression stimulation. 
   Explant and engineered tissue can demonstrate varied remodeling responses to 
hydrostatic pressure. For instance, leporine meniscal explants subjected to cyclic hydrostatic 
pressure at 1 MPa, 0.5 Hz, for 1 min on/14 min off over 4 hrs, have been shown to upregulate 
inflammatory factors and matrix degradation proteins [270]. In contrast, leporine meniscus cells 
seeded in PLLA constructs and stimulated with hydrostatic pressure at 10 MPa statically for 1 
hr every 3 days exhibited beneficial responses [271]. In these constructs, collagen and GAG 
content, as well as compressive properties, were all significantly higher than control or dynamic 
hydrostatic pressure regimens run at 0.1 or 1 Hz [271]. Furthermore, when combined with TGF-
β1, hydrostatic pressure stimulation of leporine meniscal cell-seeded PLLA constructs displayed 
additive increases in collagen and GAG deposition as well as a synergistic increase in 
compressive properties [272]. These results demonstrate the various responses meniscus cells 
may mount in response to hydrostatic pressure.  
   Direct compression stimulation of the meniscus has also been pursued, although 
insufficient loading or excessive loading can be detrimental. For example, static and dynamic 
loading regimens over 24 hrs using direct compression at 0.1 MPa and 0.08-0.16 MPa, 
respectively, have been shown to decrease mRNA levels of type I collagen, type II collagen, 
and decorin [273]. Furthermore, under the same regimens, mRNA for ECM-degrading matrix 
metalloproteinase-1 (MMP-1) and collagenase were both upregulated [273]. Similarly, dynamic 
compression of porcine meniscus explants (24 hrs, 0.1 MPa, 0.5 Hz) has been demonstrated to 
upregulate production of nitric oxide, a potent signaling molecule implicated in arthritis and 
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meniscus degeneration [274]. Thus, the use of incorrect loading regimen parameters can lead to 
matrix and tissue degradation. 
   By contrast, certain other loading regimens have shown beneficial effects. 
Physiological loads on the meniscus in vivo may exceed 1000 N [39], and it is believed this 
compressive loading helps facilitate nutrient-waste exchange in the otherwise transport-limited 
and avascular meniscus. For example, it has been shown that tensile loading of meniscus cells 
can suppress the production of inflammatory factors [275]. Further, dynamic compression (2% 
oscillatory strain, 1 Hz, 1 min on/1 min off duty cycle, 4 hrs per day for 4 days) of meniscus 
explants has been reported to increase aggrecan expression compared to statically compressed 
samples [276]. A longer duration loading regimen (0.1 MPa, 0.5 Hz, for 24 hrs) has also been 
shown to increase protein (68%) and proteoglycan  (58%) synthesis in meniscal explants [277]. 
Dynamic compression has also yielded other positive results in anatomically-shaped alginate 
scaffolds containing bovine meniscus cells [278]. The investigated loading regimen (7-15% 
strain, 1 Hz, 1 hr on/1 hr off duty cycle, 3 hrs per day, 3 days per wk for 6 wks) applied to 
meniscus constructs yielded increases in compressive equilibrium modulus and GAG content 
after 2 wks, and decreases in these values but increases in collagen content after 6 wks [278]. 
These results under different loading regimens highlight the varied biosynthetic responses that 
may occur following mechanical stimulus, and encourage the pursuit of additional research. 
   Of all of the factors being integrated to achieve successful engineering of the knee 
meniscus, mechanical stimulation is perhaps the one with the highest ambiguity and largest 
opportunity for improvement. Interestingly, while shear is generally thought of as detrimental to 
the chondrocyte phenotype, oscillatory fluid flow has been shown to upregulate calcium 
signaling and GAG production of meniscus cells in parallel plate flow chambers [279]. The use 
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of shear and other forces to generate fibrocartilage may yield benefits for meniscus tissue 
engineering in the future. Due to the large amount of variable parameters (method, time of 
application, magnitude, duration, and frequency of stimulation) the optimal and most dramatic 
combination of effects for mechanical stimuli likely remains undiscovered. 	  	  
CONCLUSIONS AND FUTURE DIRECTIONS 
This review has provided an account of current concepts in meniscus pathology and repair, as 
well as meniscus tissue engineering. Undoubtedly, the need for effective therapies based on 
tissue engineering approaches is exceedingly high. The driving factors for this are high 
incidences of meniscal lesions amongst several age groups in the general population and 
significant deficiencies associated with current repair techniques. Secondary to these factors are 
degenerative changes in articular cartilage, which lead to osteoarthritis and generate 
considerable socioeconomic costs for healthcare systems worldwide. Tissue engineering aims to 
ameliorate these problems by establishing new meniscus repair techniques that, for example, 
can yield constructs that restore mechanical function by integrating with or replacing the 
patient’s tissue. Apart from its potential clinical benefit, a tissue-engineered meniscus can also 
be of great use in the study of developmental, regenerative, and degenerative processes in the 
knee. 
   Despite considerable diversity amongst current strategies for tissue engineering the 
meniscus, several important design principles are emerging. In general, these principles relate to 
a biomimetic approach to generating replacement meniscus tissue by recapitulating biological, 
structural, and functional features of the native meniscus. First, cells in replacement tissue must 
possess a similar phenotype to those found in native meniscus. This dictates the presence of a 
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both fibroblast-like and chondrocyte-like cells. In cases of total meniscus replacement, this may 
also include vascularization in the outer periphery. Second, the biochemical content in the 
meniscus (i.e., collagen, GAGs) should closely mirror the regional variation displayed natively. 
This design principle will follow naturally from the use of cells with appropriate phenotypes. 
Third, functional anisotropy must be manifest in an engineered meniscus. Functional anisotropy 
of mechanical properties may in turn be recapitulated from the presence of appropriate ECM 
content. Taken together, these principles of tissue engineering using biomimicry may guide 
tissue engineers to generating a fully functional meniscus. 
   To achieve these goals, several strategies have been proposed, with mixed results. 
Several cell sources have been studied for meniscus engineering, including autologous, 
allogeneic, xenogeneic, and stem cells. Yet, amongst these, no specific cell source has been 
established, although stem cells are particularly promising. Whilst the various categories of 
biomaterial scaffolds offer different advantages, no approach currently addresses all three 
fundamental requirements of a successful meniscus tissue replacement (satisfactory mechanics, 
bioactivity, and logistics). In this field, a scaffoldless self-assembly process utilizing a 
biomaterial mold is another potentially effective strategy for meniscus tissue engineering that 
largely fulfills some of the above criteria. However, and perhaps more importantly, it lacks 
complications associated with scaffolds such as integration, degradation, biocompatibility, and 
stress shielding. In addition to these approaches, the use of synergistic biochemical and 
biomechanical stimuli are fundamental to the creation of functional tissue. Thus,  based on these 
advantages, the self-assembly process may provide sufficient flexibility to lead to functional 
tissue-engineered meniscus constructs. 
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   Even though the existing studies in meniscus tissue engineering show promising 
results, research needs to progress further. At the basic level, more long-term scaffold and 
scaffoldless studies aimed at improving mechanical properties and matching them to tissue need 
to be undertaken. Especially vital is the avoidance of scaffold degradation before mechanically-
competent tissue can be formed. In line with this, seeded cells must be encouraged to maintain 
their phenotype and synthetic capacity in a scaffold. Additionally, the reproducibility of 
engineered tissue needs to be established. Going a step further, experimental (animal) studies 
and well-designed prospective, randomized, and controlled clinical trials with long-term 
quantitative outcome measurement are key to in vivo evaluation of research in this field. The 
outlining of indications and contraindications, the selection of suitable patients for tissue repair 
with engineered meniscus, and the establishment of specialized surgical techniques are therefore 
necessary. Moreover, the development of non-invasive assessment procedures for generated 
tissue, both pre-implantation and post-implantation, is required. Directions for future research 
should also be guided by minimization of healthcare costs. These essential goals will be pivotal 
to the potential widespread clinical application of tissue-engineered meniscus. Although the 
challenge is vast, recent scientific advances suggest that a solution to this as-of-yet intractable 
problem may be emerging from the collaborative efforts of biomedical engineers, clinicians, 
and industry leaders.  	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TABLES AND FIGURES 	  	  
TABLE 1.1 – COMPRESSIVE PROPERTIES OF THE KNEE MENISCUS. 
Study Species Location Aggregate modulus  
(±SD; MPa)  
Permeability (±SD; 
10-15 m4 N-1 s-1) 
Sweigart et al. 
[37] 
Human Medial superior: 
Anterior 
Central 
Posterior 
Medial Inferior:  
Anterior 
Central 
Posterior 
 
0.15 ± 0.03 
0.10 ± 0.03 
0.11 ± 0.02 
 
0.16 ± 0.05 
0.11 ± 0.04 
0.09 ± 0.03 
 
1.84 ± 0.64 
1.54 ± 0.71 
2.74 ± 2.49 
 
1.71 ± 0.48 
1.54 ± 0.49 
1.32 ± 0.61 
Bovine Medial superior: 
Anterior 
Central 
Posterior 
Medial Inferior:  
Anterior 
Central 
Posterior 
 
0.21 ± 0.06 
0.14 ± 0.05 
0.11 ± 0.04 
 
0.16 ± 0.06 
0.11 ± 0.03 
0.13 ± 0.06 
 
6.22 ± 2.55 
5.73 ± 6.19 
4.73 ± 2.56 
 
5.79 ± 4.31 
5.65 ± 4.13 
5.40 ± 5.36 	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TABLE 1.2 – TENSILE PROPERTIES OF THE KNEE MENISCUS. 
Study Animal type Direction Location Stiffness (±SD; 
MPa) 
Fithian et al. 
[38] 
Human Circumferential Lateral 
meniscus: 
Anterior 
Central 
Posterior 
Medial 
meniscus: 
Anterior 
Central 
Posterior 
 
 
159.1 ± 47.4 
228.8 ± 51.4 
294.1 ± 90.4 
 
 
159.6 ± 26.2 
228.8 ± 51.4 
294.1 ± 90.4 
Tissakht et al. 
[280] 
Human Circumferential Lateral 
meniscus: 
Anterior 
Central 
Posterior 
Medial 
meniscus: 
Anterior 
Central 
Posterior 
 
 
124.58 ± 39.51 
91.37 ± 23.04 
143.73 ± 38.91 
 
 
106.21 ± 77.95 
77.95 ± 25.09 
82.36 ± 22.23 
Radial Lateral 
meniscus: 
Anterior 
Central 
Posterior 
Medial 
meniscus: 
Anterior 
Central 
Posterior 
 
   
48.47 ± 25.67 
45.86 ± 24.20 
29.85 ± 12.77 
 
 
48.31 ± 24.35 
46.20 ± 27.56 
32.55 ± 11.27 
Lechner et al. 
[281] 
Human Circumferential Medial 
meniscus: 
Anterior 
Central 
Posterior 
 
 
141.2 ± 56.7 
116.4 ± 47.5 
108.4 ± 42.9 	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TABLE 1.3 – CURRENT RESEARCH FINDINGS ON MENISCUS REPAIR TECHNIQUES 
(ALTERNATIVES TO MENISCECTOMY) FOR THE AVASCULAR ZONE. ACLT: Anterior cruciate 
ligament transection.	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TABLE 1.4 – LEADING BIOMATERIALS STRATEGIES FOR MENISCUS TISSUE ENGINEERING. 
Rated on three primary criteria. Categories were qualitatively rated from one to four stars in 
mechanics (mechanical properties, geometry, anisotropy, lubrication), bioactivity (cell 
phenotype, ECM synthesis, immunogenicity, potential for host tissue integration), and logistics 
(supply, material processability and sterilization, ease of surgical implantation). 
 
Rated 
Criterion 
Synthetic 
Scaffolds 
Hydrogel 
Scaffolds 
ECM Component 
Scaffolds (e.g., 
collagen, GAG) 
Tissue-Derived 
Scaffolds (e.g., SIS, 
decellularized matrix) 
Scaffold-Free 
(e.g., self-
assembly) 
Mechanics    ***    *    ***    **    *** 
Bioactivity    *    **    **    ****    **** 
Logistics    ****    ****    ***    *    ** 
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TABLE 1.5 – INFLUENCE OF SELECTED GROWTH FACTORS ADMINISTERED TO MENISCUS 
CELLS. 
 
Growth Factor Effects Culture Conditions 
TGF-β1 ↑↓ Proliferation Monolayer [103, 241, 242] 
 ↑↑ Collagen Synthesis Monolayer [249]; Scaffold [242, 244];  
Explant [290]; Scaffoldless [232] 
 ↑↑ GAG/Proteoglycan Monolayer [103, 249]; Scaffold [103, 244, 291]; 
Explant [103, 290]; Scaffoldless [232] 
 ↑ SZP Secretion Monolayer [250]; Explants [250] 
 ↑ Contraction Scaffold [255] 
   
b-FGF ↑↑↑ Proliferation Monolayer [241-243]; Scaffold [244] 
 ↑ Collagen Synthesis Monolayer [241, 243]; Scaffold [244] 
 ↑ GAG/Proteoglycan Monolayer [243, 249]; Explants [290] 
   
PDGF-AB ↑↑ Proliferation Monolayer [241, 245]; Scaffold [292];  
Explant [292] 
 ↑ Collagen Synthesis Monolayer [241]; Scaffold [242] 
 ↑ GAG/Proteoglycan Monolayer [249]; Explant [290] 
 ↑ Contraction Scaffold [254] 
 ↑↑ Migration Monolayer [245]; Scaffold [292]; Explant [292] 
   
IGF-I ↑ Proliferation Monolayer [103, 242]; Scaffold [244] 
 ↑↓ Collagen Synthesis Monolayer [249]; Scaffold [242] 
 ↑ GAG/Proteoglycan Explant [290] 
 ↑ Migration Monolayer [245] 
   
EGF ↑ Proliferation Monolayer [241] 
 ↑ Collagen Synthesis Monolayer [241] 
 ↑ Migration Monolayer [245] 
   
HGF ↑↑ Proliferation Monolayer [245]; Scaffold [292]; Explant [292] 
 ↑↑ Migration Monolayer [245]; Scaffold [292]; Explant [292] 
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FIGURE 1.1 – ANATOMY OF THE KNEE JOINT: ANTERIOR VIEW. The knee meniscus is situated 
between the femur and the tibia. Crossing the meniscus are various ligaments, which aid in 
stabilizing the knee joint.  
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FIGURE 1.2 – ANATOMY OF THE MENISCUS: SUPERIOR VIEW OF THE TIBIAL PLATEAU. This 
view of the tibial plateau highlights the ligaments of Humphrey and Wrisberg, which attach the 
meniscus to the femur. The menisci are attached to each other via the transverse ligament. The 
horn attachments connect the tibial plateau to the meniscus. 
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FIGURE 1.3 – REGIONAL VARIATIONS IN VASCULARIZATION AND CELL POPULATIONS OF THE 
MENISCUS. Left: Though fully vascularized at birth, the blood vessels in the meniscus recede 
during maturity. In adulthood, the red-red region contains the overwhelming majority of blood 
vessels. Right: Cells in the outer, vascularized section of the meniscus (red-red region) are 
spindle-shaped, display cell processes, and are more fibroblast-like in appearance, while cells in 
the middle section (white-red region) and inner section (white-white region) are more 
chondrocyte-like, though they are phenotypically distinct from chondrocytes. Cells in the 
superficial layer of the meniscus are small and round. 
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FIGURE 1.4 – HOW FORCE IS TRANSDUCED UPON AND THROUGHOUT THE KNEE MENISCUS. 
Free body diagram of the forces acting on the knee meniscus during loading (for simplicity, 
only the lateral meniscus is shown). During everyday activity, the menisci are compressed by 
the downward force of the femur. Since the meniscus is a wedge, the femoral force is enacted at 
an angle, and thus a vertical component exists which is countered by the upward force of the 
tibia. Additionally, a horizontal component of the femoral force exists, which is exerted radially 
outward on each meniscus. This horizontal force is in turn countered by the anchoring force of 
the attachments at the posterior and anterior horns of the meniscus. Additionally, as this 
compression occurs, circumferential stress is created along the meniscus. Therefore, the menisci 
function by converting compressive loads to circumferential tensile loads. At the same time, 
shear forces are developed between the collagen fibers within the meniscus while the meniscus 
is deformed radially. 
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FIGURE 1.5 – THE CLASSICAL, SCAFFOLD-BASED APPROACH FOR MENISCUS TISSUE 
ENGINEERING. Generation of a functional meniscus requires several key considerations. 
Characterization of the meniscus is essential for establishing design parameters. Following this, 
judicious choice of cell type(s), scaffold material(s), and exogenous stimuli must be made. 
Implantation in vivo may be substituted for, or performed subsequent to, bioreactor culture. 
Using these tools, tissue engineering aims to regenerate or replace the meniscus.  
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FIGURE 1.6 – THE STRATEGY OF TISSUE SELF-ASSEMBLY FOR MENISCUS TISSUE 
ENGINEERING. This approach utilizes a hydrogel mold to form completely biologic tissue 
constructs. Selection of cells is of paramount importance. Following isolation from allogeneic 
or xenogeneic sources, articular chondrocytes (ACs) and meniscus cells (MCs) are expanded to 
achieve the high numbers needed for robust tissue engineering. Mesenchymal stem cells, but 
also potentially embryonic stem cells, are a promising alternative cell source for subsequent 
differentiation into meniscus cells. Cells are then seeded in high density in a non-adherent 
biomaterial mold, secreting ECM that coalesces into a continuous tissue over several days. 
Exogenous stimuli are added during culture to increase the synthetic activity and functional 
properties of neotissue, which is eventually implanted in vivo.  
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CHAPTER 2 – A COPPER SULFATE AND HYDROXYLYSINE 
TREATMENT REGIMEN FOR ENHANCING COLLAGEN 
CROSSLINKING AND BIOMECHANICAL PROPERTIES IN 
ENGINEERED NEOCARTILAGE 
 
ABSTRACT 
The objective of this study was to improve the biomechanical properties of engineered 
neotissues through promoting the development of collagen crosslinks. It was hypothesized that 
supplementing medium with copper sulfate and the amino acid hydroxylysine would enhance 
the activity of lysyl oxidase enzyme to form collagen crosslinks, increasing the strength and 
integrity of the neotissue. Neocartilage constructs were generated using a scaffoldless, self-
assembling process and treated with copper sulfate and hydroxylysine, either alone or in 
combination, following a two-factor, full factorial study design. Following a 6-week culture 
period, the biomechanical and biochemical properties of the constructs were measured. Results 
found copper sulfate to significantly increase pyridinoline (PYR) crosslinks in all copper 
sulfate-containing groups over controls. When copper sulfate and hydroxylysine were 
combined, the result was synergistic, with a 10-fold increase in PYR content over controls. This 
increase in PYR crosslinks manifested in a 3.3-fold significant increase in the tensile properties 
of the copper sulfate + hydroxylysine group. Additionally, an 123% increase over control values 
was detected in the copper sulfate group in terms of the aggregate modulus. These data 
elucidate the  
 
 
 
 
Chapter published as: Makris, E.A., MacBarb, R.F., Responte, D.J., Hu, J.C., & Athanasiou, 
K.A. A Copper Sulfate and Hydroxylysine Treatment Regimen for Enhancing Collagen 
Crosslinking and Biomechanical Properties in Engineered Neocartilage. FASEB journal: 
official publication of the Federation of American Societies for Experimental Biology. 27(6): 
2421-2430, 2013.  
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role of copper sulfate and hydroxylysine toward improving the biomechanical properties of 
neotissues through collagen crosslinking enhancement.  
 
INTRODUCTION 
Arthritis is the second most frequent chronic disease in the United States. Currently affecting 
46.4 million people and costing the U.S. over $128 billion per annum, the economic burden of 
this disease is tremendous and growing344. The most common form of arthritis, known as 
osteoarthritis (OA), is characteristic of joint cartilage degeneration345. Due to the inability of 
articular cartilage to self-repair, there are currently no clinical options for treating OA. The 
ability to generate engineered articular cartilage in vitro, therefore, holds much promise as an 
effective reparative treatment for OA. Many advances have been made in articular cartilage 
tissue engineering strategies toward developing a biomechanically robust repair tissue able to 
integrate with the surrounding healthy cartilage. Though much work remains to be done to 
engineer clinically relevant repair cartilage, tissue engineering approaches offer new hope 
toward bringing a degenerated joint back to an uncompromised state.  
 Current tissue engineering approaches for generating articular cartilage typically involve 
a combination of cells, signals (e.g., growth factors, mechanical stimulation), and scaffolds. 
Deviating from the typical tissue engineering paradigm, our group has developed a self-
assembly method in which we forgo the use of a scaffold. By culturing articular chondrocytes at 
high densities in 3-dimensional cultures using non-adherent agarose wells, we are able to form 
robust neocartilage in a manner akin to native cartilage morphogenesis212, 230, 305. This process is 
advantageous in that it is not affected by the inherent problems associated with scaffolds, such 
as biodegradability, stress-shielding, and hindering of cell-to-cell communication. However, as 
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with scaffold-based tissue engineering approaches, self-assembled articular cartilage often fails 
to match the high mechanical strength of native tissue, leaving it incapable of withstanding the 
complex loading scheme of an articular joint. These inferior properties mainly manifest in the 
tensile properties of engineered neotissue; targeted efforts to increase the tensile properties of 
engineered articular cartilage are, therefore, crucial to creating tissues with clinical impact. 
The ability of articular joints to withstand high loads is mainly due to the load adsorbing 
and distributing properties of articular cartilage. With structure and function being intimately 
linked, a direct tie between mechanical integrity and both extracellular matrix (ECM) 
composition and structure has been observed. In the case of articular cartilage, the typical 
structure-function paradigm links the presence of an organized collagen network with the 
tissue’s tensile strength, while compressive stiffness has been related to glycosaminoglycan 
(GAG) distribution within the tissue346. However, recent investigations in both native and 
engineered articular cartilage have found this paradigm to shift. Such studies have reported that 
the collagen network significantly affects the compressive properties of articular cartilage335, 347. 
Specifically, a better correlation between the compressive modulus and the collagen content has 
been described348. Similarly, another study examining the correlation between the 
biomechanical and biochemical properties of superficial zone articular cartilage reported a 
correlation among the compressive modulus and both collagen and GAG with R2 values of 0.36 
and 0.24, respectively239. To explain this finding, it was hypothesized that increased collagen 
content may decrease the extrafibrillar volume and create a higher effective fixed charge 
density, which could increase tissue compressive properties349.  
The structure-function relationships related to collagen crosslinking have also been 
studied, although not as extensively as the effects of GAG and collagen. Pyridinoline (PYR) 
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crosslinks have been correlated with the tensile properties of native articular cartilage238. 
Likewise, a significant correlation among collagen crosslinks and compressive properties of 
native articular cartilage has also been reported348. Such studies indicate that the specific 
organization of the collagen architecture, including fiber density, diameter, orientation, and 
degree of crosslinking, all play a significant role in determining the mechanical integrity of both 
native and engineered tissues. These additional structure-function relationships will need to be 
elucidated to fully understand the biomechanics of cartilage. 
 Although current attempts to increase the tensile properties of engineered articular 
cartilage frequently focus on collagen content and alignment, increasing interfibrillar collagen 
crosslinks may provide an additional means to increase the tensile properties of neocartilage. 
While several investigations have characterized the nature of collagen crosslinking in native 
tissue, only a few studies have focused on the type, amount, and influence of collagen 
crosslinking in engineered tissues350. For instance, it has been shown that chondrocytes cultured 
on polyglycolic acid scaffolds or suspended within alginate beads produce collagen crosslinks; 
however, reported values were far from those of native articular cartilage351, 352. Furthermore, 
another study has demonstrated that collagen networks in engineered cartilage require proper 
crosslinking to stabilize the matrix and to provide it with mechanical strength353. Taken 
together, these studies illuminate the crucial role of crosslinks in the stabilization and 
mechanical support of the collagen network within both native and engineered cartilages. 
Methods must therefore be investigated to induce the formation of collagen crosslinks within 
engineered neocartilage to generate tissues with functional properties matching those of native 
tissue. 
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 In native cartilage, the formation of lysine-derived, covalent PYR crosslinks is 
dependent on the enzyme lysyl oxidase (LOX). To investigate the importance of LOX in 
articular cartilage, explants were treated with β-aminopropionitrile, a potent inhibitor of 
extracellular LOX activity. This treatment resulted in disorganization of the collagen 
architecture within the explants as well as a significant decrease in the biomechanical properties 
of the tissue354. Such work highlights the importance of LOX-mediated collagen crosslinks on 
the functional integrity of articular cartilage. LOX is a cuproenzyme, meaning its activity is 
dependent on the presence of copper12. Once activated by copper, LOX is able to modify the 
amino acids lysine and hydroxylysine into PYR crosslinks, the most abundant type of crosslink 
in native articular cartilage (Fig. 1)11, 355, 356. It is important to note that copper sulfate is not a 
common ingredient in culture mediums, leaving LOX in its inactive form in in vitro culture. 
Therefore, copper sulfate supplementation may be a powerful means to enhance the amount of 
collagen crosslinks and, therefore, improve the functional properties of engineered tissues.   
Previous work on LOX has shown this enzyme to act extracellularly, requiring collagen 
fibrils in a quarter-staggered array as a substrate to generate crosslinks357, 358. Furthermore, the 
proper aldehyde precursors for LOX must be present in the immature collagen fibrils, including 
both lysine and hydroxylysine (Fig. 1). While lysine is present as an essential component in 
culture medium, hydroxylysine can only be formed when the enzyme lysyl hydroxylase 
catalyzes the conversion of lysine into its hydroxylated form. This is crucial to generate mature 
PYR crosslinks11, 355. Despite its importance in the development of a functionally mature 
collagen matrix, this essential collagen crosslink precursor is currently not used in cartilage 
tissue engineering, meriting studies to investigate its potential for increasing interfibrillar 
collagen crosslinking in engineered articular cartilage.  
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The overall objective of this study was to enhance collagen crosslinking in engineered 
articular cartilage to improve the biomechanical properties towards those of native tissue. 
Articular cartilage constructs were generated using the self-assembly process and supplemented 
with copper sulfate and hydroxylysine either alone or in combination following a full factorial 
study design. Overall, it was hypothesized that chondrogenic media supplemented with copper 
sulfate and hydroxylysine would additively or synergistically enhance the amount of LOX-
mediated collagen crosslinks, thus increasing the tensile strength of the engineered neotissue.  
 
MATERIALS AND METHODS 
Harvest/isolation/self-assembly  
Juvenile bovine knee joints were obtained (Research 87, Boston, MA, USA) and harvested for 
the articular cartilage. Articular cartilage was minced from the condyles and patellar grove, and 
digested in a base medium of Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
1% penicillin/streptomycin/fungizone (PSF) and 2% collagenase (Worthington, Lakewood, NJ, 
USA) for 18 hours. Following digestion, chondrocytes were isolated and purified via filtration 
and centrifugation, and then stored in base medium containing 20% fetal bovine serum and 10% 
dimethyl sulfoxide in liquid nitrogen until needed for seeding.  
 For self-assembly, chondrocytes were defrosted, counted, and seeded into 5 mm 
diameter, 2% agarose wells at 5 million cells/well as previously described212. For the first week 
of culture, constructs were fed 500 µl of chondrogenic medium consisting of DMEM, 1% PSF, 
1% non-essential amino acids, 100 nM dexamethasone (Sigma, St. Louis, MO, USA), 1% ITS+ 
(BD Scientific, Franklin Lakes, NJ, USA), 40 µg/mL L-proline, 50 µg/mL ascorbate-2-
phosphate, and 100 µg/mL sodium pyruvate (Fischer Scientific, Pittsburgh, PA, USA). At day 
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7, the constructs were moved from the agarose molds into non-adherent tissue culture plates. 
Constructs were fed 1 ml of chondrogenic media until the end of the 6-week culture period.  
 
Treatments 
In this study, the effect of both copper sulfate (Sigma-Aldrich, St. Louis, MO, USA) and 
hydroxylysine (Sigma-Aldrich, St. Louis, MO, USA) on self-assembled neocartilage was 
investigated. Following a full-factorial study design, constructs were treated with 0.0016 
mg/mL copper sulfate and 0.146 mg/ml hydroxylysine either alone or in combination (copper 
sulfate + hydroxylysine group), or left untreated to serve as controls. Treatments were carried 
out for the entire culture duration, after which the neotissue was assayed, as described below.  
 
Histology  
Portions of constructs were embedded in Histoprep (Fisher Chemical, Vernon Hills, IL, USA) 
and sliced to 14 µm. After being fixed in chilled formalin, sections were stained with Picrosirius 
Red for total collagen and Safranin O/Fast Green for GAG.  
 
Biochemistry  
The wet and dry (following lyophilization for 2 days) weights of the construct segments 
designated for biochemical analysis were determined, after which the samples were digested in 
papain as previously described229. A chloramine-T hydroxyproline assay using a SIRCOL 
collagen assay standard (Accurate Chemical and Scientific Corp., Westbury, NY, USA) was 
used to assess for total collagen, while GAG content was measured using a dimethylmethylene 
blue dye-binding assay kit (Biocolor, Newtownabbey, Northern Ireland). DNA content was 
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determined using a Picogreen Cell Proliferation Assay Kit (Molecular Probes, Eugene, OR, 
USA).  
 
High performance liquid chromatography (HPLC) 
Segments of constructs were digested in 800 µl of 6 N HCl for 18 hours at 100°C prior to 
drying in a vacuum concentrator. Digested, dried samples were then re-suspended in 50 µl of 10 
nmol pyridoxine/ml and 2.4 µmol homoarginine/ml. After a 5-fold dilution with 0.5% HFBA in 
10% acetonitrile, 10 µl of each sample was run on the HPLC as previously described in the 
literature323. To quantify the crosslink content, PYR standards (Quidel, San Diego, CA, USA) 
were used.  
 
Compressive testing 
Following a previously established protocol, creep indentation testing was used to evaluate the 
compressive properties of the engineered neocartilage at the end of 6 weeks359. A micrometer 
was used to measure the thickness of a specimen prior to testing. Samples were then glued to a 
stainless steel surface and submerged in phosphate buffered saline for 15 minutes to reach 
equilibrium. Next, a 0.8 mm diameter flat, porous indenter tip was applied to the sample by a 
0.7 g mass until the sample crept to equilibrium. Finally, a semi-analytical, semi-numerical, 
linear biphasic model was used to approximate the aggregate modulus (HA), permeability, and 
Poisson’s ratio as previously described359. 
 
Tensile testing 
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Tensile testing was conducted using an Instron uniaxial testing machine (Model 5565, Canton, 
MA, USA). After being cut into dog-bone shapes, sample thickness and width were measured 
via ImageJ software. Samples were then glued at either extremity to paper strips, which were 
loaded into the Instron grips. A pull to failure test was then run at a strain rate of 1% of the 
gauge length (measured as the distance between the glued ends of the dog bone) per second 
until sample failure. The Young’s Modulus (EY) of the sample was calculated as the slope of the 
linear portion of the resulting stress vs. strain curve, while the ultimate tensile strength (UTS) 
was measured as the maximum stress reached during testing.  
 
Statistics 
To test the hypothesis that media supplemented with copper sulfate and hydroxylysine would 
improve the biomechanical properties of engineered articular cartilage, a 1-way ANOVA (n = 6 
per group) was used. When the 1-way ANOVA showed significance (p < 0.05), a Fisher’s post 
hoc test was applied. Data that had a positive interaction on an additive scale and resulted in a 
combined group that was greater than the addition of the two singular treatments were 
determined to be synergistic. Data for this study are represented as mean ± standard deviation 
(SD).  
 
RESULTS 
Gross morphology and histology 
Table 1 describes the morphological characteristics of the neocartilage (wet weight, water 
content, thickness, diameter, and cell content). While constructs from all groups displayed 
uniform diameter, significant differences were detected in terms of their thickness, wet weight, 
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and water content. Controls presented significantly greater thickness and wet weight over all 
treated groups. The copper sulfate group displayed lower water content compared to all other 
groups. When applied alone, hydroxylysine promoted cell proliferation in the engineered tissue. 
No significant differences were found to exist among groups in terms of neocartilage 
morphology, with all constructs maintaining a smooth, flat, disc-shaped appearance (Table 1, 
Fig. 2). Histologically, all constructs stained positive for both collagen and GAG, as displayed 
in Figure 2.  
 
Biochemistry 
Collagen content normalized to construct wet weight (Col/WW) is presented in Figure 3A. The 
mean ± SD percentages of Col/WW were 1.10 ± 0.14, 0.77 ± 0.08, 0.98 ± 0.24, and 0.75 ± 0.12 
for control, hydroxylysine, copper sulfate, and copper sulfate + hydroxylysine, respectively. 
While Col/WW was significantly decreased in all hydroxylysine-treated groups compared to 
controls, no significant differences were detected between the copper sulfate group and controls. 
GAG normalized to construct wet weight (GAG/WW) found the hydroxylysine group to have 
significantly higher GAG levels than all other groups (Fig. 3B). No significant differences were 
detected between controls and all copper sulfate-treated groups. The mean ± SD percentages of 
GAG/WW were 3.2 ± 0.3, 5.4 ± 1.1, 3.1 ± 0.3, and 4.9 ± 1.0 for control, hydroxylysine, copper 
sulfate, and copper sulfate + hydroxylysine, respectively. However, when GAG was normalized 
to cell content of the constructs, the hydroxylysine group had significantly lower amount of 
GAG content per cell, suggesting a decreased synthetic activity of the cells in this group.  
HPLC was used to measure the amount of PYR crosslinks formed in the engineered 
neotissue (Fig. 3). When the amount of PYR crosslinks was normalized to construct wet weight 
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(PYR/WW), both treatments containing copper sulfate were found to have significantly greater 
numbers of crosslinks compared to controls (Fig 3C). With a value of 9.9 ± 5.5 nmol/g, the 
copper sulfate + hydroxylysine treatment resulted in a synergistic 1016% increase over control 
values, which were measured at 0.9 ± 0.8 nmol/g. The hydroxylysine and copper sulfate groups, 
on the other hand, were found to have 3.1 ± 1.5 nmol/g and 4.9 ± 0.9 nmol/g, respectively. 
When the amount of PYR crosslinks was normalized to collagen content of the constructs 
(PYR/Col), similar trends were detected (Fig. 3D). The mean ± SD values of PYR/Col were 
0.08 ± 0.07, 0.39 ± 0.17, 0.49 ± 0.15, and 1.61 ± 0.15 nmol/mg for control, hydroxylysine, 
copper sulfate, and copper sulfate + hydroxylysine, respectively. 
 
Biomechanics 
To understand the influence of copper sulfate and hydroxylysine on the biomechanical 
properties of engineered articular cartilage, biomechanical testing was conducted (Fig. 4). Creep 
indentation testing found that all treatments significantly increased the HA of the engineered 
neocartilage over controls (Fig. 4A). The mean ± SD of HA values were 95 ± 41, 146 ± 50, 211 
± 35, and 153 ± 30 kPa for control, hydroxylysine, copper sulfate, and copper sulfate + 
hydroxylysine, respectively. The copper sulfate group presented the highest HA and resulted in a 
123% significant increase over controls. The mean ± SD permeability values were 3.07 ± 0.83, 
4.05 ± 2.77, 4.06 ± 2.66, and 1.99 ± 2.04 ×  10−15 m4/N.s, for control, hydroxylysine, copper 
sulfate, and copper sulfate + hydroxylysine, respectively, signifying no differences among the 
groups. Poisson’s ratio, on the other hand, was significantly lower in the copper sulfate-treated 
group. The mean ± SD values were 0.24 ± 0.06, 0.27 ± 0.05, 0.13 ± 0.12, and 0.14 ± 0.11, for 
control, hydroxylysine, copper sulfate, and copper sulfate + hydroxylysine, respectively. 
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 Tensile testing found that the copper sulfate and copper sulfate + hydroxylysine groups, 
with values of 1.0 ± 0.2 MPa and 1.3 ± 0.5 MPa, respectively, had significantly greater EY 
values than either the control or hydroxylysine groups (Fig. 4B). Specifically, the copper sulfate 
+ hydroxylysine group presented the highest tensile modulus among all groups, resulting in a 
significant 3.3-fold increase over controls. No significant differences were detected between the 
control and hydroxylysine groups, with values of 0.4 ± 0.7 MPa and 0.4 ± 0.1 MPa, 
respectively. In terms of the UTS, the copper sulfate + hydroxylysine-treated group exhibited a 
higher value than all other groups (Fig. 4C). Overall, the UTS values of the engineered 
neotissue were 0.18 ± 0.03, 0.20 ± 0.05, 0.26 ± 0.06, and 0.46 ± 0.15 MPa for the control, 
hydroxylysine, copper sulfate, and copper sulfate + hydroxylysine, respectively. 
 
DISCUSSION 
The purpose of this study was to enhance collagen crosslinking in engineered articular cartilage 
and therefore improve the tissue’s biomechanical properties. To carry out this goal, two agents 
with important in vivo roles in collagen crosslink formation were administered to the engineered 
tissue: copper sulfate and hydroxylysine. It was hypothesized that supplementing chondrogenic 
media with both copper sulfate and hydroxylysine would additively or synergistically increase 
the quantity of LOX-mediated collagen crosslinks in self-assembled articular cartilage, 
strengthening the collagen network and, thus, improving the tensile properties of the neotissue. 
The hypothesis was confirmed via a full factorial study design, demonstrating that the 
treatments enhanced both collagen crosslink content and biomechanical properties. Specifically, 
the combination of copper sulfate and hydroxylysine synergistically enhanced the PYR 
crosslinks of the neotissue by 1016% over controls, manifesting in a tensile modulus within this 
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group that was 3.3-fold larger than that of the control. In terms of the compressive properties, 
all treatments significantly increased the HA over controls. The copper sulfate treatment 
displayed the highest compressive modulus and resulted in an 123% increase over controls. 
Novel contributions of this study include demonstrating that 1) exogenous application of both 
copper sulfate and hydroxylysine increase the number of collagen crosslinks in engineered 
cartilage, 2) these treatments enhance both the tensile and compressive properties of the tissue, 
and 3) when applied alone, hydroxylysine promotes cell proliferation within the 3-dimensional 
culture environment provided by self-assembly.   
In addition to the novel contributions listed above, the treatments examined in this study 
resulted in other biochemical and morphological findings, which, when considered together, 
help explain the most significant findings of this study. For instance, all treated constructs 
presented with significantly lower thickness and higher pyridinoline content, suggesting that 
collagen crosslinking prevents expansive cartilage growth in vitro360. Further, concerning the 
proliferative effect of hydroxylysine, past work has shown that proliferative activity minimizes 
the synthetic activity of chondrocytes361. This may provide a plausible explanation of why these 
highly cellular constructs presented with significantly lower collagen and GAG (when 
normalized to the cell content), greater water content, and concomitantly lower biomechanical 
properties272, 362. It should be noted that no significant differences in cell number were found 
between control and copper sulfate + hydroxylysine-treated constructs. Possibly, the highly 
crosslinked collagen network within the combination-treated constructs inhibited the 
proliferative activity of hydroxylysine due to strong cell-ECM interactions363. Another 
possibility is that with addition of copper sulfate, LOX was activated even further, thus 
modifying and sequestering the proliferative effect of hydroxylysine. While this mechanism 
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remains unverified, the benefit of copper curtailing hydroxylysine’s proliferative effect is that 
the combined treated group did not suffer from loss of GAG and collagen when normalized to 
cell content, unlike the hydroxylysine treatment group. This finding, in combination with the 
synergistic increase in pyridinoline crosslinks within the copper sulfate + hydroxylysine treated 
group, may provide an explanation of why the combined treatment resulted in constructs having 
higher tensile properties than all other treatments.  
 Copper sulfate was chosen in this study for its potential to enhance collagen crosslinking 
in engineered tissue based on its principal role in forming LOX-mediated PYR crosslinks in 
vivo. The importance of copper sulfate has been demonstrated in various developmental studies. 
Such work has linked dietary copper deficiencies in mammals with abnormal skeletal and 
vascular development364. Further, LOX activity has been correlated with dietary copper, 
indicating that abnormal development is likely due to the inability of LOX to form stabilizing 
crosslinks in copper-deficient animals365. The effect of copper sulfate on cartilage has also been 
studied in vitro. One such study found the addition of copper in the range of 0.001 – 0.034 
mg/mL to upregulate collagen synthesis in cultured human articular chondrocytes by 
approximately 25%, while proteoglycan levels remained unchanged366. In a separate study, 
0.002 – 0.319 mg/mL copper sulfate was administered to porcine cartilage explants grown in 
vitro. At concentrations of less than 0.016 mg/mL, the copper sulfate was found to have no 
effect on proteoglycan synthesis. However, at concentrations greater than 0.04 mg/mL, copper 
sulfate was found to cause a dose-dependent increase of this ECM protein367. Together, these 
studies signify the important effects of copper sulfate for the development of a stabilized 
collagen matrix in a dose-dependent manner.  
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While several investigations have taken place showing the important effect of copper 
sulfate from a developmental standpoint as well as on native cartilage explants and 
chondrocytes, no studies have thus far investigated the potential for copper sulfate to enhance 
engineered cartilage. It should be re-emphasized that the basic media formulations used in most 
cartilage tissue engineering endeavors, such as DMEM, do not contain copper sulfate, limiting 
LOX-mediated collagen crosslinking. Limited development of crosslinks could affect the 
biomechanical integrity of the forming collagen network, leading to the relatively low 
biomechanical properties observed in engineered tissues. Reflecting on past work in which 
chondrocytes were treated with copper sulfate, the present study supplemented self-assembled 
articular cartilage with 0.0016 mg/mL copper sulfate. Results found increased levels of collagen 
crosslinks (444% increase over controls) to correspond with significant, 2.2-fold changes in 
both the tensile and compressive properties compared to controls. Although this study did not 
directly assess the activation of LOX by copper sulfate, other studies have amply verified the 
dependence of LOX on the presence of copper11, 12, 355. Overall, the results of this study shed 
light onto the potential to improve engineered cartilage via the enhancement of PYR collagen 
crosslinking as promoted by copper sulfate supplementation.  
The concentration of copper sulfate used in this study to promote PYR collagen 
crosslinking did not affect the viability of the cells within the engineered cartilage. Past work 
has found free circulating copper sulfate ions at physiological concentrations to lead to hydroxyl 
radical formation via reduction of Cu2+ by either superoxides or ascorbic acid, the latter of 
which is an important media component for engineered tissues368, 369. Therefore, when 
supplemented at too high of a concentration, copper ions can cause cellular toxicity. Results of 
this study found that the relatively low concentration of copper ions supplemented in the media 
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did not have a toxic effect on the cells, as the total cell number per construct did not 
significantly change in those subjected to copper sulfate. These results are similar to those 
found in a study on engineered arteries, where similar levels of copper sulfate were used with 
no toxic side effects370. Another possible detriment of using copper sulfate is that, in its ionic 
form, it has been shown to reduce the half-life of ascorbic acid371. With ascorbic acid being 
crucial for stimulating collagen production for in vitro tissue culture, decreasing the longevity of 
ascorbic acid could negatively impact collagen synthesis. Results, however, found that copper 
sulfate did not significantly change the amount of collagen in the engineered tissue, providing 
further validation that the amount used in this study is not deleterious to the formation of 
engineered articular cartilage. 
Previously, only one study investigated the effects of copper sulfate on modifying the 
biochemical and structural properties of engineered tissue. In that case, engineered arteries were 
supplemented with either 0.2 or 0.4 g copper sulfate/ml for the entire 7-week culture period, or 
treated with 0.2 g copper sulfate/ml for the first 4 weeks followed by 0.4 g copper sulfate/ml for 
the remaining 3 weeks of the culture period. Results found the latter regimen of copper sulfate 
supplementation to increase the number of crosslinks in the tissue to 2.5 mol PYR/mol collagen, 
compared to 1 mol PYR/mol collagen in tissue treated with 0.2 or 0.4 g copper sulfate/ml 
supplemented for the entire duration of culture. In spite of the significant crosslink increase, no 
significant differences in the maximum elastic modulus or burst pressure of the engineered 
arteries were found370. The authors attributed this lack of improvement in tensile properties to 
the low levels of collagen fibrils present in their tissue370. In contrast, the present study showed 
copper sulfate was able to significantly increase both the number of crosslinks as well as the 
tensile properties of the tissue. Thus, as previously proposed231, the tensile strength of a 
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collagen matrix does not only depend on collagen crosslinks, but also on the interplay within the 
collagen network among parameters such as fibril density, diameter, and orientation.  
In addition to copper sulfate activation of LOX to catalyze the formation of PYR 
crosslinks, proper incorporation of lysine in both its normal and hydroxylated forms into the 
collagen fibrils is essential to crosslink formation372. Dietary supplementation of radiolabeled 
hydroxylysine has shown that hydroxylysine is not incorporated into skin collagen, as this 
amino acid can be readily processed by gut bacteria373, 374. In contrast, whether hydroxylysine 
made directly available to chondrocytes can be incorporated into collagen is currently unknown. 
With respect to articular cartilage, dietary supplementation versus direct medium addition of 
chondroitin sulfate can yield profoundly different effects375-377, and the same might be the case 
for hydroxylysine. With regards to the incorporation of amino acids in their hydroxylated forms 
into collagen fibrils, only a limited number of studies currently exist. Exogenously administered 
hydroxylysine is capable of being incorporated into proteins in vitro by prokaryotic 
microorganisms378, 379, which share a similar pathway to mammalian cells to generate protein 
out of amino acids380. Work using chick embryos has shown that exogenous hydroxyproline can 
be incorporated into collagen molecules381, suggesting that hydroxylysine might likewise be 
incorporated into collagen in this study.  
Although the way chondrocytes use exogenously applied hydroxylysine remains 
unknown, the present study has found the combination of hydroxylysine and copper sulfate to 
synergistically increase the PYR content of the neotissue more than 10-fold. Physiologic PYR 
levels in 1 – 3 week-old bovine articular cartilage have been reported at 95.5 ± 29.4 nmol/g348. 
Should the generated cartilage be implanted, crosslinks within the implant are expected to 
continue to increase by utilizing the copper that is naturally available in vivo. While the 
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combined treatment promoted a synergistic increase in the PYR content of the neotissue over 
the individual treatments, a significant, although not synergistic, enhancement was observed in 
the tensile properties of the constructs of the same group. This suggests that a non-linear 
correlation may exist between collagen crosslinks and the tensile properties of engineered 
tissues. There is also the possibility of crosslinks forming between monomeric hydroxylysines 
outside of the collagen fibers. Future studies will therefore be important to help elucidate how 
chondrocytes interact with exogenously applied hydroxylysine.  
Aside from the physical architecture of the collagen matrix, it has been shown that the 
ability of LOX to generate collagen crosslinks is dependent on the monomeric or polymeric 
state of the collagen fibers themselves. LOX activity has been found to be dependent on the 
molecular chain length of the substrate382. Specifically, LOX activity was much higher on intact 
collagen fibrils than on monomeric collagen. It was suggested that LOX acts on collagen fibril 
intermediates, binding to and stabilizing growing, as opposed to mature, fibrils. Therefore, it 
can be seen that recapitulating the in vivo formation of collagen fibrils is crucial for enzyme-
mediated collagen crosslinking. This suggests that perhaps the way collagen fibrilogenesis 
occurs in vitro does not provide LOX with the intermediate collagen fiber substrate it requires, 
decreasing its ability to correctly form PYR crosslinks in engineered tissue. Future work toward 
better understanding collagen matrix formation in engineered tissues and how it compares to 
that of native tissues may help explain why engineered tissues have comparatively inferior 
biomechanical properties. Such studies will help provide insight toward developing more 
mechanically functional collagen networks in engineered tissues which will, in turn, help 
advance the field toward generating clinically relevant replacement and reparative tissues. 
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While this study hypothesized that enhanced collagen crosslinking would increase the 
tensile properties of engineered articular cartilage, results found the copper sulfate treatment to 
also significantly enhance the compressive properties of the tissue by 123% over control values, 
as well as over other treated groups. Interestingly, results found the hydroxylysine containing 
groups to have significantly increased GAG/WW over controls; GAG levels in copper sulfate-
treated constructs, however, were not significantly different than controls. This result may at 
first appear counterintuitive, especially when one considers the structure-function paradigm 
associated with articular cartilage, that tensile properties are associated with collagen content 
while compressive properties are linked to GAG content346. Although GAG plays an important 
role in providing articular cartilage with compressive robustness, recent reports have found 
collagen density and organization also to be important for the compressive properties of this 
tissue335, 347, 348. It has been shown that a better collagen network can more effectively 
immobilize negatively charged proteoglycans, thus increasing the mechanical stability of the 
network in both tension and compression383. Therefore, with increased collagen crosslinks, it 
follows that the increased stabilization of the collagen network increases resistance to 
compressive loading. Additionally, the copper sulfate alone treatment significantly decreased 
the water content of the engineered neotissue. With no significant differences between the 
thickness and diameter of the copper sulfate-treated constructs compared to all other groups, 
this suggests that copper sulfate promotes the development of a denser ECM. This is further 
corroborated by maintenance of the collagen and GAG content in this group compared to 
controls. Taken together, copper sulfate appears to yield a functionally superior ECM in 
engineered neocartilage in terms of construct biomechanical properties. With both tensile and 
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compressive properties improved, copper sulfate offers much promise as a potent agent toward 
generating clinically relevant repair cartilage.  
An additional finding in this study was that exogenous application of hydroxylysine 
significantly increased the number of cells per construct, 117% over controls. This finding is 
pertinent to the field of tissue engineering, as a major problem with clinically relevant cell 
sources is their limited availability. When working with such cell sources, methods to induce ex 
vivo proliferation are therefore necessary to achieve high enough cell numbers to engineer 
tissues. Unfortunately, past work has found that passaging and expanding cells in monolayer 
typically leads to a loss of phenotype384. Results of this study suggest that simply adding 
hydroxylysine to the media of engineered neocartilage significantly increases cell numbers. 
Although the potential of hydroxylysine, as any chemical agent applied to articular 
chondrocytes, to affect the phenotype of the cells exists, application of hydroxylysine in the 
combined group resulted in significantly increased mechanical properties and cartilage-like 
tissue as also confirmed by histology and biochemistry. Thus, results of this study suggest that 
hydroxylysine did not alter the chondrogenic phenotype. While future work should be carried 
out to investigate the effects of hydroxylysine as a potent proliferative agent in different 3-
dimensional environments, using other cell types, as well as monitoring cellular phenotype 
following proliferation, this work promises a new avenue to promote the expansion of cells in 3-
dimensional culture. Ultimately, this may be an important step toward solving the limited 
availability of clinically relevant cell sources for tissue engineering applications. 
 Making up 50-80% of the dry weight of articular cartilage, collagen fibers act as the 
main mechanical support structure of cartilage, providing the tissue with the means to 
effectively distribute and withstand high tensile loading within the joint space385. While offering 
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much promise as an effective remedy for diseased cartilage, engineered cartilage replacements 
currently do not have the mechanical strength to withstand the high levels of in vivo loading. 
This study focused on a novel approach to enhance the tensile properties of engineered cartilage 
through reinforcing the collagen network via PYR crosslinks. Using copper sulfate and 
hydroxylysine, two important agents in the development of such crosslinks, this study found the 
use of both agents to synergistically enhance the number of PYR crosslinks in the engineered 
tissue. Further, both copper sulfate and copper sulfate + hydroxylysine treatments significantly 
enhanced the tensile properties of the tissue. Additionally, all treatments significantly increased 
the compressive modulus over controls, with the copper sulfate treatment displaying the highest 
values. Hydroxylysine was also identified as a promising agent to promote cellular proliferation 
in a 3-dimensional culture environment. Overall, this work speaks to the importance of ensuring 
proper collagen crosslinking in the generation of robust tissues capable of having a clinical 
impact. Future work should attempt to understand how hydroxylysine is used by articular 
chondrocytes, use gene expression assays to investigate whether copper sulfate upregulates 
LOX expression, as well as focus on understanding how collagen networks are developed in 
engineered tissues. Together, such work will aid in the quest to generate clinically relevant 
regenerative tissues. 
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TABLES AND FIGURES 
 
 
TABLE 2.1 – ENGINEERED NEOCARTILAGE’S PROPERTIES AT THE END OF A 6-WEEK CULTURE 
PERIOD. Values marked with different letters within each category are significantly different (p 
< 0.05), with A > B > C. 
Group Wet weight (mg) 
Water 
content (%) 
Thickness 
(mm) 
Diameter 
(mm) 
Cells/construct 
(millions) 
Control 51.9 ± 2.7A 86.9 ± 1.9A 1.95 ± 0.34A 5.94 ± 0.12 6.08 ± 3.31B 
Hydroxylysine 45.2 ± 1.2B 86.7 ± 1.3A 1.45 ± 0.06B 6.01 ± 0.16 13.2 ± 1.84A 
Copper sulfate 29.3 ± 1.8C 83.2 ± 2.2B 1.20 ± 0.08B 5.86 ± 0.21 8.09 ± 2.31B 
Copper sulfate 
+ hydroxylysine 28.9 ± 1.1
C 86.5 ± 1.3A 1.29 ± 0.11B 6.01 ± 0.17 7.25 ± 4.36B 
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FIGURE 2.1 – MOLECULAR MECHANISM OF LOX-MEDIATED PYR COLLAGEN CROSSLINKING. 
The molecular pathway of collagen crosslinks in musculoskeletal tissues initiated by the 
extracellular enzyme LOX. Triple helix and telopeptide lysines are tracked by color, from initial 
to mature crosslinks. Bone contains both PYR and pyrrole collagen crosslinks, while articular 
cartilage features only PYR crosslinks. (Adapted from Eyre et al.355). 
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FIGURE 2.2 – GROSS MORPHOLOGY AND HISTOLOGY OF SELF-ASSEMBLED NEOCARTILAGE AT 
THE END OF THE 6-WEEK CULTURE PERIOD. Both control and treated constructs formed 
uniform neocartilage without physical abnormalities. Constructs stained positive for Safranin-
O/Fast Green staining for GAG and Picrosirius Red staining for collagen in all groups.  
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FIGURE 2.3 – BIOCHEMICAL PROPERTIES OF TISSUE-ENGINEERED NEOCARTILAGE. A) 
Col/WW, B) GAG/WW, C) PYR/WW, and D) PYR/Col. Col/WW was significantly decreased 
in all hydroxylysine-treated groups compared to controls. No significant differences were 
detected between the copper sulfate group and controls. In terms of GAG/WW, no significant 
differences were detected between controls and the copper sulfate-treated groups, while 
hydroxylysine significantly increased the amount of GAG/WW over controls. HPLC found all 
copper-sulfate treated groups to have significantly greater amounts of PYR/WW compared to 
controls, with a synergistic increase measured in the copper sulfate + hydroxylysine group. 
Similar trends were detected when the amount of PYR crosslinks were normalized to construct 
collagen content. Bars denote means ± SD, and groups not connected by the same letter are 
statistically different (p<0.05).  
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FIGURE 2.4 – BIOMECHANICAL PROPERTIES OF SELF-ASSEMBLED NEOCARTILAGE. A) HA B) 
EY, and C) UTS. Creep indentation testing found that all treatments significantly increased the 
compressive modulus of the engineered neocartilage. The copper sulfate group presented the 
highest HA and resulted in a 123% significant increase over controls. Both the copper sulfate 
and copper sulfate + hydroxylysine groups significantly increased the tensile modulus of the 
constructs over the control and hydroxylysine groups. The copper sulfate + hydroxylysine group 
presented the highest tensile modulus among all groups, resulting in a significant 3.3-fold 
increase over controls. Results for the UTS, however, found only the copper sulfate + 
hydroxylysine group to be significantly higher than all groups. Bars denote means ± SD, and 
groups not connected by the same letter are statistically different (p<0.05).  
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CHAPTER 3 – HYPOXIA-INDUCED COLLAGEN CROSSLINKING AS A 
MECHANISM FOR ENHANCING MECHANICAL PROPERTIES OF 
ENGINEERED ARTICULAR CARTILAGE. 
 
ABSTRACT  
Objective: The focus of tissue engineering of neocartilage has traditionally been on enhancing 
extracellular matrix and thus biomechanical properties. Emphasis has been placed on the 
enhancement of collagen type and quantity, and, concomitantly, tensile properties. The 
objective of this study was to improve crosslinking of the collagen network by testing the 
hypothesis that hypoxia could promote pyridinoline (PYR) crosslinks and, thus, improve 
neocartilage's tensile properties. 
Methods: Chondrocyte expression of lysyl oxidase (LOX), an enzyme responsible for the 
formation of collagen PYR crosslinks, was first assessed pre- and post- hypoxia application. 
Then, the mechanical properties of self-assembled neocartilage constructs were measured, after 
4 weeks of culture, for groups exposed to 4% O2 at different initiation times and durations, i.e., 
during the 1st and 3rd weeks, 3rd and 4th weeks, 4th week only, continuously after cell seeding, 
or never. 
Results: Results showed that LOX gene expression was upregulated ∼20-fold in chondrocytes 
in response to hypoxia. Hypoxia applied during the 3rd and 4th weeks significantly  
 
 
 
 
 
 
Chapter published as: Makris, E.A., MacBarb, Hu, J.C., & Athanasiou, K.A. Hypoxia-induced 
collagen crosslinking as a mechanism for enhancing mechanical properties of engineered 
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increased PYR crosslinks without affecting collagen content. Excitingly, neocartilage tensile 
properties were increased ∼2-fold. It should be noted that these properties exhibited a distinct 
temporal dependence to hypoxia exposure, since upregulation of these properties was due to 
hypoxia applied only during the 3rd and 4th weeks. 
Conclusions: These data elucidate the role of hypoxia-mediated upregulation of LOX and 
subsequent increases in PYR crosslinks in engineered cartilage. These results hold promise 
toward applying hypoxia at precise time points to promote tensile integrity and direct construct 
maturation. 	  
INTRODUCTION 
Articular cartilage (AC) pathologies, as a result of injury/trauma or age-related degeneration, 
are a major health problem in the developed world. Osteoarthritis (OA) is undoubtedly the most 
frequent chronic musculoskeletal disease, limiting the daily activities of the elderly (1). Over 
the past two decades, progress has been made on the development of therapeutic approaches for 
the treatment of early stage cartilaginous defects, thus slowing down their progression to OA. 
However, current therapeutic procedures including washing, shaving and debridement, stem cell 
stimulation-based procedures and explant grafts have thus far proved to be incapable to effect 
long-term cartilaginous repair (2). Tissue engineering has the potential to generate tissues by 
developing a biomechanically competent extracellular matrix (ECM) in vitro (3). However, 
limitations in the development of neotissues that mimic the structural composition and, hence, 
biomechanical behavior of native tissues present a great challenge in that field (4). Therefore, it 
is important for technologies to be developed that generate neotissues capable of bearing 
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physiological loads, and various exogenous stimuli during neocartilage culture have been 
examined. 
In engineering cartilage, hypoxia has been proposed for both stem cells and 
differentiated chondrocytes. For stem cells, hypoxia has been reported to promote chondro-
differentiation (5-7) and to impede hypertrophy (8). Hypoxia inducible factor 1 (HIF-1) has 
been hypothesized as critical for hypoxic induction of chondrogenesis (8). For engineering 
articular cartilage, however, hypoxia has shown mixed results. For instance, some studies have 
suggested that Sox9 expression is largely independent of hypoxia (9), while others have shown 
that this transcription factor increases with reduced oxygen levels (10). Likewise, extracellular 
matrix (ECM) components (e.g., aggrecan, collagen type II, proteoglycan 4) have been shown 
to be upregulated with hypoxia in certain cases (10, 11), while others have shown that 
cartilaginous ECM production is indifferent to hypoxia (12) or even suppressed by it in certain 
instances (13, 14). In brief, though the majority of evidence supports hypoxia as an effective 
method for enhancing engineered cartilage constructs, mechanisms behind such improvements 
have largely remained elusive. For hypoxia to be used efficiently and reliably in cartilage tissue 
engineering, a robust mechanistic connection between hypoxia and mechanical properties must 
be determined. 
 In the human body, normal oxygen tension, or normoxia, is between 5-13% (15). 
Oxygen levels lower than 5% are considered hypoxic (16), while the atmospheric oxygen 
tension of 21% should be considered hyperoxic (17). For differentiated chondrocytes, oxygen 
tension can be as low as 1–2.5%, thus qualifying cartilage as functioning under a hypoxic 
environment (14). As a result, oxygen concentration during in vitro culture likely needs to be 
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below 5% to induce significant hypoxia inducible factor 1 (HIF-1) stabilization and its 
subsequent up-regulation of various matrix-associated genes. 
The anisotropic, structural and mechanical properties of articular cartilage, including its 
well-developed, collagen fiber architecture, determine the functionality and mechanical integrity 
of the tissue (18). Apart from collagen content and organization, the load-bearing capacity of 
collagen is related to other ECM components. Two features that directly influence the stiffness 
of native articular cartilage and determines the maturity of collagen are the type and quantity of 
collagen crosslinks (19, 20). Thus far, these critical features have not been sufficiently 
mimicked in the ECM of engineered tissues; lack of progress on this front may be a factor for 
the current limitations in tissue modulus and strength (19, 21).  An opportunity exists in the 
modulation of collagen crosslinking in engineered neocartilage to enhance tissue structural and 
functional integrity. While hypoxia has been associated with collagen crosslinking in several 
other tissues (22-24), its use for inducing crosslinks in engineered cartilage remains unexplored.  
In this study, engineered cartilage is formed using a scaffoldless, self-assembling 
process that removes the potentially confounding effects of scaffolds. The objectives of this 
study are to examine two hypotheses: 1) that hypoxia (4% oxygen) will enhance the mechanical 
properties of engineered articular cartilage by mediating collagen crosslinking via LOX, and 2) 
this specific response to hypoxia is dependent on application time. 
 
MATERIALS AND METHODS 
Chondrocyte isolation 
Articular cartilage was sterilely harvested from the distal femur of knee joints obtained from 1-
week-old calves (Research 87, Boston, MA, USA). Tissue was minced into 1 mm pieces and 
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digested in 0.2% collagenase type II (Worthington, Lakewood, NJ, USA) for 18 hours in cell 
culture medium (Dulbecco’s modified Eagle’s medium (DMEM) with low glucose (1g/L)) (Life 
Technologies corp., Carlsbad, CA, USA), 10% fetal bovine serum (FBS) (Atlanta Biologicals), 
1% non-essential amino acids (NEAA) (Life Technologies corp., Carlsbad, CA, USA), 25 mg 
of L-ascorbic acid (Sigma-Aldrich, St. Louis, MO, USA), and 1% penicillin/ streptomycin/ 
fungizone (PSF) (BioWhittaker Inc., Walkersville, MD, USA). After digestion, articular 
chondrocytes were washed three times in PBS with centrifugation and filtered through a 70-µm 
filter. Cells then were counted and were frozen at -80°C in culture medium supplemented with 
10% FBS and 10% dimethyl sulfoxide (Fischer Scientific, Pittsburgh, PA, USA). Cells were 
then stored in liquid nitrogen until used. 
  
Construct formation via the self-assembling process 
Constructs were generated by seeding articular chondrocytes into cylindrical, non-adherent 
wells using a technique adapted from previous work (3, 25). A stainless steel mold consisting of 
5 mm diameter cylindrical prongs was placed into molten 2% agarose (Life Technologies corp., 
Carlsbad, CA, USA) in a 48-well plate. The agarose solidified at room temperature, and the 
mold was removed. Two changes of control medium (DMEM with GlutaMAX (Life 
Technologies corp., Carlsbad, CA, USA), 100 nM dexamethasone (Sigma-Aldrich, St. Louis, 
MO, USA), 1% NEAA, 1% PSF, 1% ITS+ premix (BD Scientific, Franklin Lakes, NJ, USA), 
50 mg/mL ascorbate-2-phosphate (Sigma-Aldrich, St. Louis, MO, USA), 40 mg/mL L-proline 
(Sigma-Aldrich, St. Louis, MO, USA), and 100 mg/mL sodium pyruvate (Fischer Scientific, 
Pittsburgh, PA, USA)) were used to saturate the agarose before cell seeding. Following 
isolation, articular chondrocytes were thawed within 5 days of freezing. Viability assessed using 
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trypan blue was >90%. To create each construct, 5.5 million cells in 100 µl control medium 
were seeded into each gelled, cylindrical agarose well, followed by addition of 400 µl control 
medium after 4 h. Cells coalesced into free-floating, disc-shaped constructs upon the non-
adhesive agarose; t = 1 day was defined as 24 h after seeding. Constructs were cultured in the 
agarose wells until t = 10 days, at which point they were unconfined transferred to 48-well 
plates where they were unrestricted by circumferential confinement. Constructs received 500 µl 
medium change every 24 h and remained in culture until t = 28 days. All culture was at 37 °C 
and 10% CO2. 
 
Hypoxia application 
Following seeding, constructs were divided into five treatment groups. Constructs in the first 
group (control) were incubated continuously at 37°C, 5% CO2, and 21% O2. Constructs from 
the other groups were incubated under the same conditions but also treated with 4% O2 
(hypoxia) during the following culture periods: t=1-7 days and 15-21 days (1st and 3rd weeks), 
t= 8-14 days and 22-28 days (3rd and 4th weeks), t=22-28 days (4th week), and t=1-28 days 
(continuous hypoxia). Every other day, 500µl of medium was changed. After four weeks of 
culture, constructs were divided into parts for histological, biochemical, and biomechanical 
assessments. 
 
Histology 
Samples of the neotissue were cryoembedded in Histoprep (Fisher Chemical, Vernon Hills, IL, 
USA) and sectioned at 14 µm with orientation from top to the bottom of the construct, in all 
groups. Following sectioning, samples were fixed in formalin for 15 min. Qualitative evaluation 
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of collagen and GAG content of the samples was performed by using Safranin-O/fast green and 
Picrocirious red stains as previously described (26). Phenotype maintenance of articular 
chondrocytes was evaluated with immunohistochemistry (IHC). Briefly, samples were fixed in 
chilled (4°C) acetone, rehydrated, and stained for collagen type I and II by following protocols 
provided by Chondrex and Vectastain as previously described (26). Native bovine articular 
cartilage and patellar tendon were used as positive type II and type I controls, respectively.  
Quantitative biochemistry 
Biochemical samples were lyophilized, and dry weight was recorded. Subsequently, samples 
were digested using a pepsin-elastase protocol as previously described (26). Collagen content in 
the engineered tissue was evaluated using a colorimetric hydroxyproline assay (27).A Blyscan 
Glycosaminoglycan Assay kit (Biocolor, Newtownabbey, Northern Ireland) was used for 
sulfated GAG content quantification (28) . Cell content in the engineered tissue was 
approximated using a Picogreen dsDNA reagent (Molecular Probes, Eugene, OR, USA) for 
DNA quantification and a conversion factor of 7.7 pg DNA/cell.  
 
High performance liquid chromatography  
The abundance of pyridinoline crosslinks in the engineered tissue was quantified using high 
performance liquid chromatography (HPLC). Portions of the constructs were weighed wet, 
digested in 400µl 6N HCL and dried in a vacuum concentrator. 50 µL of an aqueous solution 
containing 10 nmol pyridoxine/mL and 2.4 µmol homoarginine/mL was used for sample re-
suspension and then diluted fivefold with an aqueous solution of 0.5% HFBA acetonitrile in 
10% acetonitrile. Following this, 10 µL of each sample was injected into a 25 mm C18 column 
(Shimadzu, Columbia, MD, USA) and eluted using a solvent profile as previously described 
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(29). A calibration curve was performed using pyridinoline standards (Quidel, San Diego, CA, 
USA)  for crosslink quantification.  
 
Creep indentation testing 
Compressive properties were evaluated using creep indentation as previously described (30). 
Specimens equilibrated in PBS for 15 minutes and then indented to ~15% strain using a flat, 
porous indenter tip (0.8 mm diameter). The compressive properties of the samples were 
obtained using a semi-analytical, semi-numeric, linear biphasic model (30). 
 
Tensile testing 
Tensile properties were determined using a uniaxial material testing apparatus (Instron Model 
5565) and tested as previously described (31, 32). Samples were tested until failure by applying 
a strain rate of 1% of the gauge length per second. Tensile stiffness and ultimate tensile strength 
(UTS) were determined based on stress-strain plots. 
 
RT-PCR 
Real time PCR analysis was performed to investigate hypoxia-mediated gene expression of the 
target genes. Dynamic changes in LOX expression can occur during the first 18 hours of a 
culture’s introduction to hypoxia (17, 33). In order to observe LOX expression at steady state, 
measurements within the short time period immediately after hypoxia exposure were avoided. 
On the other hand, since LOX-induced crosslink formation can require weeks to mature, it was 
desirable to assess for LOX expression as early as possible. Thus, hypoxia was applied in 3 wk-
engineered neocartilage for two days and the gene expression of lysyl oxidase was quantified as 
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previously described (17). S18 (housekeeping gene) and lysyl oxidase (LOX) primers were 
purchased from US Biological. RT was performed by incubating 500 ng of RNA with 
SuperScript III (Life Technologies corp., Carlsbad, CA, USA) as recommended by the 
manufacturer. Real-time PCR was done using SYBR Green mastermix and 1 µm primers on a 
Rotor-gene 3000 real-time PCR machine (Corbett Research, Bath, UK). A 10 min denaturing 
step was employed, followed by 45 cycles of 95 °C (15 s) and 60 °C (60 s). The take-off cycle 
(CT) for each gene of interest (GOI) was compared to the housekeeping gene GAPDH. Relative 
gene expressions were calculated using the 2−ΔΔCT method. 
 
Statistical analysis 
All biochemical and mechanical assessments in this study were performed using n = 5 - 8 
samples per group. Numerical data are represented as mean ± 95% confidence interval for the 
mean (95% CI). The presence of outliers was determined using either Grubb’s test and/or by 
noting assaying errors. Prior to performing statistical tests, the data were checked for both 
normality and equal-variance using Levene’s test. To compare among equal treatment groups 
one-way analysis of variance (ANOVA) was performed using StatView software (StaView inc 
Cary, Nesbit, MS, USA). If significance was identified, Fisher’s post hoc testing was applied. 
Unequal sample sizes were addressed by nonparametric all-pairs multiple comparisons based on 
pairwise rankings in the one-way design with the Steel-Dwass procedure. P-values less than 
0.05 were considered significant. 
 
RESULTS 
Gross morphology and histology 
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At the end of the culture period the morphological properties and composition of the engineered 
constructs were assessed via gross inspection and histological evaluation. All constructs 
presented with similar flat surfaces without abnormalities and no significant differences were 
detected in morphology among the groups. Table 1 describes morphological characteristics 
(diameter, thickness, and wet weight) of the constructs. Histology showed that all constructs 
stained uniformly positive for both GAG and collagen content (Fig. 1). Additionally, IHC 
showed that neocartilage from all groups stained positive for collagen type II and negatively for 
collagen type I proving normal articular cartilage phenotype maintenance in all groups (Fig. 1).  
 
Biochemical properties 
Growth of the constructs was evaluated through assessment of the amount of collagen, GAG, 
DNA, and PYR of neotissue at the end of the culture period. Table 2 describes the biochemical 
characteristics of the constructs. Concerning the GAG content normalized to constructs’ wet 
weight no significant differences were detected among the groups (p=0.718). In terms of the 
percentage of collagen normalized to construct wet weight (Col/WW), no significant differences 
were detected among control, and late hypoxia application groups (3rd and 4th weeks, and 4th 
week group) (p=0.2716 and p=0.9919 respectively). Interestingly, constructs treated with 
hypoxia at an early stage (1st and 3rd weeks and all weeks groups) presented with significantly 
lower amount of collagen over control and late treated groups (p=0.004 and p=0.004). Hypoxia 
applied during 3rd and 4th weeks significantly increased the amount of PYR/WW over controls 
(34% increase) (p=0.003), while no significant effects were detected on the other applied groups 
over controls (p=0.4160, p=0.9753, and p=0.9991 for 1st and 3rd weeks, 4th week and continuous 
groups, respectively) (Table 2). However, when pyridinoline content normalized to constructs’ 
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collagen content (PYR/Col) early application of hypoxia (1st and 3rd weeks, continuous groups) 
exhibited the highest amount of collagen crosslinks (p<0.001 and p=0.001, respectively) (Table 
2). Furthermore, in the 3rd and 4th weeks group the amount of PYR/Col was significantly higher 
over controls (p=0.0499), while in the 4th week group no significant differences were detected 
(p=0.4583). Results suggest that early hypoxia treatment, although it significantly decreases 
collagen synthesis in the engineered tissue, promotes higher pyridinoline crosslinks than when 
applied late during the self assembling process. The 3rd and 4th weeks hypoxia application group 
suggests an optimal treatment for promoting collagen crosslinking without affecting the 
collagen content of the constructs and, thus, enhancing the mechanical properties of the 
engineered tissue. 
 
Biomechanical properties 
To quantify the influence of low oxygen tension applied at different time periods on 
biomechanics of self-assembled neocartilage, compressive properties represented by the 
aggregate modulus, permeability and poison’s ratio and tensile properties represented by 
Young’s modulus (EY) and UTS and were determined. On regards of compression properties no 
significant difference was detected among the groups (p=0.4017, p=0.1101, and p=0.3124 for 
aggregate modulus, permeability, and Poisson’s ratio, respectively) (Table 3). Low oxygen 
tension applied during 3rd and 4th weeks of self assembling process significantly increased the 
tensile stiffness of the constructs over control group (~80% increase) (p<0.0001). Similar trends 
were observed concerning the UTS of the constructs (Table 3). Enhanced mechanical properties 
reflected the observed changes in the pyridinoline content.  
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RT-PCR 
Real time PCR was employed to investigate the effects of hypoxia in the engineered 
neocartilage using the self-assembly method. Application of hypoxia in the neotissue promoted 
18-fold increase in the gene expression of lysyl oxidase over controls cultured under normoxic 
conditions. 
 
DISCUSSION 
This is the first study to demonstrate that hypoxia’s effect on enhancing engineered cartilage’s 
tensile properties is through collagen crosslinking. Experimental data proved both hypotheses 
motivating the study, showing 1) hypoxia is a viable method for promoting collagen 
crosslinking in engineered tissue through LOX gene expression and 2) distinctly different 
responses can be elicited by this stimulus by manipulating application time and duration. 
Hypoxia can be restricted to influence only the tensile properties of the constructs, while other 
neocartilage properties such as gross morphology, collagen and GAG biochemistry, and 
compressive stiffness remain unaltered. By determining a method wherein hypoxia can be 
isolated to act only through collagen crosslinks, this study provides a robust method for 
improving the tensile properties of engineered cartilage that has the potential to be extended to 
other engineered tissues.  
In this study, hypoxia was applied in tissue engineered articular cartilage to enhance 
crosslinking by promoting gene expression of lysyl oxidase. Low oxygen tension (4% O2) 
applied during the 3rd and 4th weeks of self assembly of neocartilage significantly increased the 
amount of pyridinoline molecules (PYR/WW and PYR/Col) over controls and the other treated 
groups with concomitant increase in the gene expression of lysyl oxidase (18-fold) over 
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controls. In contrast, no significant differences were observed among the 3rd and 4th weeks, the 
4th week and control groups for collagen, GAG and DNA content per WW and DW. 
Additionally, hypoxia applied during the 3rd and 4th weeks increased the tensile stiffness of 
neocartilage by approximately 80% over controls p<0.0001). These results demonstrate that 
application of hypoxia can be directed to promote collagen crosslinking and enhance the tensile 
properties in engineered cartilage, independently of other biochemical and biomechanical 
properties. 
 In contrast, hypoxia applied during times other than the 3rd and 4th weeks did not result 
in improved properties. At times, these properties were diminished, shedding light onto the 
mixed results seen in the cartilage engineering literature that employ hypoxia. Specifically, 
early application of hypoxia (1st and 3rd weeks and continuous application groups) significantly 
increased the PYR/Col content. This can be explained by the longer time that hypoxia-mediated 
collagen crosslinking formation was allowed to develop in these groups compared to late 
application groups. For instance, the characteristic time constants for the formation of immature 
(difunctional) and mature (trifunctional) pyridinoline crosslinks have been reported to be 1-2 
and 7-30 days, respectively (34). However, early hypoxia application had no effect on 
PYR/WW and significantly decreased the collagen content of neotissue at these groups. Thus, 
the mechanical properties of neotissue remained unchanged. Biochemical evaluation further 
showed no significant differences in terms of the number of cells per construct and GAG/WW 
in these groups; It would, thus, appear that early hypoxia application is actually detrimental to 
engineering self-assembled cartilage when it is applied during a time previously identified as 
the collagen synthesis phase (25). 
  These results are similar to a previous study investigating the effects of 5% and 20% O2 
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applied continuously for 2, 4 and 6 weeks in a scaffold-free chondrocyte culture (13). In this 
study, engineered cartilage from scaffold-free cultured chondrocytes at 20% O2 produced better 
ECM than that at 5% O2. Thus, the present study offers an examination on the conflicting 
results currently seen with hypoxia; hypoxia applied during the collagen synthesis phase of 
engineered cartilage can diminish collagen production and therefore adversely affect construct 
biomechanical properties. This time dependence issue should be further investigated in other 
cartilage engineering approaches.  
In 3-dimensional cultures or engineered tissues, work on studying the effects of different 
oxygen concentrations might be impaired by poor oxygen diffusion that creates an oxygen 
gradient within tissue (35). Additionally, HIF-1α protein is very unstable at the environmental 
oxygen level while its mRNA is not affected by hypoxic conditions (16). This makes it difficult 
to demonstrate, experimentally, HIF-1α protein increases in response to hypoxia. However, the 
link between hypoxia, LOX gene expression, and LOX-mediated collagen crosslinking has been 
explored in many other tissues (17, 23, 25, 36). Specifically, growth of porcine aortic 
endothelium cells in 0% or 2% oxygen tension resulted in little change in cell numbers or cell 
protein, but a fall in collagen synthesis and in proline and lysine hydroxylases, as well as a rise 
in LOX gene expression, were observed (36). Similarly, the crosslink pattern and the gene 
expression of lysyl hydroxylase 2 (LH2) were investigated using skin cells from systemic 
scleroderma, cultured under low oxygen tension conditions. Prolonged hypoxia induced a 
marked increase of the mRNA level of LH2 in relation to collagen I (22). Thus, the use of 
hypoxia to promote LOX- and LH- mediated collagen crosslinking can be considered as a 
robust mechanism and this experiment showed not only that hypoxia can be used in engineering 
cartilage, but that its effects can be isolated to tensile properties only. 
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Further proof of the robustness of the hypoxia-tensile relationship can be seen in 
engineering other tissues (17, 35, 37). It has been reported that 7% O2 applied in human 
vascular-derived myofibroblasts seeded onto a biodegradable scaffold similarly increases 
construct properties as seen in this study (37). In another case, 4% O2 enhanced gene expression 
of LOX and LH2 (17). It is, thus, conceivable that the use of hypoxia can be translated to other 
musculoskeletal tissues. The extracellular matrix of native ligaments, tendons, bone, and other 
musculoskeletal tissues is composed of proteoglycans and fibrillar proteins, such as elastin and 
collagen. The load-bearing capacity of collagen is, apart from collagen content and 
organization, highly dependent on collagen crosslinking, which stabilizes the collagen fibrils 
(38). The in vitro formation of these highly important ECM components can be affected by 
mechanical, biochemical, and environmental stimuli, such as oxygen concentration (37, 39, 40). 
As with this experiment, hypoxia could potentially improve the mechanical properties of other 
engineered musculoskeletal tissues through collagen crosslinking enhancement. However, 
application time for these engineered tissues must be optimized as to restrict its effects on 
crosslinks only.  
Due to HIF-1α’s link with other ECM gene expression, this study provides strong 
support for further development of other hypoxia duty cycles. Specifically, hypoxia may be 
applied during certain times to encourage proper differentiation, switching to normoxia to 
induce collagen synthesis, and returning to hypoxia to promote crosslinking. The motivation 
that underlies such a duty cycle can be found in multiple studies. For stem cells, hypoxia, 
through HIF-1α overexpression, has been shown to be effective and sufficient in inducing a 
chondrocytic phenotype on human bone marrow stem cells without use of exogenous growth 
factors (41). Similar results have been obtained with adipose-derived stem cells (42). While 
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hypoxia seems beneficial for chondrodifferentation, early application during neocartilage tissue 
engineering does not result in improved properties as demonstrated by this and prior work (13). 
Thus, the present study provides strong support for further development of other hypoxia duty 
cycles, suggesting that, until robust mechanisms can be determined for hypoxia’s effects on 
ECM synthesis, this potent stimulus should only be applied for differentiation and for collagen 
crosslinking. 
Aside from pyridinoline, other cartilage crosslinks such as arginoline and advanced 
glycation end products (AGEs) might similarly be manipulated to influence neocartilage 
stiffness. Arginoline makes up for half of the mature cross-links in native cartilage (43) but 
cannot be measured via HPLC, necessitating future studies on its characterization in engineered 
tissues. AGEs occur over a time-scale of decades as sugars react with the lysine and arginine 
residues during aging. Examples of common AGEs include crosslinks, such as pentosidine (44-
46), methylglyoxal-lysine dimer (MOLD) (45), and threosidine (47), as well as Nε-
(carboxymethyl)lysine (CML) (48) and Nε-(carboxyethyl)lysine (CEL) (49). Though past work 
has correlated AGEs with stiffening of the collagen matrix (50), AGEs have also been 
implicated in the progression of age-related cartilage degeneration such as osteoarthritis (51). 
AGEs may thus be an inferior candidate when compared to pyridinoline and arginoline for 
enhancing neocartilage mechanical properties. 
In this experiment, low oxygen tension (4% O2) was investigated at various application 
times during the self-assembling process both to identify optimal regimens for hypoxia 
application and to elucidate a mechanism through which hypoxia-induced increases in cartilage 
mechanical properties occur. Hypoxia applied during the collagen synthesis phase resulted in 
decreased collagen content. However, hypoxia applied later in culture served to induce LOX 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  125 
expression, crosslink formation, and increased tensile properties. Strong evidence from both this 
study and a plethora of prior studies suggest that this occurs through the robust mechanism of 
HIF-1α-induced upregulation of LOX. The results shown here are promising as they show that 
hypoxia can be used to tissue engineer neocartilage with robust tensile properties. In the future, 
while one may consider the possibility of employing hypoxia to achieve similar biomechanical 
improvements in cartilage just showing signs of mechanical degradation, a different regimen 
will have to be identified for intra-articular regulation of oxygen tension. Additionally, hypoxia 
may be beneficial for enhancing the mechanical properties of autografts or allografts.  
TABLES AND FIGURES 	  
 
 TABLE 3.1 – GROWTH METRICS AND BIOCHEMICAL CONTENT OF 4 WEEKS NEOCARTILAGE 
CONSTRUCTS. The effects of hypoxia as a function of application time during the self-assembly 
of articular cartilage (control, 1st & 3rd weeks, 3rd  & 4th weeks, 4th week, and continuous 
hypoxia groups) were examined on gross morphology (diameter, thickness, and wet weight) and 
biochemical properties (water content and DNA) of 4 weeks neocartilage constructs. Values are 
mean±95% CI. No significant differences were detected among controls and hypoxia treated 
groups. See Results section for details. Col=collagen, GAG=glycosaminoglycan, WW=wet 
weight. 
Groups Diameter 
(mm) 
(P = 0.4645) 
Thickness 
(mm) 
(P = 0.2384) 
Wet weight 
(mg) 
(P = 0.4566) 
Water content 
(%) (P = 0.7472) 
Cell number 
(millions) 
(P = 0.2669) 
Control 5.21 ± 0.22 1.53 ± 0.11 29.87 ± 4.93 88.75 ± 13.23 3.01 ± 2.86 
1st & 3rd 
weeks 5.17 ± 0.33 1.35 ± 0.25 29.65 ± 8.80 90.50 ± 12.11 4.03 ± 3.26 
3rd & 4th 
weeks 5.11 ± 0.23 1.40 ± 0.22 26.45 ± 2.06 87.46 ± 7.93 4.24 ± 5.22 
4th week 5.09 ± 0.33 1.48 ± 0.42 28.30 ± 7.42 87.81 ± 9.52 4.46 ± 4.39 
Continuous 5.20 ± 0.24 1.45 ± 0.35 28.09 ± 10.95 88.19 ± 5.43 2.64 ± 2.22 
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TABLE 3.2 – BIOCHEMICAL PROPERTIES OF SELF ASSEMBLED NEOCARTILAGE. Biochemical 
properties of the engineered neocartilage as represented by Col/WW, GAG/WW, PYR/WW and 
PYR/Col. Values are mean±95% CI. See Results section for details. Col=collagen, 
GAG=glycosaminoglycan. WW=wet weight, PYR=pyridinoline. 
Groups Collagen/WW 
(%) 
(P < 0.0001) 
GAG/WW 
(%) 
(P = 0.718) 
PYR/WW 
(nmol/g) 
(P = 0.0036) 
PYR/Col 
(nmol/mg) 
(P < 0.0001) 
Control 3.03 ± 0.61A 4.39 ± 2.10 4.99 ± 1.86B 0.16 ± 0.030D 
1st & 3rd 
weeks 1.93 ± 1.27
B 3.84 ± 3.85 5.68 ± 1.00A,B 0.30 ± 0.169A 
3rd & 4th 
weeks 3.33 ± 1.23
A 4.96 ± 3.44 6.63 ± 1.90A 0.20 ± 0.034C 
4th week 3.03 ± 1.50A 4.91 ± 3.50 5.19 ± 1.06B 0.17 ± 0.105C,D 
Continuous 1.91 ± 0.44B 4.44 ± 2.96 5.08 ± 1.88B 0.26 ± 0.063B 
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TABLE 3.3 – BIOMECHANICAL PROPERTIES OF THE ENGINEERED NEOCARTILAGE. 
Compression properties of tissue engineered neocartilage constructs represented by aggregate 
modulus, permeability and Poison’s ratio and tensile properties represented by Young’s 
modulus and ultimate tensile strength (UTS). Values are mean±95% CI. See Results section for 
details. 
Group Aggregate 
modulus  
(MPa)  
(P = 0.4017) 
Permeability 
(10−15 m4/N's) 
(P = 0.1101) 
Poisson's 
ratio 
(P = 0.0773) 
Young's 
modulus  
(MPa) 
(P < 0.0001) 
UTS (MPa) 
(P = 0.4600) 
Control 0.11 ± 0.06 18.50 ± 15.69 0.09 ± 0.22 0.45 ± 0.23B,C 0.07 ± 0.04 
1st & 3rd 
weeks 0.10 ± 0.06 16.85 ± 16.89 0.08 ± 0.02 0.19 ± 0.23
C 0.11 ± 0.07 
3rd & 4th 
weeks 0.12 ± 0.05 11.62 ± 9.68 0.05 ± 0.11 0.82 ± 0.53
A 0.06 ± 0.09 
4th week 0.13 ± 0.04 16.04 ± 8.70 0.01 ± 0.02 0.53 ± 0.54A,B 0.11 ± 0.11 
Continuous 0.11 ± 0.06 24.98 ± 28.31 0.06 ± 0.12 0.25 ± 0.19B,C 0.18 ± 0.18 
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FIGURE 3.1 – GROSS MORPHOLOGY, HISTOLOGY, AND IMMUNOHISTOCHEMISTRY (IHC) OF 
SELF-ASSEMBLED NEOCARTILAGE. Both controls and hypoxia treated constructs (LOX) 
formed uniform neocartilage constructs with similar flat surfaces without physical 
abnormalities. The orientation of cryosectioning was from top to bottom in all groups (14 µm 
sections). Safranin-O/fast green staining for glycosaminoglycans and Picrosirius Red staining 
for collagen showed that constructs produced these matrix components uniformly for all groups. 
IHC illustrated that all groups were positive stained for collagen type II but not for collagen 
type I, suggesting articular cartilage phenotype. 
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CHAPTER 4 – IMPROVING THE BIOMECHANICAL PROPERTIES OF 
MUSCULOSKELETAL TISSUES THROUGH EXOGENOUS AND 
ENDOGENOUS APPLICATION OF LYSYL OXIDASE 	  
ABSTRACT 
The inability to recapitulate native tissue biomechanics, especially tensile properties, hinders 
progress in regenerative medicine. To address this, strategies have focused on enhancing 
collagen production. However, manipulating collagen crosslinks, ubiquitous throughout all 
tissues and conferring mechanical integrity, has been under-investigated. Invoking a mechanism 
of hypoxia inducing pyridinoline crosslinks via intermediaries such as lysyl oxidase (LOX), a 
series of studies showed that both native and engineered tissues are enhanced. Hypoxia was 
shown to enhance 1.4-6.4x pyridinoline crosslinking and concomitantly increase 1.3-2.2x 
tensile properties of collagen-rich tissues. Exogenous LOX administration enhanced 1.9x tissue 
biomechanics. Finally, LOX concentration- and time-dependent increases in pyridinoline 
content (~16x of controls) and tensile properties (~5x of controls) of neotissue were detected, 
resulting in properties on par with native tissue. LOX pre-treatment of engineered cartilage 
promoted in vivo matrix maturation resulting in an additional increase in tensile properties. 
Collectively, these results provide the first report of endogenous (hypoxia-mediated) and 
exogenous LOX applications promoting collagen crosslinking and improving the tensile 
properties of a spectrum of native and engineered tissues. 
 
 
 
Chapter submitted as: Makris, E.A., Responte, D.J., Paschos, N.K., Hu, J.C., & Athanasiou, 
K.A. Improving the biomechanical properties of musculoskeletal tissues through exogenous 
and endogenous application of lysyl oxidase. 2014 
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MANUSCRIPT 
 
Recent efforts have focused on developing de novo musculoskeletal tissues such as cartilage, 
bone, tendons, and ligaments for reparative and regenerative strategies. Tissue engineering has 
the potential to provide alternative treatment options for musculoskeletal disease and injury by 
generating neotissue that mimics the complex structure of native tissue1,2. Despite recent 
advances, poor biomechanical properties of engineered tissues limit their potential for clinical 
application3,4. In particular, tensile properties are still not on par with native tissue values, 
mainly due to the lack of interfibrillar collagen crosslinks5. Therefore, it is important that 
additional treatment modalities be evaluated toward enhancing tensile properties. 
Collagen, comprising the major fraction of the extracellular matrix (ECM) of 
musculoskeletal tissues, accounts for approximately 65-80% of these tissues’ respective dry 
weights6. After collagen biosynthesis and triple-helix formation, extracellular modification of 
lysine and hydroxylisine of the collagen fibers into their aldehyde forms, by the extracellular 
enzymes lysyl oxidase (LOX) and lysyl hydroxylase (LH), results in covalent crosslink 
formation between individual collagen molecules (Fig. 1)7. These intermolecular collagen 
crosslinks, pyridinoline and pyrrole, are present in all musculoskeletal tissues such as bone, 
cartilage, ligaments, and tendons8. The crosslinked collagen fibrils non-covalently stabilize the 
highly hydrated, negatively charged proteoglycans9. Articular cartilage features only 
pyridinoline collagen crosslinks, with the major types including the difunctional 
(initial/immature) crosslink dehydrodihydroxylysinonorleucine (DDHLNL) and the 
trifunctional (mature) crosslink hydroxylysylpyridinoline (HP). In ligaments, the most 
predominant collagen crosslink is dihydroxylysinonorleucine10, which turns into the mature 
pyridinoline form, while in tendons and menisci the trifunctional pyridinoline crosslinks, HP 
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and lysyl PYR, stabilize the fibrillar collagen structure11. Despite the differences present in the 
type of collagen crosslinks in the various musculoskeletal tissue, several studies have 
highlighted how biomechanical properties of all native musculoskeletal tissues are closely 
correlated with collagen crosslinking5,12,13, suggesting the need for recapitulating crosslinking in 
vitro in engineered tissues.  
In engineered musculoskeletal tissues, such as cartilage, tendon, ligament, or 
fibrocartilage there have been only few studies evaluating the extent of collagen crosslinks 14,15 
and, more importantly, their influence on tissue tensile and compressive properties. In contrast, 
many studies have investigated how other ECM components, such as glycosaminoglycans 
(GAG), collagen, and mineralization, contribute to biomechanical properties14,16-18. Such work 
has yielded variable results, as exemplified by the following: For instance, while it has been 
suggested that the compressive properties of native articular cartilage are best correlated with 
the proteoglycan component of the ECM19, more recent studies have shown a better correlation 
of the compressive modulus with a combination of both GAG and collagen content20-22. For 
engineered tissues, tensile stiffness has been strongly associated with total collagen content17 as 
well as pyridinoline content23. Nevertheless, a significant correlation with compressive 
properties has also been reported with respect to the pyridinoline content of engineered 
tissues23. Clearly, tissue biomechanical properties are dependent on more than merely the 
quantity of one biochemical component24. The unique structural organization, cross-linking and 
architecture of the collagen network also play equally important roles along with collagen 
quantity in determining the biomechanical functionality of the tissue. 
To the best of our knowledge, there are no studies demonstrating methods for promoting 
collagen crosslinking in native and engineered tissues. Low oxygen tension, though, has been 
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shown to have various effects in different tissues25,26, through a hypoxia-dependent mechanism. 
This molecular mechanism is based on the critical involvement of hypoxia inducible factor-1 
(HIF-1)27 which is present in articular chondrocytes28 and in many other cells29-31. In 
diarthrodial joints as well as developmental growth plates, cartilage experiences hypoxic 
conditions32; deletion of HIF-1α results in chondrocyte death along with diminished expression 
of the CDK inhibitor p57, highlighting the importance of HIF-1α expression for cell survival 
and growth arrest in this environment33. More recently, the critical role of HIF-1α in 
chondrogenic differentiation of rat mesenchymal stem cells as well as human embryonic stem 
cells has been identified34-37. Low oxygen tension has also been shown to affect the metabolism 
of articular chondrocytes targeting the production of tissue-specific cartilage ECM proteins34,38-
41. The manifold role of HIF-1 raises the potential toward promoting cartilage repair through 
stimulation of HIF-regulated pathways that promote cartilage specific matrix synthesis. 
Although studies have elucidated the pathway underlying the effects of HIF-mediated signaling 
on cartilage growth, function, and synthesis, the use of hypoxia to specifically enchance 
mechanical properties in native and engineered tissues through collagen crosslinking has not 
been explored. 
 In the series of studies presented in this manuscript, a variety of musculoskeletal tissues were 
used to assess collagen crosslinking manipulation in an attempt to promote tissue functional 
properties in vitro. Purposefully targeting collagen crosslinks should be useful for engineering 
tissues de novo, for elucidating disease processes, and for the development of potential novel 
therapeutic modalities. The first study established the presence of the triptych hypoxia-PYR 
crosslinking-biomechanics correlation in native cartilage. Figure 2 shows that hypoxia applied 
to articular cartilage explants enhanced collagen crosslinking by promoting LOX gene 
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expression, leading to significant improvement of tissue biomechanical properties. Low oxygen 
tension (2% O2) application for 4 weeks significantly increased the amount of pyridinoline 
crosslinks 43% over controls, with a concomitant increase in LOX gene expression (~44-fold) 
(Fig. 2b and 2c). The tensile stiffness of articular cartilage treated with hypoxia was 238% of 
control values. No significant differences were observed for collagen, GAG, and DNA content 
per wet weight (WW) and dry weight (DW) (Table 1), indicating that the increase in properties 
was directly associated with the formation of crosslinks. By applying the LOX inhibitor β -
aminopriopionitrile (BAPN), the effects of hypoxia (increased Young’s modulus and 
PYR/WW) were abolished, reaffirming the proposed mechanism of action. These results 
demonstrate that application of hypoxia can be directed to promote LOX-mediated pyridinoline 
collagen crosslinking and to enhance tensile properties in native articular cartilage. Hypoxia 
increased tensile properties independently of other biochemical and biomechanical properties, 
making it a good target for further investigation. These data not only call forth new biological 
questions on the mechanism of action in articular cartilage, but also generate clinical interest in 
the ability of hypoxia to alter the biomechanical properties of other tissues. 
Taking a step further, the second study sought to determine whether hypoxia could 
effectively enhance the mechanical properties of other musculoskeletal tissues via the same 
LOX-mediated mechanism. Similarly, low oxygen tension application resulted in significant 
increases (140-643% of controls) in the tensile properties of a wide spectrum of musculoskeletal 
tissues, such as the anterior (cranial) cruciate ligament, posterior (caudal) cruciate ligament, 
patellar tendon, and knee meniscus (Fig. 3a and 3b). As hypothesized, this was shown to occur 
through hypoxia-induced increases in pyridinoline crosslinks per WW (52-71% increase over 
control values) and per collagen content (63-117% increase over control values) (Fig. 2c and 
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2d). These findings were further confirmed with the addition of LOX inhibitor BAPN that 
resulted in partial ofr full abolishment of the measured differences generated from the 
application of hypoxia (Young’s moduli, PYR/WW, and PYR/Col). Hypoxia leads to increased 
tensile properties through the up-regulation of HIF-1α42, which then up-regulates LOX43, and in 
turn, catalyzes the formation of pyridinoline crosslinks44 to result in enhanced tissue 
biomechanics. This series of events appears to be rather robust, considering the multitude of 
tissues validated here. In essence, hypoxia was effective in manipulating the tensile properties 
of a spectrum of tissues through LOX-mediated crosslinking. 
Interestingly, the increase of tensile properties in articular cartilage and other collagen-
rich tissues was not the only effect of hypoxia; low oxygen tension induced other significant 
effects (Table 1). Specifically, although hypoxia induced pyridinoline crosslinks in all examined 
tissues, it decreased the amount of collagen in some tissues, such as the PCL and meniscus. 
Hypoxia-induced HIF-1α upregulation controls the expression of cartilage specific 
transcriptional factor SOX-9 that directly regulates the main matrix genes, such as those 
encoding Col-2a1, aggrecan, Col-9, and LOX34,41; Thus, these findings indicate that hypoxia 
exerts various effects upon ECM components of musculoskeletal tissues in addition to 
endogenously inducing crosslink formation. Considering the pleiotropic effects of low oxygen 
tension (e.g., angiogenesis, apoptosis, and chondrogenesis), it would be useful to identify other 
methods to enhance tensile properties, ideally through exogenous agents.  
From the several exogenous agents, which could potentially be used to enhance tissue 
tensile properties, the most straightforward route is through the exogenous addition of LOX. 
This enzyme is directly responsible for the formation of pyridinoline crosslinks. Exogenous 
addition of LOX would potentially bypass side effects caused by hypoxia, HIF-1α, and their 
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downstream products. Thus, the next series of experiments within the present study employed 
exogenous LOX administration on both native and engineered tissues. Literature lacks any 
comparable experience, with only few previous studies just show LOX application in smooth 
muscle cell monolayer cultures to increase matrix synthesis and pyridinoline content45. In the 
present study, exogenous LOX application at various concentrations applied for 2 weeks on 
native articular cartilage showed that a LOX concentration of 0.15ng/ml (High LOX) 
significantly increased pyridinoline crosslink content per WW (204% of control values) and per 
collagen (250% of control values) (Fig. 4c and 4d). This LOX concentration resulted in tensile 
stiffness and strength of articular cartilage at 186% and 185% of control values, respectively 
(Fig 4a and 4b). No significant effects were observed on collagen, GAG, and DNA content of 
the LOX-treated tissue over controls (Table 1), strongly suggesting that LOX mainly acts on the 
ECM. Thus, exogenous LOX application appears to provide a simple, yet effective, way to 
promote matrix maturation and enhance cartilage integrity, and it is anticipated the same will 
hold true across other collagenous tissues. 
To further refine how collagen crosslinks can be controlled in vitro during tissue 
development, the temporal modulation of LOX-induced collagen crosslinking was examined in 
two phases, using self-assembled neocartilage as a representative model. A Phase I study 
showed that a LOX concentration of 0.15µg/ml significantly increased the amount of 
pyridinoline crosslinks in the engineered tissue over controls by 16.2 times (Fig. 5b). More 
importantly, the tensile properties of the engineered tissue increased to 5.0 times those of the 
controls (Fig. 5a). A Phase II study, which examined the time dependence of LOX application, 
showed that early LOX application significantly increased the tensile stiffness of engineered 
neocartilage over late LOX application. In this case, the tensile stiffness of LOX-treated 
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neotissue was 5.3 times that of control, with concomitant increases in the amount of 
pyridinoline crosslinks (16.0 times) (Fig. 5c and 5e). Additionally, both treatments also 
increased the compressive properties of neotissue (Fig. 5d).  Collectively, these results proved 
the effectiveness of the LOX-mediated pathway on promoting the biomechanical properties of 
engineered tissues. Specifically, these data demonstrated that effective LOX concentration and 
application time can direct collagen crosslinking and significantly enhance the tensile properties 
in a collagen-rich tissue. 
Finally, an in vivo study was performed to investigate neotissue growth and 
development post-implantation, since this step is pivotal toward developing in vitro tissue 
engineering strategies that will result in functional replacement tissues. The in vivo growth 
environment is described to be beneficial for engineered tissue maturation, as it potentially 
provides the neotissue with nutrients, growth factors, and stimuli not applied in the tissue 
culture, thus enhancing its biochemical and functional properties18. Specifically, in this step the 
potential of using a LOX pre-treatment to further promote in vivo maturation of neotissues was 
explored. To do so, self-assembled neocartilage was first grown in vitro for 6 weeks and 
subjected to the optimal LOX treatment, as identified in the previous series of studies. At this 6-
week time point, both LOX-treated and control constructs were implanted subcutaneously into 
the backs of athymic mice, where they remained for an additional 6 weeks until the mice were 
sacrificed. In addition, control and LOX-treated tissues were simultaneously grown in vitro for 
the entire 12-week culture duration to compare with those grown in vivo.  
In vivo culture promoted the maturation of post-translational modifications, collagen 
fibers, and collagen content. Quantitative evaluation of SEM images revealed that the in vivo 
environment significantly enhanced the fibril density of control neocartilage compared in vitro 
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neotissue. In addition, both in vitro and in vivo LOX-treated neotissues exhibited significantly 
enhanced fibril density over in vitro control neocartilage (Fig. 5a). In terms of the fibril 
diameter of the neotissue, no differences were observed among any of the factors (Fig. 5b). The 
in vivo environment significantly increased the amount of PYR/WW in controls over those 
grown in vitro culture, while in vivo culture of LOX-treated neotissue increased PYR content 
per WW by 14-times (Fig. 6c). Furthermore, the in vivo growth environment significantly 
enhanced the amount of collagen content per WW in both control and LOX-treated groups (Fig. 
6d); no significant differences, however, were observed in the amount of GAG content per WW 
among all groups (Fig. 6e). In addition, in vivo treatment significantly increased tensile 
properties compared to in vitro culture (Fig. 6a). LOX-treated constructs implanted in vivo 
displayed a 3-fold increase in tensile modulus compared to the in vitro control (Fig. 6a). In 
terms of the compressive properties, the in vivo environment again provided a significant 
benefit in tissue growth over the in vitro culture for both control and LOX-treated constructs; 
however, LOX pre-treatment in the in vivo group did not further promote these effects over in 
vivo controls (Fig. 6b). Overall, these results show that in vitro LOX pre-treatment of 
engineered cartilage promotes in vivo development of the neotissue, resulting in enhanced 
matrix maturation and increased tensile properties compared to in vitro tissue. This work 
illustrates the potential of LOX as a potent agent for promoting neotissue maturation, not only 
in vitro but also in vivo, suggesting a pivotal role of PYR crosslinks in the pre- and post-
implanted tissue. 
In the present study, the biomechanical properties of the collagen crosslinked engineered 
neotissue were not only increased, but also reached values close to those of native articular 
cartilage. Specifically, under compression, the aggregate modulus of 6-week engineered 
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neocartilage treated with LOX was 220±47 kPa. For comparison, the aggregate modulus of the 
corresponding native articular cartilage, tested under the same conditions (thickness, strain), 
was 280±72 kPa. With the LOX values obtained being approximately 80% of the native tissue’s 
values, the compressive modulus is on par with native tissue values, especially when 
considering the reported range of compressive modulus of native cartilage (150-380 kPa)46,. 
Similarly, under tension, the tensile modulus of the corresponding native, 1-week old, articular 
cartilage was 5.0±1.9 MPa. Thus, the tensile modulus of the LOX-treated engineered tissue 
generated in this study (2.3±0.8 MPa) represented approximately 50% of the native tissue’s 
values. Juxtaposing the LOX data against literature values of the native cartilage Young’s 
modulus (4.0-6.0 MPa)47, one finds that the tensile values obtained in this study using LOX can 
be up to ~60% of the native tissue’s values. Thus, the stiffness indices of the collagen 
crosslinked engineered tissue reach approximately 38-79% of native tissue’s values. 
To the best of our knowledge, this is the first study describing a method for promoting 
collagen crosslinking in both native and engineered tissues. Both endogenous (hypoxia-
mediated) and exogenous LOX application enhanced the biomechanical properties of collagen-
rich tissues through pyridinoline crosslinking formation. LOX acts using a completely different 
mechanism than other currently employed stimuli, such as hydrostatic pressure, direct 
compression, or growth factors, suggesting that LOX could be combined with these stimuli to 
produce synergistic effects, and, thus, promoting even more the functional properties of 
neotissue. Biomechanical properties have consistently been a crucial barrier to the translation of 
tissue engineering technologies; LOX application thus represents an exciting development. 
Indeed, the FDA guidance document for knee cartilage repair lists the “ability of the implant to 
withstand expected in vivo…loading” as a key success criterion for the pre-clinical evaluation of 
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repair products. The quantitative increases in tensile properties observed in this study thus 
illustrate an important step toward producing neotissue that is suitable for pre-clinical work. 
The systematic examination of low oxygen tension application on tissue culture and 
growth pursued in this study provides a novel mechanistic description of HIF1α-mediated 
pyridinoline collagen crosslinking formation toward enhancing a tissue’s biomechanical 
properties (Fig. 6). This adds to the already known roles of HIF-1α in apoptosis30, peripheral 
immune tolerance, tumor angiogenesis48,37, and cell-mediated inflammation49,50. Additionally, 
hypoxia has been reported to switch the basic translation initiation machinery during protein 
synthesis51. The present study highlights that hypoxia application during tissue culture resulted 
in HIF-1α-mediated LOX gene expression, as detected by RT-PCR. As previously described, in 
vivo collagen maturation following biosynthesis occurs through extracellular modification of the 
collagen fibers by LOX and LH endopeptidases; these result in the formation of both immature 
and mature covalent pyridinoline crosslinks7,12,52. Thus, hypoxia-induced signaling promotes the 
formation of pyridinoline collagen crosslinks and subsequently enhances tensile properties. As a 
consequence, the low-oxygen modification of the tissue culture environment can conceivably be 
used not only in the engineering of articular cartilage, but potentially on any collagen-rich tissue 
where collagen crosslinks likewise play crucial biomechanical roles, such as tendon, ligament, 
fibrocartilage and skin. 
Although the exact molecular pathways of endogenous LOX gene expression and 
mediation in collagen crosslinking formation in different tissues are not yet fully elucidated and 
understood, these processes seem to take place at the initial stages of collagen growth and 
maturation53. By employing the self-assembling process that recapitulates features of cartilage 
morphogenesis1,2, this study provides additional clues on the role of endogenous LOX 
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expression and regulation in native cartilage development. For both self-assembled neocartilage 
and native cartilage during morphogenesis, the initially ubiquitous collagen type VI localizes 
around the pericellular matrix while collagen type II production rises. Although qualitative data 
show LOX localization in cartilage during development, quantitative data for LOX expression 
do not exist, making it difficult to evaluate its developmental role. The present study showed 
that LOX-induced tensile increases are time-dependent, indicating that endogenous LOX 
regulation during morphogenesis is timed to correspond with temporal changes in collagen 
types, eventually resulting in optimized tensile properties. Future studies should shed more light 
into these important aspects of collagen growth and maturation during in vivo morphogenesis 
and in vitro development of engineered tissues. 
In orthopedics, grafts and explants intended for implantation or reconstruction are often 
stored in culture media. However, it is known that the material properties of these grafts 
deteriorate with time. Serum-supplemented medium causes tissue swelling54, chondrocyte 
phenotypic differentiations55, as well as cellular outgrowth from tissue56. Although a 
chemically-defined serum-free medium has been introduced to specifically avoid these 
deleterious effects, properties of stored tissues still remain inferior over native tissues’ 
values57,58. In the present study we show that chemically-defined serum free media 
supplemented with LOX results in the maintenance, if not improvement, of graft properties. In 
addition to the role of collagen crosslinks in a tissue’s biomechanical properties, some studies 
have highlighted how pyridinoline reduces collagen type II catabolism5,59. The presence of 
pyridinoline in the ECM reduces susceptibility to matrix degradation due to metalloproteinase-1 
(MMP-1)5. In parallel, it has been reported that matrices produced by skin fibroblasts with more 
pyridinoline crosslinks were less susceptible to MMP-1 degradation59. Therefore, promoting 
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pyridinoline crosslinking in native or engineered tissues through endogenous or exogenous 
LOX application might be a potential way to prevent degenerative processes in both tissues and 
neotissues. Thus, In terms of clinical applicability, it may be advisable to consider LOX 
supplementation during the storage or transport of highly collagenous grafts intended for 
implantation. 
  
In conclusion, the present series of studies demonstrates that hypoxia-mediated or 
exogenous LOX application promotes collagen crosslinking and maturation, resulting in 
concomitant increase in finctional properties of collagen-rich tissues. These findings are 
clinically applicable in a broad spectrum of collagen-rich tissues, including articular cartilage, 
tendon, meniscus, and ligament, and could thus offer potent new agents for tissue repair 
strategies. Additionally, hypoxia or exogenous LOX can be employed to improve or maintain 
the mechanical properties of transplantation grafts such as osteochondral, meniscal, sinews, and 
possibly any other highly collagenous tissue. With several growth factors and mechanical 
stimuli being identified to increase the biochemical content and compressive properties of 
engineered tissues, but only few methods existing on how tensile properties can be improved, 
this study represents a major contribution for tissue engineering approaches. Moreover, LOX 
pre-treatment promotes in vivo development and maturation of the neotissue, resulting in further 
increase in the tensile properties in vivo. Additionally, the ability of LOX to be applied 
exogenously and to promote tissue maturation may allow for direct in vivo applications to treat 
defects or pathologies such as for example via intra-articular injections. Finally, this study 
demonstrates the potential for LOX to be combined with other exogenous factors to generate 
biomimetic tissue implants in vitro with biomechanical properties on par with native tissue 
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values. Overall, results of this study demonstrate that endogenous (hypoxia-mediated) and 
exogenous LOX application provide exciting new technologies for promoting collagen network 
maturation and enhancement of the biomechanical properties in both native and engineered 
tissues. 
 
MATERIALS AND METHODS 
 
Sample preparation 
Explants (articular cartilage, anterior (cranial) cruciate ligament (ACL), posterior (caudal) 
cruciate ligament (PCL), patellar tendon, and medial meniscus) were harvested from the knee 
joint of 1-week-old calves (Research 87 Inc.). Explants were either analyzed immediately (d=0) 
or incubated for 24 hours prior to analysis.  
 
Explant culture 
To investigate the effect of hypoxia on musculoskeletal tissues, two different types of media 
were used for explant culture: 1) cell culture medium (DMEM with low glucose (1g/L) (Life 
Technologies), 10% fetal bovine serum (FBS) (Atlanta Biologicals), 1% non-essential amino 
acids (NEAA) (Life Technologies), 25 mg of L-ascorbic acid (Sigma-Aldrich), and 1% 
penicillin/ streptomycin/ fungizone (PSF) (BioWhittaker Inc.)) or 2) cell culture medium 
supplemented with 0.25mM β -aminopriopionitrile (BAPN), (Sigma-Aldrich). Explants were 
divided into 4 treatment groups and cultured for 4 weeks: Control, BAPN, Hypoxia, Hypoxia & 
BAPN. Explants in the Control and BAPN groups were incubated at 37°C, 5% CO2, and 21% 
O2, and hypoxia groups received 2% O2.  
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Cell isolation 
Articular cartilage, harvested from the distal femur of 1-week-old calves, was digested in 0.2% 
collagenase type II (Worthington Biochemical Cor.) for 18 hours. Cells were isolated, frozen at 
-80°C for 24 hours, and stored in liquid nitrogen until needed. 
 
Neocartilage culture 
Using the self-assembling process1,2 chondrocytes were thawed, evaluated using trypan blue, 
seeded into cylindrical, non-adherent agarose wells as previously described1,60, and fed with 
chondrogenic medium61-63 (DMEM (Life Technologies), 1% non-essential amino acids (Life 
Technologies), 100 nm dexamethasone (Sigma-Aldrich), 1% ITS + premix (BD Biosciences), 
40 mg/mL l-proline (Sigma-Aldrich), 50 mg/mL ascorbate-2-phosphate (Sigma-Aldrich), 
100 mg/mL sodium pyruvate (Fisher Scientific), 0.146 mg/ml hydroxylysine (Sigma-Aldrich), 
0.0016 mg/ml copper (Sigma-Aldrich), and 1% penicillin/streptomycin/fungizone 
(Biowhittaker/Cambrex)).  
 
LOX application in native and engineered neocartilage 
Articular cartilage explants were fed with chondrogenic medium supplemented with LOX at 
two concentrations: Low (0.0015µg/ml) and High (0.15µg/ml) during a 2-week culture period. 
In engineered neocartilage, Phase I investigated the effects of three different LOX 
concentrations: Low (0.0015µg/ml), Medium (0.015 µg/ml), and High (0.15µg/ml), during a 4-
week culture period. LOX-treated groups received LOX medium during t=8-21 days. In Phase 
II, two LOX treatment windows were evaluated using the concentration identified in Phase I 
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(i.e., 0.15µg/ml): control, Early LOX (applied t=8-14 days), and Late LOX (applied t=15-21 
days) during a 6-week culture period.  
 
Gross morphology 
ImageJ was used to determine the diameter and thickness of each sample. The central 3 mm of 
each construct was used for creep indentation testing1 while the outer ring was divided for 
tensile testing, histology, and quantitative biochemistry, as previously described64. 
 
Histology/ Immunohistochemistry (IHC) 
For histology, constructs were cryoembedded at -20°C in HistoPrepTM (Fisher Scientific) and 
were sectioned at 14 µm. Sections were then fixed in 10% formalin and stained using Safranin-
O/fast green or Picrosirius red for GAG and collagen, respectively. For IHC, sections were 
fixed in 4°C acetone and stained for collagen type I and II, as previously described65. 
 
Quantitative biochemistry 
Samples were weighed, frozen, and lyophilized, and dry weights were recorded. Samples were 
then digested in phosphate buffer with 5 mm EDTA, 5 mm N-acetyl-cysteine, and 125 µg/mL 
papain (Sigma-Aldrich) for 18 hours at 65°C. Following digestion of the samples, total collagen 
was quantified using chloramine-T hydroxyproline assay66. Sulfated GAG of articular cartilage 
and neocartilage was quantified using the Blyscan Glycosaminoglycan Assay (Biocolor), and 
total number of cells was estimated with a Picogreen DNA Assay (Life Technologies) assuming 
7.7 pg DNA per cell, as previously described64.  
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Real time PCR 
To study hypoxia-induced gene up regulation, real time PCR was employed. Past work has 
found LOX gene expression to change within 18 hours following exposure to hypoxic 
conditions 67,68. Following a 24-hour incubation in normoxic conditions, articular cartilage 
explants were subjected to hypoxia for an additional 24 hours. Immediately after this exposure 
to hypoxia, LOX gene expression was measured as previously described 68, using S18 (US 
Biological) as the housekeeping gene and a LOX primer (US Biological). 
 
High performance liquid chromatography (HPLC) 
HPLC samples were digested in 6 N HCl at 100°C for 18 hours. Following digestion, samples 
were dried using a vacuum concentrator and re-suspended in a solution of 10 nmol 
pyridoxine/ml and 2.4 µmol homoarginine/ml. Samples were subsequently diluted fivefold with 
0.5% HFBA in 10% acetonitrile and analyzed as described previously69. Pyridinoline standards 
(Quidel Corp.) were used to quantify crosslink content.  
 
Creep indentation testing 
Compressive properties were evaluated using creep indentation as previously described70. 
Specimens were equilibrated in PBS for 15 minutes and then indented to ~15% strain using a 
flat, porous indenter tip (0.8 mm diameter). The compressive properties of the samples were 
obtained using a semi-analytical, semi-numeric, linear biphasic model70. 
 
Tensile testing 
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Tensile properties were determined using a uniaxial material testing apparatus (Instron, Model 
5565) as previously described61,63. Samples were tested until failure by applying a strain rate of 
1% of the gauge length per second. Tensile stiffness and ultimate tensile strength (UTS) were 
determined based on stress-strain plots. 
 
Quantitative evaluation of SEM images using ImageJ 
Samples were prepared and evaluated as previously described18. To quantify SEM images, 
ImageJ was used to measure both fibril density and diameter. 
 
Statistical analyses 
Data, based on n = 7, are represented as means ± standard deviations. Analysis of variance 
(ANOVA) was used for intergroup comparisons. Tukey’s post hoc testing was applied if 
p<0.05. For all figures, statistical significance is indicated by bars not sharing the same letters.  	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TABLES AND FIGURES 
 
 
TABLE 4.1 – BIOMECHANICAL PROPERTIES AND BIOCHEMICAL CONTENT OF NATIVE AND 
ENGINEERED TISSUES. Values are mean±95% SD. Tukey’s post hoc testing was applied if 
p<0.05. Groups not connected by the same letter are significantly different. EY=Young’s 
modulus, UTS=ultimate tensile strength, HA=aggregate modulus, Col=collagen, 
GAG=glycosaminoglycan, WW=wet weight. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Study Group EY (MPa) UTS (MPa) COL/WW % 
Hypoxia in anterior  
cruciate ligament 
d=0 7.3±3.8A 5.0±3.6A 14.4±3.2  
Control 0.9±0.4C,D 0.7±0.4D 13.6±2.9 
BAPN 0.5±0.4D 0.7±1.0D 14.0±4.3 
Hypoxia 2.3±0.7B 2.3±0.7B 13.6±2.0 
Hypoxia & BAPN 1.0±0.8C 1.3±0.6C 12.6±0.9 
Hypoxia in posterior 
cruciate ligament 
d=0 12.8±6.0A 12.8±6.0A 16.2±1.7A  
Control 0.5±0.3D 0.5±0.3D 15.0±2.1A 
BAPN 1.0±0.1C 1.2±0.4C 16.1±2.4A 
Hypoxia 1.7±0.9B 1.7±0.9C 13.7±1.3B 
Hypoxia & BAPN 1.4±0.6B,C 4.2±2.5B 13.1±2.4B 
Hypoxia in patellar  
tendon 
d=0 23.7±13.3A 13.3±6.5A  15.2±2.1A 
Control 0.7±0.3D 0.7±0.3C 14.2±3.1A 
BAPN 0.7±0.5D 1.0±0.7C 11.2±1.7B 
Hypoxia 4.6±2.3B 2.3±2.0B 15.6±1.2A 
Hypoxia & BAPN 2.0±1.6C 0.8±0.7C 10.4±1.8B 
Hypoxia in knee  
meniscus 
d=0 49.5±10.0A 14.6±6.7A 24.1±2.2A 
Control 20.7±2.4C 19.8±3.6C 22.5±3.1A 
BAPN 9.0±4.5D 7.4±3.6D 22.9±1.7A 
Hypoxia 29.0±3.0B 30.0±4.0B 18.9±2.8B 
Hypoxia & BAPN 11.5±2.7D 10.3±2.3D 19.8±3.9B 
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TABLE 4.1 (CONTINUED)  
 
 
  
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  149 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.1 – HIERARCHICAL ARCHITECTURE OF COLLAGEN FIBRILS. Upper: A heterofibril 
consisting of collagen types II, IX, and XI is a major component of the extracellular matrix of 
musculoskeletal tissues. Middle: Each mature (trifunctional) crosslink interconnects three 
different collagen molecules within the fibril. Lower: Intermolecular pyridinoline crosslinks are 
found in particular locations due to the specificity of the enzyme lysyl oxidase (Adapted from 
Eyre et al71.). 
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FIGURE 4.2 – BIOMECHANICAL AND BIOCHEMICAL PROPERTIES OF HYPOXIA-TREATED 
ARTICULAR CARTILAGE. a) Tensile stiffness as represented by Young’s modulus, b) 
pyridinoline content normalized to tissue wet weight (PYR/WW), c) pyridinoline content 
normalized to tissue collagen content (PYR/Col), and d) hypoxia-mediated LOX gene 
expression as detected by RT-PCR. Results demonstrate that low oxygen tension (2% O2) 
application for 4 weeks significantly increased the amount of pyridinoline crosslinks 43% over 
controls, with concomitant increase in LOX gene expression (~44-fold). Additionally, the 
tensile stiffness of articular cartilage treated with hypoxia was 238% of control values. Results 
were further confirmed with the LOX inhibitor β-aminopropionitrile (BAPN), as the measured 
differences resulting from the application of hypoxia (Young’s moduli, PYR/WW, and 
PYR/Col) were abolished with the addition of BAPN.  Bars denote means ± SD, and groups not 
connected by the same letter are significantly different. PYR=pyridinoline, WW=wet weight, 
Col=total collagen.  
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FIGURE 4.3 – BIOMECHANICAL AND BIOCHEMICAL PROPERTIES OF HYPOXIA-TREATED 
ANTERIOR CRUCIATE LIGAMENT (ACL), POSTERIOR CRUCIATE LIGAMENT (PCL), 
PATELLAR TENDON, AND KNEE MENISCUS. a) Tensile stiffness as represented by Young’s 
modulus, b) ultimate tensile strength (UTS), c) pyridinoline content normalized to tissue wet 
weight (PYR/WW), and d) pyridinoline content normalized to tissue collagen content 
(PYR/Col). Results demonstrate that application of hypoxia can be directed to promote LOX-
mediated pyridinoline collagen crosslinking per WW (52-71% increase over control values) and 
per collagen (63-117% over control values), and to enhance tensile properties in various 
collagen-rich tissues (140-643% of control values). Results were further confirmed with the 
LOX inhibitor β-aminopropionitrile (BAPN), as the measured differences resulting from the 
application of hypoxia were partially or fully abolished with the addition of BAPN. Bars denote 
means ± SD, and groups not connected by the same letter are significantly different. 
PYR=pyridinoline, WW=wet weight, Col=total collagen. 
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FIGURE 4.4 – BIOMECHANICAL AND BIOCHEMICAL PROPERTIES OF LOX-TREATED 
ARTICULAR CARTILAGE.  a) Tensile stiffness as represented by Young’s modulus, b) ultimate 
tensile strength (UTS), c) pyridinoline content normalized to tissue wet weight (PYR/WW), and 
d) pyridinoline content normalized to tissue collagen content (PYR/Col). Results demonstrate 
that exogenous LOX application at a concentration of 0.15ng/ml (High LOX) significantly 
increases the amount of pyridinoline crosslinks over controls, normalized per WW (104% 
increase) and per collagen (150% increase), and concomitantly enhances the tensile properties 
of the tissue (86% over controls). Bars denote means ± SD, and groups not connected by the 
same letter are significantly different. PYR=pyridinoline, WW=wet weight, Col=total collagen.  
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FIGURE 4.5 – PHASE I AND II GROSS MORPHOLOGY, HISTOLOGY, IMMUNOHISTOCHEMISTRY 
(IHC), BIOMECHANICAL PROPERTIES AND BIOCHEMICAL CONTENT OF LOX-TREATED 
ENGINEERED NEOCARTILAGE. a-b) Both control and constructs treated with LOX (Phase I and 
II) formed uniform neocartilage without physical abnormalities. Safranin-O/fast green staining 
for glycosaminoglycans and Picrosirius Red staining for collagen showed that constructs 
produced these matrix molecules uniformly for all groups. IHC illustrated that all groups 
exhibited collagen type II but not collagen type I, suggesting an articular cartilage phenotype. 
Phase I: c) Tensile stiffness as represented by Young’s modulus and d) pyridinoline content 
normalized to neotissue wet weight (PYR/WW). Tensile stiffness was significantly enhanced by 
High LOX treatment (5.0 times over controls). These trends in biomechanical properties were 
mirrored by the crosslink content, which was 16.2 times greater for the High LOX group over 
controls. Phase II: e) Tensile stiffness as represented by Young’s modulus, f) compressive 
modulus, and g) pyridinoline content normalized to neotissue wet weight (PYR/WW). Tensile 
stiffness was 5.3 times greater for the Early LOX group over controls. Pyridinoline content was 
significantly increased for both Early and Late LOX treatments (16.0 times over controls). Early 
LOX treatment significantly increased compressive stiffness and Late LOX treatment resulted 
in an aggregate modulus that was not significantly different from either control or Early LOX 
groups. Bars denote means ± SD, and groups not connected by the same letter are significantly 
different. PYR=pyridinoline, WW=wet weight.  
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FIGURE 4.6 – SEM IMAGES AT T=12 WEEKS. (a) the in vivo environment to significantly enhance 
the fibril density of control neotissues over those grown in the in vitro culture environment. In addition, 
both in vitro and in vivo LOX-treated neotissues presented with significantly enhanced fibril density over 
in vitro control neocartilage (b) In terms of the fibril diameter of the neotissue no differences were 
detected among all groups. Bars labeled with different letters or star exhibit significant differences (p < 
0.05).  
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FIGURE 4.7 – PROPERTIES OF NEOCARTILAGE AT T=12 WEEKS AFTER IN VITRO CULTURE AND 
IN VIVO GROWTH IN NUDE MICE.	  Self-assembled articular cartilage was cultured for 6 weeks with 
LOX treatment applied during weeks 3 and 4. Neocartilage was then implanted in nude mice for 
additional 6 weeks; neocartilage constructs cultured at the same time in vitro as controls (n=6). 
Biomechanical evaluation revealed (a) in vivo implants to have significantly increased tensile modulus 
over their in vitro counterparts, while the in vivo grown LOX-treated constructs displayed a significantly 
increased tensile modulus that was 3-times greater than that of in vitro control. (b) The in vivo 
environment provided a significant benefit in tissue’s compressive properties over the in vitro culture. 
Biochemical analysis showed (c) the in vivo environment to significantly increase the amount of 
PYR/WW in controls over those grown in vitro culture and the in vivo LOX treatment to further promote 
that increase 14-times the in vitro control values. (d) The in vivo growth environment significantly 
enhanced the amount of collagen content per WW in both control and LOX treated groups. (d) No 
significant differences were observed in the amount of GAG content per WW. Bars labeled with 
different letters or star exhibit significant differences (p < 0.05).  
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FIGURE 4.8 – A NOVEL MECHANISTIC DESCRIPTION OF HIF-1α-MEDIATED PYRIDINOLINE 
COLLAGEN CROSSLINKING FORMATION TOWARD ENHANCING BIOMECHANICAL PROPERTIES 
IN NATIVE AND ENGINEERED COLLAGEN-RICH TISSUES. a) Hypoxia application during tissue 
culture promotes HIF-1α-mediated endogenous LOX gene expression. b) Upregulation of LOX 
gene expression results in different LOX enzymes belonging in the same family (LOX-1, LOX-
2, LOX-3, LOX-4, LOX-propeptide). c) Collagen maturation following biosynthesis occurs 
through extracellular modification of the collagen fibers by LOX, resulting in the formation of 
covalent pyridinoline crosslinks. Exogenous LOX application can promote the same effects 
bypassing the side effects of hypoxia. d) LOX (endogenous and exogenous)-mediated 
pyridinoline crosslinking formation enhances tensile properties of tissues and neotissues. 
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CHAPTER 5 – DIGOXIN AND ATP ENHANCE THE FUNCTIONAL 
PROPERTIES OF NEOCARTILAGE IMPLANTS THROUGH 
INTRACELLULAR ION MODULATION 
 	  
ABSTRACT 	  
Objective: Towards developing engineered cartilage for the treatment of arthritic pathologies, 
achieving relevant functional properties prior to implantation remains a significant challenge. 
Digoxin and adenosine triphosphate (ATP) are agents known to modulate intracellular Ca2+ 
signaling, a pathway through which mechanical stimuli acts in maintaining healthy cartilage 
matrix. The objective of this study is to determine whether these agents can promote matrix 
production in engineered neocartilage and increase its functional biomechanical properties 
Design: Neocartilage constructs were formed by scaffold-free self-assembly of primary bovine 
articular chondrocytes. Digoxin, ATP, or both agents were added to the culture medium for 1 
h/day at days 10-14. At the end of a 4-week culture period, neocartilage properties were 
assessed for gross morphology, biochemical composition, and biomechanical properties. Ca2+ 
dyes and time-lapse confocal microscopy were used to characterize Ca2+ oscillations induced by 
these agents. 
Results: Digoxin and ATP were shown to increase the frequency of intracellular Ca2+ 
oscillations in chondrocytes. In neocartilage constructs, digoxin and ATP increased collagen 
content by 52-110% over untreated controls, while maintaining proteoglycan content near 
native  
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tissue values. Furthermore, digoxin and ATP increased the tensile modulus by 280% and 180%, 
respectively, while the application of both agents increased the modulus by 380%. The trends in 
tensile properties were found to correlate with the amount of collagen crosslinking. 
Conclusions: This study provides a novel approach toward modulating intracellular calcium 
signaling in articular chondrocytes to direct neocartilage maturation and increase its functional 
properties. 
 
INTRODUCTION 	  
Affecting 46.4 million people annually, arthritis is the second most common chronic disease in 
the United States, creating a tremendous socioeconomic impact (1). Current therapies for 
cartilage pathologies include disease modifying osteoarthritis drugs, microfracture, cell- and 
scaffold-based procedures, and allograft transplantation. Although satisfactory short-term 
outcomes have been achieved with these techniques, they do not offer a permanent solution. 
Furthermore, the biomechanical properties of engineered tissues still remain far from native 
tissue values, leaving the neotissue incapable of withstanding the rigorous mechanical 
environment of articulating joints (2). Therefore, focusing on methods to bring the functional 
properties of engineered cartilage closer to native articular cartilage is crucial toward 
developing regenerative treatments. 
Mechanical stimulation has been shown to be an important regulator of cartilage 
function and matrix homeostasis. In vitro experiments have shown that stimuli, such as dynamic 
compression and hydrostatic pressure, can induce chondrocytes to increase collagen and 
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proteoglycan synthesis (3, 4). These mechanotransduction pathways have been linked to ion 
channels and changes in intracellular Na+ and Ca2+ concentrations (5, 6). For example, 
hydrostatic pressure applied to chondrocytes has been shown to inhibit the Na+/K+-ATPase and 
the Na+/K+/2Cl- co-transporter (5) and induce Ca2+ transients (7, 8). Micropipette indentation of 
chondrocytes induce Ca2+ transients via opening of stretch-activated Ca2+ channels (6). Fluid 
flow has also been observed to induce immediate Ca2+ transients in chondrocytes (9). Therefore, 
modulation of intracellular ion concentration provides a potentially beneficial tissue engineering 
strategy that is an alternative to mechanical stimulation. 
 Digoxin and ATP has been shown to alter intracellular Ca2+ through two different 
pathways. Digoxin’s main action has been linked to inhibiting the Na+/K+-ATPase and 
reversing the function of the Na+/Ca2+ exchanger (NCX), thereby raising intracellular Ca2+ (10). 
The rise in intracellular Ca2+ also raises Ca2+ stores in the endo/sarcoplasmic reticulum. The 
effects of digoxin on articular chondrocytes have not yet been investigated. 
In addition to being a source of energy, ATP also functions as an extracellular signaling 
molecule, activating cell surface purinergic (P2Y and P2X) receptors for the regulation of 
various cell functions (11). Activation of P2Y receptors (G-protein coupled receptors) release 
ER-stored Ca2+ via the IP3 pathway, while activation of P2X receptors (ligand-gated ion 
channels) open the cell to cation (e.g., Na+, K+, Ca2+) fluxes (11). Chondrocytes, specifically, 
have been shown to maintain a level of 2-3 nM ATP in the extracellular medium during in vitro 
culture (12) and express both P2Y and P2X receptor subtypes. During mechanical stimulation, 
ATP is thought to be release from chondrocytes and induce Ca2+ transients in a 
autocrine/paracrine fashion. Such Ca2+ transients are thought to be responsible for the beneficial 
effects of mechanical stimulation, such as increased matrix production (13-15). Because the 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  160 
model suggests that mechanical stimuli are transduced to units of extracellular ATP, it is a 
promising chemical stimulus for cartilage tissue engineering. 
 In the present study, digoxin and ATP were applied to self-assembled neocartilage 
constructs to test the hypothesis that these agents will enhance their matrix content and 
biomechanical properties. A high dose of digoxin (20 µM) was applied to investigate its effect 
in neotissue; a low dose of digoxin (200 nM) was tested to explore a lower therapeutic dose. A 
concentration of 250 µM ATP was used, as this dosage had been shown to increase chondrocyte 
collagen synthesis (16). ATP and digoxin were applied simultaneously under the hypothesis that 
they will have an additive or synergistic effect. For a positive control, 20 µM ouabain was used, 
since its beneficial effects on chondrocytes through ion modulation have already been reported 
(17). Finally, KB-R7943, an inhibitor of the NCX, and suramin, an inhibitor of the P2Y 
receptor, were used to probe the mechanism of action of digoxin and ATP, respectively. All 
agents were applied at days 10-14 for 1 h/day, as this treatment window was shown to work best 
for mechanical and chemical stimuli that similarly alter calcium transients (3). 
 
MATERIALS AND METHODS 
 
Chondrocyte isolation 
Superficial and middle/deep zone bovine articular chondrocytes were isolated from the femoral 
condyle and trochlear groove of calves (Research 87 Inc.), as previously described (3). All 
tissue engineered cartilage constructs were derived from cells of the same harvest. 
 
Self-assembly of neocartilage constructs and growth 
Disk-shaped neocartilage constructs were grown, as previously described (18). Briefly, 5.5x106 
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chondrocytes were seeded into 5 mm diameter, 2% agarose wells. After 4 h, 400 µL medium 
was carefully added. 500 µL medium was changed every 24 h until day 10. At day 10, 
constructs were unconfined from the wells and placed into 6-well plates, where the medium was 
changed every 48 h. At 4 weeks, constructs were portioned for testing. The medium formulation 
consisted of DMEM (25 mM glucose with GlutaMAX™, Invitrogen), 100 nM dexamethasone 
(Sigma), 1% penicillin/streptomycin/fungizone, 1% ITS (BD Biosciences), 1% NEAA 
(Invitrogen), 100 µg/mL sodium pyruvate (Fischer Scientific), 50 µg/mL ascorbate-2-phosphate 
(Sigma), 40 µg/mL L-proline (Sigma).  
 
Application of digoxin, ouabain, ATP, KB-R7943, and suramin 
At days 10-14, the constructs were treated daily with a low or high concentration of digoxin 
(200 nM and 20 µM; Sigma), ATP (250 µM; Sigma), ouabain (20 µM; Sigma) or both digoxin 
(200 nM) and ATP. For the groups involving the use of inhibitors, constructs were first treated 
with KB-R7943 (10 µM; Tocris Biosciences) or suramin (100 µM; Tocris Biosciences) alone 
for 30 min. The constructs were then incubated in medium containing both the inhibitor and the 
respective agent for 1 h. After treatment, constructs were washed for 30 min and returned to 
normal culture conditions. Stock digoxin was prepared at 20 mM in DMSO (Sigma); KB-R7943 
at 20 mM in DMSO; ouabain at 1 mM in PBS; and suramin at 2 mM in culture medium. ATP 
was freshly prepared in medium before application. 
 
Analysis of growth metrics 
Pictures of gross construct morphology were taken and construct total wet weights measured. 
Each construct was then sectioned into appropriately sized pieces for biochemical and 
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biomechanical analysis. Water content was calculated with samples used for biochemical 
analysis. 
 
Histology and immunohistochemistry 
Samples were cryosectioned at 16 µm, fixed in formalin, and stained with Safranin O/Fast 
Green and Picrosirius Red. Collagen II and collagen I immunohistochemistry were conducted, 
as described previously (19). Briefly, cryosections were fixed in cold acetone and incubated 
with mouse anti-collagen I (Accurate) and rabbit anti-collagen II (Cedarlane Labs) primary 
antibodies. The secondary antibodies used were anti-mouse and anti-rabbit IgG antibodies, 
respectively, from the Vectastain ABC kit. Color was developed using the Vectastain ABC 
reagents and DAB (Vectastain).  
 
Biochemical analysis 
Lyophilized portions of the constructs were digested in papain for 18 h at 60°C. Total collagen 
content was determined by measuring hydroxyproline content using a chloramine T assay (20). 
Total sulfated glycosaminoglycan (GAG) content was measured using the Blyscan sGAG assay 
kit (Accurate). DNA content was measured using the Quant-iT PicoGreen assay kit (Invitrogen) 
and normalized to cell number using a conversion of 7.7 ng DNA/cell. Pyridinoline crosslinks 
were measured as previously described (21). Briefly, tissue samples were digested in 800 µL 6 
N HCl at 100°C for 18 h, dried with a SpeedVac, re-suspended in 50 µL of a solution containing 
10 nmol pyridoxine/mL and 2.4 µmol homoarginine/mL (Sigma) in water, and analyzed under 
high performance liquid chromatography (HPLC). 
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Biomechanical analysis  
For compressive testing, 3 mm diameter punches were tested with a creep indentation 
apparatus, as previously described (17). Aggregate modulus, permeability, and Poisson’s ratio 
were calculated using a semianalytical, seminumeric, linear biphasic model and finite element 
analysis (22). For tensile testing, dog bone-shaped samples were made, photographed, and 
subjected to uniaxial tension using an Instron (Model 5565). Cross-sectional areas were 
calculated using the photographs and ImageJ software. The linear region of the stress-strain 
curve was used to determine the Young’s modulus. The ultimate tensile strength (UTS) was 
determined as the maximum stress reached in the curve.  
 
Ca2+ imaging of chondrocytes stimulated with ATP, digoxin, and ATP + digoxin 
Chondrocytes were seeded on glass cover slips (No.1, 25 mm x 25 mm) at 70,000 cells/cm2, 
cultured overnight, and stained with 2.5 µM Fluo-4/AM (Invitrogen) for 1-2 h in the presence of 
0.75 µM Pluronic F-127 (Invitrogen). Coverslips were placed into a custom-built drug perfusion 
system, which used gravity flow to continuously profuse the cells with fresh solution at a flow 
rate of ~1.5 mL/min. With an Olympus FV1000 confocal microscope, time-lapse images (6 
s/frame) were acquired over 30 min in a field of view containing ~20-30 cells using a 60X water 
immersion objective (NA1.2, corrected for the thickness of the No.1 glass coverslip). 
Fluorescence was collected at 488 nm excitation and 505-605 nm emission. During the first 15 
min, buffer solution (Tyrode’s solution containing 1 mM Ca2+) was perfused over the cells to 
capture baseline Ca2+ activity. During the next 15 min, buffer solution, containing either ATP 
(250 µM), digoxin (200 nM), or the combined drugs, was perfused over the cells. Using ImageJ 
software, regions of interest were drawn around each cell, fluorescence values measured, and 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  164 
Ca2+ traces established. Traces were loaded into a Matlab program to count the number of Ca2+ 
oscillations, which were defined as peaks exceeding a threshold of 1.3 times the baseline 
fluorescence intensity. Frequency of oscillations was defined as the average number of 
oscillations per cell over 15 min. Each slide represented one sample (n = 4-6). 
 
Statistics 
All data sets were analyzed with one-factor ANOVA to determine significance among groups 
and Fischer’s LSD post hoc test (p<0.05) using StatView software. To test for synergistic or 
additive effects between digoxin and ATP, the interaction term of a two-factor ANOVA was 
used, as previously described (23), where the factors assessed were digoxin and ATP. 
Univariate regression was run to correlate pyridinoline content and tensile modulus. 
 
RESULTS 
 
Gross morphology and histology 
At the end of 4 weeks of culture, all self-assembled constructs had smooth surfaces and uniform 
morphology (Fig. 1) (Table 1).  All constructs stained uniformly for GAG and collagen with no 
gross differences in staining intensity among the groups (Fig. 2A). In addition, neocartilage 
from all groups stained positively for type II collagen and negatively for type I collagen (Fig. 
2A), indicating the formation of hyaline-like cartilage phenotype. 
 
Biochemical properties 
Digoxin- and ATP-treated constructs had significantly higher collagen per wet weight (WW) 
than untreated controls (52-110% increase) (Fig. 2B). In line with previous results (17), ouabain 
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increased collagen/WW by ~90% over controls. Unexpectedly, the application of inhibitors KB-
R7943 and suramin did not abolish the action of digoxin and ATP, suggesting an alternative 
mechanism of action. These results indicate that digoxin and ATP can increase collagen 
synthesis in tissue engineered cartilage constructs. 
The digoxin (low) and digoxin (low)+ATP group had a significantly higher amount of 
pyridinoline per collagen (PYR/collagen) than the ouabain, digoxin (high), and ATP groups 
(Table 1). Consistent with previous results from our group, PYR/collagen for the control group 
was 1.36 ± 0.24 nmol/mg. Univariate regression analysis revealed that PYR/collagen was 
statistically correlated to the Young’s modulus (R2 = 0.70) (Fig. 4), indicating that the formation 
of collagen crosslinks was a major contributor to neocartilage biomechanical properties. 
All digoxin-treated groups had lower GAG content (GAG/WW) than controls (Table 1). 
Ouabain and ATP did not affect GAG content. Pre-treatment with the NCX inhibitor KB-R7943 
abolished digoxin-induced changes in the GAG content of neotissue. Finally, the number of 
cells per construct was significantly decreased in the digoxin (high) group compared to controls, 
while no significant differences were observed in the other groups (Table 1). 
 
Biomechanical properties 
Compressive and tensile tests were conducted to determine the biomechanical properties of the 
self-assembled cartilage constructs. In terms of the tensile properties, digoxin (low), digoxin 
(high), ATP, and ouabain significantly increased the construct’s Young’s modulus over 
untreated controls by 282%, 170%, 148%, and 120%, respectively (Fig. 3A). Combined 
treatment of digoxin (low) and ATP resulted in the highest increase in tensile modulus (~380% 
increase over controls). Pre-treatment with the NCX inhibitor KB-R7943 partially inhibited 
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digoxin-induced effects, while pre-treatment with suramin completely abolished ATP-induced 
effects. Similar trends were shown in the ultimate tensile strength (UTS) of the constructs (Fig. 
3B). In terms of compressive properties, no significant differences were detected among the 
groups (Table 2). Results here indicate that digoxin and ATP significantly enhanced the tensile 
properties of the constructs, while their combined treatment resulted in an additive increase. 
 
Ca2+ imaging of 2D cultured chondrocytes 
Without any stimulation, chondrocytes are known to express a basal level of Ca2+ oscillations, a 
natural signaling process that has been linked to the regulation of matrix production following 
mechanical stimuli. Addition of digoxin (200 nM) and ATP (250 µM) significantly increased 
the frequency of intracellular Ca2+ oscillations in cultured chondrocytes over basal levels (Fig. 
5C). When comparing between drugs, ATP induced a higher frequency of Ca2+ oscillations than 
digoxin, while the combination of drugs induced a frequency similar to ATP alone. 
Digoxin and ATP induced Ca2+ oscillations of different characteristics (Fig. 5B). 
Representative traces are shown in Fig. 5B, but it is noted that chondrocyte Ca2+ activities were 
heterogeneous. Digoxin-induced Ca2+ transients showed little periodicity, were generally small 
in amplitude, and had a rolling shape (Fig. 5B, top). Digoxin induced a response in ~60% of the 
cells, while the other 40% did not show any response to the agent. ATP induced a single, large 
Ca2+ peak immediately after drug application in more than 95% of the cells. This initial peak 
was followed by trains of periodic oscillations (3-8 peaks) that continued over the next 15 min 
in ~20% of the cells (Fig. 5B, bottom). In the other ~80% of the cells, only 0-2 peaks were 
observed immediately after the initial peak, which was then generally followed by inactivity 
(Fig. 5B, bottom). Digoxin combined with ATP generated Ca2+ oscillations that were 
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characteristically similar to ATP alone. Results here show that digoxin and ATP were able to 
increase the frequency of Ca2+ oscillations in chondrocytes. 
 
DISCUSSION 	  
Tissue engineering holds great potential toward treating articular cartilage defects resulting 
from trauma or degenerative diseases, such as osteoarthritis. However, current methods to 
develop neocartilage in vitro result in functionally inadequate matrix possessing poor 
biomechanical properties. To address this problem, mechanical stimuli, such as dynamic 
compression or hydrostatic pressure, have often been used to increase chondrocyte matrix 
production (3, 4). Because the mechanotransduction pathway is thought to involve intracellular 
Ca2+ signaling (5-8). the application of Ca2+-modulating agents to tissue engineered cartilage 
presents an alternative strategy that may achieve similar results to mechanical stimulation. 
The results of this study demonstrate that digoxin or ATP can increase the biochemical 
and biomechanical properties of neocartilage. The application of either digoxin (200 nM and 20 
µM) or ATP (250 µM) significantly increased collagen content of neocartilage by ~1.5- to 2-
fold over controls and tensile modulus by ~2- to 4-fold over controls. When digoxin (200 nM) 
and ATP (250 µM) were applied together, they additively increased the tensile modulus by ~5-
fold over controls. Thus, this study demonstrates that modulation of intracellular Ca2+ in 
articular chondrocytes via digoxin and ATP is a viable strategy to enhance neocartilage 
functional properties. These results also further establish the importance of Ca2+ signaling 
pathways in chondrocyte metabolism and matrix homeostasis. 
The use of digoxin and ATP was motivated in part by the fact that both are clinically 
used, albeit for indications not related to cartilage pathologies. Digoxin is a cardiac glycoside 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  168 
and one of the most prescribed agents for treating heart failure and arrhythmias (24). Digoxin 
was chosen in light of previous results demonstrating that ouabain (20 µM), a cardiac glycoside 
similar in structure to digoxin, increased the collagen content (90% increase over controls) and 
tensile properties (110% increase over controls) of self-assembled neocartilage (17). Digoxin is 
also an FDA-approved drug, while ouabain remains an experimental drug that is not easily 
translatable to the clinical setting. ATP was chosen because of its role in the chondrocyte 
mechanotransduction pathways (13-15, 25). ATP has been injected intravenously in patients as 
a nutritional supplement (26). Because these agents are effective in increasing neocartilage 
properties and are currently clinically used, they demonstrate great potential as immediate 
candidate agents for translational tissue engineering applications. 
The 200 nM (low) dose of digoxin was found to have a better effect on construct 
properties than the 20 µM (high) dose of digoxin. Both doses significantly increased collagen 
content to similar values (54-73% increase over controls), but the low dose increased the tensile 
modulus more than the high dose. The lower tensile properties of the digoxin (high) group can 
be attributed to its lower collagen crosslinking content. It is also possible that the 20 µM dose of 
digoxin promoted a cytotoxic effect on the cells, as potentially indicated by the lower DNA 
content. Therefore, 200 nM of digoxin was determined to be an effective dose that enhances 
both collagen content and tensile properties of neocartilage constructs without having 
significant adverse effects. 
Digoxin, when compared to ouabain, was found to have a more potent effect. 
Specifically, digoxin (low) significantly increased the Young’s modulus by 54% and digoxin 
(low and high) significantly increased the UTS by ~50% over that of ouabain (20 µM). Given 
the current data, these differences can be attributed to digoxin’s ability to induce more collagen 
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crosslinks than ouabain. Interestingly, previous reports have reported different mechanisms of 
action of these drugs. For example, digoxin and ouabain can induce different hemodynamic 
effects in rats (27), indicating the two drugs may have different cellular effects. Digoxin not 
only affects the Na+/K+-ATPase, but may also affect intracellular receptors and transmembrane 
calcium channels differently than ouabain (28). Although these molecular mechanisms are still 
under investigation, this study supports that digoxin has a more potent effect over ouabain in 
enhancing neocartilage properties. 
Although digoxin and ATP promoted neocartilage collagen content and tensile 
properties, these two properties did not correlate as typically expected (29). Previous attempts to 
correlate mechanical properties with matrix components, such as collagen, GAG, and 
mineralization, have been met with inconsistent results (21, 29-31). In one study, a significant 
correlation was found between tensile strength and collagen content of engineered cartilage 
(32), while another study reported no significant correlation between the Young’s modulus and 
collagen content (30). A tissue’s tensile properties most likely arise from the interactions among 
multiple matrix components. Some of these have received little attention, such as pyridinoline 
crosslinks within the collagen network. Indeed, in the present study, regression analysis 
revealed that for the treated groups, tensile properties were found to correlate (R2=0.70) with the 
amount of pyridinoline crosslinks normalized to collagen (Fig. 4). Interestingly, the digoxin 
(low) group exhibited the highest amount of PYR/collagen, showing for the first time that 
digoxin can increase collagen crosslinks in articular cartilage. 
Although the control group contained a higher crosslink to collagen ratio when 
compared to all treated groups, its tensile properties were lower. This paradox may be explained 
by the timing of treatment application. In self-assembled neocartilage, collagen content plateaus 
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roughly at 10 days, which is then followed by tissue maturation (33). Treatment with the agents 
at days 10-14 may have induced additional collagen synthesis that may not have had sufficient 
time to form crosslinks, as formation of mature (trifunctional) pyridinoline crosslinks requires 7 
to 28 days (34). Therefore, the control group did not exhibit correlation between the Young’s 
modulus and PYR/collagen content as the other groups. 
The compressive properties of neocartilage remained indifferent to treatment, despite 
observed changes in the GAG content. All digoxin-treated groups significantly lowered the 
GAG content, while ouabain and ATP had no effects on GAG. While most articular cartilage 
engineering approaches result in relatively low levels of collagen, they are able to attain 
quantities of GAG on par with native tissue (19). This imbalance in the physiological GAG to 
collagen ratio has typically resulted in engineered tissues with reasonable compressive 
properties but very low tensile properties. Therefore, it is of interest to target approaches that 
increase the collagen content and tensile properties of engineered cartilage without necessarily 
further enhancing the compressive properties. Intracellular ion modulation with digoxin and 
ATP provides a method for increasing tensile properties and collagen content independent of 
affecting the compressive modulus. 
Time-lapse confocal microscopy revealed that digoxin and ATP increased the frequency 
of intracellular Ca2+ oscillations in chondrocytes. Effects of digitalis glycosides on Ca2+ 
signaling of non-excitable cells, such as chondrocytes, have not been previously studied. 
However, in these excitable cells, such as cardiomyocytes, digoxin at high doses has been 
shown to induce spontaneous release of Ca2+ transients from overloaded and unstable 
intracellular Ca2+ stores (35). Therefore, the increased frequency of spontaneous Ca2+ 
oscillations in digoxin-induced chondrocytes may follow a similar mechanism. 
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ATP has been well known to induce trains of Ca2+ oscillations in chondrocytes (36) and 
in other cell types. In chondrocytes, Ca2+ oscillations induced by ATP have been attributed to 
the activation of P2Y receptors and release of ER-stored Ca2+ via the IP3 pathway (37). It is 
unclear why ATP induces periodic trains of Ca2+ oscillations in only a specific proportion of the 
cells (20%), as reported here and in previous studies (36), but the heterogeneity of the 
chondrocyte population may be a factor. 
Since the two agents additively increased construct tensile properties, it was of interest 
to see if an explanation could be derived from the level of Ca2+ signaling. Because ATP-
stimulated chondrocytes exhibited periodic trains of Ca2+ oscillations, they appear to behave 
like excitable cells. With digoxin’s known effects on excitable cells, cooperation between ATP 
and digoxin was hypothesized to manifest in an additive or synergistic increase in Ca2+ 
signaling activity. However, this was not observed when the two agents were combined. 
Although the additive effects of the agents cannot be explained by the frequency of Ca2+ 
transients, other characteristics of the Ca2+ signal yet to be characterized, such as the amplitude 
of oscillations, may be a contributing factor. 
The mechanisms of action of digoxin and ATP were also explored using the inhibitors 
KB-R7943 and suramin, respectively. KB-R7943 binds to and inhibits the reverse mode of the 
NCX and has been shown to prevent digoxin-induced rises in intracellular Ca2+. In the present 
study, addition of KB-R7943 partially abolished digoxin (low)-induced changes in Young’s 
modulus and GAG content but did not abolish digoxin-induced changes in other construct 
properties. Therefore, digoxin may act by pathways independent of the NCX. Inhibition of the 
Na+/K+-ATPase may alter cell resting potential, cell swelling, and MAPK activation (38) among 
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other effects. Interestingly, these cellular changes are also known to occur in chondrocytes 
during mechanical compression of cartilage (39-41). 
Suramin, a reported inhibitor of P2YR, abolished ATP-induced changes in the Young’s 
modulus, but did not affect ATP-induced changes in the collagen content. These results indicate 
that ATP can act by pathways independent of the P2YR. ATP is known to also bind cell surface 
P2X receptors, ligand-gated ion channels, which can affect intracellular ion concentrations and 
cell signaling. In addition, chondrocyte surface ecto-nucleotidases can convert extracellular 
ATP into adenosine (11), a widely studied extracellular signaling molecular in cartilage biology. 
Depletion of extracellular adenosine has been shown to promote cartilage degradation (42), 
indicating a role of adenosine in cartilage matrix homeostasis. Therefore, digoxin and ATP may 
have multiple effects on the chondrocyte that requires further study. These Ca2+-independent 
pathways may also contribute to the additive effects seen by digoxin and ATP, which could not 
be initially explained by the Ca2+ signaling characteristics. 
 In conclusion, the present study supports that modulating intracellular calcium 
concentration via exogenous application of the chemical agents digoxin and ATP can alter the 
development of engineered articular cartilage. These agents are chosen to mimic the effects of 
stimuli involved in mechanotransduction. Application of 200 nM digoxin and 250 µM ATP 
individually increases the tensile modulus and collagen content of the engineered neocartilage, 
while their combination results in additive increases in both biochemical and functional 
properties. Overall, this study provides insight into important aspects of chondrocyte 
mechanotransduction-like pathways and suggests the use of novel pharmacological agents. 
Additionally, the ability of these agents to be applied exogenously raises the potential for direct 
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in vivo applications of these drugs, for example via intra-articular injections, to treat 
degenerative cartilage pathologies such as osteoarthritis. 
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TABLES & FIGURES 
 
TABLE 5.1 – GROSS MORPHOLOGY OF NEOTISSUE.	   Neocartilage wet weight (WW), water 
content, glycosaminoglycan (GAG) content, cells/construct, and PYR/collagen content at the 
end of 4 weeks of culture. 
Group Wet Weight 
(mg) 
Water 
Content 
(%) 
GAG/WW    
        (%) 
Cells/ 
Construct 
(millions) 
PYR/collagen 
(nmol/mg) 
Control 38.5±1.5c 85.1±1.5ab 4.1±0.6a 5.8±0.2ab 1.36±0.24a 
Ouabain 32.6±1.0d 87.1±3.2a 4.7±1.2a 5.1±0.6bc  0.83±0.15cd 
Digoxin (low) 41.6±3.5ab 84.9±1.6ab 3.5±0.4bc 6.1±0.5a 1.07±0.21b 
Digoxin (high) 33.1±3.2d 86.4±2.0a 2.5±0.2c 4.5±0.4c  0.81±0.20cd 
ATP 41.7±1.7a 85.0±1.4ab 4.0±0.8a 5.8±0.4ab  0.68±0.11d 
Digoxin (low) + ATP 40.0±2.5abc 86.6±1.2a 3.3±0.6bc 5.7±0.7ab  1.06±0.21bc 
Digoxin (low) + KB-R7943 38.9±2.5bc 83.5±2.2b 3.9±0.6ab 6.1±0.7a  0.75±0.18cd 
ATP + Suramin 40.5±1.7abc 83.3±1.3b 4.2±1.0a 5.5±0.8ab  0.83±0.23bcd 
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TABLE 5.2 – NEOCARTILAGE COMPRESSIVE PROPERTIES AT THE END OF 4 WEEKS OF 
CULTURE.  
Group Aggregate 
Modulus (kPa) 
Permeability 
(10-15 m4/N·s) 
Poisson Ratio 
Control 125±45 46±26a 0.12±0.06 
Ouabain 111±40 20±12b 0.08±0.05 
Digoxin (low) 139±49 28±12ab  0.10±0.05 
Digoxin (high) 120±35 21±14b  0.11±0.08 
ATP 90±23 29±22ab 0.11±0.07 
Digoxin (low) + ATP 123±36 17±8b 0.14±0.05 
Digoxin (low) + KB-R7943 93±36 33±19ab 0.09±0.07 
ATP + Suramin 123±19 38±22ab 0.13±0.10 
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FIGURE 5.1 – REPRESENTATIVE IMAGES OF SELF-ASSEMBLED NEOCARTILAGE CONSTRUCTS 
FROM EACH GROUP AT THE END OF 4 WEEKS OF CULTURE. All constructs appeared flat and 
disc-shaped with no gross morphological differences. 
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FIGURE 5.2 – NEOCARTILAGE GAG AND COLLAGEN CONTENT AT THE END OF 4 WEEKS OF 
CULTURE. (A) Histological staining showed the presence of GAGs (Safranin O/Fast Green 
stain) and total collagen (Picrosirius Red stain) throughout the construct. Immunohistochemistry 
indicated the presence of type II collagen and the absence of type I collagen. Scale bar: 50 µm. 
(B) Measurement of the collagen content indicated that all chemical agents increased collagen 
production over controls. 
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FIGURE 5.3 – NEOCARTILAGE TENSILE PROPERTIES. Neocartilage Young’s modulus (A) and 
UTS (B) after 4 weeks of culture. Digoxin and ATP, either alone or combined, were able to 
increase the tensile properties of neocartilage compared to controls. 
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FIGURE 5.4 – RELATIONSHIP BETWEEN PYRIDINOLINE CONTENT AND YOUNG’S MODULUS. 
PYR/collagen plotted with Young’s modulus (both normalized to control) indicated a strong 
correlation between collagen crosslinks and tensile properties. 
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FIGURE 5.5 – INTRACELLULAR CA2+ SIGNALING IN 2D CULTURED ARTICULAR CHONDROCYTES 
STIMULATED WITH DIGOXIN AND ATP. (A) Representative images of chondrocytes cultured on 
glass slides showing an increase in intracellular Ca2+ upon induction with ATP at 15 min. (B) 
Representative Ca2+ traces induced by each agent. ATP and digoxin+ATP induced similar 
responses. Traces were shifted on the y-axis for better visualization. Downward drifts were due 
to photobleaching. (C) All agents increased the frequency of Ca2+ oscillations over baseline 
controls, as determined by a paired t-test (significance denoted by an asterisk). ATP and 
digoxin+ATP induced more Ca2+ oscillations than digoxin alone, as determined by a one-way 
ANOVA comparing the different drugs (black bars). 
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CHAPTER 6 – A CHONDROITINASE-ABC AND TGF-β1 TREATMENT 
REGIMEN FOR ENHANCING THE MECHANICAL PROPERTIES OF 
TISSUE ENGINEERED FIBROCARTILAGE 
 
ABSTRACT  
The development of functionally equivalent fibrocartilage remains elusive despite efforts to 
engineer tissues such as the knee menisci, intervertebral disc, and TMJ disc. Attempts to 
engineer these structures often fail to create tissues with mechanical properties on par with 
native tissue, resulting in constructs unsuitable for clinical applications. The objective of this 
study was to engineer a spectrum of biomimetic fibrocartilages representative of the distinct 
functional properties found in native tissues. Using the self-assembly process, different co-
cultures of meniscus cells (MCs) and articular chondrocytes (ACs) were seeded into agarose 
wells and treated with the catabolic agent chondroitinase-ABC (C-ABC) and the anabolic agent 
transforming growth factor-β1 (TGF-β1) via a two-factor (cell ratio and bioactive treatment), 
full factorial study design. Application of both C-ABC and TGF-β1 resulted in a beneficial or 
positive increase in the collagen content of treated constructs compared to controls. Significant 
increases in both the collagen density and fiber diameter were also seen with this treatment, 
increasing these values 32% and 15%, respectively, over control values. Mechanical testing 
found the combined bioactive treatment to synergistically increase the Young’s modulus and  
 
 
 
 
Chapter published as: MacBarb, R.F., Makris, E.A., Hu, J.C., & Athanasiou, K.A. A 
Chondroitinase-ABC and TGF-β1 Treatment Regimen for Enhancing the Mechanical 
Properties of Tissue-Engineered Fibrocartilage. Acta Biomaterialia. 9(1):4626-4634, 2012.  
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ultimate tensile strength of the engineered fibrocartilages compared to controls, with values 
thatC-ABC and TGF-β1 interact to develop a denser collagen matrix better able to withstand 
tensile  loading. This study highlights a way to optimize the tensile properties of engineered 
fibrocartilage using a biochemical and biophysical agent together to create distinct 
fibrocartilages with functional properties mimicking those of native tissue. 
 
INTRODUCTION 
Fibrocartilage is uniquely situated within specific joint spaces of the body to facilitate the 
distribution of peak loads. Viscoelastic in nature, this tissue is capable of deforming its shape to 
effectively spread loads across a greater surface area. Found, for example, in the knee, 
intervertebral, and temporomandibular joints, fibrocartilage is distinctively situated to allow for 
congruent meshing of the articulating structures within these joint spaces, ensuring smooth, 
stable articulation and stress absorption10, 223, 224. However, fibrocartilage lacks an innate ability 
to self-repair following disease or injury. With a lack of clinically available treatment options 
for patients suffering from injured or diseased fibrocartilage, the need for an effective remedy is 
crucial. Fibrocartilages engineered in vitro offer new hope as a long-term treatment option to 
repair or replace injured or degenerated fibrocartilaginous tissues.  
Collagens make up the majority of the extracellular matrix (ECM) of a 
fibrocartilaginous tissue. Within a specific fibrocartilage, these collagen fibers align with the 
peak tensile loads in a given joint space, situating the tissue to best distribute complex forces. 
While fibrocartilages are primarily composed of collagen type I, they also contain lower 
amounts of collagen type II as well as glycosaminoglycans (GAGs). The levels at which these 
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main ECM components are found are characteristic of the anatomical location and function. The 
heterogeneous distribution and organization of ECM result in anisotropic biomechanical 
properties specific to each fibrocartilage type. Efforts to tissue engineer fibrocartilages able to 
withstand the mechanical complexity of a joint space must therefore focus on creating a well-
developed, collagen-rich matrix.  
 Capitalizing on chondrocytes’ unique ability to form dense, ECM-rich clusters when 
seeded at high densities, a scaffold-free, self-assembly approach to cartilage tissue engineering 
has been developed212. With primary TMJ disc and intervertebral disc cells presenting as an 
implausible cell source due to limited cell numbers in the tissue as well as low levels of matrix 
production in vitro, this technology has recently been extended to co-cultures of varying ratios 
of meniscus cells (MCs) and articular chondrocytes (ACs), allowing for the formation of a 
spectrum of fibrocartilages4, 47, 225. While current efforts to tissue engineer fibrocartilage have 
succeeded in creating constructs with compressive properties on par with native tissue values, 
tensile properties have lagged greatly behind4, 5, 226-228. This is a significant problem for 
fibrocartilages, as they function under both compression and tension. For instance, resistance to 
compression in the knee menisci occurs via tensile, hoop stresses developed in the wedged-
shape of this tissue. Likewise, tension-compression is also observed in the TMJ disc10. Here, 
ligaments around the periphery of the disc secure the tissue within in the joint space, and as the 
condyle translates during jaw opening, it compresses the disc, causing inherent tension much 
like that of a trampoline31. Exogenous stimuli such as TGF-β1 and chondroitinase-ABC (C-
ABC) have therefore been investigated to enhance the tensile properties of self-assembled, 
engineered fibrocartilages4, 8, 99, 217. 
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 Previous work with C-ABC has shown that this enzyme’s temporary depletion of GAG 
enhances the tensile properties of treated articular cartilage explants229. It has also been shown 
that there is a window of effectiveness for C-ABC’s application; applying C-ABC at both t = 2 
wk and t = 4 wk of culture is superior to a single treatment at either time point for enhancing the 
tensile properties of tissue-engineered articular cartilage8. In another study, tissue-engineered 
meniscus cartilage was treated with C-ABC at an earlier time point to determine if treating a 
more immature matrix would have a greater effect on tissue development, as chondrocytes 
produce the majority of their matrix during the first week of self-assembly230. Results found a 
single, early application of C-ABC at t = 1 wk to be beneficial in enhancing the tensile 
properties of the tissue99.  
 Recent work has shown concurrent application of C-ABC and TGF-β1 results in further 
enhancement of the mechanical properties of tissue-engineered cartilage compared to treatment 
with either agent alone99, 231. Application of these two agents on tissue-engineered neocartilage 
was found to synergistically increase collagen content and additively increase the tissue’s 
tensile strength231. In a separate study, engineered meniscus fibrocartilage experienced a 5-fold 
increase in the radial tensile modulus as well as a 196% increase in collagen content after being 
treated with both C-ABC and TGF-β199. Through depleting GAG, C-ABC releases GAG 
fragments, such as hyaluronic acid fragments, into the tissue, and such fragments have been 
reported to have an anabolic effect on surrounding cells232. Microarray analysis of self-
assembled articular cartilage treated with C-ABC, however, has found no changes in gene 
expression as a result of this treatment, suggesting the GAG fragments are being effectively 
removed from the tissue231. Further, inspection of C-ABC treated engineered articular cartilage 
via scanning electron microscopy (SEM) has found C-ABC to work via a biophysical 
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mechanism, through altering the physical structure of a collagen network. Microarray analysis 
work has also found that TGF-β1 promotes chondrocytes to synthesize more ECM through a 
MAPK biochemical pathway231. It was concluded that these bioactive agents are able to 
collaboratively increase the functional properties of tissue-engineered cartilage because they act 
via different mechanisms: one being biophysical, the other biochemical. With previous work on 
enhancing the functional properties of a spectrum of engineered fibrocartilage focused on TGF-
β1 alone, it is important to institute both TGF-β1 and C-ABC with the goal of further enhancing 
the functional properties of such tissues.  
 The overall objective of this study was to generate biomimetic fibrocartilages 
representative of the vast array of distinct fibrocartilages found in the body. Given the previous 
success of engineering such tissues with compressive properties on par with native tissue 
values, this study emphasized enhancing the tensile properties of engineered fibrocartilage.  To 
capture the heterogeneous nature of the different types of fibrocartilage, a spectrum of 
fibrocartilaginous tissues was generated using the self-assembly process and optimized using C-
ABC and TGF-β1 alone or in combination. Tissues having different ratios of MCs and ACs 
were created to recapitulate the diversity of collagen type I to collagen type II found in 
fibrocartilages. After optimizing a C-ABC treatment regimen, tissues were treated with the 
bioactive agents C-ABC and TGF-β1 using a two-factor, full factorial study design with cell 
ratio and bioactive treatment as the factors. Overall, it was hypothesized that the combination of 
C-ABC and TGF-β1 would significantly increase the tensile properties of each of the co-culture 
constructs without compromising their compressive properties. It was further hypothesized that 
by increasing the tensile properties, the combined bioactive treatment regimen would generate 
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co-culture ratio-dependent fibrocartilages having distinct functional properties within the range 
of native tissue. 
 
MATERIALS AND METHODS 
Cell isolation and self-assembly into fibrocartilage constructs 
Bovine articular chondrocytes and meniscus cells were harvested from juvenile bovine knee 
joints (Research 87, Boston, MA). Minced articular cartilage was digested in base medium of 
Dulbecco’s modified Eagle’s medium (DMEM) with 1% penicillin/streptomycin/fungizone 
(PSF), containing 0.2% collagenase (Worthington, Lakewood, NJ) for 18 hours. Minced 
menisci were digested in base medium containing 0.25% Pronase E (Sigma, St. Louis, MO) for 
1 hour prior to 18 hours in 0.2% collagenase-containing base medium. Isolated cells were 
frozen in base medium containing 20% fetal bovine serum and 10% dimethyl sulfoxide until 
needed for seeding.   
 Cells were self-assembled at 50:50 and 75:25 MC:AC co-culture ratios as previously 
described4, 212. Based on preliminary work, a 100:0 MC:AC cell ratio was not used in this study, 
as neither C-ABC nor TGF-β1 alone or in combination was found to have significant effects on 
this cell ratio, resulting in constructs with subpar functional properties compared to constructs 
containing both MCs and ACs. Briefly, MC and AC cell suspensions were seeded into 5 mm 
diameter, 2% agarose wells at t = 0 hr. By t = 4 hr, the cells had assembled into constructs. 
Constructs were fed 500 µl of chondrogenic medium consisting of DMEM, 1% PSF, 1% non-
essential amino acids, 100 nM dexamethasone (Sigma, St. Louis, MO), 1% ITS+ (BD 
Scientific, Franklin Lakes, NJ), 40 µg/mL L-proline, 50 µg/mL ascorbate-2-phosphate, and 100 
µg/mL sodium pyruvate (Fischer Scientific, Pittsburgh, PA), every day. At t = 1 wk, constructs 
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were removed from the agarose molds and placed into 48 well plates for the duration of the 5 
wk culture period.  
 
Bioactive treatment regimens 
 
Two bioactive agents were investigated in this study: C-ABC (Sigma-Aldrich, St. Louis, MO) 
and TGF-β1 (PeproTech, Rocky Hill, NJ). Constructs treated with C-ABC received 2 U/mL C-
ABC with a 0.05 M acetate activator in chondrogenic medium for 4 hr at 37°C once at t = 7 d 
and again at t = 21 d. This dual C-ABC treatment was developed in preliminary studies to 
confirm that this regimen was superior to a single treatment at either time point for enhancing 
the tensile properties of the tissue-engineered fibrocartilage. In TGF-β1 treated constructs, TGF-
β1 was given continuously at 10 ng/ml with every medium change from t = 0 hr to the end of 
culture4. To investigate the interaction of these bioactive agents, treatments consisted of the 
following: C-ABC alone, TGF-β1 alone, the two bioactive agents combined, or none. At t = 5 
wk, each construct was segmented for various assessments, as described below.  
 
Histology and immunohistochemistry (IHC) 
 
Samples were frozen in HistoPrep (Fisher Chemical, Vernon Hills, IL), sectioned at 12 µm, 
fixed in chilled formalin, and stained with Safranin O/Fast Green and picrosirious red for GAG 
and total collagen, respectively. For IHC, sections were fixed in chilled acetone, after which 
endogenous peroxidase was blocked using 3% H2O2. Samples were then blocked with horse 
serum (Vectastain ABC kit, Vector Labs, Burlingame, CA) and incubated with mouse anti-
collagen type I (AccurateChemicals, Westbury, NY) or rabbit anti-collagen type II (Cedarlane 
Labs, Burlington, NC) antibodies. Corresponding 2° antibodies as well as the Vectastain ABC 
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and DAB solutions were applied as instructed by the Vectastain ABC kit (Vector Labs, 
Burlingame, CA) for collagen visualization. 
  
Quantitative biochemistry 
 
Sample wet weights were taken after blotting, followed by lyophilization for t = 2 d to 
determine their dry weights. Samples were then digested in papain as previously described99. 
Total collagen was assessed using a chloramine-T hydroxyproline assay with a SIRCOL 
collagen assay standard (Accurate Chemical and Scientific Corp.). GAG content was 
determined using a dimethylmethylene blue (DMMB) dye-binding assay kit (Biocolor, 
Newtownabbey, Northern Ireland). DNA content was measured using a Picogreen Cell 
Proliferation Assay Kit (Molecular Probes, Eugene, OR).  
 
Biomechanical testing  
 
Uniaxial, unconfined stress-relaxation compressive testing was applied on 3 mm biopsy 
punches from the center of the tissue-engineered constructs. Samples were placed in a PBS-
filled petri dish and loaded onto the stage of an Instron uniaxial testing machine (Model 5565, 
Canton, MA). Sample height was determined by applying a 0.02 N tare load. Following pre-
conditioning at a 5% strain for 15 cycles at 1 Hz, the sample was compressed at a 1% strain rate 
per sec to 10%, 20%, and 30% strains. Samples were held at a given strain for 400 sec, which 
allowed sufficient time for the force vs. time curve of each strain level to equal zero, signifying 
the sample had fully relaxed. Following this holding time, the next sequential strain level was 
applied. A Kelvin solid model was used to fit the results of the 20% stress relaxation test and to 
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calculate the viscoelastic material properties of the samples; this included the relaxation and 
instantaneous moduli, as well as the viscosity of the tissue. 
 Uniaxial tensile testing was also conducted using the Instron. Constructs were cut into 
dog bone shapes and glued onto strips of paper at either extremity. The gauge length was 
measured between the glued ends. The paper strips holding the sample were loaded into grips, 
and a pull to failure test was applied at a 1% strain rate per sec. The linear portion of the stress 
vs. strain curve was used to determine the Young’s Modulus of the sample, while the peak of 
the linear region was taken as the ultimate tensile strength (UTS).      
 
SEM 
Samples were dehydrated in increasing ethanol and stored in 100% ethanol at 4°C. Just prior to 
imaging, samples were further dehydrated using a critical point dryer and sputter-coated with 
gold. For each sample, three separate locations were imaged using a Philips XL30 TMP SEM, 
and collagen matrix fiber density and diameter were quantified using ImageJ as previously 
described231. 
 
Statistical analysis  
To test the hypothesis that the combined bioactive treatment was a significant factor in 
increasing the functional properties within a given cell ratio, a 1-way ANOVA (n = 8 per group) 
was used within each cell ratio. Results of the 1-way ANOVA for the 50:50 cell ratio are 
represented by upper case letters, while those of the 75:25 cell ratio are represented by lower 
case letters. Separately, to test the hypothesis that the cell ratio and the bioactive treatments 
were both significant factors in altering construct composition, a 2-way ANOVA (n = 8 per 
group) was used to analyze the data. When either the 1- or 2-way ANOVA showed significance 
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(p < 0.05), a Tukey’s HSD post hoc test was applied. Data that had a positive interaction on an 
additive scale and resulted in a combined group that was greater than the addition of the two 
singular treatments were determined to be synergistic, while those that had a negative 
interaction on an additive scale but resulted in a combined group that was greater than either 
treatment alone were determined to be beneficial or positive. Data for this study are represented 
as mean ± standard deviation with bars or groups marked by the same letter having no 
significant differences, while those that are marked by different letters are significantly different 
from one another.  
 
RESULTS 
Gross morphology  
At t = 5 wk, all constructs maintained a flat, disc-shaped morphology (Fig. 1). However, as the 
ratio of MCs to Acs increased, construct diameter, thickness, and total wet weight decreased 
(Table 1). Treated constructs from the 50:50 cell ratio group had significantly lower wet 
weights, diameters, and thicknesses compared to untreated controls. For example, when treated 
with both C-ABC and TGF-β1, the wet weight, diameter, and thickness of the 50:50 constructs 
were decreased by 66%, 24%, and 29%, respectively. Similar, decreasing trends were seen in 
75:25 constructs, though TGF-β1 alone significantly increased the wet weight 12% compared to 
controls within this cell ratio.  Further, all bioactive treatments increased the thickness of the 
75:25 constructs compared to controls. In terms of construct hydration, combination treated 
constructs of both cell ratio groups had significantly decreased water content compared to 
controls or either treatment alone, signifying a denser matrix in the combined treated groups. 
These results are summarized in Table 1.  
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Histology and IHC 
 
Overall, collagen and GAG staining were stronger in the 50:50 compared to the 75:25 cell ratio 
constructs. Staining trends within each cell ratio, however, were similar, with the combined 
bioactive treatment resulting in more uniform, dense collagen and GAG staining compared to 
all other treatments for both cell ratios (Fig. 1).   
 To test whether the cell ratio and bioactive treatment factors had an effect on the 
collagens being produced within a construct, IHC staining specifically for collagen type I and II 
was performed (Fig. 1). IHC staining found distinct trends to occur among the bioactive 
treatment levels within each cell ratio. Collagen type I stained positive in the control treatment 
within the 50:50 cell ratio group, while 50:50 constructs treated with C-ABC alone or in 
combination with TGF-β1 had much lighter, diffuse collagen type I staining. The 75:25 cell 
ratio group had positive collagen type I staining in all bioactive treatment levels, with stronger 
staining appearing in the combination treated constructs. Collagen type II staining was positive 
in all treatment levels for each cell ratio. Overall, collagen type II staining was slightly more 
intense in the 50:50 than the 75:25 cell ratio, particularly within the C-ABC treated and 
combination treated constructs.  
 
Quantitative biochemistry  
 
The number of cells per construct was significantly decreased with the addition of C-ABC alone 
or in combination with TGF-β1, while control and TGF-β1 treated constructs were not 
significantly different from each other. Overall, the 50:50 cell ratio had higher cellularity within 
the control and TGF-β1 treatments, at approximately 3 million cells/construct, while the 75:25 
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control and TGF-β1 treatments had approximately 2 million cells/construct. Following 
treatment with either C-ABC alone or the combination treatment, cell number decreased by 
70% in the 50:50 cell ratio and by 32% in the 75:25 cell ratio (Table 1).  
 Collagen/WW (Fig. 2A) in the 50:50 cell ratio constructs was significantly affected by 
the various bioactive treatments employed in this study. C-ABC increased collagen/WW 40% 
over control values, while a 60% increase over controls was measured in TGF-β1 treated 
constructs. When the two bioactive agents were combined, collagen content was increased by 
80% over control constructs. Furthermore, in the combined treatment, the two factors were 
found to result in a beneficial or positive significant enhancement of the collagen content in the 
50:50 cell ratio compared to treatment with either bioactive agent alone. A similar significant 
effect was observed for collagen/WW in the 75:25 cell ratio, with values increasing 104% in 
combination treated constructs over controls. Comparison between the two cell ratios found the 
50:50 cell ratio factor to have significantly more collagen/WW compared to the 75:25 cell ratio, 
while the C-ABC + TGF-β1 treatment factor resulted in significantly higher collagen/WW than 
any other treatment factor across both cell ratios. 
GAG/WW (Fig. 2B) was significantly decreased in combination treated 50:50 and 75:25 
cell ratios compared to controls. GAG content was significantly greater in the 75:25 cell ratio 
constructs, ranging from approximately 4 – 6.5%, compared to the 50:50 cell ratio constructs, 
which ranged from approximately 2 – 5%. Within the bioactive treatment factor, the combined 
bioactive treatment had significantly less GAG than controls or TGF-β1 treated constructs. 
 
Biomechanics  
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Biomechanical testing was run to understand the influence of the cell ratio and bioactive 
treatment factors on the mechanical properties of the engineered fibrocartilages (Table 2). 
Similar trends in compressive properties were found among all tested strain levels; therefore, 
only the 20% strain level results are shown to represent these properties. Stress-relaxation, 
unconfined compression testing at 20% strain found no significant differences among 
treatments within the 50:50 cell ratio for the relaxation modulus, with values ranging from 95 ± 
16 kPa to 125 ± 40 kPa. The relaxation modulus for the combined treated constructs within the 
75:25 cell ratio was significantly lower than controls, at 40 ± 14 kPa compared to 57 ± 8 kPa, 
respectively. Significant differences were observed among treatments within both cell ratios for 
the instantaneous modulus and viscosity. At a 20% strain, the instantaneous modulus in TGF-β1 
alone treated constructs was 5-fold and 2.4-fold higher in the 50:50 and 75:25 cell ratios 
compared to respective controls, while similar increases were observed in the viscosity. The 
combination treatment within either cell ratio, however, was not significantly different than 
corresponding control values, although they trended higher than their respective controls. 
 Tensile testing showed the most exciting results of this study (Fig. 3). With significant 
effects in response to bioactive treatments for both the Young’s modulus (Fig. 3A) and the UTS 
(Fig. 3B), results mirrored those observed for the collagen/WW data for each cell ratio. 
Compared to controls, within the 50:50 cell ratio, C-ABC increased the Young’s modulus 
226%, while TGF-β1 increased this parameter by an additional 237%. The combined treatment 
further increased the Young’s modulus by an additional 260%. Overall, the combined treatment 
synergistically increased the Young’s modulus 724% compared to controls, from 414 ± 121 kPa 
in the controls to 3410 ± 706 kPa in the combined treated constructs. In a similar fashion, the 
UTS in combined treated constructs was 12.7-fold higher than control values in the 50:50 cell 
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ratio. Within the 75:25 cell ratio, a 208% increase was observed by the combination treatment 
over controls, reaching a value of 2295 ± 241 kPa in the combination treated constructs, while 
the UTS in the combined treated constructs was 4.1-fold higher than that of controls. Overall, 
the combined treatment was found to additively increase the Young’s modulus and UTS 
compared to either treatment applied alone, while the 50:50 cell ratio factor had significantly 
higher tensile properties than the 75:25 cell ratio factor. 
 
SEM  
 
With the 50:50 cell ratio showing the greatest percent increases among bioactive treatments for 
the collagen/WW and tensile properties, portions of constructs representative of each treatment 
within this cell ratio were analyzed via SEM to investigate if the different treatments were 
altering the matrix. Resulting images were quantified for fiber density and diameter (Fig. 4). 
Overall, fiber density in the SEM images ranged from 75% to 80%, while fiber diameter ranged 
from 34 to 50 nm. C-ABC treatment was found to significantly increase the density of the fibers 
10.2% over controls, while TGF-β1 alone had no effect on the density. For the diameters, TGF-
β1 alone was found to significantly increase the fiber diameter 18.4% over control values, 
although C-ABC alone decreased fiber diameter 9.3%. Interestingly, when constructs were 
treated with C-ABC and TGF-β1 in combination, both the fiber diameter and the density 
increased 31.9% and 15.0%, respectively, compared to controls (Fig. 4). Further, these increases 
were greater than either treatment alone, signifying a synergistic behavior between these two 
agents in modifying collagen network organization. 
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DISCUSSION 
 This study focused on generating distinct tissue-engineered fibrocartilages by treating different 
MC:AC co-culture ratios with the bioactive agents C-ABC and TGF-β1. It was hypothesized 
that the combined use of C-ABC and TGF-β1 would significantly increase the tensile properties 
of the co-culture ratio constructs without compromising their compressive properties. Through 
enhancing their tensile properties, it was further hypothesized that the combined bioactive 
treatment regimen would promote the development of biomimetic fibrocartilages having co-
culture ratio-dependent biochemical and biomechanical properties within the range of native 
tissue. Through a two-factor, full factorial study design, the hypotheses were confirmed: First, 
the tensile properties of the engineered tissues for both cell ratio groups were significantly 
enhanced when C-ABC and TGF-β1 stimuli were combined. The compressive properties of the 
50:50 cell ratio were also not compromised, unlike the 75:25 cell ratio, which showed a 
reduction in the relaxation modulus. Second, by enhancing the tensile properties of the co-
cultures, overall construct functional properties fell within the range of native tissue properties 
for both cell ratio groups by the combined bioactive treatment. 
 Fibrocartilages generated from different seeding ratios of MCs and ACs were found to 
have distinct functional properties. This can be correlated with each cell type having different 
synthetic abilities in vitro. In culture, MCs have been found to produce lower amounts of ECM 
components compared to ACs. For example, MCs embedded in agarose were found to 
synthesize 25% less proteoglycans than ACs in the same system. Furthermore, of this 25%, 
approximately 54% of the GAGs synthesized by the MCs were lost to the surrounding 
medium233. Medium was not assessed in this experiment as some treatments in this study (i.e., 
all that contained C-ABC) work by causing ECM components to leach out of the constructs. 
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Therefore the media of different treatments are incomparable. In a separate study, the genes 
encoding for the proteoglycans, collagens, and enzymes important for collagen synthesis and 
degradation were measured. Results found significantly lower expression levels of α1(I) 
procollagen, α1(II) procollagen, procollagen-lysine 2-oxoglutarate 5-dioxygenase 1, 2, and 3, 
and lysyl oxidase genes were measured in freshly isolated MCs than in freshly isolated ACs. 
Instead, higher expression of the matrix metallopeptidase 13 gene, a member of the matrix 
metalloproteinase family, was measured in MCs after 18 d of culture in alginate beads234, 235. 
These findings provide much insight as to why MCs alone may not be suitable for producing 
mechanically sound engineered fibrocartilaginous tissues; without a well-developed matrix, the 
mechanical integrity of a tissue will be compromised. As shown by this study, incorporating a 
certain percentage of ACs into co-culture with MCs allows for mechanically robust 
fibrocartilages having different functional properties to be produced.  
 The biophysical effect of C-ABC is dependent on its ability to temporarily deplete 
GAGs, which ultimately allows for the formation of a more functional collagen network with 
greater tensile strength231. Immature cartilage explants were found to experience an imbalance 
in the normal GAG:collagen ratio when grown in vitro, resulting in a loss of tensile 
properties236. A more physiologic GAG:collagen ratio was reinstated following treatment with 
C-ABC, recovering the loss of tensile properties229, 236. Such studies have led researchers to 
believe that an imbalance between GAG and collagen occurring in in vitro cartilage growth 
induces a pre-stress in the tissue, altering the tissue’s mechanical properties. This theory may 
apply to tissue-engineered fibrocartilages, which tend to have higher than normal GAG levels 
compared to their native tissue counterparts. This will, in turn, alter the engineered tissue’s 
GAG:collagen ratio, causing an unnatural pre-stress in the developing matrix of the tissue that 
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may affect its ability to form a mechanically robust matrix. By simultaneously increasing the 
collagen content while decreasing the GAG content, treatment with C-ABC reinstates a more 
physiologic GAG:collagen ratio in engineered fibrocartilages. Through significantly decreasing 
the GAG content and allowing for the development of a more functional collagen network, C-
ABC enhanced the tensile properties of the tissue engineered fibrocartilage, as hypothesized.  
 In addition to generating tissues with a more physiologic GAG:collagen ratio, treatment 
with C-ABC significantly decreased the cellularity of the engineered fibrocartilage. Previous 
studies have reported that as cartilage matures in vivo, the cellularity of this tissue decreases via 
apoptosis by more than half the original number237-239. The significant decrease in cellularity of 
the C-ABC engineered fibrocartilage therefore suggests that C-ABC is expediting the 
maturation of the tissue in vitro. Further, a study investigating the cell viability of porcine 
cartilage explants found that loss of GAG via C-ABC treatment did not cause cell death, 
suggesting the loss of GAG from the engineered fibrocartilage to not be the cause of the 
decreased cell number240. In a separate study on engineered articular cartilage, while C-ABC 
was found to suppress cell proliferation in the tissue, treatment produced more mature 
constructs compared to controls241. Although the direct cause for decreased cellularity following 
treatment with C-ABC remains unknown, the resulting maturation of engineered cartilage and 
fibrocartilage merits future studies to better understand this beneficial phenomenon.  
 It is important to note that the purpose of this study was to increase the tensile properties 
without compromising the compressive properties of the tissue-engineered fibrocartilage. In 
general, compressive properties of the combined treated constructs were not compromised and 
fell within the range of native tissue for the TMJ disc, intervertebral disc, and knee menisci242-
244. The only exception was the C-ABC + TGF-β1 treated 75:25 cell ratio constructs, which had 
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a significantly lower relaxation modulus than respective controls. The instantaneous modulus 
and the viscosity values for this group were not significantly lower than the control values, 
however. This result appears paradoxical when one considers the accepted structure-function 
relationship of articular cartilage242-244. Past studies on articular cartilage have found a strong 
correlation between GAG content and compressive properties, as well as between collagen 
content and tensile properties. In this study, as the percentage of MCs increased, the structure-
function behavior deviated from what would be expected based on the articular cartilage 
paradigm. Along with other recent work, this study challenges the existing structure-function 
paradigm, showing that it does not necessarily hold for fibrocartilage. Instead, tissues 
containing low GAG levels, such as fibrocartilages, appear to have a more complex mechanism 
that has more to do with the interplay between collagen and GAGs, as opposed to each 
component being independently responsible for a specific mechanical property243, 245. Studies 
must therefore be conducted to explain the intricate interaction between ECM structures and the 
function of fibrocartilaginous tissues; such data will be useful for optimizing design criteria 
towards creating tissues able to withstand in vivo loading.  
Results from this study shed some light onto the complexity of the tensile behavior of 
tissue-engineered fibrocartilages. In this study, C-ABC treatment was found to significantly 
increase the collagen density of the engineered fibrocartilage via SEM analysis. Biochemical 
analysis, on the other hand, found the collagen/WW to be significantly increased in a positive or 
beneficial way within the combined treated group. This corroborates the SEM analysis of 
collagen density, as higher collagen content will lead to a denser collagen network. Together, 
these results suggest that increased collagen in the engineered constructs is contributing to the 
increases in tensile properties in the combined treated group, as GAG significantly decreased 
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within this same group. Further, various studies concerning the tensile mechanics of native 
fibrocartilages have correlated higher tensile properties with greater collagen content and 
density31, 47, 246-248. Together, a strong correlation between tensile properties and collagen 
content and density can be seen in both engineered and native fibrocartilages.  
Another parameter affecting the tensile properties of fibrocartilage is collagen fiber 
diameter. Native tissue studies have found thicker collagen fibers to correspond to areas of 
higher tensile strength249. Collagen fiber diameter has been found to vary in fibrocartilaginous 
tissues, ranging between 30 – 70 nm in the TMJ disc and between 50 – 100 nm in the annulus 
fibrosus and the knee menisci45, 250, 251. Quantification of fibril diameters within the engineered 
tissues found them to range between 34 and 50 nm, on par with diameters seen in native TMJ, 
spine, and knee fibrocartilages. Further, among bioactive treatment levels, the combined 
bioactive treated constructs had significantly greater fiber diameters than all other treatments. 
This information provides a mechanistic view for how C-ABC and TGF-β1 alter the developing 
matrix in engineered fibrocartilage; by increasing collagen fiber diameters, these agents increase 
the tensile properties of engineered tissue.  
The complexity of fibrocartilage is further extended to its anisotropic tensile properties. 
For instance, the tensile modulus of the annulus fibrosus of the intervertebral disc was found to 
be 5.6 – 17.4 MPa in the circumferential direction, in contrast to 0.8 MPa in the axial 
direction252. The TMJ disc has also been shown to display anisotropy; both testing direction and 
location affect the disc’s Young’s modulus, ranging between 3 and 75 MPa30, 31. Tensile 
stiffness values of the menisci are two to three times higher in the circumferential direction 
compared to values in the radial direction253. Although the anisotropic tensile properties of 
native fibrocartilages are crucial for their function, such properties were not expected, and 
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therefore not assessed for, in this study, as the constructs were not subjected to culture gradients 
or directional forces. However, it is exciting to note that the tensile properties of the engineered 
fibrocartilages were synergistically enhanced by treatment with both C-ABC and TGF-β1 to 
reach levels seen in native tissue. The value of the Young’s modulus for both the 50:50 and 
75:25 cell ratios were 3.5 MPa and 2.5 MPa in the combined treated groups, respectively, 
exceeding the tensile properties measured for the axial direction of intervertebral discs and 
within the lower range of values seen for the TMJ disc. It is worth repeating that the collagen 
fiber diameters measured in the engineered tissues were on par with those measured in these 
two native fibrocartilages. Further work in engineering anisotropy into these tissues, as well as 
refining the methods identified here to enhance collagen fiber diameters, density and content, 
will likely have significant effects in further improving the tensile properties to the levels seen 
in fibrocartilages such as the knee meniscus.  
Recent attempts to induce anisotropic mechanical properties in engineered fibrocartilage 
have used electrospinning to create aligned nanofiber scaffolds. Most studies have created these 
scaffolds out of polycaprolactone (PCL), a biocompatible polymer that degrades over a course 
of 1 – 2 years. When electrospun, this material has produced nanofibers ranging from 1 – 4 µm 
in diameter, having an average tensile modulus of 10 MPa in the pre-dominant direction of fiber 
alignment254. When seeded with cells, aligned nanofibrous scaffolds have been found to direct 
neotissue formation according to the pre-determined architecture. Further, the tensile modulus 
has been found to increase by roughly 40 – 50% in seeded vs. unseeded scaffolds245, 255. In one 
example, annulus fibrosus cells were seeded on electrospun, aligned PCL scaffolds. Uniaxial 
tensile testing revealed no difference in the tensile modulus in the direction parallel or 
perpendicular to the pre-dominant fiber direction between t = 1 d and t = 4 wk seeded 
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constructs. Testing at an oblique, 30° angle with respect to the pre-dominant fiber direction, 
however, found the tensile modulus to double, from a value of 3 MPa at t = 1 d to 6 MPa at t = 4 
wk post-seeding256. While electrospinning shows promise as a tool to induce anisotropy, much 
work needs to be done to fully understand the effects of this process for tissue engineering 
applications. Nevertheless, it is exciting to know that anisotropy can be engineered into 
fibrocartilaginous tissues, as shown with electrospinning studies, suggesting that appropriate 
methodologies need to be designed to capture anisotropy in the self-assembly process.  
While this study has not employed methods to align collagen fibers, treatment with both 
C-ABC and TGF-β1 nonetheless increased the Young’s modulus of the engineered 
fibrocartilage 723% and 208% in the 50:50 and 75:25 co-culture ratios, respectively, compared 
to controls. Modifying the self-assembly process to induce collagen fiber alignment should be 
explored to further enhance the mechanical properties of scaffold-free engineered fibrocartilage. 
One approach may be through generating shape-specific constructs; combined with native 
loading schemes, these constructs may be prompted to capture the complex arrangement of 
native collagen fibers. Previous work on self-assembled meniscus constructs, for example, has 
found that geometric constraint by a meniscus-shaped mold guides collagen fibril alignment, 
resulting in anisotropic tensile properties5. Such efforts will lead to the development of a tissue 
able to adapt to and survive in the native joint environment.  
 
CONCLUSIONS  
 
This work speaks to the potential of tissue engineering to create tissues to repair or replace 
fibrocartilage that is unable to heal on its own accord, an important implication considering the 
current lack of treatment options for degenerated TMJ discs, knee menisci, and intervertebral 
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discs. Distinct tissue-engineered fibrocartilages with functional properties approaching native 
tissue were created by treating different MC:AC co-cultures with C-ABC and TGF-β1. SEM 
analysis showed that these agents together alter the physical structure and organization of the 
developing collagen network, allowing it to better withstand tensile forces. This alludes to a 
possible mechanism by which these agents collaboratively augment the collagen network in 
engineered fibrocartilage. It was found that the engineered fibrocartilages had collagen fibril 
diameters and tensile properties on par with native tissues.  Future work will be focused on 
subjecting shape-specific, self-assembled constructs to biomechanical stimulation mimicking in 
vivo loading schemes to generate tissues that capture the anisotropy of native fibrocartilages.  
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TABLES AND FIGURES 	  
 
 TABLE 6.1 – CONSTRUCT PROPERTIES AT T = 5 WK. Values marked with different letters within 
each category are significantly different (p < 0.05), with A > B > C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Ratio 
(MC:AC) 
Bioactive 
Treatment 
Wet Weight 
(mg) 
Hydration 
(%) 
Diameter 
(mm) 
Thickness 
(mm) 
Cells/Construct 
(106) 
50:50 
None 
C-ABC 
TGF-β1 
Combined 
30.19 ± 1.49A 
12.38 ± 1.10C 
17.35 ± 1.25B 
10.16 ± 0.17D 
87.25 ± 1.45A 
85.47 ± 0.68B 
84.89 ± 0.66B 
82.72 ± 0.64C 
6.67 ± 0.10A 
5.61 ± 0.11B 
5.72 ± 0.18B 
5.08 ± 0.06C 
0.61 ± 0.08A 
0.33 ± 0.04C 
0.46 ± 0.05B 
0.44 ± 0.06B 
3.05 ± 0.40A 
0.94 ± 0.23B 
3.28 ± 0.30A 
0.86 ± 0.33B 
75:25 
None 
C-ABC 
TGF-β1 
Combined 
13.44 ± 0.80b 
8.76   ± 0.16c 
15.00 ± 0.52a 
7.87   ± 0.43c 
88.40 ± 2.10a 
86.80 ± 0.92ab 
86.02 ± 0.82b 
82.00 ± 1.25c 
5.20 ± 0.11a 
4.68 ± 0.09c 
4.99 ± 0.10b 
4.24 ± 0.06d 
0.44 ± 0.06c 
0.47 ± 0.09c 
0.79 ± 0.04a 
0.66 ± 0.06b 
1.95 ± 0.18a 
1.33 ± 0.07b 
2.15 ± 0.41a 
1.33 ± 0.11b 
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TABLE 6.2 – CONSTRUCT VISCOELASTIC COMPRESSIVE PROPERTIES AT T = 5 WK. 
Fibrocartilage was treated with either C-ABC alone, TGF-β1 alone, the two agents combined, or 
left untreated (control). The relaxation modulus showed no significant differences in the 50:50 
constructs, but was significantly decreased in the combined treated 75:25 constructs compared 
to controls. The instantaneous modulus and viscosity was highest in the TGF-β1 alone treatment 
for both cell ratios. Values marked with different letters within each category are significantly 
different (p < 0.05), with A > B > C.  
Cell Ratio 
(MC:AC) 
Bioactive 
Treatment 
Relaxation Modulus 
(kPa) 
Instantaneous 
Modulus (kPa) 
Viscosity 
(kPa*s) 
50:50 
None 
C-ABC 
TGF-β1 
Combined 
52.10 ± 32.8A 
71.33 ± 26.5A 
86.10 ± 40.0A 
63.90 ± 10.9A 
190.18 ± 95.0C 
650.01 ± 189.8B 
933.70 ± 131.1A 
397.14 ± 112.7C 
7742.06   ± 4695.0B 
14403.08 ± 1682.7B 
22395.50 ± 3986.2A 
11072.00 ± 3941.8B 
75:25 
None 
C-ABC 
TGF-β1 
Combined 
70.40 ± 28.5a 
51.21 ± 19.1ab 
44.56 ± 10.2ab 
30.02 ± 15.6b 
451.58 ± 122.6bc 
243.32 ± 82.4c 
748.53 ± 237.7a 
497.48 ± 146.6b 
6833.66   ± 2493.9ab 
2681.81   ± 1918.6c 
7747.91   ± 1876.5a 
4230.19   ± 1704.8bc 
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FIGURE 6.1 – GROSS MORPHOLOGY, HISTOLOGY AND IHC OF CONSTRUCTS AT T = 5 WK. 
Fibrocartilage was treated with either C-ABC alone, TGF-β1 alone, the two agents combined, or 
left untreated (control). Collagen was stained for using picrosirious red, GAG was stained for 
using Safranin O/Fast Green, while IHC was used to stain for collagen types I and II. Collagen 
and GAG staining was stronger in the 50:50 constructs, with the combined treatment producing 
constructs with the most uniform staining in both cell ratios. IHC staining showed different 
patterns of collagen types I and II between cell ratios as well as among bioactive treatments 
within each cell ratio. Scale bar for histology and IHC images is 500 µm and the markings on 
the morphology images are 1 mm apart.  
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FIGURE 6.2 – BIOCHEMICAL PROPERTIES OF CONSTRUCTS AT T = 5 WK. Fibrocartilage was 
treated with either C-ABC alone, TGF-β1 alone, the two agents combined, or left untreated 
(control). Col/WW (A) exhibited significance among bioactive treatments, with constructs from 
both cell ratios having the greatest collagen content in the combined treatment. C-ABC and 
TGF-β1 significantly increased the collagen content in the 50:50 constructs in a beneficial or 
positive manner. Bioactive treatments significantly decreased GAG/WW (B) compared to 
controls. Bars not connected by the same letter are significantly different (p < 0.05).  
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FIGURE 6.3 – TENSILE PROPERTIES OF CONSTRUCTS AT T = 5 WK. Fibrocartilage was treated 
with either C-ABC alone, TGF-β1 alone, the two agents combined, or left untreated (control). 
The Young’s modulus (A) and UTS (B) exhibited significance among bioactive treatments, 
corresponding to trends in the collagen content (Fig. 2, A). Constructs from both cell ratios had 
the greatest collagen content and tensile properties with the combined treatment. C-ABC and 
TGF-β1 together synergistically increased the Young’s modulus and UTS of the 50:50 
constructs. Bars not connected by the same letter are significantly different (p < 0.05).  
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FIGURE 6.4 – SEM ANALYSIS OF 50:50 FIBROCARTILAGE CONSTRUCTS AT T = 5 WK. Includes 
images of control, C-ABC treated, TGF-β1 treated, and C-ABC + TGF-β1 treated constructs. 
To measure collagen fibril diameter and density, 3 locations on n = 3 fibrocartilage constructs 
from each bioactive treatment level were quantified. Results found C-ABC in significantly 
increase collagen density, while C-ABC + TGF-β1 significantly increased collagen fibril 
diameter over all other treatments. Bars not connected by the same letter are significantly 
different (p < 0.05). Scale bar is 1 µm. 
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CHAPTER 7 – STRAIN-INDUCED MATRIX SYNTHESIS AND 
ORGANIZATION IN SHAPE-SPECIFIC NEOTISSUES 
 	  
ABSTRACT 	  
Tissue engineered musculoskeletal soft tissues typically lack the appropriate mechanical 
robustness of their native counterparts, hindering their clinical applicability. With structure and 
function being intimately linked, efforts to capture the anatomical shape and matrix 
organization of native tissues are imperative to engineer functionally robust and anisotropic 
tissues capable of withstanding the biomechanically complex in vivo joint environment. The 
present study sought to tailor the use of passive axial compressive loading to drive matrix 
synthesis and reorganization within self-assembled, shape-specific fibrocartilaginous constructs, 
with the goal of developing functionally anisotropic neotissues. Specifically, shape-specific 
fibrocartilaginous neotissues were subjected to 0, 0.01, 0.05, or 0.1N axial loads early during 
tissue culture. Results found the 0.1N load to significantly increase both collagen and 
glycosaminoglycan synthesis by 27% and 67%, respectively, and to concurrently reorganize the 
matrix by promoting greater matrix alignment, compaction, and collagen crosslinking compared 
to all other loading levels. These structural enhancements translated into improved functional 
properties, with the 0.1N load significantly increasing both the relaxation modulus and Young’s 
modulus by 96% and 255%, respectively, over controls. Finite element analysis further revealed 
the 0.1N uniaxial load to induce multi-axial tensile and compressive strain gradients within the 
shape-specific neotissues, with maxima of 10.1%, 18.3%, and -21.8% in the XX-, YY- and ZZ-
directions, respectively.  
 
 
 
Chapter submitted as: MacBarb, R.F., Paschos, N.K., Abeug, R. Makris, E.A., Hu, J.C., & 
Athanasiou, K.A. Strain-induced Matrix Synthesis and Organization in Shape-Specific 
Neotissues. Tissue Engineering Part A. (November 2013).  
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This indicates that strains created in different directions in response to a single axis load drove 
the observed anisotropic functional properties. Together, results of this study suggest that strain 
thresholds exist within each axis to promote matrix synthesis, alignment, and compaction within 
the shape-specific neotissues. Tailoring of passive axial loading, thus, presents as a simple, yet 
effective way to drive in vitro matrix development in shape-specific neotissues toward more 
closely achieving native structural and functional properties.   
 
INTRODUCTION 	  
Musculoskeletal soft tissues support body movement by withstanding complex mechanical 
loads, with each tissue having morphological and mechanical characteristics specific to its 
biomechanical role. Failure or degeneration of a single tissue in a diarthrodial joint can lead to 
functional impairment of the entire joint. Unfortunately, current treatment modalities often fail 
to fully restore joint functionality257. Tissue engineering has therefore garnered increasing 
interest over the last decade as a means to generate clinically relevant musculoskeletal implants. 
A potential advantage of this approach is to generate neotissues with specific characteristics that 
are necessary for withstanding the mechanical complexity of joints. Given that the highly 
specialized biomechanical roles of musculoskeletal soft tissues are closely related to their 
matrix organization191, it has become of critical importance to capture the anisotropic 
functionality of native tissues during in vitro neotissue development. 
Mechanical stimulation has shown efficacy in driving the biomechanical characteristics 
of engineered tissues297-303. Natively, musculoskeletal soft tissues are subject to loading during 
all phases of their lifespan. Importantly, loading is critical to the development, maturation, and 
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maintenance of their mechanical integrity273, 275, 282, 304, 305. Efforts to identify beneficial 
biomechanical stimuli have focused on determining efficacious loading types (e.g., 
compressive, tensile, hydrostatic pressure, shear) and regimens (e.g., static versus dynamic, 
durations, resting periods, magnitudes). While stimuli have been successful in increasing some 
functional characteristics of engineered tissues, their properties remain far from reaching native 
tissue values, particularly in an anisotropic manner. It is, therefore, necessary that the effect of 
loading on neotissue development be more carefully assessed to fine-tune its use toward 
engineering clinically robust neotissues with anisotropic characteristics necessary to perform 
their intended biomechanical role.  
 With structure and function being intimately linked, a key criterion for engineering 
functionally anisotropic constructs is that they attain a native-like matrix organization. To 
achieve this goal, several studies have developed anatomically shaped matrix scaffolds made of 
either natural or synthetic fibers, or even the two combined306-309. Such scaffolds, however, have 
been found to exhibit insufficient biomechanical integrity, particularly in the case of naturally 
derived fibers310, 311. Scaffolds also suffer from biodegradability and biocompatibility issues, as 
especially seen with synthetic scaffolds312-314. Further, it has been suggested that use of any 
scaffolding material may hinder both cellular communication and responsiveness to external 
stresses212. Such drawbacks have led to the development of a scaffold-free, self-assembling 
process to cartilage and fibrocartilage tissue engineering3, 212. In this method, high densities of 
cells are seeded into non-adherent wells, where they quickly coalesce and, over time, produce a 
robust matrix in a manner akin to native morphogenesis230. Further, self-assembled neotissue 
has been readily formed into several complex, clinically relevant shapes, such as the knee 
meniscus 5 and temporomandibular joint (TMJ) disc315. While these anatomically shaped 
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neotissues have been found to exhibit mechanical properties that are at times on par with native 
tissues, they still lack the overall anisotropic functionality and biomechanical integrity of their 
native tissue counterparts.  
Mechanical strain has been shown to result in fiber alignment within collagen-rich 
neotissues316-319. For example, engineered vessels subjected to circumferential strain during an 8 
wk culture period exhibited highly organized matrices capable of withstanding pressures up to 
2000 mmHg (267 kPa)320. Similarly, in ligament tissue engineering, axial mechanical strain was 
found to induce uniaxial collagen alignment and anisotropic functional properties318. It has also 
been shown that self-assembling fibrocartilaginous neotissues around a central post guides 
development of circumferential collagen fiber organization5. Together, such work indicates that 
mechanical strain can be strategically tailored to promote matrix reorganization toward 
engineering more functionally robust neotissues.  
 Recently, the concept of using strain to improve matrix organization has been 
investigated in self-assembled TMJ disc neotissues. In this study, biconcave neotissues were 
subjected to a 1g mass (0.01N load) early during development321. The significance of this study 
was that neotissue loaded with 1g had tensile properties trending higher than unweighted 
controls; however, the 1.1 – 2% strains induced by this load were insufficient to cause 
detectable changes in collagen organization. This study further found the 1g mass unable to 
promote the neotissue to capture the anisotropic functional trends of the native TMJ disc. The 
present study, therefore, aimed to tailor the use of different levels of passive axial compression 
to trigger region-specific collagen reorganization within self-assembled, TMJ disc-shaped 
neotissues. Overall, it was hypothesized that a strain threshold exists to drive matrix synthesis 
and alignment within the biconcave constructs, leading to the development of functionally 
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anisotropic neotissues.  
 
MATERIALS AND METHODS 
 
Cell isolation 
Articular chondrocytes (AC) and meniscus cells (MC) were harvested from juvenile bovine 
knee joints (Research 87, Boston, MA), as previously described272. Isolated cells were frozen in 
freezing medium comprising Dulbecco’s Modified Eagle’s Medium (DMEM), 20% fetal bovine 
serum and 10% dimethyl sulfoxide until cell seeding.  
 
Self-assembly into shape-specific neotissue 
Using co-cultures of MC and AC, biconcave, TMJ disc shape-specific constructs were self-
assembled as previously described321. Briefly, at t = 0 d, 50:50 MC:AC co-culture suspensions 
were seeded into, shape-specific 2% agarose wells at 12 M cells/well to induce the formation of 
biconcave neotissues displaying a thin, inner middle zone surrounded by a thicker, outer band 
region (Fig 1A). Shape-specific agarose top pieces were placed on top of the constructs at t = 3 
d to fully confine their geometry; the constructs remained confined for the remainder of culture. 
Agarose/construct assemblies were placed in 6-well culture plates and fed 6 ml of chondrogenic 
medium consisting of DMEM, 1% penicillin/streptomycin/fungizone (PSF), 1% non-essential 
amino acids, 100 nM dexamethasone (Sigma, St. Louis, MO), 1% ITS+ (BD Scientific, 
Franklin Lakes, NJ), 40 µg ml-1 L-proline, 50 µg ml-1 ascorbate-2-phosphate, and 100 µg ml-1 
sodium pyruvate (Fischer Scientific, Pittsburgh, PA), every other day. At t = 5 wk, constructs 
were removed from culture and analyzed regionally for their properties.  
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Passive axial compression of shape-specific constructs 
The present study imparted axial compressive loading via 4.75 mm diameter, type 304 stainless 
steel posts machined to weigh 1, 5, or 10g, corresponding to 0.01, 0.05, and 0.1N loads, 
respectively. Posts were applied to the shape-specific constructs from t = 10 – 14 d based on 
previous work identifying this time as a critical window in which self-assembled neotissue is 
most responsive to mechanical stimulation212, 277. To ensure proper medium diffusion under the 
post as well as to maintain the tissue’s biconcavity, the posts were positioned perpendicular to 
top of the shape-specific agarose top pieces, such that they were aligned with the neotissue 
middle zone.  
 
Quantitative biochemistry and high-performance liquid chromatography (HPLC) 
At t = 5 wk, wet weights of samples designated for biochemical analysis were taken, after which 
samples were lyophilized and their dry weights recorded. Following papain digestion217, total 
collagen content was measured using a chloramine-T hydroxyproline assay with a SIRCOL 
collagen assay standard (Accurate Chemicals, Westbury, NY). A dimethylmethylene blue dye-
binding assay kit (Biocolor, Newtownabbey, (UK) was used to measure sulfated 
glycosaminoglycan (GAG) content. Pyridinoline (PYR) collagen crosslinks were analyzed and 
quantified via HPLC using PYR standards (Quidel, San Diego, CA), as previously described322, 
323. 
 
Histology and Immunohistochemistry (IHC) 
HistoPrep (Fisher Chemical, Vernon Hills, IL) was used to freeze samples, which were 
sectioned at 12 µm. Slides were then fixed in formalin before being stained with Safranin 
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O/Fast Green to examine GAG distribution and with Picrosirius Red for total collagen content. 
Separately, slides were fixed in chilled acetone for collagen type I and II IHC as previously 
described272.  
 
Stress-relaxation compressive testing 
Neotissue compressive properties were measured via uniaxial unconfined stress-relaxation 
compression testing321. Briefly, 2 mm biopsy punches were taken from both the middle zone 
and band region of the biconcave neotissue. Following height detection, samples were pre-
conditioned for 15 cycles at 5% strain at 1 Hz, after which they were compressed at a strain rate 
of 1% of the sample height per second to both 10% and 20% strains. Matlab (Mathworks, 
Natick, MA) was used to the fit the resulting data to a Kelvin solid model to determine both the 
instantaneous modulus (Ei) and relaxation modulus (Er). 
 
Uniaxial tensile testing 
Neotissue tensile properties were obtained from the middle zone in the X-direction and from the 
band region in the Y-direction using a uniaxial testing machine (Test Resources, Shakopee, 
MN)321. Dog bone-shaped samples were glued at their extremities to a paper frame, which was 
clamped into the machine grips. A strain-to-failure test was then run at a 1% of the gauge length 
(measured as the distance between the glued ends of the paper frame) per second. For each 
sample, the Young’s modulus (EY) was calculated as the slope of the linear region of the stress-
strain curve, while the ultimate tensile strength (UTS) was determined as the curve’s peak.  
 
Finite Element Analysis (FEA) 
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Three-dimensional, computational models of the biconcave neotissue were developed via 
Autodesk Inventor (Autodesk, San Rafael, CA). Using ABACUS/CAE (Dassault Systèmes, 
Vélizy-Villacoublay, France), material properties were set to match estimated t = 10 d 
functional properties of the neotissue, as previously described321. Specifically, the neotissue was 
modeled using a 4-noded linear tetrahedral mesh consisting of 52,636 elements. The resulting 
biconcave model was confined in the Z-direction along its bottom surface to represent the axial 
constraint of the agarose well, while the construct remained free to move in both the X- and Y-
directions to mimic the ability of the neotissue to expand and contract in the wells. A linear, 
elastic model was used to measure the biconcave model’s response to each passive axial loading 
level (1, 5, and 10g) once it had fully relaxed to the respective load. The loads were modeled as 
a pressure distribution across the middle zone of the top surface of the biconcave model. For 
each load, the resulting stress, strain, and displacement were displayed as a heat map. 
  
Scanning Electron Microscopy (SEM) 
Samples were dehydrated in increasing ethanol and stored in 70% ethanol at 4 oC. Just prior to 
imaging, samples were transferred into 100% ethanol, dehydrated in a critical point dryer, and 
gold sputter-coated. Each sample was imaged in three separate locations within their middle 
zones using a Philips XL30 TMP scanning electron microscope. To quantify SEM images, 
ImageJ was used to measure both fibril density and diameter as previously described231. Fibril 
alignment was quantified using the ImageJ plugin OrientationJ324. Ten uniformly sized regions 
of interest were randomly selected from an overlain grid on SEM images of the neotissue 
middle zones, from which the software then calculated the corresponding alignment in terms of 
a coherency factor. Six middle zone images were analyzed this way for each loading level. The 
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coherency factor, which indicates the degree of local orientation, is an index between 0 and 1. A 
coherency of 1 corresponds to perfectly oriented and aligned fibrils, while a coherency of 0 
refers to completely unoriented fibrils.  
 
Statistical Analysis 
To determine whether the different passive axial compressive loads resulted in significant 
changes in neotissue functional and structural properties, a one-way ANOVA (n = 8 per group) 
was used. If the one-way ANOVA showed significance (p < 0.05), a Tukey’s HSD post hoc test 
was then applied. All data are represented as mean ± standard deviation (SD), with bars or 
groups marked by different letters to represent significant differences. For structure-function 
relationships, significant correlations (p < 0.05) were considered strongly positive at R2 value > 
0.5, weakly positive at 0 < R2 < 0.5, weakly negative at -0.5 < R 2< 0, or strongly negative at R2 
< -0.5. 
 
RESULTS 
 
Gross morphology and growth metrics 
While neotissue constructs from all groups maintained the shape-specific biconcavity 
throughout the entire culture duration, loading level was found to significantly affect construct 
morphology (Fig. 1B). Specifically, although the major diameter (as measured along the X-axis 
between the outside edges of the band region) was not altered by any of the loading levels, the 
minor diameter (as measured along the Y-axis between the outside edges of the band region) of 
10g loaded constructs was significantly greater than that of controls. Further, while the band 
region thickness did not change with the different loads, the middle zone of 10g loaded 
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constructs was half as thick as the middle zone of controls. In terms of water content, there were 
no significant differences in whole construct wet weight or band region hydration among 
groups. The middle zone of the 10g loaded constructs, however, displayed significantly 
decreased hydration compared to controls.  
 
Quantitative Biochemistry and HPLC 
Construct collagen, GAG, and PYR content was measured in both the band and middle zone 
regions at t = 5 wk (Fig. 2). No significant differences in collagen per wet weight (Col/WW), 
GAG per wet weight (GAG/WW), PYR per wet weight (PYR/WW), or PYR per collagen 
content (PYR/Col) were found among the band regions of any of the groups. While no 
significant differences in collagen or GAG content was detected among control, 1g, or 5g 
loaded constructs in their respective middle zones, the 10g mass significantly increased both 
middle zone Col/WW and GAG/WW by 27% and 67%, respectively, over that of controls. 
Further, both PYR/WW and PYR/Col were found to be significantly greater in the middle zone 
of 10g loaded constructs, with values 6.8- and 5.2-fold, respectively, those of controls.  
 
Histology and IHC  
Representative images of histological and IHC stained middle zone samples are shown in Fig. 3. 
Corroborating the biochemical results, similar collagen and GAG staining was observed in the 
middle zone of control, 1g, and 5g loaded constructs, while the 10g mass prompted denser 
collagen and GAG staining in this region. Collagen I IHC staining became denser with 
increasing load. Collagen II staining, on the other hand, appeared to slightly decrease in 
intensity with increasing load.  
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Stress-relaxation compressive testing 
Compressive testing at t = 5 wk found both 10% and 20% strain levels to yield similar trends 
among the groups; therefore, only the 20% strain level results are presented (Fig. 4A-B). No 
significant differences in either the Er or Ei were found among the band regions of any of the 
constructs or among the middle zone of control, 1g, or 5g loaded constructs. The 10g mass, 
however, caused a significant increase in both the Er and Ei in the middle zone by 
approximately 96% and 145%, respectively, over the middle zone of all other groups.  
 
Uniaxial tensile testing 
Similar to compressive results, uniaxial tensile testing revealed no significant differences in the 
band region of any constructs in terms of either the EY or UTS (Fig. 4C-D). In terms of the 
middle zone, while the 1g loaded constructs trended higher in terms of both the EY and UTS 
compared to controls, the 5g mass prompted a significant increase in the middle zone tensile 
properties over controls. The 10g loaded constructs, on the other hand, resulted in significantly 
greater tensile properties in the middle zone compared to all other groups, exhibiting a 255% 
and 273% increase in the EY and UTS, respectively, over those of controls.  
 
FEA 
Modeling of the biconcave, engineered neotissue in response to 1, 5, and 10g masses resulted in 
the development of different strain distributions and magnitudes within the model’s middle 
zone, as seen in Fig. 5. For all loading situations, tensile strains were approximately 1.6x greater 
in the YY- compared to the XX-direction, while compressive strains were observed only in the 
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ZZ-direction. Comparing among loads, maximum strains imparted by the 10g mass were 9.2-, 
10.1-, and 9.9-fold greater than maximum strains achieved by 1g in the XX-, YY-, and ZZ-
directions, respectively. The 5g mass, on the other hand, increased XX-, YY-, and ZZ-
maximum strains by 4.6-, 5.1-, and 5.0-fold over respective maxima achieved by the 1g mass in 
each direction.  
 
SEM  
SEM images of construct middle zone regions were quantified for fibril diameter, density, and 
alignment at t = 5 wk (Fig. 6). Middle zone matrix density was found to be significantly greater 
in constructs loaded with 10g, with values 1.3-fold those of all other groups. The 10g mass was 
further found to significantly enhance fibril diameter in the neotissue’s middle zone 1.2-fold 
that of controls. In terms of alignment, fibrillar coherency in the middle zone was found to be 
significantly greatest in constructs loaded with 10g compared to all other groups, with fibrils 
aligning predominantly in the Y-direction.  
 
Structure-function relationships 
Neotissue middle zone Col/WW, GAG/WW, PYR/Col, collagen fibril alignment, and collagen 
fibril density were correlated with both the Er and EY values (Fig. 7). All correlations were 
found to be positive and statistically significant. In terms of the middle zone compressive 
modulus, strong positive correlations were found with PYR/Col (R2 = 0.64), GAG/WW (R2 = 
0.53), and collagen fibril density (R2 = 0.55). Collagen fibril alignment (R2 = 0.41) and 
Col/WW (R2 = 0.44) demonstrated weak positive correlations with the compressive modulus. 
For the middle zone tensile modulus, the highest strong correlation was with collagen fibril 
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alignment (R2 = 0.75), followed by PYR/Col (R2 = 0.64), and Col/WW (R2 = 0.54), while weak 
correlations were found with collagen fibril density (R2 = 0.42) and GAG/WW (R2 = 0.42). 
 
DISCUSSION 
 
The objective of this study was to tailor the use of passive axial compression to drive both 
region-specific matrix synthesis and reorganization toward enhancing the functional properties 
of shape-specific, engineered fibrocartilage. Results found the 10g mass to fulfill this objective, 
as it prompted significantly increased structural and functional properties in the biconcave 
neotissue’s middle zone, while the band region remained unaltered, leading to the development 
of functionally anisotropic constructs. Specifically, in the middle zone, the 10g mass 
significantly increased both GAG and collagen synthesis, and simultaneously promoted matrix 
reorganization via significantly increased collagen fibril density, alignment, and crosslinking, 
by 67%, 27%, 30%, 202%, and 263%, respectively, over all other loading levels. This enhanced 
matrix content and organization translated into significantly augmented tensile and compressive 
properties in the middle zone of 10g loaded constructs, which were found to be 3.5-, 3.7-, 2.1-, 
and 2.3-fold that of controls in terms of the EY, UTS, Er, and Ei, respectively. Further, FEA 
found the 10g mass to induce different strain gradients within each of the three axes of the 
neotissue’s middle zone, with the XX-strain ranging from 5.7 – 10.1%, the YY-strain ranging 
from 7.2 – 18.3%, and the ZZ-strain ranging from -16.1 – -21.8%. This suggests that, contrary 
to the hypothesis that a single strain threshold exists, separate strain thresholds may actually be 
necessary within the XX-, YY-, and ZZ-directions that together promote matrix synthesis and 
reorganization within the biconcave neotissue. Additionally, it was also found that 5 d of 
loading (from t = 10 – 14 d) was sufficient for the region-specific collagen fibril reorganization 
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to be maintained throughout the remainder of the culture period, when no load was present. 
Together, these data suggest that exogenous strain applied early during neotissue development 
can be strategically fine-tuned to control lasting matrix synthesis and reorganization toward 
achieving improved functional properties in shape-specific neotissues. 
Mechanical stimulation via axial loading enhanced the fibril alignment of the 
fibrocartilaginous neotissues in an anisotropic manner. To understand how load influenced such 
alignment, FEA was conducted, finding the passive axial load-induced strains to be greatest in 
the middle zone of the biconcave model. Further, the increasing strain magnitudes and 
distributions resulting from the increasing loads correlated with SEM results of the middle zone, 
showing alignment to occur with higher load primarily in the direction of greatest tensile strain: 
the YY-direction. This is physiologically significant, as the native TMJ disc presents with 
middle zone matrix alignment in the same direction192. In terms of engineered tissues, similar 
correlations between loading direction and alignment have been observed in collagen gels in 
response to axial tensile strain325 and in fibrin gels in response to axial compressive strain326. 
Such work has found increasing loading levels to correspond to increased alignment in the 
direction of loading. These previous studies, however, examined these effects in neotissues of 
uniform geometries, resulting in principally either tensile or compressive strains. In the present 
study, the utility of a biconcave neotissue prompted the translation of a uniaxial load into multi-
axial tensile and compressive strains. Thus, unlike previous work, this study was able to 
promote region-specific alignment within the middle zone of the biconcave construct, leading to 
the development of functionally anisotropic neotissues.  
In addition to driving matrix synthesis and alignment, passive axial compressive loading 
was also found to promote matrix compaction and collagen crosslinking in the neotissue’s 
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middle zone. Specifically, this compaction and crosslinking was only observed at the 10g 
loading level, where the neotissue had a significantly thinner and denser middle zone as well as 
increased PYR/WW and PYR/Col compared to all other groups. Previous work has found fiber 
alignment and compaction to go hand-in-hand; cell-seeded collagen gels have been found to 
undergo simultaneous fiber alignment and compaction in response to mechanical strain327-329. 
Further, treatment of cell-seeded collagen gels with either sodium azide, an ATP inhibitor, or 
cytochalasin D, a cytoskeletal inhibitor, has been found to inhibit such matrix reorganization 
following mechanical stimulation330, 331. Previous work has also correlated increased 
biomechanical properties in engineered neotissues with increased crosslinks7, 322, suggesting that 
the greater functional properties in the middle zone of 10g loaded constructs is likely related to 
the increased crosslink content in this region. Together, such work indicates that cells, in 
response to a mechanical input, generate intrinsic traction forces to reorganize randomly 
oriented collagen fibers by aligning, compacting, and crosslinking them such that they counter 
the newly loaded environment328. This, therefore, suggests that the strain-induced matrix 
changes observed in the self-assembled neotissue are primarily a cellular mechanotransductive 
response. In correlating cellular response to strain level, previous work has shown that 
anisotropic strains of ≥ 5 – 10% are necessary to induce fiber alignment and matrix compaction 
in cell-seeded collagen gels325, 326. Results of the present study suggest that greater strain 
thresholds may be necessary to induce matrix reorganization in the self-assembled, biconcave 
neotissues. Specifically, only the 10g mass, which promoted strains in the XX-, YY-, and ZZ-
directions in excess of this 5 – 10% range in the neotissue middle zone, was found to align, 
compact, and crosslink the matrix.  
  To better understand how the strain-induced matrix reorganization influenced the 
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functional properties of the biconcave neotissue, structure-function relationships were 
evaluated. Results of this analysis found significant, positive correlations between both collagen 
and GAG content with both tensile and compressive properties, respectively. The strongest 
observed correlations for the tensile modulus was with collagen fibril alignment, PYR/Col, and 
collagen content. Positive, although weak, correlations were also found between the tensile 
stiffness modulus and both collagen density and GAG content. Previous work has shown that 
several types of proteoglycans, including dermatan sulfate and chondroitin sulfate, help regulate 
collagen fibrillogenesis and aid in microfibril aggregation to form a denser matrix, which may 
explain the positive correlations between GAG content and the tensile modulus53, 332, 333. In 
terms of the compressive properties, the strongest positive correlations were detected with 
PYR/Col, GAG content and collagen fibril density, while weak positive correlations were found 
with both collagen content and alignment. Such findings support recent reports that likewise 
counter the traditionally accepted structure-function relationships of cartilaginous tissues, which 
correlated GAG content exclusively with compressive properties and collagen content with 
tensile properties242, 334. Instead, it is now shown that a highly complex and integrated 
relationship appears to exist that connects not only overall matrix composition, but also its 
architecture with the functionality of both native and engineered cartilaginous tissues30, 243, 245, 
272, 322, 335. Gaining a better understanding of the intricate relationship between structure and 
function in engineered tissues should be the focus of future studies to aid in advancing tissue 
engineering endeavors.  
Previous work has highlighted the physiologic strain levels of cartilaginous tissues. Such 
work indicates that strains ≤ 20% are within physiologic range for articular cartilage, whereas 
strains ≥ 40 – 60% are considered extreme and can lead to tissue degradation336, 337. Similar 
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strain levels have been predicted for both the meniscus and TMJ disc; FEA analysis has found 
tension-compression strain magnitudes in the range of ≥ 20 – 25% to correlate with normal 
physiologic loading338, 339. Based on the present study’s FEA analysis, it is predicted that the 
10g mass may be close to approaching an upper strain limit for passive axial compression, as 
maximum compressive strains in the ZZ-direction were found to be 21.8%. It is therefore 
important that future work determine if higher passive axial loads are potentially more 
beneficial toward promoting enhanced functional properties in the biconcave neotissues and at 
which point the axial compression becomes detrimental. It has also been previously shown via 
single cell studies that there is a “critical strain threshold” at approximately 33% applied axial 
compressive strain, at which point chondrocytes can no longer fully recover from the applied 
load340, 341. Modeling work has further predicted that bulk tissue strains are approximately 1.5x 
higher within the microenvironment of the cells within loaded cartilaginous tissues342, 343. This 
prior work, therefore, suggests that the cells within the biconcave constructs may be facing 
strains approximately 1.5x those applied to the tissue. Thus, future work should also consider 
the effects of passive axial loading on the cells comprising self-assembled neotissues, which 
may in turn help to infer upon both the local cellular and tissue level mechanical response of 
neotissues to axially applied strain.  
Overall, this study suggests that passive axial compression, which represents a relatively 
simple and inexpensive means for inducing mechanical loading, is a promising tool for 
increasing the functional properties of engineered fibrocartilage. A novel finding of this study is 
that matrix reorganization in the self-assembled, biconcave neotissues is likely due to the 
development of anisotropic, tensile-compressive network strains in response to the passive axial 
load. Additionally, not only is there a dose dependent response to increased mechanical load, 
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but strain thresholds also appear to exist in different directions above which matrix 
reorganization, synthesis, and collagen crosslinking become apparent. Future studies should be 
conducted to determine the effects of passive axial loading on other shape-specific constructs, 
as this could lead to different strain distributions and, thus, neotissues having differential 
functional properties. Such work will greatly aid tissue engineers in their quest to drive in vitro 
neotissue development toward capturing the anisotropy and biomechanical complexity of 
musculoskeletal soft tissues, leading to neotissue implants of clinical relevance. 
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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 7.1 – SCHEMATIC OF BICONCAVE CONSTRUCT AND NEOTISSUE GROSS MORPHOLOGY. 
Schematic of biconcave construct indicating the band region and middle zone (A). Gross 
morphology and growth metrics of neotissue at t = 5 wk (B). Shape-specific neotissue was 
subjected to 1, 5, or 10 g masses, corresponding to 0.01, 0.05, and 0.1 N loads, respectively, 
from t = 10 – 14 d. Values marked with different letters within each category are significantly 
different (p < 0.05), with A > B > C. Markings on the morphology images are 1 mm apart. 
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FIGURE 7.2 – GAG/WW, COL/WW, PYR/WW, AND PYR/COL OF NEOTISSUE AT T = 5 WK. 
Shape-specific neotissue was subjected to 1, 5, or 10 g masses, corresponding to 0.01, 0.05, and 
0.1 N loads, respectively, from t = 10 – 14 d. The 10 g mass promoted significant increases in 
terms of all four parameters (A-D) within the neotissue’s middle zone over values achieved in 
the middle zone of controls; no differences were observed in the neotissue’s band region at any 
loading level. Bars not connected by the same letter are significantly different (p < 0.05). 
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FIGURE 7.3 – HISTOLOGY AND IHC OF THE MIDDLE ZONE OF BICONCAVE NEOTISSUE AT T = 5 
WK. Shape-specific neotissue was subjected to 1, 5, or 10 g masses, corresponding to 0.01, 0.05, 
and 0.1 N loads, respectively, from t = 10 – 14 d. Collagen was stained using Picrosirius Red, 
GAG was stained using Safranin O/Fast Green, while IHC was used to stain for collagen types I 
and II. Denser collagen and GAG staining was observed in 10 g loaded constructs compared to 
all other groups. While Collagen type I staining increased with increasing load, collagen type II 
staining appeared to slightly decrease with increasing load. Scale bar is 100 µm for both 
histology and IHC images.  
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FIGURE 7.4 – RELAXATION MODULUS, INSTANTANEOUS MODULUS, YOUNG’S MODULUS, AND 
ULTIMATE TENSILE STRENGTH OF BICONCAVE CONSTRUCTS AT T = 5 WK. Shape-specific 
neotissue was subjected to 1, 5, or 10 g masses, corresponding to 0.01, 0.05, and 0.1 N loads, 
respectively, from t = 10 – 14 d. The 10 g mass promoted significant increases in terms of all 
four parameters (A-D) within the neotissue’s middle zone over values achieved in the middle 
zone of controls; no differences were observed in the neotissue’s band region at any loading 
level. Bars not connected by the same letter are significantly different (p < 0.05). 
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FIGURE 7.5 – RESULTS OF FINITE ELEMENT ANALYSIS. Strain distributions of 3D CAD 
renderings of biconcave constructs in the XX-, YY-, and ZZ-directions after being subjected to 
either a 1, 5, or 10 g mass, corresponding to a 0.01, 0.05, and 0.1 N load, respectively. CAD 
models were developed using a 4-noded linear tetrahedral mesh of 52,636 elements with 
material properties set to match estimated t = 10 d neotissue functional properties. Nodes at the 
bottom of the model were constrained in the Z-direction, and the passive axial load was 
modeled as a pressure distribution across an area of 54 mm2 on the top surface of the model. 
Maximum strains induced by each loading level in each axial direction are provided in the table 
to the left.  
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FIGURE 7.6 – SEM IMAGES OF NEOTISSUE MIDDLE ZONE AND MATRIX ANALYSIS. SEM images 
taken in the middle zone of biconcave constructs at t = 5 wk (top). Shape-specific neotissue was 
subjected to 1, 5, or 10 g masses, corresponding to 0.01, 0.05, and 0.1 N loads, respectively, 
from t = 10 – 14 d. Fibril density (A), fibril diameter (B), and fibril alignment (C) were 
analyzed from SEM images at t = 5 wk. Results found the 10 g mass to promote significant 
increases in terms of all three parameters (A-C) within the neotissue’s middle zone over values 
achieved in the middle zone of controls. Further, the 10 g mass promoted fibrils to align 
predominantly in the Y-direction of the construct middle zone. Bars not connected by the same 
letter are significantly different (p < 0.05). Scale bar is 2 µm. 
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FIGURE 7.7 – STRUCTURE-FUNCTION CORRELATIONS OF NEOTISSUE MIDDLE ZONE 
PROPERTIES AT T = 5 WK. All correlations were found to be positive and statistically significant 
(p < 0.05). For the middle zone compressive modulus, strong positive correlations (R2 > 0.5) 
were found with PYR/Col, GAG/WW, and collagen fibril density, while weak positive 
correlations (0 < R2 < 0.5) were found with collagen fibril alignment and Col/WW. For the 
middle zone tensile modulus, strong positive correlations were found with collagen fibril 
alignment, PYR/Col, and Col/WW, while weak positive correlations were found with collagen 
fibril density and GAG/WW. 
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CHAPTER 8 – INDUCED COLLAGEN CROSS-LINKS ENHANCE 
CARTILAGE INTEGRATION 
 	  
ABSTRACT 	  
Articular cartilage does not integrate due primarily to a scarcity of cross-links and viable cells at 
the interface. The objective of this study was to test the hypothesis that lysyl-oxidase, a 
metalloenzyme that forms collagen cross-links, would be effective in improving integration 
between native-to-native, as well as tissue engineered-to-native cartilage surfaces. To examine 
these hypotheses, engineered cartilage constructs, synthesized via the self-assembling process, 
as well as native cartilage, were implanted into native cartilage rings. Both groups were treated 
with lysyl-oxidase for varying amounts of time. For both groups, lysyl-oxidase application 
resulted greater apparent stiffness across the cartilage interface 2–2.2 times greater than control. 
The construct-to-native lysyl-oxidase group also exhibited a statistically significant increase in 
the apparent strength, here defined at the highest observed peak stress during tensile testing. 
Histology indicated a narrowing gap at the cartilage interface in lysyl-oxidase treated groups, 
though this alone is not sufficient to indicate annealing. However, when the morphological and 
mechanical data are taken together, the longer the duration of lysyl-oxidase treatment, the more 
integrated the interface appeared. Though further data are needed to confirm the mechanism of 
action, the enhancement of integration may be due to lysyl-oxidase-induced pyridinoline cross- 
links. This study demonstrates that lysyl-oxidase is a potent agent for enhancing integration 
 
 
 
 
Chapter published as: Athens, A.A., Makris, E.A., & Hu, J.C. Induced Collagen Cross-Links 
Enhance Cartilage Integration. PloS one. 8(4):e60719, 2013.  
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between both native-to-native and native-to-engineered cartilages. The fact that interfacial 
strength increased manifold suggests that cross-linking agents should play a significant role in 
solving the difficult problem of cartilage integration. Future studies must examine dose, dosing 
regimen, and cellular responses to lysyl-oxidase to optimize its application. 
 
INTRODUCTION 	  
Because of articular cartilage’s lack of inherent healing potential, lesions tend to degenerate to 
osteoarthritis (OA), a significant problem affecting over a third of adults aged 65 [1]. Currently, 
there are no cartilage treatments that offer long-term functionality. Mosaicplasty and 
microfracture require defect site preparation via cartilage removal. Subsequently, the defect is 
filled by either cartilage plugs or a “super clot” [2]. Autografts and allografts are also options. 
For these and other procedures success is predicated upon the fill tissue’s integration with native 
cartilage. Various strategies and materials have been proposed to integrate cartilage and bone 
[3-6]. However, cartilage-to-cartilage integration has proven to be notoriously difficult, even 
when using tissue engineering approaches [7,8]. To achieve long-term, durable repair, grafts 
and engineered articular cartilage alike need to be integrated with native cartilage. Without 
proper integration the implant will fall out of place or degrade rapidly [9], likely due to the high 
stress concentrations that occur at cartilage interfaces in vivo.  
The general consensus regarding the main factors that hinder integration are: 1) Cell 
death, at the wound edge [8] and in surgically prepared defects, leads to metabolically inactive 
tissue, which prevents cell adhesion and migration to the injury site [10-14]. 2) Cell migration 
to the wound edge is hindered by the dense collagen network [10-14]; in native cartilage, cells 
are locked into lacunae and are not observed to migrate [15]. 3) Lack of cross-links between 
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matrices of native and implant tissues [16,17]. In short, the insufficiency of viable cells at the 
wound edge prevents synthesis of integrative matrix between the two surfaces to be joined [12-
14,18,19], in part by lack of matrix synthesis. Even when viable cells are present, the newly 
synthesized matrix may not be sufficiently cross-linked to the native tissue. This study aims to 
overcome all of these factors by supplying viable cells to the interface via engineered 
neocartilage to mitigate the issues of cell death and lack of cell migration at the wound edge, 
and  by exogenously inducing cross-links.  
One way to deliver cells at an interface may be via the use of a construct engineered using 
the self-assembling process, which is an established method for generating tissue with abundant 
cells at the construct edge [20]. This method has also generated neocartilage with properties 
approaching those of native tissue [20]. Maintenance of cartilage with normal functional 
properties requires sustaining cell density; large areas of cell death would undoubtedly result in 
biomechanically inferior matrix or none at all [21]. Thus, this study seeks to use tissue 
engineered constructs created via chondrocyte self-assembly to deliver a higher cell density to 
the wound edge in order to enhance integration.  
Another suggested mechanism for the enhancement of integration is collagen pyridinoline 
(PYR) cross-links [22]. PYR cross-links have been shown to be a major factor in determining 
the stiffness of connective tissues.  PYR naturally forms within cartilage and other 
musculoskeletal tissues during development and aging via the enzyme lysyl oxidase (LOX), a 
metalloenzyme that converts amine side-chains of lysine and hydroxylysine into aldehydes. In 
vivo, LOX is most active at sites of growing fibrils [1]. A potential method for inducing 
collagen cross-linking across cartilage interfaces is thus the exogenous application of this 
enzyme. Since LOX is a small-sized molecule, at roughly ~50kDa, and since cross-link 
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formation occurs over several weeks, exogenous LOX can be applied to in vitro cultures on a 
continuous basis to ensure full penetration via diffusion and to allow sufficient time for cross-
link formation. By employing LOX, one would expect the formation of "anchoring" sites, 
composed of PYR cross-links in the collagen network of the engineered tissue as well as of the 
native tissue, to bridge the two tissues together. Thus, LOX application combined with the 
delivery of high cell numbers to the wound edge are expected to promote tissue integration. 
Using the self-assembling process, the objective of this study was to determine whether 
LOX can alter the integration of native-to-construct and native-to-native tissue systems through 
two experiments. It was hypothesized that application of LOX would enhance integration, as 
evidenced through tensile measurements. The first experiment sought to examine whether LOX 
would promote integration between native cartilage and neocartilage and to determine time and 
duration of application. The second experiment sought to determine whether the results from the 
first experiment can be replicated in a native-to-native cartilage system.  
 
MATERIALS AND METHODS 
 
Chondrocyte self-assembly 
Articular cartilage was harvested from distal femura of one-week old male calves (Research 87 
Inc., Boston, MA) less than 36hr after sacrifice. Following harvest, the tissue was digested in 
0.2% collagenase type II (Worthington, Lakewood, NJ) in culture medium for 24hr as 
previously described [23]. Culture medium formulation is as follows: DMEM with 4.5 mg/mL 
glucose and L-glutamine, 100 nM dexamethasone, 1% fungizone, 1% penicillin/streptomycin, 
1% ITS+, 50 µg/mL ascorbate-2-phosphate, 40 µg/mL L-proline, and 100 µg/mL sodium 
pyruvate. Cell viability was assessed using trypan blue exclusion, and cells were frozen at -80°C 
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using DMEM containing 20% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 
10% dimethyl sulfoxide until use. To reduce animal variability, cells from four animals were 
pooled together for cell seeding. 
 
Self-assembly of constructs  
Cylindrical, non-adherent, agarose wells were prepared  by placing 5mm diameter stainless steel 
posts in 48 well plates filled with 1 ml of 2%, molten agarose, as previously described [24]. 
After the agarose gelled, posts were removed. The resultant wells were saturated with two 
exchanges of medium. After thawing, cells were counted, viability was assessed using trypan 
blue exclusion, and cells were seeded into the agarose wells at a concentration of 5.5 
million/100 µl medium. After 4hr, an additional 400 µl of medium was added per well. 
Constructs were cultured at 10% CO2, 37°C, in a humidified incubator for a total of t=28d (t=1d 
defined as 24hr post seeding). Medium was changed daily (500 µl).  
 
Tissue integration 
To examine the study's hypotheses, two separate, but concurrent, experiments were conducted. 
First, the use of LOX was examined for the construct-to-native interface. At t=28d, engineered 
constructs were removed from culture and prepared for integration with native articular 
cartilage. The t=28d culture time was chosen to coincide with prior work in self-assembled 
cartilage and with other cartilage tissue engineering efforts. Bovine articular cartilage explants, 
measuring 6mm x 1mm, were harvested using biopsy punches. A concentric, 4 mm diameter 
defect was punched from the explant. From the engineered constructs, 4 mm diameter biopsies 
were obtained and press-fitted into the defect in the explant (Fig. 1). To ensure that all 
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constructs were in firm contact with the explants, cyanoacrylate was applied; a penetration 
depth of 25 µm (~2.5% of thickness) and degradation within the culture period were verified 
using histology. These constructs/explant assemblies were cultured for an additional 14d, at 
which point they were removed for assessments. The second experiment consisted of explants 
instead of constructs. Native-to-native tissue assemblies were formed using the same geometry 
as described above. 
 
Collagen cross-linking via lysyl oxidase  
The LOX medium contained a concentration of 0.15 µg/ml LOX (GenWay Biotech, Inc., San 
Diego, CA). This concentration is based a pilot study in which three concentrations, 0.0015, 
0.015, and 0.15 µg/ml of LOX, were examined. The results showed that only 0.15 µg/ml of 
LOX improved pyridinoline content over the culture duration employed; at this concentration, 
neither the collagen nor glycosaminoglycan per wet weight was altered when LOX was applied 
to either native or engineered cartilage separately. For the construct-to-native study, four groups 
were examined: The control (Group A) consisted of construct/explant assemblies maintained in 
culture medium only. Group B was treated with the LOX medium during t=15-28d. Group C 
was treated during t=29-35d. Group D was treated during t=15-35d. These groups were chosen 
to examine LOX treatment prior (Group B), after (Group C), or throughout (Group D) 
integration with the native tissue. Assemblies were assessed at t=42d to allow for a total of 14d 
of integration time. For the native-to-native study, two groups were examined. The control 
group was allowed to integrate for 14d in culture medium, while the LOX Group was 
maintained in a LOX medium during the same time. 
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Histology  
Frozen sections were collected at 14 µm on positively charged slides to promote maximal 
adherence. These were fixed in 10% neutral buffered formalin and dehydrated through 
ascending alcohol percentages (50%, 60%, 70%, 80%, 90%, 95%, 100%) to minimize 
dehydration artifacts. Picrosirius red was used to demonstrate collagen distribution, as 
previously described [20].  
 
Biochemistry  
Total collagen was assessed using a hydroxyproline assay, and glycosaminoglycan content was 
measured using a Blyscan kit, both as previously described [20]. 
 
Tensile testing 
Assemblies were cut into strips 1mm wide. Thickness and width were verified photographically 
using ImageJ (National Institutes of Health, Bethesda, MD). Specimens were glued onto test 
strips separated by a pre-defined spacing of 1mm, and the strips were clamped and exposed to 
constant uniaxial strain of 1% of the 1mm spacing per second until failure using a uniaxial 
materials testing machine (Instron 5565). Force-deformation data were collected and then 
normalized with respect to the cross-sectional area and initial spacing length of the specimens. 
From this, an apparent “stiffness” was derived by calculating the slope of the linear region of 
the graph. The ultimate tensile apparent strength (UTS) was defined as the maximum stress 
attained by the specimen before failure.  
 
Statistical analysis 
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Based on prior data used to determine LOX concentration, application time, and effects on 
cellular activity, a power analysis was performed to determine an n=6 required to discern 
differences in tensile properties at p<0.05. Data were compiled as mean±standard deviation and 
analyzed using a single factor ANOVA. If the F-test was statistically significant, a Tukey’s post 
hoc test was employed to identify significant groups. Significance was defined as p<0.05.  
 
RESULTS 
 
Integration of engineered constructs to native articular cartilage  
For all treatment durations, LOX-treated construct-to-native assemblies displayed better 
integration as compared to controls using gross morphology, histology, and biomechanical 
evaluations. Prior to histological processing, the assemblies were evaluated straight from culture 
for gross morphology.  Although LOX addition increased the stiffness of the assemblies, it did 
not affect the size and dimensions of the samples. Grossly, gaps were seen between the 
construct and native tissue in 33% of the controls (Fig. 2). Gaps were not seen for any of the 
LOX-treated specimens. Similarly, histological evaluation showed gaps in the controls, while 
LOX-treated samples showed construct adherence to the native tissue. Tensile testing across the 
integration interface showed significantly higher apparent stiffnesses when LOX was applied 
during t=15-35d (Group D) (1.6±0.6 MPa, versus control values of 0.7±0.2 MPa (Fig. 3, top). 
Significantly higher apparent strength values were observed for both Groups B and D 
(0.42±0.07 MPa and 0.39±0.06 MPa, respectively), where LOX was applied before formation 
of the construct-to-native assembly (Fig. 3, bottom). Control and Group C values were 
0.23±0.08 MPa and 0.28±0.1 MPa. No significant differences were detected in the GAG/ww or 
collagen/ww among the construct or the explant portions of the assemblies. Specifically, no 
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significant differences were detected in the GAG/ww content among the constructs (4.5±1.4%, 
2.9±1.4%, 3.1±0.5%, and 4.5±0.6% for Groups A-D, respectively) or among the explant rings 
(8.6±1.1%, 10.9±1.9%, 9.6±01.2%, and 10.5±2.8% for Groups A-D, respectively). 
Additionally, no significant differences were detected in the collagen/ww content among the 
constructs (5.4±2.2%, 5.7±1.7%, 5.7±0.7%, and 7.2±3.1% for Groups A-D, respectively) or 
among the explant rings (5.6±3%, 10.6±7.5%, 6.2±3%, and 10.5±3.2% for Groups A-D, 
respectively). 
 
Integration between native cartilage tissues 
Qualitatively, the only difference between control and LOX-treated native-to-native assemblies 
was seen by histology (Fig. 4). The apparent stiffness of the LOX-treated group was more than 
twice that of the control (1.5±1.1 MPa versus 0.7±0.4 MPa), though neither this property nor the 
apparent strength were statistically significant (Fig. 5). GAG and collagen content were not 
different between the two groups.  
 
DISCUSSION 
 
Motivated by the as-of-yet unsolved issue of cartilage integration, the objective of this study 
was to examine the hypothesis that LOX would induce cartilage integration. This enzyme 
naturally occurs in cartilage and promotes PYR cross-links in collagen, thereby holding 
potential for strengthening cartilage-to-cartilage interfaces. The hypothesis was proven to be 
correct as evidenced by the biomechanical and histological data. At the dosage applied, this 
naturally occurring enzyme did not alter cellular response with respect to collagen and GAG 
production. Engineered tissues, formed using a self-assembling process, were integrated to 
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native tissue explants by applying LOX to a ring-and-implant assembly (Fig. 1). Additionally, 
LOX was applied to native-to-native cartilage interfaces to examine whether this novel 
integration method can also be applicable to cases where there is not an abundance of cells at 
the wound edge. The results showed that cartilage integration can be enhanced if the interface is 
stocked with metabolically active cells and cross-links simultaneously. Enhanced interfacial 
properties were observed for construct-to-native but not for the native-to-native case. Group D, 
which was treated with LOX for the longest period of time, had statistically higher tensile 
properties than did the other three groups. Group D had approximately 2.2 times the tensile 
strength of controls. This was confirmed with morphological and histological data. The results 
of this study are significant for both current and prospective cartilage regeneration and repair 
methods. 
It is worth noting that, despite the lack of any significant differences in the collagen and 
GAG content in either the construct or explant groups, there were significant LOX-induced 
increases in interface biomechanics. The fact that interfacial mechanical properties (apparent 
stiffness and apparent strength) increased significantly, in the absence of increases in the main 
ECM components, suggests that cross-links play a central role in integration. Unfortunately, a 
relationship between the strength of the interface and the number of cross-links at the interface 
cannot be directly assessed. This is because the interface cannot be isolated without adjacent 
tissues that, too, contain cross-links. It is, therefore, difficult to ascertain the fraction of cross-
links belonging to the interface alone. The mechanism of LOX-induced collagen cross-linking 
is well-established [22] and a strong candidate for explaining the results obtained in this study, 
though this was not directly proven here. Future studies may consider techniques such as time-
resolved fluorescence spectroscopy [25] to quantify PYR at the interface. 
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It was observed during tensile testing that samples always broke at the interface, 
indicating that the interface is not as strong as either neocartilage or native cartilage. The 
mechanical property of the interface is, thus, due to newly synthesized matrix that has had 
relatively little time to develop cross-links in contrast to the rest of the tissues. It is known that 
LOX-induced PYR formation requires 7 to 30 days [26], which may also explain why increased 
apparent strength was observed only for groups whose LOX treatment was initiated 28d prior to 
tensile assessment. In these cases, PYR cross-link precursors were allowed to accumulate within 
the constructs prior to their being press-fitted into the native tissue, at which time these 
precursors readily bridged the construct and native tissue together by maturing into cross-links. 
In terms of native-to-native interfaces, in future studies it may be prudent to consider longer 
durations of LOX application 
It is worthy to note that, for the timescale applied, diffusion of LOX should not be a 
bottleneck to its effectiveness. LOX is a relatively small molecule of ~50kDa. For comparison, 
BMP-1 is 30kDa, and the diffusion coefficient of 40 kDa dextran has been determined to be 
~60µm2/s) [27]. However, LOX may require time to act before it promotes integration since it 
can take weeks to complete the final PYR product. This can be seen with Group C, which 
consists of LOX applied at t=25-39d only. This treatment did not result in significant increases 
in tensile properties. It is unclear whether this is due 1) to the short duration of LOX application 
or 2) to the late initiation of application. These two variables should be examined in a future 
study at greater detail. For example, a variety of initiation and culture times can be examined, 
extending the total time of culture up to 8 weeks to identify the "ceiling" of effectiveness. Once 
this saturation level has been determined, one can then optimize not only the time of initial 
application, but also the total duration of application.  
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Aside from the dependence on in vitro culture time [28], cytokines present in vivo can 
also influence integration. A study examined the effects of steroid hormones in bovine cartilage 
that is lacking a known inhibitor to integration, interleukin-1β. An increase of ~50 kPa in 
mechanical integration was seen [29], as compared to the 700 kPa obtained in this study for the 
native-to-native controls. Also, it has also been shown that, without the assistance of exogenous 
agents, strength of half that which is seen in intact cartilage can be achieved in an equine model 
for chondrocyte transplantation [30]. It is worth noting that, in the present study, by delivering 
cells to the interface in concert with LOX, integration strength can be increased to 1.6 MPa 
(Group D). Given that chondrocyte transplantation is a current therapy that, similar to the self-
assembled constructs employed in this study, delivers metabolic cells to the wound edge, it is 
conceivable for LOX to assist this clinical procedure. Of course, additional studies on 1) 
optimal dosing time, 2) cross-linker concentration, and 3) activity profile as related to not only 
the chondrocytes but also other cell types surrounding cartilage would need to be completed to 
ensure safety and efficacy, prior to deploying this technique clinically. 
A major component of articular cartilage ECM is the electronegative aggrecan. This 
electric charge is an obstacle to integration because the similar charges in two pieces of tissue 
would cause them to repel [7]. Further studies need to be completed to fully understand the role 
which aggrecan’s electronegativity plays in blocking integration. Future studies might also 
include the combination of LOX with other bioactive agents that are known to influence 
cartilage behavior. Already, transforming growth factor β1 (TFG-β1) has shown efficacy when 
combined with a biomaterial [31], and it would be interesting to examine how LOX can assist 
this case. TFG-β1 may work in synergism with LOX, the cytokine and enzyme working in 
tandem to effect greater collagen production and cross-linking.  
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It should be mentioned that, for this study, LOX concentration was based on a pilot 
study that examined LOX on native and engineered cartilages separately (described in 
“Materials and Methods”). Following this study’s exciting results, it may be prudent to conduct 
a systematic examination of various LOX concentrations to identify a minimum, yet effective, 
concentration between 0.015 and 0.15 µg/ml that enhances interfacial stiffness and strength to 
the levels of the engineered or native cartilages, or even for other tissues where cross-linking 
plays important functional roles. For instance, integrating engineered knee meniscus to native 
knee meniscus has shown dependence on maturation state [32], and therefore the extent of 
collagen cross-links, and LOX may be used similarly for this tissue. Finding this minimum dose 
will be significant in not only reducing cost but also in mitigating any potential for this enzyme 
to interfere with other cellular processes, despite this being a naturally-occurring enzyme. 
Already, it has been shown here that LOX does not interfere with chondrocyte metabolism with 
respect to collagen and GAG synthesis, but, for its use in vivo, the effects of LOX on other cells 
may need to be elucidated prior to conducting animal studies with this enzyme. A similar 
process would allow the identification of an optimal LOX concentration for maximizing the 
native-to-native integration strength; this will be immensely useful from a clinical perspective, 
once the safety and efficacy of exogenous LOX has been shown.  
While other cross-linkers such as ribose, glutaraldehyde, genipin, and methylglyoxal 
have all been investigated in conjunction with engineered articular cartilage [33,34], these 
agents have all been shown to alter cellular activity. Some of these agents are even cytotoxic 
and thus preclude their use with live cells in influencing integration. Furthermore, unnatural 
cross-linkers such as glutaraldehyde have been shown to elicit a foreign body giant cell reaction 
[35], in contrast to LOX, which is found naturally in multiple musculoskeletal tissues. This 
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study demonstrates that LOX is a potent agent for enhancing integration between native and 
tissue engineered cartilage. It also paves the way for the use of LOX in improving native 
cartilage integration. These results could potentially be used to solve the problem of large 
cartilage defects by allowing tissue engineered cartilage implants to be integrated into the 
surrounding tissue.  
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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8.1 – SCHEMATIC OF THE EXPERIMENT EXAMINING INTEGRATION OF TISSUE 
ENGINEERED CARTILAGE TO NATIVE CARTILAGE. For Group B, LOX was applied during 
construct formation, t = 15–28 d. For Group C, LOX was applied after forming the construct-to-
native assemblies, t = 29–35 d. For Group D, LOX was applied both before and after the 
formation of the construct-to-native assemblies, t = 15–35 d. 
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FIGURE 8.2 – GROSS MORPHOLOGY AND HISTOLOGY OF CONSTRUCTS/EXPLANT ASSEMBLIES. 
Straight from culture, most controls resembled LOX-treated samples, though gaps were seen in 
one-third of the controls (upper left panel). None of the LOX-treated samples displayed gaps 
that were grossly visible; a representative sample (Group D) is shown (upper right). Gaps in the 
controls were also seen after histological processing using picrosirius red (lower left) versus 
LOX-treated samples (lower right, Group D). 
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FIGURE 8.3 – TENSILE MECHANICAL DATA OF CONSTRUCT/EXPLANT INTERFACE. Significantly 
higher apparent stiffness (top) was seen when LOX was applied during t = 15–35 d (Group D) 
than controls (Group A). Significantly higher apparent strength was obtained across the 
integration interface when engineered cartilage was treated with LOX before being press-fitted 
into the native cartilage (bottom). Bars with different letters are significantly different (p<0.05). 
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FIGURE 8.4 – GROSS MORPHOLOGY AND HISTOLOGY OF EXPLANT/EXPLANT ASSEMBLIES. 
Neither control nor LOX-treated native-to-native assemblies displayed grossly visible gaps 
when removed from culture (top row). However, gaps can be seen after histological processing 
using picrosirius red in the control group, unlike the LOX-treated group (bottom). 
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FIGURE 8.5 – TENSILE MECHANICAL DATA OF EXPLANT/EXPLANT INTERFACE. No differences 
in apparent stiffness (top) or apparent strength (bottom) were seen when LOX was applied to 
native-to-native integration. 
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CHAPTER 9 – ENGINEERING FUNCTIONAL NEOTISSUES WITH IN VIVO 
INTEGRATION POTENTIAL FOR REPAIRING FIBROCARTILAGE 
DEFECTS	  
 
ABSTRACT 	  
Patients suffering from damaged or diseased fibrocartilages currently have no effective long-
term treatment options. Existing clinical options, such as autografts, allografts, or scaffold-
based neotissues, are greatly hindered by their low biomechanical properties and their inability 
to integrate with healthy native tissue. The present study sought to develop novel methods to 
enhance the biomechanical integrity of engineered implants as well as to address the two pivotal 
factors that currently inhibit fibrocartilage integration: 1) low native tissue cellularity, and 2) the 
lack of collagen crosslinks at the native-to-implant interface. Specifically, highly cellularized, 
scaffold-free neofibrocartilage implants were subjected to a novel combination of stimuli, 
including the biophysical agent chondroitinase-ABC, the biochemical agent transforming 
growth factor-β1, and the enzyme responsible for collagen crosslinking, lysyl oxidase. 
Combined use of these agents drove in vitro neofibrocartilage matrix maturation toward 
synergistically enhanced Young’s modulus and ultimate tensile strength values, which were 
increased 245% and 186%, respectively, over controls. Furthermore, an in vitro fibrocartilage 
defect model found this treatment regimen to significantly increase the integration tensile 
properties between neofibrocartilage and native tissue. Translating this technology to an in vivo 
fibrocartilage defect  
 
 
 
 
To be submitted as: Makris, E.A.* & MacBarb, R.F.*, Paschos, N.K., Hu, J.C., & Athanasiou, 
K.A. Engineering Functional Neotissues with In Vivo Integration Potential for Repairing 
Fibrocartilage Defects. Proceedings of the National Academy of Sciences of the United States 
of America. (December 2014).  *indicates co-first author 
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model found this combination pre-treatment to prime the neofibrocartilage for significantly   
enhanced integration potential in vivo, with interfacial tensile stiffness and strength 730% and 
745% greater, respectively, than values achieved during in vitro integration. Together, these 
studies demonstrate that this novel combination of exogenous agents promotes biomechanically 
robust self-assembled neofibrocartilage implants capable of generating integration interfaces 
with functional properties on par with intact native fibrocartilage. 
 
SIGNIFICANCE STATEMENT 	  
Damaged or diseased fibrocartilages, such as the knee menisci, intervertebral discs, and 
ligaments, are unable to self-repair, necessitating clinical management. Unfortunately, current 
treatment options only provide short-term pain relief. While tissue engineering of replacement 
fibrocartilages offers much promise as a long-term reparative therapy, their insufficient 
mechanical robustness and inability to effectively bond to native healthy tissue surrounding the 
defect hinders their clinical applicability. The present study, therefore, investigated the potential 
of a combination of novel agents to promote integration of mechanically robust engineered 
fibrocartilage upon implantation. Results of this work shed light onto the possibility of novel 
methods to engineer clinically relevant fibrocartilage implants capable of self-bonding to 
adjacent tissue.  	  
INTRODUCTION 	  
Collagen-rich, fibrocartilaginous musculoskeletal soft tissues, such as the knee menisci, 
intervertebral discs, temporomandibular joint (TMJ) discs, tendons, and ligaments, lack an 
intrinsic ability to self-repair following disease- or injury-induced degradation. As such, 
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different fibrocartilage repair techniques have been developed, which typically utilize either 
autograft or allograft tissue, or scaffold-based neotissues. However, such approaches are 
hindered by their inability to successfully integrate with host tissue upon implantation386, 387. 
Proper integration is critical to graft success, as it ensures that the implant remains stabilized 
and is, therefore, able to competently function in vivo388, 389. With the insufficiency of current 
grafts, tissue engineering of neofibrocartilage implants that mimic the complex structures of 
native tissues holds great potential as a long-term clinical solution for acute fibrocartilage 
injuries and chronic degenerative pathologies257. Toward engineering such implants, it is 
imperative that they are able to withstand the high mechanical loads of joints, and perhaps even 
more importantly, are strategically engineered to promote integration with the host tissue upon 
implantation. Without these critical features, they, like current grafts, will likely fail. Thus, it is 
critical that novel treatment modalities are developed that specifically target 1) the maturation 
and extracellular matrix (ECM) organization, and 2) the integration potential of engineered 
fibrocartilage implants.  
There are several factors that may either directly or indirectly impede proper 
fibrocartilage integration389. The four most commonly addressed factors include: 1) the 
avascularity of the host tissue390, 2) cell death at the periphery of the defect391, 3) hindrance of 
cellular migration due to a dense collagen matrix at the wound edge392, and 4) the lack of 
stabilizing collagen crosslinks at the native-to-implant interface393. Together, these factors result 
in a metabolically inactive wound edge that limits both matrix synthesis and crosslink 
formation, hindering integration with any type of implant394. Various methods have been 
developed in an attempt to overcome the yet unresolved hurdle of integration. For instance, 
biological tissue adhesives have been used at the integration interface395, 396, as well as 
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enzymatic degradation to temporarily reduce the amount of negatively charged proteoglycans at 
surfaces of the graft and host tissues397, 398. While such methods have had a beneficial effect 
toward encouraging integration, a highly stable, biomechanically robust integration interface, 
able to withstand the complex distribution of forces within joints, has yet to be achieved. Thus, 
efforts to enhance the integration potential of neofibrocartilage implants must be established to 
ensure successful outcomes following implantation.   
A self-assembling process has been developed to generate highly cellularized and 
metabolically active neotissues212, which may aid in integration upon implantation. Specifically, 
seeding high-density co-cultures of meniscus cells (MC) and articular chondrocytes (AC) into 
non-adherent agarose wells promotes the development of neofibrocartilage in a manner akin to 
native morphogenesis3, 230. Past work has identified several exogenous factors to enhance the 
overall functional properties of self-assembled neotissue, including the bioactive agent 
transforming growth factor-β1 (TGF-β1) and the biophysical agent chondroitinase-ABC (C-
ABC)4, 99. While combined use of these factors has been found to enhance neotissue functional 
properties through increased collagen content, density, and fibril diameter272, 315, their tensile 
properties remain inferior to those of native tissue. Thus, efforts to further promote in vitro 
tissue maturation in addition to enhancing their integration potential are necessary to generate 
mechanically robust neofibrocartilage implants able to withstand the high in vivo loads of joints.  
Promoting collagen crosslinking in neofibrocartilages may provide a viable solution 
toward furthering in vitro maturation as well as facilitating in vivo integration with the host 
tissue. Natively, lysine-derived, covalent pyridinoline (PYR) crosslinks have been shown to be 
instrumental to development of a mechanically robust collagen matrix7. Such crosslinks are 
formed via the enzyme lysyl oxidase (LOX), which turns amino acid precursors (lysine and 
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hydroxylysine) into mature PYR crosslinks over time11-13. Capitalizing on the potential of 
promoting the formation of PYR crosslinks, this study employed a novel combination of stimuli 
consisting of exogenous LOX, C-ABC, and TGF-β1 to enhance the tensile properties of self-
assembled neofibrocartilage implants as well as effect and stabilize their integration with native 
tissue. This study was conducted in three Phases: The objective of Phase 1 was to promote in 
vitro maturation of engineered fibrocartilage. Phase 2 sought to foster the integration between 
native and self-assembled fibrocartilages in vitro. Finally, Phase 3 investigated the potential of a 
LOX+C-ABC+TGF-β1 pre-treatment to prime neofibrocartilage for enhanced integration in 
vivo. Overall, it was hypothesized that through collagen enhancement and PYR crosslink 
formation, combined treatment of LOX+C-ABC+TGF-β1 would 1) induce time-dependent 
maturation and enhance the tensile properties of the neofibrocartilage constructs, 2) promote in 
vitro integration between engineered and native fibrocartilages, and 3) carry over an effect into 
the in vivo environment to further promote such integration.  	  
RESULTS 
Phase 1: In vitro maturation of engineered fibrocartilage 
The first phase of this study employed a two-factor, full factorial study design, which included a 
treatment factor (control, LOX, C-ABC+TGF-β1, and LOX+C-ABC+TGF-β1) and a culture 
duration factor (t = 6 or 12 wk). At both t = 6 and 12 wk, self-assembled neofibrocartilage 
constructs were analyzed biochemically, biomechanically, and via scanning electron 
microscopy (SEM) to test the ability of these factors to promote neotissue maturation and 
tensile property enhancement. All constructs presented with flat, uniform morphology at both t 
= 6 and 12 wk (Fig. 1A-B), with C-ABC+TGF-β1 and LOX+C-ABC+TGF-β1 constructs 
having significantly decreased wet weights, hydrations, diameters, and thicknesses compared to 
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controls at each respective time point (Table 1). Histologically, collagen staining was more 
dense and uniform in C-ABC+TGF-β1 and LOX+C-ABC+TGF-β1 groups, while 
glycosaminoglycan (GAG) staining was denser in control and LOX groups at t = 6 wk. Similar 
results were observed histologically at t = 12 wk; however, GAG staining appeared to increase 
in both control and LOX groups at this time (Fig. 1A-B).  
Biochemical analysis found significantly greater collagen per wet weight (Col/WW) in 
C-ABC+TGF-β1- and LOX+C-ABC+TGF-β1-treated constructs at both t = 6 and 12 wk 
compared to LOX and control constructs. Specifically, at t = 6 wk, the LOX+C-ABC+TGF-β1 
group exhibited a 180% increase in Col/WW over controls, and at t = 12 wk, a 228% increase 
over controls was observed in this group (Fig. 2A). In terms of collagen crosslinks, PYR per 
wet weight (PYR/WW) was found to be significantly greater in both LOX and LOX+C-
ABC+TGF-β1 treated constructs at t = 6 wk, with values 1.9- and 2.7-fold those of respective 6 
wk controls. By t = 12 wk, the LOX+C-ABC+TGF-β1-treated constructs exhibited significantly 
greater PYR/WW over all other groups, with a value 3.8-fold those of 12 wk controls (Fig. 2B). 
GAG per wet weight (GAG/WW), on the other hand, was found to be significantly greater in 
control and LOX groups compared to C-ABC+TGF-β1 and LOX+C-ABC+TGF-β1 groups at 
both the 6 and 12 wk time points (Table 1).  
Uniaxial tensile testing at t = 6 wk found the LOX+C-ABC+TGF-β1 treatment to 
synergistically increase both the Young’s modulus (EY) and ultimate tensile strength (UTS) 
202% and 121%, respectively, over 6 wk controls (Fig. 2C-D). These synergistic enhancements 
were also observed in t = 12 wk constructs, finding the LOX+C-ABC+TGF-β1-treated 
neofibrocartilage to have EY and UTS values 245% and 186%, respectively, over 12 wk 
controls. Results further found the 12 wk time point to be a significant factor toward enhancing 
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neotissue tensile properties. Stress-relaxation unconfined compressive testing found both the 
relaxation modulus (Er) and instantaneous modulus (Ei) to be significantly greater in LOX 
constructs compared to all other groups at at t = 6 wk (Table 1). By t = 12 wk, both control and 
LOX groups presented with greater Er and Ei values compared to C-ABC+TGF-β1 and 
LOX+C-ABC+TGF-β1 constructs.  
Neofibrocartilage constructs were imaged via SEM to investigate the effects of the two 
factors on in vitro matrix development and organization (Fig. 1A-B). Results found 6 wk 
constructs treated with LOX+C-ABC+TGF-β1 to have a denser collagen matrix displaying 
bundling of fibrils into fibers compared to control constructs, which appeared less dense and 
with no sign of bundling. By t = 12 wk, while the control matrix remained relatively unaltered, 
the bundling of fibrils into densely packed and organized fibers was even more evident in 
LOX+C-ABC+TGF-β1-treated constructs. Quantitative analysis of the SEM images at both 6 
and 12 wk found C-ABC+TGF-β1 and LOX+C-ABC+TGF-β1 constructs to have significantly 
enhanced collagen fibril densities over controls. The LOX+C-ABC+TGF-β1 treatment was 
further found to significantly increase the collagen fibril diameter by 92% over controls at the 6 
wk time point; by the 12 wk time point, these increases were found to be synergistic, with 
values increased by 104% over 12 wk controls. (Fig. 1C-D). Further, the 12 wk time point was 
again found to be a significant factor toward promoting maturation of the neofibrocartilage 
matrix in terms of significantly increasing both the fibril density and diameter.  
  
Phase 2: In vitro integration of native and engineered fibrocartilage 
The second phase of this study sought to promote integration between native and engineered 
fibrocartilages via an in vitro model of integration. Briefly, 3 mm diameter punches of 6-wk-old 
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neofibrocartilage were press-fit into same size defects in native fibrocartilage explant rings, 
forming engineered-to-native assemblies (Fig. 3A). Prior to assembly formation, 
neofibrocartilage was subjected to the same four treatments from Phase 1; the only exception 
being that LOX was applied both pre- and post-assembly formation to further aid in promoting 
integration (Fig. 3B). Native-to-native assemblies were also created to determine the ability of 
LOX to promote integration between native fibrocartilages. Following 6 wk of in vitro 
integration, the integration interface of engineered-to-native and native-to-native assemblies 
were analyzed histologically and biomechanically.  
 Histological evaluation of the integration interface found both LOX and LOX+C-
ABC+TGF-β1 treatments to promote fusion of the interface in engineered-to-native assemblies; 
control and C-ABC+TGF-β1-treated assemblies, however, showed little to no integration (Fig. 
4A). This was also shown biomechanically: both LOX and LOX+C-ABC+TGF-β1 treatments 
significantly enhanced the integration interface tensile stiffness and strength in engineered-to-
native assemblies over controls or C-ABC+TGF-β1-treated constructs (Fig. 4B-C). Specifically, 
the EY and UTS of the integration interface in LOX-treated assembles were 2.2- and 2.4-fold 
respectively, those of controls. Similarly, LOX+C-ABC+TGF-β1-treated assembles presented 
with integration interface EY and UTS values that were 2.2- and 2.6-fold, respectively, those of 
controls. In terms of the native-to-native assemblies, histological evaluation showed little to no 
integration in either control or LOX-treated groups, which was further confirmed 
biomechanically (Fig. 4D-F). Results further revealed the integration interface in LOX-treated 
engineered-to-native assembles to have ~7.5-fold greater tensile stiffness and strength compared 
to those of LOX-treated native-to-native assemblies.  
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Phase 3: In vivo integration of native and engineered fibrocartilage 
Previous work has shown that the nutrient rich subcutaneous environment promotes in vivo 
neotissue maturation231, 399, 400. The objectives of Phase 3, therefore, were 1) to investigate 
whether subcutaneous implantation of engineered-to-native assemblies into the backs of nude 
mice would help to further fortify the integration interface area, and 2) if this fortification could 
be enhanced via use of the LOX+C-ABC+TGF-β1 pre-treatment established in Phase 2. All 
treatments in the third phase were administered to neofibrocartilage during the first 6 wk of 
culture, prior to formation of the engineered-to-native assemblies (at t = 42 d) and subcutaneous 
implantation (at t = 43 d). Specifically, a single vs. double application of LOX, in addition to C-
ABC and TGF-β1, was administered to neofibrocartilage implants to investigate whether a 2nd 
LOX application, just prior to formation of the engineered-to-native assemblies, would further 
reinforce the integration interface in vivo (Fig. 3A,C). Six wk post-surgery, the mice were 
humanely sacrificed, and the tissue assemblies were harvested and analyzed histologically and 
biomechanically.  
 Histological evaluation of the engineered-to-native assemblies post-sacrifice revealed 
untreated assemblies to be partially integrated; both the single and double LOX treatments, 
however, were found to promote more complete fusion of the integration interface. Further, the 
neofibrocartilage in the double LOX-treated assemblies presented with denser collagen staining 
compared to the engineered tissue in single LOX-treated assemblies (Fig. 5A). Biomechanical 
testing found both LOX treatments to significantly increase the tensile stiffness and strength of 
the integration interface compared to untreated assemblies (Fig. 5B-C). Specifically, the EY and 
UTS of the integration interface in single LOX-treated assemblies were 3.3- and 3.2-fold, 
respectively, those of controls. The double LOX treatment, on the other hand, increased the EY 
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and UTS of the integration interface 4.3- and 4.7-fold control values, respectively. Analysis was 
also conducted to compare the in vitro integration results of Phase 2 with the in vivo results of 
Phase 3 (Fig. 5D-E). A two-tailed, paired Student’s t-test revealed the in vivo double LOX 
treatment to promote significantly enhanced EY and UTS values that were 304% and 230% 
greater, respectively, than those achieved in combination-treated constructs in vitro. In 
comparing the EY and UTS of the integration interface of in vivo double LOX-treated 
assemblies to in vitro control assemblies revealed 730% and 745% significant increases, 
respectively, in the combination-treated in vivo assemblies over in vitro controls. No significant 
differences, however, were observed between in vitro and in vivo controls. Further, two-way 
ANOVA analysis found both the LOX+C-ABC+TGF-β1 pre-treatment as well as the in vivo 
subcutaneous environment to be significant factors toward enhancing the integration interface 
stiffness and strength in fibrocartilaginous engineered-to-native assemblies.  
 
DISCUSSION 	  
In light of the current insufficiencies of fibrocartilage implants, this study sought to enhance the 
biomechanical integrity of neofibrocartilage as well as to facilitate and stabilize their integration 
with native tissue. This goal was addressed via a novel combination of stimuli: LOX, C-ABC, 
and TGF-β1. Innovative aspects of this study include finding that the LOX+C-ABC+TGF-β1 
treatment 1) enhances the tensile properties of self-assembled fibrocartilage via time-dependent 
maturation of the neotissue’s ECM, and 2) promotes integration between engineered and native 
tissues. With only LOX- and LOX+C-ABC+TGF-β1-treated assemblies showing significantly 
improved integration over controls, this study demonstrates that LOX is a potent agent for 
enhancing integration between native-to-implant surfaces, confirming the pivotal role of PYR 
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crosslinks at the integration interface. Furthermore, this work shows, for the first time, that a 
pre-treatment carries over an effect into an in vivo model toward achieving functional 
integration. Specifically, results found neofibrocartilage implants pre-treated with LOX+C-
ABC+TGF-β1 to have a significantly stiffer and stronger integration interface with native tissue 
following in vivo implantation over untreated controls. Methods used in this study were able to 
address the two most cumbersome factors that currently hinder integration, including cell death 
at the wound edge and the lack of collagen crosslinks at the integration interface. Thus, using 
self-assembled neofibrocartilage implants allows for implantation of highly cellular, 
metabolically active implants that, when treated with LOX+C-ABC+TGF-β1, are primed for 
enhanced integration potential following implantation toward achieving values on par with 
intact native fibrocartilage.  
Phase 1 of this study established that longer culture duration promotes a more 
biomechanically robust matrix in LOX+C-ABC+TGF-β1-treated constructs. Specifically, the 
LOX+C-ABC+TGF-β1 treatment was found to synergistically enhance the neotissue’s tensile 
properties by 202% over controls at 6 wk and by an additional 43% by 12 wk. While the 12 wk 
time point was found to be a significant factor toward enhancing neotissue tensile properties, it 
was not a significant factor toward enhancing collagen content. Previous work has shown that 
as highly collagenous native tissues develop and mature, the density and diameters of their 
collagen fibrils increase, along with increased fibrillar bundling and matrix compaction; 
together, these structural modifications translate to a matrix capable of withstanding greater 
tensile loading294-296. Similarly, the present study found the 12 wk time point to be a significant 
factor toward increasing the collagen fibril diameter and density in LOX+C-ABC+TGF-β1-
treated constructs, as well as to promote distinct collagen bundling. Thus, results indicate that, 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 09:28:15 EET - 137.108.70.7
  264 
over time, the LOX+C-ABC+TGF-β1 treatment promotes in vitro neofibrocartilage maturation 
similar to the maturation observed during native tissue morphogenesis, resulting in a 
neofibrocartilage construct with greater tensile properties.   
Concurrent with the observed matrix modifications, neofibrocartilage constructs treated 
with LOX+C-ABC+TGF-β1 also experienced increased intermolecular collagen crosslink 
content. While no significant difference in crosslink content was observed between LOX- and 
LOX+C-ABC+TGF-β1-treated constructs at t = 6 wk, by t = 12 wk, the crosslink content in 
combination-treated constructs was significantly increased over all other groups. It has been 
shown that LOX-mediated PYR collagen crosslinks take ~7 – 30 d to fully mature13. While no 
significant differences were observed in PYR content in 6 wk vs. 12 wk time points, it is, 
therefore, likely that the longer culture duration allowed for the development of more mature 
PYR crosslinks to form. Previous work has indicated that it is specifically the mature crosslinks 
that are correlated with the tensile robustness of native fibrocartilaginous tissues401, 402. With 
more time for the crosslinks to mature in vitro, constructs receiving LOX and grown to 12 wk 
were better suited to withstand tensile loads. By combining LOX with C-ABC+TGF-β1, 
therefore, neofibrocartilage grown to 12 wk had the benefits of all three agents, including 1) 
increased collagen content as a result of TGF-β1, 2) a compacted collagen matrix having 
greater fibril diameters as a result of C-ABC, and 3) more mature PYR crosslinks that aided in 
the bundling of fibrils into more mechanically robust fibers. Thus, results indicate that the 
increased tensile properties are directly related to matrix maturation, organization, and 
crosslinking, showing combined use of these three agents to be a potent regimen to promote 
matrix maturation and enhanced neotissue biomechanical integrity over time (Fig. 6). 
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One can consider several exogenous agents that could potentially be used to enhance 
neotissue collagen crosslinking and, concomitantly, their functional properties. Hypoxia 
application in neocartilage has been proven to promote HIF-1- and LOX-mediated PYR 
crosslinking7. Similarly, copper application in neotissues has been shown to enhance collagen 
crosslink formation and biomechanical properties322. These more traditional systems for 
enhancing crosslink formation, however, are associated with deleterious side effects; for 
example, copper application and the downstream products of hypoxia and HIF-1α decrease 
collagen synthesis in neotissues7, 322. The present study, therefore, found an exogenous LOX 
treatment to provide a simple and direct, yet effective, way to promote neofibrocartilage 
integrity by enhancing PYR crosslinking without affecting collagen content. Further, when 
combined with C-ABC and TGF-β1, enhanced PYR content via exogenous LOX application 
synergistically increased the tensile properties of self-assembled neofibrocartilage constructs. 
In applying the treatments investigated in Phase I to an in vitro model of integration, 
results of Phase II found LOX to promote integration between neofibrocartilage and native 
tissue. Specifically, the integration interface stiffness and strength were significantly increased 
an average of 114% and 148%, respectively, in engineered-to-native assemblies treated with 
either LOX alone or with LOX+C-ABC+TGF-β1. The finding that the LOX+C-ABC+TGF-β1 
treatment regimen did not promote integration any further than LOX alone suggests that LOX 
is the crucial factor contributing to the enhanced integration potential of neofibrocartilage. This 
indicates that increased PYR collagen crosslinks is critical to the formation of a more robust 
integration interface. Previous work has found β-aminopropionitrile, an agent that irreversibly 
inhibits LOX activity, thus blocking collagen crosslink formation, to inhibit integration between 
cartilage explants403, further showing the importance of crosslinks at the integration interface. 
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Thus, results of the present study show that using exogenous LOX to upregulate PYR crosslink 
formation not only aids in promoting maturation of the neotissue along with C-ABC and TGF-
β1, but is also integral to facilitating and stabilizing the integration interface between 
engineered implants and native tissue (Fig. 6).  
As a part of Phase II, native-to-native assemblies were also treated with LOX for 1 wk 
following assembly formation, followed by an additional 5 wk of in vitro culture. While LOX 
treatment doubled the tensile stiffness of the interface of native-to-native assemblies compared 
to untreated native-to-native controls, the effect of LOX was 7.5-fold more potent toward 
enhancing the tensile properties of engineered-to-native assemblies. Natively, collagen 
crosslinks in fibrocartilaginous tissues remain in an unstable, immature, reducible form during 
early development; however, as the tissue matures, these reducible crosslinks are converted into 
more stable, mature, non-reducible PYR crosslinks404. Thus, the low cellularity and highly 
dense, mature crosslink-stabilized matrix likely inhibited exogenous LOX from having much 
effect at promoting integration in native-to-native assemblies391, 394. This suggests that the high 
cellularity, immature collagen matrix, and high collagen crosslinking potential of the self-
assembled constructs enabled the neofibrocartilage to better respond to LOX, resulting in the 
formation of PYR crosslinks at the integration interface. Overtime in culture, therefore, the 
metabolically active integration interface in engineered-to-native assemblies matured to 
produce significantly stronger bonding than in the metabolically inactive native-to-native 
assemblies.  
The final phase of this work found that pre-treating self-assembled fibrocartilage 
implants with a double LOX application in addition to C-ABC+TGF-β1 carried over a 
significant effect into the in vivo environment, resulting in further promoting integration 
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between native and engineered fibrocartilage. Specifically, this treatment increased the 
integration interface EY and UTS by 4.3- and 4.7-fold, respectively, values achieved in 
untreated implanted assemblies. Further, when compared to integration values achieved using 
the same treatment in vitro, the in vivo environment was found to improve the integration 
interface tensile stiffness and strength by 304% and 230%, respectively. These significant 
enhancements are likely attributable to the nutrient rich environment and mechanical stresses 
placed on the engineered-to-native assemblies in the subcutaneous environment231, 399, 400. 
However, because no significant differences were found between the integration properties of 
in vitro and in vivo control assemblies, the 4.1-fold significant enhancement in the integration 
properties of LOX+C-ABC+TGF-β1-treated in vivo compared to in vitro engineered-to-native 
assemblies indicates the subcutaneous environment had a more potent effect in the pre-treated 
neofibrocartilage. Thus, the pre-treatment likely primed the implant to better respond to the in 
vivo environment, further accelerating its maturation and, hence, interfacial integration with 
native tissue (Fig. 6). This speaks to the potential for LOX+C-ABC+TGF-β1-treated 
neofibrocartilage implants to further mature and form even more stable integration interfaces 
given longer in vivo culture time. Future work must therefore investigate the effects of this 
treatment toward promoting long-term integration in functional defect sites in vivo.  
While a plethora of work exists on repairing defects in various fibrocartilaginous 
tissues, ranging from in vitro, to in vivo, and clinical work, integration has mainly been treated 
as an auxiliary portion of these studies. As a result, most of the literature on fibrocartilage 
repair provides only qualitative means to examine possible integration, such as histological and 
magnetic resonance imaging techniques266, 405-414. The present study, however, highlights the 
necessity for conducting mechanical characterization of the integration interface. As shown in 
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the present study, although an implant may appear highly integrated in certain areas with the 
surrounding native tissue via histological assessment, mechanical integrity of the integration 
interface may be substantially weak (such as seen in the in vivo engineered-to-native control 
assemblies). Treated engineered-to-native assemblies, which appeared similar, although more 
uniformly integrated, compared to controls via histology, had significantly stronger integration 
interfaces. Thus, it is imperative that future studies investigating fibrocartilage repair techniques 
include mechanical testing of the integration interface as one of the key success criteria for 
engineered repair tissues. This metric will provide an additional means toward the goal of 
engineering mechanically robust and stable repair tissues suitable for long-term clinical 
applications.  
Of the few studies that have mechanically characterized the integration interface in 
fibrocartilaginous repair models415, 416, only one study has utilized a pull-to-failure test similar 
to the test used in the present study. This study generated electrospun nanofibrous scaffolds 
containing entrapped collagenase, with the goal of locally controlling matrix degradation at the 
meniscus wound interface to enhance native-to-native tissue repair. Results found the 
integration interface tensile strength to trend higher in defects containing the collagenase-
releasing scaffold compared to empty defects or those containing non-collagenase-releasing 
scaffolds following 50 d of in vitro culture, with the integration interface tensile strength of the 
best group averaging at 13.5 kPa417. The present study similarly found the integration interface 
tensile strength to trend higher in LOX-treated native-to-native assemblies, with a value of 25.9 
kPa. Use of the LOX+C-ABC+TGF-β1 and the highly cellular neotissue in engineered-to-
native assemblies, however, resulted in integration EY values of 240 kPa following in vitro 
culture, which were further promoted following in vivo culture to 890 kPa. In comparing the 
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achieved integration interface tensile modulus to those of intact fibrocartilaginous tissues, 
results of the in vivo portion of this study indicate that the integration interface in assemblies 
containing LOX+C-ABC+TGF-β1-treated neofibrocartilage was ~100% of the tensile modulus 
of intact intervertebral disc anulus fibrosus tissue in the axial direction252, ~28% of intact native 
TMJ disc middle zone tissue in the mediolateral direction80, and ~18% of intact native meniscal 
tissue in the radial direction253. Thus, results indicate this combination treatment significantly 
improves the integration robustness of engineered fibrocartilage implants to values on par with 
those of intact native tissue.  
 In summary, this study addresses the current insufficiencies of fibrocartilage implants, 
namely their subpar biomechanical integrity and, more importantly, their inability to integrate 
with native tissue upon implantation. Specifically, this study shows that a novel LOX+C-
ABC+TGF-β1 pre-treatment synergistically enhances the biomechanical functionality and 
primes the integration of highly cellularized, metabolically active, self-assembled fibrocartilage 
implants. By addressing two of the most difficult factors that currently inhibit integration, the 
tensile properties of the integration interface achieved in vivo were on par with values of intact 
native fibrocartilage. Methods developed in this study are translatable toward addressing 
defects in a wide variety of fibrocartilaginous tissues. Future work will be focused on adapting 
these methods toward further promoting the functional properties and integration potential of 
neofibrocartilage in site-specific, large animal fibrocartilage defect models.  	  
MATERIALS AND METHODS 	  
Neofibrocartilage culture & integration 
Juvenile bovine AC and MC were isolated and self-assembled at a 50:50 ratio, as previously 
described272. For Phase 1, constructs were grown and analyzed at t = 6 and 12 wk. For Phases 2 
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and 3, integration was investigated by press-fitting 3 mm diameter punches of 6-wk-old 
neofibrocartilage into donut-shaped, 6 mm outer x 3 mm inner diameter native fibrocartilage  
explants (porcine-derived mandibular disc fibrocartilage), which were cultured for an additional 
6 wk either in vitro or in vivo (Fig. 3). Native-to-native assemblies were likewise created for 
Phase 2. For both the in vitro and in vivo integration phases, the integration interface was 
analyzed at t = 12 wk. To ensure the constructs remained in place, 1 µl of biodegradable 
cyanoacrylate was applied to the interface at one specific location of both engineered-to-native 
and native-to-native assemblies, penetrating ~ 2.5% of the thickness of the tissue. Although 
histology verified the glue to fully degrade prior to testing, all analysis was conducted opposite 
where the cyanoacrylate glue was administered to ensure any enhancements observed in 
integration were not related to the affects of the tissue glue.  
 
Treatments 
This study employed a novel combination of treatments, including LOX, C-ABC, and TGF-β1. 
For Phase 1, LOX was applied continuously at 0.15 ng/ml from t = 7 – 21 d6, C-ABC was 
applied at 2 U/ml for 4 hrs at t = 7 d and t = 21 d272, while TGF-β1 was applied at 10 ng/ml for 
the entire culture duration4. The same four treatments were used in Phase 2; the only difference 
being that LOX was applied two times, from t = 7 – 21 d and again from t = 35 – 49 d. In Phase 
3, the three treatment levels were: control, single LOX (from t = 7 – 21 d) + C-ABC+TGF-β1, 
and double LOX (from t = 7 – 21 d and t = 35 – 42 d) + C-ABC+TGF-β1. All treatments in 
Phase 3 were administered prior to engineered-to-native assembly formation and in vivo 
implantation.  
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Histology 
Segments of constructs from Phase 1, as well as of the integration interface from assemblies of 
Phases 2 and 3, were cyroembedded and sectioned at 14 µm. Following formalin fixation, slides 
were stained with either Picrosirius Red for total collagen or Safranin-O/Fast Green for GAG, 
as previously described272.  
 
Biochemistry & HPLC 
Construct segments were weighed before and after lyophilization, and then digested in papain as 
previously described99. Total collagen content was measured via a chloramine-T hydroxyproline 
assay using a SIRCOL standard (Accurate Chemical and Scientific Corp., Westbury, NY). GAG 
content was measured using a dimethylmethylene blue dye-binding assay kit (Biocolor, 
Newtownabbey, Northern Ireland). Pyridinoline (PYR) collagen crosslink content was analyzed 
via HPLC using PYR standards (Quidel, San Diego, CA), as previously described322, 323. 
 
Mechanical testing 
An Instron uniaxial testing machine (Model 5565, Canton, MA) was used to measure 
unconfined, stress-relaxation data of the neotissue from Phase 1, which were fit to a Kelvin 
solid model to obtain the neotissue’s viscoelastic properties at both t = 6 and 12 wk. 
Specifically, both Er and the Ei were calculated, as previously described272. For tensile testing, 
dog-bone-shaped samples from Phase 1, and 1 mm wide strips containing the integration 
interfaces from Phases 2 and 3, were cut, glued to a paper frame at either extremity, and loaded 
into the grips of a uniaxial testing machine (Test Resources, Shakopee, MN). A pull-to-failure 
test was then conducted, from which the EY and UTS were obtained, as previously described272. 
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SEM 
Following ethanol dehydration, Phase 1 neotissue samples were critically point dried and gold 
sputter coated. A Philips XL30 TMP SEM was used to image three separate locations on each 
sample. ImageJ was used to quantify the collagen fibril density and diameter of each image, as 
previously described231. 
 
In vivo implantation 
Nine male athymic mice, 6–8 weeks in age, were obtained in accordance with the Animal Use 
and Care Administrative Advisory Committee, University of California, Davis. Mice were 
anesthetized under general anesthesia, after which a 3 mm incision was made, and two 
subcutaneous pouches were created on either side of the incision, one on each side of the thorax. 
Each pouch received one engineered-to-native assembly, such that no mouse received two 
assemblies from the same treatment group (control, single LOX+C-ABC+TGF-β1, or double 
LOX+C-ABC+TGF-β1). The incision was then closed using staples; 6 wk post-surgery, the 
mice were humanely sacrificed, and the tissue harvested and analyzed.   
 
Statistics 
For Phase 1, a one-way ANOVA (n = 6 per group) was used to test the hypothesis that a 
LOX+C-ABC+TGF-β1 treatment regimen would enhance the in vitro maturation and tensile 
properties of the neofibrocartilage. Separately, to test the hypothesis that treatments and culture 
durations were both significant factors in promoting neotissue enhancement, a two-way 
ANOVA (n = 6 per group) was also used to analyze the data from Phase 1. Data that had a 
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positive interaction on an additive scale and resulted in a combined group that was greater than 
the addition of the two singular treatments were determined to be synergistic. For Phases 2 and 
3, one-way ANOVAs (n = 6 per group) were used to determine the effect of the novel treatment 
regimen on enhancing the tensile properties of the integration interface. Upon finding 
significance (p < 0.05), a Tukey’s HSD post hoc test was applied for all Phases. To compare 
between Phase 2 and Phase 3 results, two-way ANOVA and Student’s t-test analyses were used. 
Data from all phases are represented as mean ± standard deviation. 	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TABLES AND FIGURES 	  	  
TABLE 9.1 – PHASE 1 NEOTISSUE GROSS MORPHOLOGICAL AND COMPRESSIVE PROPERTIES 
AT T = 6 AND 12 WK. Values are provided for t = 6 wk (top) and t = 12 wk (bottom). Values marked 
with different letters within each category are significantly different (p < 0.05), n = 6 per group, with 
A > B > C.  
	    
6 wk 
constructs 
Wet 
weight 
(mg) 
Hydration  
(%) 
Diameter 
(mm) 
Thickness 
(mm) 
GAG/WW 
(%) 
Er 
(kPa) 
Ei 
(kPa) 
Control 13.54 ± 0.39A 
87.48 ± 
1.32A 
5.49 ± 
0.04A 
0.61 ± 
0.06A 
5.97 ± 
0.41A 
42.59 ± 
2.49B 
228.66 ± 
59.92B 
LOX 12.75 ± 0.36A 
86.18 ± 
1.25A 
5.53 ± 
0.10A 
0.48 ± 
0.07B 
6.89 ± 
0.81A 
75.74 ± 
47.98A 
652.17 ± 
218.19A 
C-ABC + 
TGF-β1 
6.75 ± 
0.17B 
81.95 ± 
2.75B 
4.55 ± 
0.07B 
0.42 ± 
0.05C 
2.94 ± 
0.42B 
14.18 ± 
2.90C 
240.67 ± 
67.42B 
LOX +  
C-ABC   
+ TGF-β1 
6.51 ± 
0.23B 
80.45 ± 
3.88B 
4.55 ± 
0.03B 
0.42 ± 
0.03C 
1.83 ± 
0.48C 
14.26 ± 
5.11C 
230.01 ± 
87.84B 
12 wk 
constructs 
Wet 
weight 
(mg) 
Hydration  
(%) Diameter (mm) Thickness (mm) GAG/WW (%) 
Er 
(kPa) 
Ei 
(kPa) 
Control 22.76 ± 
1.99
A 
84.19 ± 
1.54
A 
6.22 ± 
0.09
A 
0.70 ± 
0.14
B 
11.00 ± 
1.28
A 
220.24 ± 
51.01
A 
443.62 ± 
231.04
AB 
LOX 21.08 ± 
1.24
A 
83.29 ± 
2.20
A 
5.89 ± 
0.08
A 
0.74 ± 
0.03
A 
10.30 ± 
1.08
A 
268.21 ± 
117.19
A 
823.72 ± 
178.73
A 
C-ABC + 
TGF-β1 
7.68 ±  
1.73
B 
81.73 ± 
1.06
B 
4.51 ± 
0.14
B 
0.49 ± 
0.05
C 
2.59 ± 
1.21
B 
19.92 ± 
9.54
B 
277.66 ± 
115.61
B 
LOX +  
C-ABC   
+ TGF-β1 
6.32 ±  
0.15
B 
80.16 ± 
0.70
B 
4.58 ± 
0.01
B 
0.48 ± 
0.03
C 
0.65 ± 
0.56
C 
7.23 ± 
8.88
B 
120.77 ± 
38.51
C 
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FIGURE 9.1 – PHASE 1 NEOTISSUE GROSS MORPHOLOGY, HISTOLOGY, AND SEM AT T = 6 
AND 12 WK.	   (A and B) Gross morphology (markings on ruler = 1 mm), Picrosirius Red for 
collagen and Safranin O/Fast Green for sulfated glycosaminoglycans (GAG) stained sections 
(scale bar = 100 µm), and representative scanning electron microscopy (SEM) images (scale bar 
= 1 µm) of untreated, LOX, C-ABC+TGF-β1, and LOX+C-ABC+TGF-β1 neofibrocartilage at t 
= 6 wk (A) and t = 12 wk (B). Collagen fibril density (C) and diameter (D) quantified from SEM 
images, bars not connected by the same letter are significantly different (p < 0.05), lower case 
letters denote significant differences for 6 wk constructs, upper case letters denote significant 
differences for 12 wk constructs, n = 6 per group, mean ± SD.	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FIGURE 9.2 – PHASE 1 NEOTISSUE FUNCTIONAL PROPERTIES AT T = 6 AND 12 WK.	   Collagen 
content per construct wet weight (A), pyridinoline content per construct wet weight (B), 
Young’s modulus (C), and ultimate tensile strength (D) of untreated, LOX, C-ABC+TGF-β1, 
and LOX+C-ABC+TGF-β1 neofibrocartilage at t = 6 and 12 wk. Bars not connected by the 
same letter are significantly different (p < 0.05), lower case letters denote significant differences 
for 6 wk constructs, upper case letters denote significant differences for 12 wk constructs, n = 6 
per group, mean ± SD. 	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FIGURE 9.3 – PHASE 2 AND 3 EXPERIMENTAL DESIGNS.	   A fibrocartilage defect model was 
formed by press fitting 3 mm punches of 6-wk-old neofibrocartilage into same-size native 
fibrocartilage defects and grown either in vitro or in vivo for an additional 6 wk (A). Control 
(none), LOX, C-ABC+TGF-β1, or LOX+C-ABC+TGF-β1 pre-treatments were applied to 
neofibrocartilage prior to integration assembly formation and in vitro culture in Phase 2 (B). 
Control (none), single LOX+C-ABC+TGF-β1, or double LOX+C-ABC+TGF-β1 pre-treatments 
were applied to neofibrocartilage prior to integration assembly formation and in vivo culture in 
the backs of athymic mice in Phase 3 (C).  
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FIGURE 9.4 – PHASE 2 IN VITRO INTEGRATION INTERFACE HISTOLOGY AND TENSILE 
PROPERTIES.	  Picrosirius Red (for collagen) stained integration interface sections for control and 
LOX+C-ABC+TGF-β1 pre-treated engineered-to-native assemblies (A) (scale bar = 100 µm). 
Interface Young’s modulus (B) and ultimate tensile strength (C) of control, LOX, C-
ABC+TGF-β1, and LOX+C-ABC+TGF-β1 pre-treated engineered-to-native assemblies. 
Picrosirius Red (for collagen) stained integration interface sections for control and LOX-treated 
native-to-native assemblies (D) (scale bar = 100 µm). Interface Young’s modulus (E) and 
ultimate tensile strength (F) of control and LOX treated native-to-native assemblies. Bars not 
connected by the same letter are significantly different (p < 0.05), n = 6 per group, mean ± SD.  
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FIGURE 9.5 – PHASE 3 IN VIVO INTEGRATION INTERFACE HISTOLOGY AND TENSILE 
PROPERTIES; COMPARISON WITH PHASE 2 IN VITRO RESULTS.	   Picrosirius Red (for collagen) 
stained integration interface sections (A) (scale bar = 100 µm), interface Young’s modulus (B), 
and ultimate tensile strength (C) of control, single LOX+C-ABC+TGF-β1, and double LOX+C-
ABC+TGF-β1 pre-treated engineered-to-native assemblies. Bars not connected by the same 
letter are significantly different (p < 0.05), n = 6 per group, mean ± SD. Comparison between 
Phase 2 (in vitro) and Phase 3 (in vivo) results for interface Young’s modulus (D) and ultimate 
tensile strength (E). Asterix represents significance between in vitro and in vivo results, and 
Greek letters represent significance between control and LOX+C-ABC+TGF-β1 treatment 
following 2-way ANOVA analysis, n = 6 per group, mean ± SD.  
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FIGURE 9.6 – NEOFIBROCARTILAGE MATRIX MATURATION, ORGANIZATION, AND 
CROSSLINKING FOLLOWING LOX+C-ABC+TGF-β1 PRE-TREATMENT.	   Following self-
assembly of neofibrocartilage (A), neotissue is grown in the presence of TGF-β1 starting at t = 0 
days (B), promoting matrix synthesis. The first C-ABC treatment at t = 7 days (C) temporarily 
depletes glycosaminoglycan (GAG) content and compacts the matrix. LOX is added from t = 8 
to 20 days (D), resulting in pyridinoline (PYR) crosslink formation, while GAG partially 
recovers. The second C-ABC treatment at t = 21 days (E) removes any recovered GAG, 
furthering compacting the matrix. Increased in vitro culture duration of the neotissue to t = 72 
days results in matrix maturation and bundling of fibrils into fibers (F). Together, these 
treatments, in addition to a second LOX treatment (Phases 2 and 3), prime the neofibrocartilage 
matrix for enhanced integration potential with native tissue by t = 42 days.  
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CHAPTER 10 – TOPOGRAPHICAL VARIATIONS IN BIOMECHANICAL 
AND BIOCHEMICAL PROPERTIES IN THE ANKLE JOINT: DISPARITIES 
THAT EXPLAIN THE PATHOGENESIS OF CHONDRAL LESIONS 
 
ABSTRACT 	  
Introduction: The incidence of chondral lesions in the talar dome is remarkably higher 
compared to other locations of the ankle joint. The purpose of this study was to identify 
differences in the biomechanical and biochemical properties among the articulating surfaces of 
the ankle joint, in both native tissue and engineered neotissue, generated using chondrocytes 
from these locations. 
Methods: The biomechanical and biochemical properties of the different topographies within 
the ankle joint (tibial plafond, talar dome, and distal fibula) were evaluated in native tissue 
explants. Femoral condyle tissue was used as control. Chondrocytes from the same locations 
were used to form neocartilage constructs via tissue engineering. The functional properties of 
the neocartilage constructs were analyzed in comparison to native tissue values. 
Results: Articular cartilage harvested from tibial plafond, distal fibula, talar dome, and femoral 
condyles exhibited Young’s modulus values of 4.8, 3.8, 1.7, and 4.0 MPa, respectively. In 
addition, the compressive properties of the corresponding tissues were measured to be 370, 242, 
255, and 274 kPa, respectively. Tibial plafond exhibited 3-fold higher tensile properties and 2-
fold higher compressive properties compared to its articulating talar dome; the same disparity 
was observed in engineered neocartilage. Similar trends were detected in biochemical data for  
 
 
 
 
Chapter submitted as: Makris, E.A., Paschos, N.K., & Athanasiou, K.A. Topographical 
variations in biomechanical and biochemical properties in the ankle joint: Disparities that 
explain the pathogenesis of chondral lesions. 2013  
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both native and engineered tissues. 
Conclusions: Cartilage properties of the various topographic locations within the ankle joint are 
significantly different. In particular, the opposing articulating surfaces of the ankle joint have 
significantly different biomechanical and biochemical properties. The incompatibility observed 
between tibial plafond and talar dome cartilage and cells could explain the increased occurrence 
of chondral lesions in the talus. 
Clinical Relevance: Therapeutic modalities need to consider the exact topographic source of 
the cells or cartilage grafts used. Further, the formation of neocartilage constructs represents a 
promising tool for the treatment of these lesions.	  	  
	  
INTRODUCTION 	  
The ankle joint represents an increasingly common site for various chondral and osteochondral 
disorders. The incidence of chondral lesions located in the talus is believed to be significantly 
higher than typically reported, with the majority of such lesions occurring in young and active 
individuals as a result of ankle injury or fracture 1-4. These lesions are severely debilitating as a 
result of both cartilage and bone degeneration and, eventually, lead to the development of 
osteoarthritis. Interestingly, most of the articular cartilage lesions reported in the ankle joint 
involve the talus and, more specifically, the talar dome. In contrast, the tibial plafond represents 
an uncommon site of chondral lesions, with a ratio of 1 to 14-20 lesions of the talus 5,6. The 
difference in chondral lesions between these two opposing cartilage surfaces in the ankle is 
surprising, especially when considering examples from the knee and hip joint, where cartilage 
lesions occur in a more comparable rate among the different articulating surfaces of the joint 7,8. 
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The prevalence of cartilage lesions and degenerative changes is dramatically lower in 
the ankle joint in comparison to the knee 9,10. Little is known regarding the pathogenic 
mechanisms responsible for this difference. A few reports describe the anatomical and 
biomechanical differences among the cartilage comprising different joints, which could be 
responsible for the disparity in the prevalence of osteoarthritis 11,12 Significant topographical 
variations in the cartilage material properties have been described that may be related to the 
increased risk of degeneration 13. In addition, variations in the biochemical properties of the 
extracellular matrix (ECM) and the metabolic activity of the chondrocytes between the ankle 
and the knee joint have been reported 14,15. This suggests that biomechanical and biological 
factors may be involved in the pathogenesis of chondral lesions. However, a comparison of the 
biomechanical and biological characteristics of cartilage in the opposing articulating surfaces of 
the ankle joint, in relation to the knee, has yet to be performed. 
Several treatment modalities have been used for the management of chondral lesions at 
the ankle joint. Unfortunately, treatment, especially in young patients, is particularly 
challenging; unsatisfactory outcomes are commonly reported, on account of the inability to 
repair the articular cartilage damage and restore normal joint function 2,16,17. Tissue engineering 
opens a new field in the management of ankle lesions by developing tissues that can replace the 
damaged cartilage 18,19. A technique for the development of engineered scaffold-free 
neocartilage has been described 20. The self-assembling approach for neocartilage development 
is considered a representative model of native tissue morphogenesis, maturation, and 
maintenance 21. Furthermore, such neotissues recapitulate the morphological structure and 
organization of native tissues and, thus, present as a model that imitates the fundamental in vivo 
biological processes 20,22. Self-assembly has been successful in engineering neocartilage tissue 
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that exhibits biomechanical and functional properties that approach those of native tissue, 
representing a promising future treatment approach 22. As such, self-assembled neotissues are 
considered a suitable model for studying chondrocyte behavior during cartilage development, 
maturation, and, importantly, during tissue regeneration. 
The aim of the present study was twofold: 1) to identify potential differences in the 
biomechanical properties among the different articulating surfaces of the ankle joint and 2) if 
topographical differences are identified, to investigate the biological differences between cells 
from the opposing surfaces using self-assembled neocartilage tissue generated using 
chondrocytes from different topographical locations of the ankle joint. Explants and tissue 
engineered constructs from femoral condyles were used as a control. Our hypothesis was that 
native articular cartilage from different locations in the ankle joint and engineered neotissue 
formed using cells corresponding to these different locations would exhibit dissimilar 
biomechanical and biological properties, that would correlate with the respective incidence of 
chondral lesions reported at these locations. 
 
MATERIALS AND METHODS 	  
Chondrocyte isolation and construct formation 
Articular cartilage explants were harvested from different topographical locations of bovine 
knee and ankle joints using 5mm punches and assayed to investigate the native, location-
dependent biomechanical and biochemical properties (Figure 1). For construct formation, 
chondrocytes were isolated as previously described 23. Briefly, tissue from the tibial plafond, 
distal fibula and talar dome (femoral condyle was used as a control) was minced into 1 mm 
pieces, followed by digestion in 0.2% collagenase type II (Worthington, Lakewood, NJ, USA) 
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for 18 h as previously described 20,23. The digestion took place in cell culture medium made of 
Dulbecco's modified Eagle's medium (DMEM) (Life Technologies corp., Carlsbad, CA, USA) 
containing low glucose (1 g/L), 10% fetal bovine serum (FBS) (Atlanta Biologicals), 1% non-
essential amino acids (NEAA) (Life Technologies corp., Carlsbad, CA, USA), 25 mg of l-
ascorbic acid (Sigma–Aldrich, St. Louis, MO, USA), and 1% penicillin/streptomycin/fungizone 
(PSF) (BioWhittaker Inc., Walkersville, MD, USA). After the tissue had fully digested, the 
articular chondrocytes were washed three times in DMEM, including centrifugation and 
filtration through a 70-µm filter. Cells were then counted, and 4.5 million cells from each 
location were seeded into 2% agarose wells to form neotissue constructs (n=7 per group) 20. 
Constructs were fed 500 µl chondrogenic medium, consisting of DMEM, 1% PSF, 1% NEAA, 
100 nM dexamethasone (Sigma-Aldrich, St. Louis, MO, USA), 1% ITS+ (BD Scientific, 
Franklin Lakes, NJ, USA), 40 µg/ml L-proline, 50 µg/ml ascorbate-2-phosphate, and 100 µg/ml 
sodium pyruvate (Fisher Scientific, Pittsburgh, PA, USA) daily until t = 10 d. At this time point, 
the constructs were unconfined from the agarose and transferred to 48 well plates, where they 
were fed 1 ml chondrogenic medium every other day until the end of culture at week 4. 
 
Histology 
Histologic evaluation of the tissue was performed as previously described 24. Samples were 
cryoembedded and sectioned at 14 µm. Histology samples were fixed in formalin and then 
stained with Safranin-O/fast green and Picrosirius Red for glycosaminoglycan (GAG) and 
collagen staining, respectively. 
 
Quantitative biochemistry 
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Samples were frozen at −20°C for 24 h and then lyophilized to determine their dry weights. 
Subsequently, a pepsin digestion protocol was used to digest each sample 24. A Blyscan 
Glycosaminoglycan DMMB Assay kit (Accurate Chemical and Scientific Corp.) was used to 
quantify sulfated GAG content. Collagen abundance was determined using a chloramine-T 
hydroxyproline assay using a SIRCOL collagen standard. 
 
High Performance Liquid Chromatography (HPLC) 
Both native and engineered neotissue samples were digested in 800 µl of 6 N HCL at 100°C for 
18 h, after which they were dried in a vacuum concentrator. Next, samples were suspended in 
50 µl of 10 µM pyridoxine and 2.4 mM homoarginine, and then diluted 5x in 0.5% 
heptafluorobutyric acid in 10% acetonitrile. For HPLC, 10 µl of each sample was used as 
previously described (CITE), using PYR standards (Quidel, San Diego, CA, USA) to quantify 
the cross-link content. 
 
Biomechanical testing 
Samples were tested for tensile and compressive properties. For tensile testing, a uniaxial 
material testing system (Instron Model 5565) was used to apply uniaxial tension to dog-bone 
shaped samples created using a dermal punch 24. Samples were glued into paper frames and 
loaded into the machine grips. The gauge length was measured as the distance between the 
glued ends of the dog-boned samples. Upon loading, a pull-to-failure test was run at a 1% gauge 
length per second until failure. The slope of the linear portion of each stress-strain curve was 
reported as the Young’s modulus (EY), while the peak of the curve was recorded as the ultimate 
tensile strength (UTS). For compressive testing, a creep indentation apparatus was used 25. 
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Samples were tested as previously described 24 using a semi-analytical, semi-numeric, biphasic 
model 26 and finite element optimization 13 to yield each sample’s aggregate modulus, 
permeability, and Poisson’s Ratio. In addition, a correlation between engineered neotissue 
properties with potential pathogenic mechanisms involved in osteochondral lesion formation 
was performed. 
 
Statistical analysis 
All quantitative assessments in this study were performed using n=7. To compare among 
different groups one-way analysis of variance (ANOVA) was performed using JMP9 software 
(SAS institute, Cary, North Carolina, USA). If significance was identified (p < 0.05), a Tukey’s 
HSD post hoc test was applied. For positive correlations in regression analysis, a strong 
correlation was considered present when 1>R2>0.5, and a weak when 0.5>R2>0. In respect, a 
strong negative correlation was set at -1<R2<-0.5, and a weak negative correlation at 0>R2>-0.5. 
 
RESULTS 	  
Gross Morphology and Histology 
No significant differences were observed in the macroscopic appearance between cartilage 
explants taken from different topographical locations. At the end of a 4-week culture period, 
chondrocytes from all topographical locations formed disc-shaped constructs, having flat 
surfaces and no macroscopic deformities. In terms of the growth metrics of neocartilage (Table 
1), neotissue from the talar dome had approximately 50% increased thickness compared to all 
other groups. The increased water content and wet weight reflect this difference. Neocartilage 
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formed from cells of the tibial plafond, on the other hand, presented with significantly increased 
diameter. Histological evaluation of the neotissue was consistent among all groups (Figure 2). 
Biochemical analysis 
Collagen GAG, and pyridinoline content of native cartilage from different topographical 
locations of the ankle joint were evaluated. In terms of collagen content of native tissue, the 
tibial plafond cartilage exhibited 3-fold increase in collagen content normalized to tissue wet 
weight (Col/WW), in comparison to the talus cartilage, that exhibited the lowest amount of 
collagen; no significant differences were observed between distal femur and fibula cartilage. 
Regarding the GAG content of the tissues, tibial plafond cartilage presented with the highest 
amount of GAG per wet weight (CAG/WW), while no significant differences were observed 
among the other groups (Figure 3). In regards to amount of pyridinoline crosslinks per wet 
weight (PYR/WW) and per collagen, no significant differences were detected among groups. 
Similar trends were observed in the neocartilage constructs formed using cells from the 
corresponding locations. Specifically, tibial plafond neocartilage presented with the highest 
amount of collagen per wet weight (Col/WW) among all groups, while the talus constructs 
presented the lowest Col/WW ratio. No significant differences were detected between the femur 
and fibula constructs’ collagen content. In terms of the GAG content of the neotissue, tibial 
plafond constructs synthesized the highest GAG/WW, approximately 50% increase, compared 
to the other groups, where no significant differences were observed among them. Evaluation of 
the pyridinoline content of neotissues revealed tibial plafond neocartilage to exhibit the highest 
amount of pyridinoline per WW among all groups. However, no significant differences were 
observed among groups with regards to pyridinoline content per collagen. Finally a positive 
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correlation was detected between pyridinoline content and tensile modulus of neotissues (Figure 
4). 
 
Biomechanical analysis 
Biomechanical evaluation of the native articular cartilage compared the functional properties of 
the tissue harvested from different topographical locations of the ankle joint and the distal 
femur. Tensile testing revealed the tibial plafond cartilage to exhibit the highest EY and UTS 
over the other regions, while talus cartilage presented with the lowest properties. Specifically, 
tensile strength was 3.2 MPa, 2.4 MPa, 1.0 MPa and 2.3 MPa for the tibial plafond, distal 
fibula, talar dome and femoral condyles respectively. No significant differences were observed 
between distal femur and distal fibula cartilage tensile properties. In terms of the compressive 
properties, tibial plafond cartilage presented with a significantly higher aggregate modulus and 
permeability, comparatively; no significant differences were observed among the other groups 
(Figure 3). 
Similar trends were observed when evaluating the biomechanical properties of neotissue 
formed using cells from different topographical locations of the ankle joint and distal femur. 
Tibial plafond neotissue presented with significantly higher compressive moduli compared to 
all groups; no significant differences were observed among the other groups. In terms of the 
tensile properties, tibial neocartilage yielded the highest EY and UTS, while no significant 
differences were observed among other groups (Figure 4). Specifically, tibial plafond constructs 
exhibited 300% more tensile strength and 170% more compressive moduli compared to the talar 
dome. 
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DISCUSSION 	  
The present study demonstrates that the biomechanical and biochemical properties of different 
topographic locations within the ankle joint exhibit significant variations. Specifically, tibial 
plafond articular cartilage exhibited significantly higher tensile properties in comparison to all 
other articular surfaces of the ankle joint. More importantly, the opposing articulating surfaces 
were found to have significantly different biomechanical and biochemical properties, 
predisposing the talar dome cartilage to degenerative pathologies. Talar dome cartilage showed 
3-times lower tensile modulus and strength compared to tibial plafond cartilage. The 
compressive properties were also higher in native tibial plafond compared to all other 
topographic areas. The disparity of both tensile and compressive properties of opposing 
cartilage surfaces, which could potentially lead to degenerative changes of the biomechanically 
inferior articular surface, explains the increased occurrence of chondral lesions in the talus. 
In addition to the mismatches detected in native cartilage, the findings of this study 
highlight the dissimilar biological behavior of cells isolated from different topographic regions 
within the ankle joint, as evaluated biomechanically, biochemically and histologically. To 
assess cellular response, the self-assembling process was used, as it has been shown to 
recapitulate the fundamental in vivo biological processes of articular cartilage generation and 
development. The biomechanical properties of the neocartilage followed the same pattern with 
native tissue. For instance, constructs made of chondrocytes from tibial plafond demonstrated 4-
times higher tensile properties compared to constructs engineered from talar dome 
chondrocytes. The compressive properties of the tibial plafond neotissue were 2-times higher 
than those formed from talar dome cells. A strong positive correlation was detected between the 
biomechanical properties and biochemical profile of the neocartilage. The amount of collagen 
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and GAG produced from tibial plafond cells was remarkably higher compared to other 
locations. The use of the self-assembling process towards neocartilage generation confirmed 
that the cells of the different topographies within the ankle joint exhibit differences in their 
synthetic and metabolic activity. Results of the present study imply that the biological response 
to injury or other pathology of the different topographic areas may likewise vary. Ankle 
chondrocytes of the talar dome may exhibit a significantly lower potential to respond to injury 
and lower healing capacity in comparison to chondrocytes of the opposing tibial plafond. 
Different biological behavior at the cellular level might be an additional pathogenic mechanism 
that explains the increased incidence of chondral lesions to the talar dome compared to the tibial 
plafond. 
Ankle and knee are remarkably different joints, in terms of their anatomic features, 
prevalence of chondral lesions, and chondrocyte characteristics, with the ankle joint exhibiting 
significantly lower susceptibility to osteoarthritis 9. Factors that could potentially explain the 
dramatically different prevalence of degenerative changes between the two joints are the 
different biomechanical properties of articular cartilage between these joints 11,13, differences in 
collagen and GAG content of the tissues 14, variances in the thickness of the four zones of 
cartilage, 10 and different metabolic activity 15 of articular chondrocytes. Further, differences 
between ankle and knee chondrocytes in their response to catabolic stimuli have been 
previously identified and described 10. Findings of this study are in accordance with previous 
reports, confirming the disparity in biomechanical properties and biochemical content between 
knee and ankle articular cartilage. In addition, the biological response of the knee and ankle 
chondrocytes was different. The present findings are inadequate to explain the difference in the 
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prevalence in osteoarthritis between the knee and the ankle joints. However, these results help 
to shed more light in the potential mechanisms being responsible for this difference. 
The use of autologous chondrocytes and cartilaginous grafts is continuously increasing 
for the treatment of chondral lesions in the ankle joint. For instance, autologous chondrocyte 
implantation for the treatment of lesions located on the talus is gaining interest 27,28. 
Traditionally, the cells were isolated from the ipsilateral knee joint. Some studies suggested the 
use of talus chondrocytes 29,30, based on the lower incidence of osteoarthritis in the ankle joint. 
Similarly, talar allografts have been used for large osteochondral defects of the talus 31,32. Even 
though, the efficiency of these procedures still needs to be evaluated with large randomized 
controlled trials, a potential limitation for the use of ankle chondrocytes was the potential loss of 
these favorable properties when expanded in monolayer culture 33. Also, there is no consensus 
in the literature regarding the proteoglycan and collagen synthesis characteristics between ankle 
and knee chondrocytes 12,14,15,33. Based on the finding of this study, chondrocytes from the tibial 
plafond produced higher amounts of collagen and GAG and also had a superior capacity for 
generating new tissue, compared to those isolated from the femur. In contrast, chondrocytes 
isolated from the talar dome appeared to have worse biomechanical properties and biological 
profile compared to femur chondrocytes. The tensile and compressive properties of the native 
femoral cartilage were inferior only to those of the tibial plafond, with the talus exhibiting 
significantly lower biomechanical properties. As a consequence, the idea of using ankle 
chondrocytes or allografts for these repairs could be beneficial only when tibial plafond 
chondrocytes or grafts are used. Further research is required in order to identify the 
characteristics of chondrocytes and cartilage tissue in different topographic locations, 
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suggesting that current therapeutic modalities need to consider the exact topographic source of 
the cells or cartilage grafts used. 
An interesting finding of this study is the comparatively large differences in tensile 
properties between the talar dome and tibial plafond, in contrast to the much smaller in terms of 
their compressive properties.  Specifically, tibial plafond cartilage demonstrates a 3-fold 
difference in tensile moduli and strength in comparison to the talar dome in native and 
engineered tissue. In contrast, talar dome exhibits only 50-60% less compressive modulus in 
native and engineered tissue. Currently, degeneration of cartilage is correlated with repetitive 
compressive forces. However, various reports indicate that cartilage is more prone to injuries 
during shear loading of the joint 34. Excessive shear strain causes abundant collagen fibril strain 
that has been shown to correspond accurately with areas of collagen destruction leading to 
cartilage damage 35. The present study demonstrated an important disparity between tibial 
plafond and talus to withstand tensile forces, indicating the presence of a complex pathogenic 
mechanism responsible for cartilage degeneration. Future research should focus on evaluating 
the role of tensile loading in the development of chondral lesions and degenerative 
osteoarthritis. 
To the best of our knowledge, this is the first study to use chondrocytes from the tibial 
plafond and other ankle locations to engineer articular cartilage without the use of scaffolds. 
Tissue engineering represents a promising technique for developing neocartilage that could be 
used in the treatment of chondral and osteochondral lesions. Different mechanical and 
biochemical stimuli can be combined to enhance the functional properties of the engineered 
tissue on par with native tissue values 23,36-38. In the present study, native tibial plafond 
exhibited significantly better properties in comparison to all other locations of the ankle joint. 
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The measured differences of tibial plafond articular cartilage were also mirrored in the 
biomechanical and biochemical properties of neocartilage constructs generated using tibial 
plafond cells. These results may suggest that cells from a specific topographic source need to be 
tailored for use in particular indications. 
 
LIMITATIONS 	  
One limitation of the present study is the fact that the biomechanical and biochemical properties 
were evaluated in an in vitro model. It remains to be seen whether these in vitro results would 
be reflected into in vivo findings. Similarly, in order to evaluate cellular behavior, no in vivo 
studies were employed as the in vitro model of self-assembling process was used. However, this 
model has been shown as representative of the processes of tissue development and maturation. 
 
CONCLUSIONS 	  
Cartilage properties of the various topographic locations within the ankle joint are significantly 
different. In particular, the opposing articulating surfaces of the ankle joint have significantly 
different biomechanical and biochemical properties. The incompatibility observed between 
tibial plafond and talar dome cartilage and cells could explain the increased occurrence of 
chondral lesions in the talus. 
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TABLES AND FIGURES 	  	  
TABLE 10.1 – GROWTH METRICS OF THE NEOCARTILAGE AT 4 WEEKS OF CULTURE. 
Jaw Region Col/WW
 
(%) 
GAG/WW 
(%) Tissue Hydration (%) 
Upper Rostral 5.9 ± 0.7A 11.5 ± 3.4A 83.7 ± 2.4C 
Upper Middle 4.0 ± 0.9AB 10.1 ± 0.8A 85.1 ± 1.9BC 
Upper Caudal 4.4 ± 1.3AB 8.7 ± 1.5AB 86.7 ± 1.6B 
Lower Rostral 4.1 ± 1.6AB 7.1 ± 2.1B 87.4 ± 0.6AB 
Lower Middle 2.7± 1.9B 5.9 ± 2.8B 88.9 ± 2.0A 
Lower Caudal 2.9 ± 1.1B 12.4 ± 2.6A 87.7  ± 0.1AB 
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FIGURE 10.1 – TOPOGRAPHIC LOCATIONS OF THE ANKLE JOINT USED FOR ARTICULAR 
CARTILAGE EXPLANT AND CHONDROCYTE HARVESTING.  
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FIGURE 10.2 – GROSS MORPHOLOGY/HISTOLOGY OF NEOCARTILAGE ENGINEERED 
CONSTRUCTS. Picrosirius red staining for collagen and Safranin-O/fast green staining for GAGs. 
Histology scale bar represents 100μm. 	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FIGURE 10.3 – BIOMECHANICAL AND BIOCHEMICAL PROPERTIES OF NATIVE CARTILAGE 
FROM DIFFERENT TOPOGRAPHICAL LOCATIONS OF THE ANKLE JOINT. Femoral condyle 
explants were used as control.	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FIGURE 10.4 – BIOMECHANICAL AND BIOCHEMICAL PROPERTIES OF NEOCARTILAGE 
ENGINEERED USING CHONDROCYTES FROM THE DIFFERENT TOPOGRAPHIC LOCATIONS OF THE 
ANKLE JOINT. Femoral condyle chondrocytes were used as control. 
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FIGURE 10.5 – PYRIDINOLINE CONTENT PER WET WEIGHT AND PER COLLAGEN IN THE 
DIFFERENT TOPOGRAPHIC LOCATIONS WITHIN THE ANKLE JOINT. A positive correlation was 
detected between pyridinoline content and tensile modulus of neocartilage as well as between 
collagen content and tensile modulus. 
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CONCLUSIONS 	  	  	  	  
The cartilages of the knee joint are critical to proper function; thus, patients suffering from 
cartilage degradation are subject to severe pain and restricted mobility, leading to a decreased 
quality of life. As outlined in the Introduction and Chapter 1, current treatment modalities are 
insufficient for repairing damaged articular cartilage and the knee meniscus, necessitate novel 
and effective technologies to help patients suffering from degenerated cartilage. This thesis 
presented a series of studies describing several new and exciting technologies that have the 
potential to generate clinically relevant, tissue engineered replacement tissues that are 
applicable to any collagen-rich tissue of the body. In particular, these studies focused on 
promoting the in vitro development of neotissues that take on the structure-function 
relationships of their native tissue counterparts such that they may be able to both adapt to and 
integrate with the native joint environment upon implantation.  
The first study (Chapter 2) investigated the potential of promoting the pyridinoline 
(PYR) collagen crosslink content in engineered tissues via exogenous application of the 
crosslink precursors hydroxylysine and copper. Furthermore, this study addressed whether 
enhanced PYR collagen crosslinking in engineered musculoskeletal soft tissues would, in turn, 
enhance their mechanical properties. Results of this study found simultaneous application of 
exogenous hydroxylysine and copper sulfate to synergistically increase the amount of PYR 
collagen crosslink content in the self-assembled constructs. Further, this increased PYR 
crosslink content resulted in significantly increased compressive and tensile properties. Thus, 
data from Chapter 6 found exogenous application of collagen crosslink precursors to enhance 
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PYR crosslink formation in engineered constructs, thereby improving their biomechanical 
properties.  
In Chapter 3, hypoxia was used as an alternative means to induce PYR crosslink content 
and, therefore, the biomechanical properties of engineered cartilage. This method was found to 
upregulate the LOX gene expression 20-fold in chondrocytes compared to those cultured under 
normoxia. Further, hypoxia applied at both the 3rd and 4th weeks of neotissue culture 
significantly increased the PYR content without compromising collagen content. Furthermore, 
this regimen correlated with a 2-fold increase in the neocartilage tensile properties. Together, 
results from this study suggest that hypoxia applied within specific time windows can be 
beneficial for enhancing the functional properties of neocartilage toward directly promote 
neotissue maturation.  
 Chapter 4 of this thesis took the results of Chapters 2 and 3 a step further by 
investigating the effects of enhanced PYR crosslink content via hypoxia application on a 
spectrum of collagen-rich native tissues. Results found hypoxia capable of enhancing the PYR 
content of this spectrum of tissues by 1.4 – 6.4-fold that of tissues cultured under normoxic 
conditions, corresponding to a significant increase in the tensile properties of these cultured in 
hypoxic vs. normoxic conditions. Further, this study for the first time established a novel 
treatment as a means to further enhance the PYR content and functional properties of 
engineered cartilage via direct application of exogenous lysyl oxidase (LOX). Specifically, 
LOX was found to increase the PYR content 16-fold that of controls, resulting in neotissue with 
tensile properties 5x greater than control tissue. Thus, this chapter entails the first study to 
report endogenous (hypoxia-mediated) and exogenous (direct LOX-mediated) methods to 
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promote collagen crosslink content and concomitantly improve the tensile properties of a 
spectrum of native and engineered tissues.  
 The next chapter of this thesis (Chapter 5) focused on enhancing neomatrix production 
in engineered articular cartilage via modulation of intracellular Ca2+ signaling. To do so, 
digoxin and adenosine triphosphate (ATP), two agents known to modulate intracellular Ca2+ 
signaling, were investigated. Results found the frequency of Ca2+ oscillations to increase in 
chondrocytes treated with digoxin and ATP. These increase Ca2+ oscillations translated into 
increased collagen content and tensile properties, with the greatest increases observed in 
neotissue treated with both agents simultaneously. Results of this study highlight the potential 
of modulating intracellular Ca2+ signaling as a means to enhance the functionality of engineered 
tissues.  
 Chapter 6 of this thesis focused on a novel treatment regimen consisting of 
chondroitinase-ABC (C-ABC) and transforming growth factor-β1 (TGF-β1) treatment toward 
enhancing matrix synthesis and the mechanical properties of engineered fibrocartilage. Results 
found application of both C-ABC and TGF-β1 to enhance neofibrocartilage collagen content, 
collagen fibril density, and collagen fibril diameter compared to controls. Further, mechanical 
testing revealed this combined bioactive treatment regimen to synergistically increase the 
Young’s modulus and ultimate tensile strength of the neotissue, with values reaching the lower 
spectrum of those measured in native tissues. Thus, Chapter 6 informed upon the use of a 
bioactive agent regimen comprising a dual C-ABC treatment at 1 and 3 weeks and continuous 
TGF-β1 application to develop a more functional collagen matrix capable of withstanding 
greater tensile loading. 
Chapter 7 tailored the use of passive axial compressive loading to drive matrix synthesis 
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and reorganization within shape-specific neotissues. Subjecting biconcave constructs to 1, 5, or 
10g masses early during tissue culture found the 10g mass to significantly increase both 
collagen and GAG synthesis in the neotissue middle zone. Matrix alignment, compaction, and 
enhanced PYR collagen crosslinking were also observed in the neotissue’s middle zone at the 
10g loading level. Regional mechanical testing further revealed the matrix synthesis and 
reorganization prompted by the 10g mass to result in significantly enhanced compressive and 
tensile properties in the neotissue’s middle zone. These results are likely attributable to the 
multi-axial tensile and compressive strain gradients achieved in the shape-specific neotissues 
subjected to the 10g mass, which induced physiologically relevant strain levels previously 
shown to elicit a mechanotransductive response by chondrocytes. Thus, Chapter 6 indicated the 
potential of passive axial loading as a simple, yet effective, tool to drive in vitro matrix 
development in shape-specific neotissues toward more closely achieving the structural and 
functional properties of the native fibrocartilage. 
Chapter 8 investigated the potential of LOX to promote integration between native and 
engineered tissues via enhanced collagen crosslink content. Results found the tensile properties 
of the integration interface to be 2 – 2.2-fold greater in assemblies treated with LOX compared 
to those left untreated. Histologically, the assemblies treated with LOX were found to have 
noticeably more uniform integration compared to controls. Thus, this study for the first time 
demonstrated the potential for LOX to be used to induce in vitro integration between native and 
engineered articular cartilage via the upregulation of PYR crosslinks at the native-to-engineered 
interface.   
The promising results of Chapter 8 prompted investigation of a means to enhance the in 
vitro maturation and integration potential of neofibrocartilage via a novel combination of 
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stimuli, including exogenous application of C-ABC, TGF-β1, and LOX in Chapter 9. Combined 
use of these agents was found to drive in vitro neofibrocartilage matrix maturation toward 
significantly increased collagen and PYR content as well as enhanced collagen fibril density 
and diameter. These matrix modifications resulted in synergistically enhanced tensile properties 
approaching native fibrocartilage values. Further, allowing the combination-treated neotissue to 
grow for 12 weeks in vitro, as opposed to 6 weeks, found the longer culture duration to be a 
significant factor toward enhancing neofibrocartilage tensile properties, with values 2-fold 
higher than those achieved in any other study of this thesis. While the in vitro fibrocartilage 
defect model showed this treatment regimen to promote integration between neofibrocartilage 
and native tissue, results of the in vivo fibrocartilage defect model found this pre-treatment to 
significantly increase the integration interface tensile stiffness and strength over values achieved 
in vitro. Further, the values achieved at the integration interface in vivo were found to be similar 
to the tensile properties of intact native fibrocartilage. Thus, results of Chapter 9 demonstrated 
the tremendous potential of a LOX+C-ABC+TGF-β1 pre-treatment to develop biomechanically 
robust neofibrocartilage implants with physiologically significant integration potential.  
 The final chapter of this thesis focused on establishing superior primary cell sources for 
engineered articular cartilage. For this study, chondrocytes from different locations in the ankle 
joint were compared against primary articular chondrocytes of the knee joint. Results found 
articular cartilage harvest from the tibial plafond, distal fibula, talar dome, and femoral condyles 
to have varying biomechanical properties, with the tibial plafond cartilage exhibiting 3-fold 
greater tensile properties and 2-fold greater compressive properties compared to the talar dome; 
similar trends were observed in neocartilage self-assembled from cells of the respective sources. 
Results of this study suggest that the cartilages of the ankle joint have location-specific 
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properties, and suggests that cells from the tibial plafond present as a more promising cell 
source than from any other location of the ankle joint in terms of generating mechanically 
robust replacement tissues. 
Overall, the work presented in this series of studies demonstrate a plethora of novel 
treatment modalities that have the potential to aid in the development of functional neotissues. 
By addressing two of the most critical short comings of current repair tissues (including their 
insufficient mechanical properties and inability to effectively integrate with native tissue upon 
implantation), this thesis speaks to the potential of engineering clinically robust, collagen-rich 
neotissues to repair and/or replace those damaged by injury or disease. Moving forward, studies 
should take place that synthesize the various findings of this thesis to aid in further promoting 
both the maturation and integration potential of engineered articular cartilage and fibrocartilage. 
Further, studies should take place in site-specific animal defect models to better test the ability 
of these treatments to provide clinically-relevant solutions. In line with these efforts, studies 
must be conducted to determine more stringent measures of the biomechanical and biochemical 
properties of engineered tissues, as well as methods to non-invasively measure the functional 
properties of tissues following implantation. Furthermore, improved indications for cartilage 
and fibrocartilage replacement and advanced minimally-invasive surgical techniques will help 
bring such technologies forward. Together, such efforts will provide a great leap forward 
toward the next generation of engineered cartilage and fibrocartilage therapies, finally providing 
patients with robust treatment modalities.  
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